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CHAPTER V 
SERUM CONCENTRATIONS OF GONADOTROPHIC AND 
STEROID HORMONES AND OVARIAN CHANGES 
DURING PREGNANCY AND THE IMMEDIATE 
POSTPARTUM PERIOD IN THE MARE 
! . 
254 
I'NTRODUCT ION 
There appear to be three unique aspects to early pregnancy 
in the mare: (i) continued ovarian activity with the develop-
ment of several large follicles (Aitken, 1927; Allen, 1974) 
(ii) the establishment of secondary corpora lutea (Cole et aZ, 
1931; Squires et aZ, 1974a) and (iii) the production of pregnant 
mare serum gonadotrophin (PMSG) from approximately Day 40 
through Day 150 of gestation (Cole and Hart, 1930; Allen, 1975) 
by the endometrial cups (Cole and Goss, 1943). Since follicular 
development is often most marked when PMSG levels are high 
and since this gonadotrophin has FSH-like properties in other 
species, it has been suggested that PMSG causes this follicular 
growth (Cole et aZ, 1931; Nalbandov, 1964). However, other 
studies have shown that the ovarian activity is not associated 
with serum levels PMSG since marked follicular grwoth occurs 
prior to Day 40 (Bain, 1967; van Nierkerk, 1965; and van Rensburg 
and van Niekerk, 1968); indeed Cole et aZ (1931) observed large follicles 
present in mares up to 40 days pregnant, before PMSG levels 
are elevated. It has been postulated that an additional 
factor is involved in stimulating the ovary during pregnancy 
in the mare, this being a pituitary gonadotrophin (Rowlands, 
1949; van Rensberg and van Niekerk, 1968). Since surges of 
follicular growth are caused by surges in serum concentrations 
of FSH in the cycling mare (see Chapter IV), the present study 
was designed to measure serum FSH levels in mares during early 
pregnancy and relate these levels to changes in ovarian 
activity as determined by palpation per rectum. In an attempt 
to further clarify the relative roles of FSH and PMSG in early 
>.-;".0.",".-'. 
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pregnancy, the time of the first elevation in serum levels of 
PMSG and serum concentrations of progesterone and, occasionally, 
serum oestradiol-17B were also determined. 
One further unique aspect of reproduction in the mare is 
the occurrence of oestrus and;JVu1ation approximately 10 days 
after parturition. Since it was shown that in the cycling mare, 
at least two, though possibly several FSH surges at approximately 
10 day intervals are necessary to prepare and prime a follicle 
before final maturation and ovulation can take place during 
oestrus: it was of particular interest to determine the serum 
FSH concentrations preceding this post-partum ovulation. 
If one assumes that such an ovulation requires similar FSH 
priming to an ovulatory follicle in the normal cycle, then 
surges of FSH must occur prior to parturition at a time when 
sex steroid hormone concentrations are markedly elevated (Holtan 
et aZ, 1975; Nett et aZ, 1975). To investigate whether FSH 
surges do occur prior to parturition in the mare, and to 
further elucidate the role of FSH in the development of an 
ovulatory follicle, the serum concentrations of FSH during 
the two to three weeks prior to parturition and up until the 
time of the post-partum oestrus were determined in this study. 
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MATERIALS AND METHODS 
A. EXPERIMENTAL ANIMALS: 
For the study of the hormonal and ovarian changes during 
early pregnancy in the mare, twelve standardbred mares ....... _,,_., ... 
(400 to 600 kg) were bled by jugular venepuncture and 
* ovarian palpations performed per rectum at 1, 2 and occasion-
ally three day intervals during the first 70 days of pregnancy 
or until ovarian ·act~vity ceased. In addition, one thoroughbred 
mare, Carol Time, was similarly studied. All mares were held 
at a commercial stud, Nevele R, Prebbleton, Canterbury, under 
the same conditions as described in Cahpter IV. The mares 
in the study were non-lactating, and all concieved by natural 
service between October and December of the 1974/75 stud 
season. 
The mares were :-
1. Ar Miss:- A 7 year old primiparous mare, first season 
at stud. 
2. Betty Patch: A 4 year old primiparous mare who did not 
conceive the preceding season. The oestrus and 
ovulation at which conception occurred was induced by 
exogenous ?rostaglandin administration (250 ~g Equimate, ePG) 
generously donated by leI Ltd). The interval between 
the preceding ovulation and PG administration was 13 days, 
with the fertile ovulation occurring 10 days later (inter-
* Palpations performed by Professor C.H.G. Irvine, Veterinary 
Science Department, Lincoln College, and the author 
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ovulatory interval = 23 days) 
3, Carol Time: This 9 year old mare had a history of 
conceiving (as diagnosed by palpation per rectum at 
35-45 days) while at stud in Australia and England, 
but failing to maintain pregnancy and never produced 
a foal. Ovarian palpation indicated that a dioestrous 
ovulation occurred eight days prior to the ovulation 
resulting in conception, this mating being the first 
of the season. 
4. Contraband: This 5 year old primiparous mare had been 
acyclic during the late October/November period, and 
induced to ovulate with exogenous gonadotrophin 
releasing hormone (GnRH) as described in Chapter VI, 
and conceived to this induced ovulation. 
5. False: A 4 year old primiparous mare, conceived to one 
service at first oestrus of season. 
6. Gay Fleur: A year old primparous mare, studied from Day 
18 of pregnancy onward. 
7. Golden Road: A 4 year old primiparous mare, studied 
from Day 19 of pregnancy onward. 
8. Miss Balmain: A 3 year old primiparous mare, conceived 
at an ovulation occurring during oestrus induced by 
prostaglandin given six days after the preceding 
ovulation, resulting in an inter-ovulatory interval of 
twe 1 ve days. 
9, Tanunda: An 8 year old mare, who was acyclic during 
late October/November, and was induced to ovulate with 
exogenous GnRH (see Chapter VI) to which she conceived. 
10, Trudys Bye Bye: A 4 year old primiparous mare, who 
conceived at the first ovulation of the season. Studied 
1'-'.'·---
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from Day 21 of pregnancy onward. 
11. Winabell: An 11 year old multiparous mare, who was 
acyclic during late October/November and conceived to 
an ovulation induced by administration of exogenous GnRH 
(see Chapter VI). 
12, Young Anne: An 18 year old multiparous mare who 
conceived to an ovulation occurring spontaneously 
but prior to which exogenous GnRH had been administered 
(see Chapter VI). 
Two mares, Carol Time and Miss Balmain were retained 
at the stud and blood samples collected at intervals of 4 
to 12 days throughout mid-gestation, and ovarian palpations 
performed until the increase in size of the foetus and its 
posi tion in the abdomen made ovarian palpation impossible. 
For the periparturient study, five standardbred mares 
at Nevele R stud (Ar Miss, Frozina, Light'n Free, Module and 
True Lustre were bled every second day, or daily as the 
expected foaling date approached, for up to three weeks prior 
to parturition, and after foaling, daily until the post-partum 
oestrus occurred. The two mares studied throughout gestation 
(Carol Time and Miss Balmain) were also included in this 
group. 
B. HORMONE MF~SUREMENTS: 
Serum concentrations of FSH, progesterone and oestradiol 
-178 were determined as described in Chapter III. Serum 
concentrations of LH and PMSG could not be determined differ-
entially after Day 35 of pregnancy so that the dramatic 
increase in equivalents of ng Hartree equine LH occurring 
at some time between Day 36 and 40 was due to PMSG cross-reacting 
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in the LH assay. These LH/PMSG determinations were made 
using both the Human System and the Niswendep Ovine System 
as described in Chapter III, the system used in each 
individual mare being indicated in Results. 
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RESULTS 
Since there was considerable inconsistency between mares 
in the hormonal and ovarian changes occurring in early 
pregnancy, the data for each mare are presented separately 
in Tables 39 to 50. While assessment of the results was 
subjective, the changes which appear-relevant are summarized 
below for each mare. In these summaries all the hormonal 
and ovarian changes in the first 30 days are described first. then the 
changes over the period during which PMSG usually appears (Days 32-39)1 
followed by changes in the remainder of the period of observations. 
1, Ar Miss: (see Table 39). 
Serum FSH concentrations were elevated following 
conception until Day 10, after which the levels were lower 
until Day 36, except for single day elevations on Days 18 
and 22 of pregnancy. During this period a follicle began 
developing (commencing on Day 14), to reach a size of 3 
Units on Day 23, following which it either ovulated or 
regressed, over the period until Day 30. Serum oestradiol 
-178 concentrations increased from Day 16 to a peak on 
Day 20, remaining at relatively high levels until Day 28. 
A further follicle began developing by Day 32, and appeared 
to ovulate by Day 39. An elevation in PMSG had occurred 
by Day 34. Serum oestradiol.178 concentrations increased 
again on Day 30 and declined slightly until Day 36. These 
high concentrations of oestradiol-178 over this prolonged 
period (Days 16 through 36) occurred when a decrease in 
uterine tone (not normally occurring in early pregnancy) was 
noted. 
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LEGEND FOR TABLES 39 to 50: 
Serum FSH, LH and oestradiol-178, progesterone and PMSG 
concentrations, and ovarian changes during pregnancy where :~ 
Day 0 = day of conception 
FSH expressed as ng/ml Nuti eFSH (see Chapter III) 
LH expressed as ng/ml Hartree eLH (see Chapter III) 
oestradiol~178 expressed as pg/ml 
progesterone expressed as ng/ml 
PMSG expressed as ng/ml Hartree eLH equivalents 
Key to ovarian palpations 
L ,... left ovary 
R = right ovary 
Descriptions include stating the size and tension of the 
ovary, e.g. L: tri~lobed, H = left ovary tri~lobed and hard; 
e.g. L: 2xl = left ovary measures 2xl Units, where I Unit = 
2.5 cm; e,g. L: S + H ~ left ovary is small and hard, 
Stating structures in the ovary, these being either FoIl = 
follicle,or Area = any soft structure not a follicle, often 
a corpus luteum. 
Stating particulars of these structures in terms of diameter 
(0,5 to 6 Units) and tension as an indication of maturity, 
where fh = fiLmish, f = firm, sh ~ softish, s = soft, vs = 
very soft, colI = collapsed (as in ovulation). rubbery = 
rubbery in tension; e.g. L: Foll- 2, sh = left ovary contains 
a softish follicle 2 Units in diameter; e.g. 2xl, H; 2x FoIl - 1, 
fh; 3.5,vs = left ovary is 2xl Units and hard, contains two 
follicles, one being I Unit in diameter and firmish in 
tension, the other being 3.5 Units in diameter and very soft, 
TABLE 39: AR MISS 
Day of FSH Oestradiol-17S 
Pregnancy ng/ml fraction pg/ml 
0 35.0 0.56 
I 
1 39.6 0.63 
4 61.8 0.98 
6 48.7 0.77 
8 46.7 0.74 
10 47.4 0,75 
12 28.5 0.45 
14 29.2 0.46 9.5 
16 19,5 0,31 17.5 
18 39.0 0.62 16.8 
20 11.9 0.19 22.4 
22 33.7 0.54 20.5 
23 27.1 0.43 
I 
16.1 
Progesterone LH or PMSG 
ng/ml ng/ml * 
0,1 
0,99 
3.2 
6.74 
6.67 
9.60 
7.20 
6.24 
5.20 
2.20 
3.65 
4.13 
4.27 
-
L:Foll .. coll 
R:S + H 
L:Foll-2, coll 
R:S + H 
L :Foll .. l, vs 
R:S + H 
L:Area-l, s 
R:S + H 
L:Area-<I, S 
R:S + H 
L:S + H 
R:S + H 
L:S + H 
R:Foll-<l, s 
L:Foll .. l,S, sh 
R:Foll-<l, s 
L:Foll-LS, sh 
R:Foll-<l, sh 
L:Foll-2, sh 
R:irreg 
L:Foll-LS, s 
R:S + H 
L:FoU-3, vs 
R:3x1, irreg 
L:Foll-2, S 
R:S + H 
Ovaries 
.. :: 
I 
I 
I 
i 
: 
I\.) 
m 
I\.) 
TABLE 39 ctd: 
Day of FSH Oestradiol-17S 
Pregnancy ng/m1 fraction pg/m1 
26 20.3 0.32 17.7 
28 24.4 0.39 16.5 
30 27.6 0.44 27.7 
32 32.8 0.52 25.4 
34 23.5 0.37 22.5 
36 38.0 0.68 22.5 
39 51.5 0.82 
41 45.1 0,72 
43 28.9 0.46 
45 40.7 0.65 
47 30.5 0.48 
49 48.8 0,78 
51 48.7 0.77 
----- -- --- -- --------
Progesterone LH or PMSG 
ng/ml ng/ml* 
3.57 
4.19 . 36.3 
3.47 30.0 
3.79 17.8 
4.13 96.1 
3.97 150.5 
4.16 836.9 
4.72 942.1 
6.08 1017.3 
4.35 1294.3 
6.05 1127.8 
6.93 1018.9 
4.53 932.3 
Ovaries 
L-:Foll-2, s 
R:S + H 
L:Foll-2.5, vs 
R:Foll-1, vs 
L :Foll-l, vs 
R:Area-l, fh 
L:2xFo11 - 1, sh:l.5, sh 
R:Area-<l, sh 
L:2xFoll - 2.5, s:1, fh 
R:Area-1, s 
L:Foll-1.5, sh 
R:Foll-l, fh 
L:3x1, Area-I, sh 
R:S + H 
L:Fo11-1.5, sh, Area-colI 
R:S + H 
L:2xFoll-2, s: 1, sh 
R:S + H 
L:Foll-3, fh 
R:S + H 
L :Foll-coll? 
R:S + H 
L:Foll-<I, sh 
R:Foll-1, fh 
N 
en 
w 
TABLE 39 ctd: 
Day of FSH Oestradiol-17S Progesterone 
Pregnancy ng/ml fraction pg/ml ng/ml 
53 31,2 0.50 7.86 
55 62.9 1,00 5.15 
57 44.7 0.71 3.79 
59 26.9 0.43 4.05 
61 23.7 0.38 5.07 
64 30.6 0.49 5.04 
67 43.6 0,69 4.32 
70 44.1 0.70 5.60 
* Footnote: LH/PMSG measured in the Niswender Ovine System 
ill or PMSG 
ng/ml * 
1115.9 
1357.0 
1316.6 
1337.2 
1362.7 
-
Ovaries 
L:Foll-<l, fh 
R:S + H, Area-<l, colI 
L:Foll-1, s 
R:Area-1. s 
L: F011-<1, s 
R:Area-<l, s 
L:S + H 
R:S + H 
L:2xFol1-<1, fh:<l, fh 
R:S + H 
1:Area-1, s 
R:Foll-<l, vs 
L:Foll-1.5, fh 
R:S + H 
L:Foll .. l, s 
R:S + H 
~ ;: 
Hi 
IV 
O"! 
,j::o 
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Serum FHS concentrations surged on Days 39 to 41, with 
a further increase on Day 45, and surges on Days49 to 51, 
55 to 57 and 67 to 70. Over this period, follicular 
development occurred on Days 41 through 47, with an ovulation 
occurring by Day 47, which appeared to form a corpus luteum 
as assessed by an increase in serum progesterone concentrat-
ions. A small follicle developed by Day 49, and possibly 
ovulated by Day 53. Subsequently, little follicular activity 
occurred until between Days 67 and 70, when a small follicle 
developed, 
2. Betty Patch: (see Table 40). 
Serum concentrations of FSH were slightly elevated 
from Days 5 through 12, with a marked peak on Day 8 of pregnancy, 
No further appreciable surge occurred until Day 21 when the 
levels became generally elevated until the end of the study, 
although a decrease was observed on Days 53 through 55. On 
Day 21, follicular development began, with a follicle in the 
right ovary reaching 2.5 Units, by Day 23, which had either 
regressed or ovulated by Day 27. In the left ovary, several 
small follicles developed over the period 23 to 31 days, 
but were not palpable by Day 35. Similarly, the right ovary 
showed a slight increase in activity over Days 31 to 33, 
Further follicular activity began on Day 37, with some small 
follicles possibly ovulating (as determined by palpation) over 
the period until Day 49. More marked follicular growth then 
began by Day 51, with the development of a 5 Unit follicle 
by Day 55, which then appeared to ovulate. After Day 60, the 
ovaries were small and hard. 
TABLE 40: BETTY PATCH 
Day of F5H Oestradiol-17S 
Pregnancy ng/m1 fraction pg/m1 
-5 3.38 0.11 11.6 
-4 4.17 0,14 
-3 2.42 0.07 19.7 
-2 4.08 0.13 
-1 6.96 0.23 12,4 
a 6.41 0.21 
1 6.49 0.21 7.9 
2 6.21 0.20 
3 7.28 0.24 
4 8.17 0.27 
5 10.8 0.35 
6 10.6 0.34 
7 10.5 0.34 
Progesterone LH or PM5G 
ng/ml ng/m1* 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
1.17 
4.53 
7.73 
8.35 
9.60 
7.55 
Ovaries 
L:5 + H 
R:Foll-2, sh 
L:5 + H 
R:Foll-2, 5, s 
L:5 + H 
R:Foll-3, s 
L:5 + H 
R:Foll-4, s 
L:5 + H 
R:Foll-5, s 
L:5 + H 
R:Foll-5.5, s 
L:5 + H 
R: Foll-coll 
L:5 + H 
R:Area-1.5. vs 
L:5 + H 
R:Area-1.5, s 
L:5 + H 
R:Area-l, rubbery 
L:5 + H 
R:Area-l, vs 
t-.) 
0'\ 
'" 
TABLE 40 ctd: 
Day of FSH 
Pregnancy ng/m1 fraction 
8 30.8 1.00 
9 13.6 0.44 
10 9.27 0.30 
11 12.1 0.38 
12 16.4 0.53 
13 11.1 0.36 
14 14.8 0.48 
15 9.94 0.32 
16 7.97 0.26 
17 11. 7 0.38 
18 15.8 0.51 
19 10.8 0.35 
20 8.98 0.29 
21 15.8 0.51 
22 14.3 0.46 
23 16.3 0.53 
, 
Oestradiol-178 Progesterone 
pg/ml ng/ml 
9.07 
8.67 
4.72 
7.92 
7.60 
8.53 
4.00 
6.13 
7.07 
8.80 
9.73 
6.93 
7.07 
5.87 
5.12 
6.88 
:-,. 
Co 
LH or PMSG Ovaries 
ng/ml* 
L:S + H 
R:Area-l, sh 
L:S + H 
R: 2xl, irreg 
L:Foll-l, f 
R:S + H 
L:S + H 
R:Fo11-1, sh, Area-1.5, rubbery 
L: Tri-1obed, h 
R:Fo11-2.5, s, Area-I, rubbery 
::' 
I 
I 
I 
tv 
m 
~ 
TABLE 40 ctd: 
Day of FSH Oestradiol-178 Progesterone 
Pregnancy ng/ml fraction pg/ml ng/mi 
24 14.2 0.46 5.87 
25 13.4 0.44 5.87 
26 15.8 0.51 5.73 
27 19.8 0.64 4.80 
28 14.7 0.48 5,33 
29 18.1 0.59 5.47 
31 12.2 0.40 5.20 
33 18.9 0.61 5.31 
35 17.9 0.58 5.87 
37 17.8 0.58 9.28 
38 22,8 0,74 10,4 
41 18.7 0,61 9,20 
43 18,3 0,59 8,80 
LH or PMSG 
ng/ml* 
14.1 
10.2 
13.0 
38.7 
1797.5 
2463,S 
Ovaries 
L:Foll .. l, fh 
R:Foll .. l, fh, Area-I, rubb~ry 
L:Tri-lobed, 3xFoll,<1,fh:<1, fh 
<1, fh 
R:Tri-lobed, FoIl-I, sh 
L:2xFoll .. <1, sh: I, sh 
R:2xFoll-l,fh: I, fh 
L:Area-l., coll 
R:2xFo11, <1, sh, 1, vs 
L:5 + H 
R:2x1, irreg 
L:Area-l, s 
R:2xFo11, 1.7, s, I, sh 
,L: 2x2, irreg 
R:Foll-l,3, sh 
L!Foll-L5, fh 
R:Foll-l, fh 
L :Foll-l, sh 
R:Foll .. l, f 
:: 
} .. i 
1 
I 
I 
I 
I 
I 
I\J 
'" co 
TABLE 40 ctd: 
Day of FSH Oestradiol-17S Progesterone 
Pregnancy ng/m1 fraction pg/m1 ng/ml 
45 16.6 0.54 7.57 
47 20,4 0.66 5.92 
49 21. 3 0.69 8.27 
51 17.0 0,55 8.96 
53 12.2 0.40 6.93 
55 10.7 0.35 6.67 
57 26.9 0.87 7.07 
59 15.8 0.51 7.68 
60 17.8 0.58 6.67 
63 14.9 0.48 8.80 
65 19,3 0,63 7.73 
67 17.4 0.56 7.12 
69 22.7 0.74 
'* Footnote: LH/PMSG measured in the Niswender Ovine System 
LH or PMSG Ovaries 
ng/m1'* 
L :Area-L 5. s 
R:Fo11-1. fh, Area-l, sh 
L~Foll-1.5, fh, 
R:2xFol1-1.5, fh, 1, sh 
L:Foll-1.5, sh 
R:2xFo11-1, fh, 1, colI 
L:Foll-2, sh 
R:Foll-2, s 
L:6x4, Foll-4. fh 
R:2x Foll-2, sh: 1, fh 
L:Foll-5, sh 
R:Foll-15, sh 
L:Foll-2, s 
R:2xl, irreg, Area-I, s 
L:Foll-l, f 
R:S + H 
L:Area-<l, fh 
R:Area-<l, fh 
L:S + H 
R:S + H 
L:S+ H 
R:S + H 
L:S + H 
R:S + H 
L:S + H 
R:S + H 
------
... : 
~:: 
',' 
" ' ~~~ . 
I\J 
0'\ 
\0 
270 
Serum progesterone concentrations rose sharply on Day 37, 
the time at which PMSG concentration increased, 
3. Carol Time: (see Table 41), 
Serum FSH concentrations were elevated from Days 4 through 
16 following conception with the peak level occurring on Day 10, 
A further elevation occurred on Day 23, and levels were consist~ 
ently increased until Day 38, The levels were then lower 
until Days 57 through 66, with further increases on Days 83 
and 86, and a surge from Day 95 to 106, A single one day 
elevation was observed on Day 137, but thereafter the concentration 
was very low until Day 200, except for a surge on Days 172 
to 176. A steady increase then occurred until Day 257, which 
was followed by very low values until Day 286. An irregular 
pattern was observed until Day 318, after which the levels 
were generally elevated until parturition, with intermittent 
surges being observed. However, results between Days 66 
and 313 of pregnancy should be interpreted with caution because 
of the relatively long intervals between sampling. 
An increase in follicular development appeared to occur on 
Day 16, with a small follicle possibly ovulating by Day 23, 
Small follicles were present from Day 30 through 49 and though 
ovulations may have occurred, this could not be confirmed by 
palpation, nor by progesterone levels, since exogenous 
progesterone was being administered at this time. On Day 53, 
one follicle began to develop reaching 2.5 Units on Day 55, and 
which appeared to ovulate (as determined by palpation) by Day 
59, After this time, the ovaries were generally 2xl Units 
and irregular, although a structure described as a 2 Unit 
follicle developed by Day 86, but was not palpable by Day 91. 
TABLE 41: 
Day of FSH 
Pregnancy ng/ml fraction 
-4 14.8 0.42 
~2 9,81 0.28 
0 8.99 0,26 
1 10.2 0.29 
4 16.4 0.47 
6 22.9 0.65 
8 13.2 0.38 
10 23.3 0.67 
12 23.0 0.66 
14 19.5 0.56 
16 20.0 0.57 
18 11. 7 0.33 
CAROL TIME 
Progesterone LH or PMSG 
ng/mlt ng/ml* 
-
Ovaries 
L:Foll-1.5, fh 
R:S + H 
L:Foll .. 2.5, sh 
R:S + H 
L:Foll-4, 5 
R:S + H 
L: Foll~ call, 
R:S + H 
L:Area-2, 
R:S + H 
L:Area-l.5, 5 
R:S + H 
L:Foll-1.5, fh 
R:S + H 
L!Foll~I.5, fh 
R:S + H 
L:Area-l, 5 
R:S + H 
L:Area-1,sh 
R:S + H 
L: Foll-1.5. sh 
R:S + H 
L:Foll-1.3, sh 
R:S + H 
~ 
I 
I 
I , 
I 
I 
I 
I'V 
'-l 
1-' 
TABLE 41 ctd: 
Day of FSH Progesterone 
Pregnancy ng/ml fraction ng/ml 
2:() 15.5 0.44 12.3 
22 12.4 0.35 
23 20.2 0.58 
26 23.0 0.66 
28 24.3 0.69 
30 23.8 0.68 
32 19.8 0.56 
34 27.7 0.79 
36 19.6 0.56 
38 26.9 0.77 
41 16.7 0,48 
43 14.1 0.40 
- ._-
ill 01' PMSG 
ng/ml* 
16.9 
18.3 
39.1 
38.3 
>1000.0 
-- - -- ---- ----
Ovaries 
L:FolI...l, s 
R:S + H 
L:2xFol1-l.5, vs, 1, f 
R: 3xl., i rreg 
L :Foll-l, coll 
R:S + H 
L:3x2 
R:S + H 
L:Area .. 1, fh 
R!S + H 
L:Area-2, fh 
R:Foll-l, sh 
L:3x1, irreg 
R!Foll-l, s 
L:Foll-l.5, sh 
R :Foll-1, s 
L : F<> 11- L 5, s 
R:Foll-<l, sh 
L :Foll-1, sh 
R:Area-<l, sh 
L: Fo11?-1.5, sh 
R :Foll-1, sh 
L:Area-1, sh 
R:Foll-l, sh 
'---------
t\.) 
~ 
t-..) 
TABLE 41 ctd: 
Day of FSH 
Pregnancy ng/m1 fraction 
45 14.3 0.41 
47 8.33 0.24 
49 12.9 0.37 
51 16.6 0.47 
53 14.2 0.41 
55 17.0 0.49 
57 24.7 0.71 
59 19.9 0.57 
61 27.6 0.79 
64 
66 21.5 0.61 
70 17.3 0.49 
Progesterone ill or PMSG 
ng/ml ng/ml* 
18.4 
Ovaries 
L:Area-1, sh 
R:Foll .. 1, sh 
L:2x1 
R:Foll-1, sh 
L:Area-1, fh 
R:Foll .. 1, s 
L:2xFo11-2, sh:1.5, fh 
R:Area-<1, s 
L;2xFo11-2.S, sh<1, s 
R:S + H 
L:F011-1.5,· sh 
R:Area .. <l,sh 
L:2x1 
R:Area-<1, s 
L:4x2 
R:Foll-2, fh 
L :Foll-1, coll 
R:Foll-1, vs 
L:2x1, irreg 
R:S + H 
L:2xl. irreg 
R:S + H 
tv 
-...J 
IN 
TABLE 41 ctd: 
Day of 
Pregnancy ng/ml 
75 16.8 
79 18.7 
83 20.1 
86 31.8 
91 12.9 
95 31.9 
99 26.0 
103 19.9 
106 22.0 
112 13,3 
116 10.7 
121 18.5 
124 14.8 
129 15.7 
133 15.3 
--- -
FSH Progesterone LH or PMSG 
fraction ng/ml ng/ml* 
0.48 
0.53 
0.57 
0.91 
0.37 
0.91 
0.74 
0.57 
0,63 
0.38 
0,31 
0.53 
0.42 
0.45 
0.44 
Ovaries 
L:2xAreas-1, s: 1, s 
R:S + H 
L :Foll-1.5, sh 
R:S + H 
L:Foll-2, sh 
R:S + H 
L:2x1, irreg 
R:2xl~ irreg 
L:2x1, irreg 
R!S + irreg 
L:2x1, irreg 
R:S + H 
L:2xl, irreg 
R:S + H 
L:2x1~ irreg 
R:2xl~ irreg 
r-.J 
-....J 
~ 
TABLE 41 ctd: 
Day of FSH 
Pregnancy ng/ml fraction· 
137 29.6 0.85 
142 3.21 0.09 
147 6.16 0.18 
151 3.94 0.11 
172 22.9 0.65 
176 23.8 0.68 
180 10.2 0.29 
184 4.85 0.14 
192 7.22 0.21 
198 9.32 0.27 
202 12.2 0.35 
206 13 0 8 0.39 
211 12 .6 0.36 
216 16.6 0.47 
221 23.8 0.68 
229 20.4 0.58 
234 22.9 0.65 
241 20.0 0.57 
248 28.4 0.81 
Progesterone LH or PMSG 
ng/m1 ng/ml* 
L:S+ H 
R:irreg 
L:S+ H 
R:S + H 
5.73 L:S + H 
R:S + H 
Ovaries 
J 
, 
.. ::' 
;.; 
I'V 
~ 
U'I 
TABLE 41 ctd: 
Day of FSH 
Pregnancy ng/ml 
257 24.8 
269 5.86 
274 6.83 
286 7.60 
293 12.6 
301 13.4 
3QS 2.61 
307 10.9 
313 4.52 
315 13.0 
318 21.4 
320 2103 
322 23.3 
324 24.2 
325 27.3 
326 20.8 
327 28.2 
328 25.2 
329 32.4 
340 19.2 
fraction 
0.71 
0.17 
0.19 
0.22 
0.36 
0,38 
0.08 
0.31 
0.13 
0.37 
0.61 
0.61 
0.67 
0.69 
0.78 
0.59 
0.81 
0.72 
0.93 
0.55 
, 
N 
....,J 
0'\ 
TABLE 41 ctd: 
Day of 
Pregnancy 
331 
332 
333 
335 
336 
337 
338 
339 
340 
341 
343 
344 
* Footn0te: 
Ovaries 
FSH 
ng/ml fraction 
10.7 0.31 
19.5 0.56 
11. 3 0.32 
21.6 0.62 
16.0 0.46 
29.5 0.84 
26.1 0.75 
18.9 0.54 
24.5 0.07 
35.0 1.00 
18.8 0.54 
31.4 0.90 (foaZed) 
LH/PMSG measured in the Niswender OVine System 
tprogesterone (150mg/dose) was administered daily on Days 20 through 
63, then 75mg/dose every second day until Day 81 
IV 
--.J 
--.J 
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PMSG was possibly pre~ent by Day 36 of pregnancy, although high 
levels were not attained until Day 41. 
4. Contraband: (see Table 42). 
Serum FSH concentrations were elevated on Days 6 through 10 
following conception, following which levels remained low 
until a small surge occurred between Days 32 and 39, with a 
marked peak on Day 38. The concentrations then increased 
on Day 50, and remained generally elevated until the end of 
the experiment on Day 71. 
Ovarian activity appeared to increase slightly on Day16, 
with the development of a follicle which reached a maximum 
size of 2 Units on Day 28, but persisted until after Day 36 
when it may have ovulated and, as suggested by the slight 
increase in serurn progesterone concentrations, established 
a corpus luteum. This possible ovulation coincided with the 
appearance of PMSG. On Day 39, further follicular development 
commenced in the other ovary, and a 2 Unit follicle 
appeared to collapse by Day 44 with establishment of a corpus 
luteum since serurn progesterone concentrations showed a marked 
increase. This corpus luteum was clearly palpable until 
Day 52, after which the ovaries were generally 2xl Units 
and irregular with little follicular activity. 
5. False: (see Table 43). 
Serurn FSH concentrations were elevated between Days 8 
and 12 following conception, with a peak level on Day 9, 
following which the levels were low with a small surge on Days 
19 through 21, and a further slight increase on Days 28 and 
29. Some degree of follicular development occurred between 
Days 12 and 15, with a 1 to 1.7 Unit structure variously 
TABLE 42: CONTRABAND 
Day of FSH Oestradiol-17B 
Pregnancy ng/ml fraction pg/ml 
-2 12.6 0.45 20.1 
-1 7.71 0.27 20.4 
0 5.60 0.20 16.3 
1 4.05 0.14 11.6 
2 7.17 0.25 12.0 
3 7.26 0.26 
4 9.38 0.33 
5 11.8 0.42 
6 14.4 0.51 
7 13.4 0047 
8 15.3 0.52 
10 15.6 0,55 
12 6.94 0.25 
Progesterone LH or PMSG 
ng/ml ng/m1* 
0.3 36.1 
0.3 39.9 
0.1 56.5 
0.1 79.3 
0.48 108.6 
0.99 107.5 
2.32 49.7 
6.53 37.3 
12.9 39.6 
8.53 41.3 
15.1 45.5 
8,8 36.9 
6.27 12.1 
--
Ovaries 
.-. 
L:Fol1-2.3, sh 
R:2x1, irreg 
L:Fol1-3, s 
R:S + H 
L:Area-1, vs 
R:S + H 
L:Area-2.5, vs 
R:Tri-lobed, H 
L:Area-2, s 
R:S + H 
L:Area-2.5, s 
R:S + H 
L :Area-2, vs 
R:S + H 
L:Foll-1.5, vs 
R:S + H 
L:Area-1. 5, vs 
R:S + H 
L:Area-l, vs 
R:Foll-<1, fh 
-
I 
-I 
" -
t\) 
~ 
1.0 
TABLE 42 ctd: 
Day of FSH Oestradiol-17S 
Pregnancy ng/ml fraction pg/ml 
14 7.89 0.28 
16 6.07 0.21 
17 4.88 D.17 
20 7.67 0.27 
22 8.47 0.37 
24 7.06 0.25 
26 5.75 0.20 
28 7.37 0.26 
30 6.77 0.24 
32 10.7 0,38 
34 12.5 0044 
36 9.87 0.35 
Progesterone LH or PMSG 
ng/ml ng/ml* 
9.33 16.9 
1604 6.93 
5.07 5.96 
6.32 
6.4 16.6 
6.0 14.9 
5.2 
8.67 45.9 
6.4 56.7 
4.67 43.1 
5.33 68.3 
3.87 75.2 
Ovaries 
L:Foll-l, fh 
R:Area-<l, sh 
L:2xFoll-1.5,sh 
R:S + H 
L!Foll-1.5, s 
-R:S + H 
L:Fel1-1.5, vs 
R:S + H 
L:Foll-l.5, s 
R:S + H 
L:Foll .. l.3, f 
R:Area-<l, s 
L:Foll-1.5, sh 
R:S + H 
L:2xFoll-2, sh, 
R:S + H 
L:3xl, Foll-l.5, sh 
R:S + H 
L:2xFoll-l.5, sh:<l, sh 
R:Foll-l, fh 
L:2xFoll-l.7, sh:<l, fh 
R:S + H 
L:Foll-l,5, sh 
R:S + H 
L-. 
I 
r-J 
co 
o 
TABLE 42 ctd: 
'" 
Day of FSH Oestradiol-178 
Pregnancy ng/m1 fraction pg/m1 
38 20.4 0.72 
39 8.84 0.31 
42 7.36 0.26 
44 8.32 0.29 
46 6.66 0.24 
I 
48 9.57 0.34 
50 14.7 0.52 
52 18.1 0.64 
55 13.9 0.49 
57 22.7 0.80 
59 19.5 0.69 
Progesterone LH or PMSG 
ng/ml ng/mlit 
4.80 137.3 
5.33 184.6 
7.12 361.1 
9.33 486.1 
8.80 504.5 
13.9 498.8 
15.6 
17.2 
19.7 
16.7 
18.8 
Ovaries 
L:Area .. 1, fh 
R: 2xl t irreg 
L-:Area-l, sh 
R:Fell-l.3, fh 
L : Are a .. 2, vs 
R:Foll-2, vs 
L:Area-1, s 
R:Poll-s, coll 
L:2x1, irreg 
R:Foll-2, vs 
L:ATea-1., sh 
R :Foll-2. 5. vs 
L:2xl, H 
R:Foll-2.5. colI 
L: Foll-<l, fh 
R:FoI1-2, coll 
L:2x1, irreg 
R :Foll-<l, sh 
L:Area-l, s 
R:Area-l, s 
L:2x1, 
R:Foll-1, fh 
I\J 
OJ 
I-' 
TABLE 42 ctd: . 
Day of FSH Oestradiol-17f3 Progesterone 
Pregnancy ng/ml fraction pg/m1 ng/ml 
61 18.1 0.64 19,5 
63 18.6 0066 18.8 
65 22,3 0.79 18,8 
67 17.6 0.62 17,6 
69 28.3 1.00 
71 23.2 0,82 15.7 
- ._- ----
* Footnote: LH/PMSG measured in the Niswender OVine System 
ill or PMSG 
ng/ml* 
Ovaries 
"-
L: 2x1 J irreg 
R: 2x1, irreg 
L:S + H 
R:Foll-<l, fh-
L:F.ol1~<l~ fh 
R:Foll-<l, fh 
L:2x1, irreg 
R:Foll-L, f 
L:5 + H 
R:S + H I.\J 
co 
N 
TABLE 43: FALSE 
Day of FSH Destradiol-178 
Pregnancy ng/ml fraction pg/m1 
-5 11.0 0.49 10.8 
-4 14.4 0.64 12.3 
-3 8.34 0.37 28.9 
-2 7.74 0.34 34.8 
-1 12.1 0.54 19.7 
0 10.6 0.47 32.1 
1 10.3 0.46 11.2 
2 16.4 0.73 12.6 
3 12.6 0.56 10.7 
4 9.84 0.44 13.9 
5 9.68 0.43 15.7 
6 6.65 0.30 16.6 
7 13.8 0.61 13.5 
Progesterone LH or PMSG 
ng/ml ng/ml* 
14.7 
24.7 
0059 
0.85 14.3 
0.37 33.0 
0.45 55.6 
2.51 24.1 
2.77 55.0 
9.60 
3.30 32,3 
4.61 17.4 
3.73 26.9 
3.09 6,46 
Ovaries 
L:F011 .. 207, sh 
R:S + H 
L:Foll-3, sh 
R:S + H 
L:Foll-4.3, s 
R:S + H 
L:Foll-4, s 
R: Foll-1, fh 
L: Foll-coll 
R:Foll-1, s 
L:Area-2, vs 
R:Foll-1, s 
L:Area-2, vs 
R:Foll-<l, s 
L:Area-2, vs 
R:Foll-<l, s 
L : Area-rubbery 
R:S + H 
L:Area-105, rubbery 
R:S + H 
j 
, 
, 
, 
::~: 
;::' 
,'. ,;. 
:.;. 
N 
co 
lrJ 
TABLE 43 ctd: 
Day of FSH Oestradiol-17B 
Pregnancy ng/ml fraction pg/ml 
8 15.3 0.68 16.8 
9 22.5 1.00 19,4 
10 18.3 0.81 17.4 
11 14.6 0.65 9.7 
12 17.4 0.77 9.9 
13 9,34 0.42 10,1 
14 8.21 0.36 9.7 
15 8.57 0.38 13.9 
16 5.20 0,23 
17 4.84 0.22 8.3 
18 9,28 0.41 80S 
19 12.2 0,54 7.1 
20 12.7 0.56 7.2 
Progesterone LH or PMSG 
ng/ml ng/m1* 
2.85 7.16 
3.17 13.0 
3.31 9.86 
4.51 7.23 
3.63 6.16 
3,52 2.14 
3.13 
3.76 7,64 
3.97 12.2 
3.17 8.33 
4.27 12.1 
3.09 11.9 
3036 
, 
Ovaries 
L:Area~1.5, rubbery 
R:S + H 
L:Area-1,5. rubbery 
R:S + H 
, 
! 
i 
J 
, 
L!Fo11?-1.5, sh. Area-I. rubbery, 
R:S + H 
L~Fo11?-1.5, sh, Area-I, rubbery 
R~S + H , 
L:3xArea-l, sh, I, sh, I, sh 
R:S + H 
L:Area-1.5, rubbery , 
R:S + H 
L: Area-loS, rubbery , 
R:S + H 
L:Foll .. L5, sh 
R:S + H 
L:Foll-l. 7. s 
R:S + H 
-
:~: 
:~. ,. 
'~i~ ':: :;,' 
::~: ' 
tv 
co 
01::>0 
TABLE 43 ctd: 
Day of FSH Oestradiol-178 Progesterone 
Pregnancy ng/ml fraction • pg/m1 ng/ml 
21 10.6 0.47 9.2 1.2 
22 5.93 0.26 8.5 3.63 
23 1.9 1.12 
24 6.11 0.27 5.2 3.55 
25 7.04 0.31 6.7 2.40 
26 9.15 0.41 8,4 3.41 
27 11.9 0.53 30.3 4.80 
28 13.5 0.6 23.7 3.73 
29 15.3 0.68 26.6 2.48 
.. ' 
* Footnote: LH measured in the Niswender Ovine System 
.. -. 
LH or PMSG Ovaries 
ng/ml* 
L:Fo11-1, s, Area-I, rubbery 
R: 
L:Area-1.5, s 
R:S + H 
L:Fo11-1.7, s 
R:S + H 
L:Fo11 .. LS, s 
R:S + H 
L:Foll-2, s 
R:S + H 
L:Area-1.7, sh 
R:S + H 
.. '. 
\ 
I 
I 
I 
I 
"-> 
(X) 
U1 
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de~cribed as an area and a follicle present on Days 19 
through 23, following which a follicle appeared to develop 
reaching a size of 2 Units on Day 27, and possible ovulating 
by Day 29. Serum oestradiol concentrations which had been low, 
increased from Day 27 to 29. 
5. Gay Fleur: (see Table 44) 
Serum FSH concentrations were elevated between Days 
22 and 26, with further surges occurring between Days 40 
and 48, and Days 57 and 61. At the start of the study on 
Day 18, a 1.5 Unit follicle was present which grew to be 
3 Units on Day 22, then persisted with apparent regression 
after Day 34. Follicular development in the other ovary 
commenced on Day 22, with 2 small follicles present until Day 
30, one of which continued to grow to reach 2 Units on 
Day 34, while the other may have ovulated. Several small 
follicles were present in both ovaries until Day 44, but on 
Day 46, two follicles both developed further to be 2 Units 
in size, and by Day 48, both appeared to have ovulated, and 
the rise in serum progesterone concentrations indicated that 
at least one corpus luteum was established. Following this, 
little ovarian activity was evident, with the ovaries being 
2xl and irregular until Day 67 when they were small and 
hard, 
PMSG was present in high concentration by Day 36, indicating 
production probably began on Day 35. 
7. Golden Road: (see Table 45) 
Serum FSH concentrations were increased between Days 23 
and 27 of pregnancy, with a further surge between Days 38 
and 47. A follicle which was present on the first day of 
TABLE 44: GAY FLEUR 
Day of FSH Progesterone 
Pregnancy ng/ml fraction ng/ml 
18 10,9 0.39 3.15 
20 n.5 0.41 4.0 
22 12.3 0.44 3,87 
24 16.0 0.57 4.05 
26 19.1 0.68 3.73 
28 10.5 0.37 5.60 
3iJ 7.89 0.28 5.07 
32 8.92 0.32 4.57 
34 10.0 0.36 4.27 
36 7.44 0.26 5.07 
37 12.2 0.43 5.15 
40 18,6 0,66 4.99 
LH or PMSG 
ng/ml* 
10.9 
14.7 
9.31 
15.8 
>1000 
>1000 
>H)OO 
Ovaries 
L:Foll .. 1.5, sh 
R:S + H 
L:Foll-2, s 
R:S + H 
L:Foll .. 3, s 
R:2x1, tri-1obed 
L:Foll-2, sh 
R:2xFo11-1, s, 1, sh 
L:Foll .. 2, s 
R:2xFo11,-I, f, 1, f 
L;Foll-2.5, sh 
R:2xFoll_1, fh<l, sh 
L:Foll-1.5, s 
R:2xFo11-1, fh, 1, fh 
L:2xFoll-2, s,l, fh 
R:3xl, Foll-I.5, sh 
L:Foll-1.5, fh 
R:FoI1-2, sh, Area-I, fh 
L:4x2, Foll-I.5, fh 
R:4x2, Foll-I.5, sh, Area-I,5, sh 
L:2xFoll-l, s, 1.5, sh, Area-I, s 
R:4x2, 2xFoll-l.5, s, 1, s 
L:3xl, Foll-I,5, sh 
R:3xl~ FoIl-I, s 
<'.-
I 
I 
I'\J 
00 
-...J 
TABLE 44 ctd: 
Day of FSH 
Pregnancy ng/ml fraction 
42 24.3 0.86 
44 18.9 0,67 
46 19.2 0,68 
48 19.9 0.71 
50 5.88 0.21 
53 
55 11.1 0.4 
57 16.6 0.59 
59 28.1 1.00 
61 15.3 0.54 
63 11. 2 0.4 
Progesterone LH or PMSG 
ng/ml ng/ml* 
4.72 
4.4 
4.91 
5.47 
8.27 
8,6 
8.4 
9.15 
8,48 
9.47 
8.93 
-
Ovaries 
L:2xFoIl-I.5, sh, 1.5, sh 
R:2xFolI, 1.5, sh, 1, sh 
L:2xFoII-2, sh, 1, sh 
R:3xFolI.I, sh, 1.5. sh, 1, sh 
L:Foll-2, vs 
R:Foll-2, sh 
L:FoII-i. fh, Area-I, s 
R:3x2, FoIl-I, £h, Area-l, s 
L:Foll-1.5, colI 
R~FoIl-<I, f, Area-I, s 
L:Foll.I, colI 
R:2xI 
L:3xI 
R:2xl 
L:2x1, irreg 
R:2xI, irreg 
L:2xI, Area-I, vs 
R:2xI, Area-I, vs 
L:2xI, irreg 
R:S + ff 
L:Area -1, sh, 
R:S + H 
:.~ , 
i;~~ 
; ~: ~ 
. ::~: 
t\.l 
(Xl 
(Xl 
TABLE 44 ctd: 
Day of FSH Progesterone LH or PMSG 
Pregnancy ng/ml fraction ng/ml ng/ml* 
65 12.2 0.43 9,33 
67 9.90 0.35 6.53 
* Footnote: LH/PMSG measured by the Niswendep Ovine System 
Ovaries 
L:S + H 
R:S + H 
: 
:;: 
i; : .
. '. 
f\J 
00 
1.0 
TABLE 45: GOLDEN ROAD 
Day of FSH Progesterone 
Pregnancy ng/ml fraction ng/ml 
19 9.35 0.47 2,29 
21 8.69 0.44 2.67 
23 15.9 0.80 2.93 
25 12.2 0.62 2.72 
27 11.9 0.6 
29 9.09 0.46 2.77 
31 10.4 0.53 3.41 
33 9.56 0.48 2.88 
35 ILl 0.56 3.04 
37 9.98 0.50 4.27 
38 14,2 0.72 4.85 
LH or PMSG 
ng/ml* 
10.5 
6.70 
18.3 
14.6 
10.8 
29.3 
10.4 
31.5 
13.8 
76.3 
>1000 
---- ----- -- -
Ovaries 
L:Foll-1.3, vs 
R:S + H 
L:Foll-1.5, s 
R:S + H 
L:Foll-2, s 
R:S + H 
L:Foll-2, s 
R:S + H 
L: Foll-2, vs 
R:S + H 
L:Foll-2, s 
R:S + H 
L: Foll-1. 5, vs 
R:Foll-<l, fh 
L :Foll .. l, vs 
R:Foll-l, s 
L:Foll-l.3, s 
R:Foll-l, s 
L:Foll-1, fh 
R:Foll-1.7, sh 
L : F 011-1, vs 
R:Foll-2.5, s 
I\.) 
\0 
o 
TABLE 45 ctd: 
Day of FSH Progesterone lH or PMSG 
Pregnancy ng/ml fraction ng/ml ng/ml 
41 18.2 0.92 5.39 
43 14.8 0.75 5.73 
45 15.1 0.76 6.53 
47 19.8 1.00 7.23 
-
49 12.2 0.62 6.53 
* Footn0te: LH/PMSG measured in the Niswender Ovine System 
Ovaries 
L:Foll-<I, vs 
R:Foll-<I, s 
L:S + H 
" 
R:Foll-<I, s 
L:S + H 
R:Foll-<I, s 
L:S + H, Area-<I, vs 
R:S + H, Area <1, vs 
L:Foll-<I, s 
R:Foll-<I, s 
I 
.. : 
if 
.l:~. ~' 
N 
\0 
I-' 
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study (Day 19) increased to be 2 Units in size by Day 23, 
and subsequently ovulated or regressed over the period up until 
Day 33. A follicle commenced development in the other ovary 
on Day 31, in~reased to be 2.5 Units on Day 38, when it 
appeared to ovulate, No further follicular growth occurred 
by Day 49 when the experiment ended. PMSG first appeared in 
serum by Day 36 or 37. Serum progesterone concentrations 
increased steadily from Day 37. 
8. Miss Balmain: (see Table 46). 
FSH concentrations were increased between Days 4 and 
10, with a marked increase on Days 8 and 9, A further smaller 
surge occurred on Days 15 through 19, with little subsequent 
change except one day increases on Days 67, 75, 82 and 86, 
Another small FSH surge occurred on Days 92 to 94, with a 
more marked increase on Days 102 to Ill. Thereafter the levels 
were generally low. The concentrations were especially low 
from Days 217 to 289 of pregnancy, After Day 289, the levels 
rose steadily until parturition, with some evidence of 
surges over this period. 
There was an incr~ase in ovarian activity, with the 
development of several small follicles which were palpable 
on Days 25 through 45, with one follicle increasing to 3 Units 
on Day 33, and then regressing or ovulating. There was a 
marked decrease in the number of follicles present on Day 45, 
but on Day 47, a further surge of follicular growth commenced, 
with one follicle developing to 3.5 Units by Day 49, after 
which it decreased in size to be 1.5 Units on Day 57. However, 
by Day 61 a 5 Unit follicle had developed in the same ovary, 
reaching a diameter of 6 Units by Day 64, and apparently 
TABLE 46: 
Day of FSH 
Pregnancy ng/ml fraction 
-5 11.9 0.28 
-4 13.5 0.32 
-3 8.23 0.20 
-2 
-1 6.67 0,16 
0 11.9 0.28 
1 11.6 0.28 
2 8,97 0,21 
3 10,7 0.25 
4 13,8 0,33 
6 14.4 0,34 
7 22,0 0,52 
MISS BALMAIN 
Progesterone LH or PMSG 
ng/m1 ng/ml 
1.68 
0.75 
0.8 
0.1 
0.59 
0.51 
0.40 
0.99 
3.68 
5,17 
8,53 
10,5 
Ovaries 
L:Foll-1, f 
R:S + H 
L:Foll-1, f 
R:S + H 
L:Foll-1.5, sh 
R:S + H 
L:Foll-2, s 
R:S + H 
L:Foll-2, s 
R.:S + H 
L:Foll-3, s 
R:S + H 
L:Foll-coll 
R:S + H 
-
L:Area-1.5, s 
R:S + H 
L :Area-1, s 
R:S + H , 
N 
\0 
W 
TABLE 46 ctd: , 
Day of FSH 
Pregnancy ng/ml 
8 42.1 
9 32.8 
10 25.8 
11 12.0 
12 12.4 
13 11,3 
14 6.51 
IS 15.6 
16 18.1 
17 17.9 
18 16.8 
19 20.6 
20 7.23 
Progesterone 
fraction ng/ml 
1.0 9.2 
0.78 10.1 
0.61 12.4 
0.29 11. 3 
0.30 9.73 
0.27 8.4 
0.16 9.73 
0.37 8.27 
0.43 10.5 
0.43 5.87 
0.40 7.87 
0.49 7.68 
0,17 9.01 
LH 0'1' PMSG Ovaries 
ng/ml '* 
L:Area-l, sh 
R:S + H 
L:Area-1~ rubbery 
R:S + H 
L:Area-l, s 
R:S + H 
L:S + H 
R:2xl, Area-I, fh 
L:S + H 
R: Area-I, s 
:::' 
1,', 
:;:: ' 
',', 
I\J 
\0 
~ 
TABLE 46 ctd: 
Day of F5H Progesterone 
Pregnancy ng/ml fraction ng/ml 
21 8.49 0.20 8.13 
22 13.4 0.32 7.01 
23 7.42 0.18 7.73 
24 9.58 0.23 6.4 
25 12.4 0.30 6.37 
26 13.9 0.33 6.23 
27 13.7 0.33 6.53 
28 13.6 0.32 8.35 
29 13.6 0.32 9.07 
30 14.1 0.34 6.32 
31 8.63 0.21 6.67 
32 12.1 0.29 7.15 
33 8.46 0.20 6.67 
LH or PM5G 
ng/m1* 
-
2.31 
21. 7 
34.5 
--
Ovaries 
L:5 + H 
R:Foll-l, f 
L:S + H 
R:2xFoll, 1.5, sh, 1, 5 
L:Foll-l, 5 
R:2xFoll, 1.5,5,1.5, sh 
L:Foll~l, sh 
R:2xFo11, 1.5, sh, 1.5, sh 
L:Area-<l, rubbery 
R:3xFo11, 1, s, 1,5, sh, 2.5 fh 
L:Foll-1.5, sh 
R:2xFoll, 3 sh, 1,5, s 
-- --
:? 
;:!: 
~! 
;::' 
I;' 
N 
\0 
U1 
TABLE 46 ctd: 
: 
Day of FSH 
Pregnancy ng/ml fraction 
35 7.91 0.19 
37 15.5 0.37 
39 10.9 0.26 
41 8.10 0.19 
42 5.22 0 012 
45 1203 0.29 
47 8007 0.19 
49 10.8 0.26 
51 13.6 0.32 
53 9.84 0023 
5S 8083 0021 
57 8.72 0 021 
Progesterone LH or PMSG 
ng/ml ng/ml* 
7025 29,5 
6.67 67.1 
8.05 791.4 
9.07 
9.5 
8.93 
11.9 
9.63 
10.3 
9,33 
1606 
9,73 
Ovaries 
L:Foll-l, sh 
R:2xFoll-<I, 5, 2, s, 
L:Foll-l, vs 
R:2xFoll-1, £h, 2,vs 
L: Foll-I. 5, vs 
R:Area-<I, s 
L:Foll-l, vs 
R:2xFoll, 1.5, s, <1, fh 
L: Foll-l, vs 
R;3xFoll-I.5, s, 1, sh, I, sh 
L:Area-<I, s 
R:Area-1,s 
L:Fol1-<l, s 
R:Foll-2, sh 
L:Area-<l, s 
R:2xFoll-3.5, s, 1.5, vs 
L:Area-l, s 
R:Foll-305, s 
L:Area-<l, s 
R:Foll-3. 5, fh 
L:Area-<l, s 
R:Foll-3.5, sh, Area-I, s 
L:S + H 
R:3xFoll,L5, s, l.S, sh, L5, sh 
-~-
I 
I 
I 
I , 
I 
I 
'" \.D en 
TABLE 46 ctd: 
Day of FSH 
Pregnancy ng/ml fraction 
S9 8.03 0.19 
61 11. 2 0.27 
63 ! 10.3 0.25 
64 14.1 0.34 
67 21.6 0.51 
69 5.6 0.13 
71 11.6 0,28 
73 6.74 0.16 
75 21. 6 0,51 
77 10.7 0.25 
80 10.7 0.25 
82 21.8 0.52 
Progesterone LH or PMSG 
ng/ml nglml* \ 
10.7 
10.1 
11. 7 
14.1 
13.3 
20.3 
17.6 
18.8 
29.1 
>30.0 
17.6 
21.3 
~-
Ovaries 
L:S + H 
R:Foll-2.5, s, Area, 1.5, sh 
L:S + H 
R:Foll~5, sh 
L:S + H 
R:Foll-3, sh 
L:S + H 
R:Foll-6, sh 
L:Foll .. 1, sh 
R:Fo11-1, fh, Area-2, vs 
L:A.rea-1, s 
R:2xFo11<1, vs, 1, s 
L:Foll-1, sh 
R:Area-1, sh 
L:Area-<l, sh 
R:Area-<l, s 
L:Area-1, s 
R:S + H 
L:Area-<l, s 
R:A.rea-<l, s 
L:Area-<I, vs 
R:2xl, irreg 
L:A.rea-<l, s 
R:Area-l, s 
-
.:: ? ,', 
;~~: 
:} 
~ 
1.0 
~ 
TABLE 46 ctd: 
Day of FSH 
Pregnancy ng/ml fraction 
84 7,47 0.18 
86 22.7 0.54 
88 12.3 0.29 
90 14.5 0.35 
92 21.9 0,52 
94 20.8 0.50 
96 15.0 0.36 
98 18.2 0.43 
100 14.0 0.33 
102 23.7 0.56 
105 21.4 0.51 
108 32.3 0.77 
Progesterone LH or PMSG 
ng/ml ng/ml* 
20.9 
16.7 
--~ 
Ovaries 
L:Area m O,5, s 
R:S + H 
L:S + H 
R:2xl, irreg 
L:S + H 
R: 2xl, irreg 
L:S + H 
R:2xFol1-1, coll,O,5~ vs 
L:S + H 
R:Area-l, sh 
L:S + H 
R:2xArea-0.5, s, 0.5, s 
L:S + H 
R:2xArea-O,5, s, 0.5, s 
L:S + H 
R:2xArea-0.5, 5, 0.5, s 
L:S + H 
R:2xArea-0.5, s, 0.5, s 
L:S + H 
R:2xArea-0.5, fh, 0.5, fh 
L: 
R:2xFoll-0.5, fh, 0.5, fh 
L:S + H 
R:2xArea-0.5, sh. 0.5, sh 
--
, 
I 
i 
i 
I 
I 
I 
r-J 
\D 
co 
TABLE 46 ctd: 
Day of FSH 
Pregnancy ng/rnl fraction 
III 21. 7 0,52 
116 13.7 0.33 
120 15.6 0.37 
124 9.04 0.22 
127 16.6 0.40 
132 13.8 0.33 
136 8.93 0.21 
140 13.3 0.32 
144 17.8 0.42 
147 12.8 0.30 
153 10.3 0.25 
157 10.8 0.26 
162 8.47 0.20 
Progesterone LH or PMSG Ovaries 
ng/ml ng/ml* 
L:S + H 
R:Area-l J coll 
L:S + H 
R:Area-l J sh 
L:S + H 
R:2xl, irreg 
L:S + H 
R:2x1, irreg 
L:S + H 
R:S + H 
L:S + H 
R;S + H 
L:S + H 
R:S + H 
L:S + H 
R:S + H 
L:S + H 
R:S + H 
,;> 
" 
, 
,', .. 
:( ::' 
,-.' 
" 
'. 
>' 
~;: . 
;::'. 
!~: 
::; 
,', 
r-J 
~ 
~ 
TABLE 46 ctd: 
Day of FSH 
Pregnancy ng/m1 
165 14.2 
170 8.00 
174 7.59 
178 14.5 
183 8.43 
188 6.52 
192 16.9 
195 9. 79 
199 9.10 
204 16.2 
208 11. 3 
213 10.3 
217 14.1 
221 5.61 
225 7.39 
233 15 07 
239 5046 
243 4,05 
Progesterone 
fraction ng/ml 
0.34 
0.19 
0.18 
0.35 
0.20 
0.15 
0.40 
0.23 
0.22 
0.35 
0.27 
0.25 
0.34 4.93 
0,13 
0,18 
0037 
0013 
0010 
LH or PMSG Ovaries 
ng/ml* 
L:S + H 
R:S + H 
L:S + H 
R:S + H 
L:S + H 
R:S + H 
L:? 
R:S + H 
~. ~ ~ 
w 
o 
o 
TABLE 46 ctd: 
Day of FSH 
Pregnancy ng/ml fraction 
247 1.53 0.04 
252 3.85 0.09 
257 5.35 0.13 
262 12.0 0.29 
270 6.11 0.15 
275 8.64 0.21 
282 6.55 0,16 
289 11.5 0.27 
298 11. 7 0.28 
310 16.9 0040 
315 14.6 0.35 
327 19.0 0.45 
335 15.7 0.37 
342 13.8 0.33 
343 21,4 0.51 
344 27.3 0.65 
345 17.5 0.42 
346 27.1 0.65 
347 21.9 0.52 
---
'" Footnote: LH/PMSG measured in the Niswende~ Ovine System 
Ovaries 
(foaZed) 
I 
I , 
1 
--, 
'-'·1 
-, 
., 
1 
] 
w 
o 
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ovulating by Day 67. A marked increase in serum progesterone 
concentrations occurred on Day ~9, suggesting a corpus luteum 
was established. Following this, little ovarian activity 
occurred, The ovaries decreased in si~e to be small and hard 
from Day 127 onwards. PMSG was present in serum by Day 37 to 38. 
9. Tanunda: (see Table 47), 
FSH concentrations Were slightly elevated between Days 
6 and 11, with a peak on Day 7 after conception. A further small 
surge occurred on Days 23 to 27; and also on Days 37 to 41. 
Following this the levels remained low until the end of· the 
study. 
Some activity began in the right ovary by Day 13, 
with small areas able to be palpated until Day 25, when a 2 
Unit follicle was present which appeared to have ovulated by 
Day 27. By Day 29, several small follicles were present, 
and by Day 33, there was evidence that at least one, though 
possibly more of these had regressed or ovulated. On Day 37 
the left ovary increased in size and two small follicles develop-
ed in the right ovary, and on Day 38, a 2 Unit follicle was 
present in the left and a 1.5 Unit and 1 Unit follicle present 
in the right, These follicles were not present by Day 41, 
suggesting ovulation had occurred. Serum progesterone 
concentrations showed a brief elevation on Days 41 through 45. 
On Day 43, a further surge of follicular development commenced~ 
and by Day 47, a 2.5 and a 14 Unit follicle were present in 
the left ovary, and a 4 Unit follicle in the right. The 2.5 
Unit follicle apparently ovulated by Day 49, and the 14 Unit 
follicle by Day 51. At this time, a marked increase in serum 
progesterone concentrations to very high levels occurred. 
TABLE 47: TANUNDA 
Day of FSH Progesterone 
Pregnancy ng/ml fraction ng/m1 
-2 4.19 0.33 0.80 
-1 4.94 0.39 0.1 
0 8.22 0.65 0.1 
1 5.23 0.41 0.1 
2 8.62 0.68 3.4 
3 11.6 0.87 7.2 
4 8.88 O~ 70 14.0 
5 7.77 0.61 16.8 
6 9.42 0.74 7.2 
7 12.4 0.98 18.5 
9 10,4 0.82 14.4 
11 9.07 0.71 11.5 
13 7.68 0.60 14.7 
---
LH or PMSG 
ng/ml* 
-
33.2 
41. 8 
62.3 
80.1 
56.3 
49.7 
39.2 
28.1 
30.1 
54.2 
25.3 
28.7 
23.3 
Ovaries 
L:Fol1-3, sh 
R:S + H 
L:Fol1-2.5, sh 
R:Fo11-1, fh 
L : Fo 11- 3 , co 11 
R:S + H 
L~Area-2.5. call 
R:S + H 
L:Area-2, sh 
R:S + H 
L:Area-2, sh 
R:S + H 
L:2x2, fh 
R:S + H 
L:Area-1, rubbery 
R:S + H 
L:Fo11-1.5, f 
R:S + H 
L:Area··1, s 
R:S + H 
L:Area-1, call 
R: 2xl, irreg 
'.- -
I 
:;::, 
~~: 
~i: . 
':. :; ~ . 
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w 
TABLE 47 ctd: 
Da) of FSH Progesterone 
Pregnancy ng/mI fraction ng/m1 
15 7.87 0.62 7.32 
16 6.16 0.49 9.2 
19 3.65 0.29 9.07 
21 4.38 0.34 4.59 
" 
23 6.48 0.51 4.13 
25 9.56 0.75 7.2 
27 6.78 0.53 6.4 
29 3.44 0.27 4.53 
31 3.58 0.28 5.2 
33 4.62 0.36 8,13 
35 3.07 0.24 8"27 
37 9.89 0.78 12.2 
~ ---- --~1.-
, 
1H or PMSG 
ng/ml* 
23.8 
33.3 
13.8 
15.5 
22.4 
28.6 
17.1 
24.4 
36.0 
16.4 
31.0 
770.2 
-----
-
Ovaries 
L:Foll-0.5, s 
R:Area-I, sh 
L:Foll-l, sh 
R~2xArea, 1, fh, 1; fh 
L:2xl, irreg 
R:2xArea-I, fh, I, fh 
L:Area-l, s 
R:2x2, irreg 
L:Area-l, s 
R:Area-I, s 
L:Area-I, sh 
R:Foll-2, fh 
L:Area-0.5, s 
R:Area-0.5, s 
L:Foll-1.5, sh 
R:2xFolI-l.5, fh, I, fh 
L:2xFoll, 1.3, s.1.3, s 
R:2xFoII, I, fh, 1.5, s 
L:Foll-I. vs. Area-I.5. sh 
R:2xI, irreg 
L:2xArea-I, s. I, s 
R: 2xI, irreg 
L:4x2,FoII-I.5. sh 
R:2xFoll-I. f. 1. f 
I 
I 
i 
I , 
I 
I 
I 
! 
( 
w 
o 
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TABLE 47 ctd: 
Day of FSH Progesterone 
Pregnancy ng/m1 fraction ng/ml 
38 1207 1.0 4.67 
41 8.99 0.71 9.2 
43 4.52 0.36 14.1 
45 1.42 0.11 15.7 
47 3.18 0.25 4.8 
49 1.77 0.14 10.9 
51 2.42 0.19 21.9 
54 3.96 0.31 22.7 
56 5.84 0.46 19.5 
58 6,39 0.50 11.2 
60 2.47 0.19 14.8 
62 16.9 
LH or PMSG Ovaries 
ng/ml* 
1805.3 L:2xFoll-2, s, 0.5, 5 
R:2xFoll, I, sh, 1.5, fh 
>2000,0 L :Area-1. 5, vs 
R:2x1, irreg 
L:Foll-1.5, vs 
R:2xFollNO.5, fh, 0.5, fh 
L:3xFoll-3, sh, 1.5, sh, 1.5, sh 
R:Foll-2.5 s 
L:2xFoll-2.5, sh, 14, sh 
R~Foll-4, sh 
L:Foll-14, s, Area-2.5, s 
R!12x0, Foll-5, s 
L:Area-B, vs 
R!Foll-12, sh 
L:Bx4 - Areas, 5 and f 
R:Foll-5, s 
L:3xFoll, 2 colI, 2 colI, 1.5, sh 
R:6x4, Fo11-4, 5, Areas 
L:Area-2, vs 
R:3xFoll, 2, s, 3, s, 3, vs 
L:Foll-2.5, vs 
R:Bx4, 2xFoll-4, sh, 3, sh 
L:6x4, Areas - s 
R:6x8, Foll-6, s and Areas 
I 
I 
I 
, 
I 
I 
j 
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"~ 
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TABLE 47 ctd: 
Day of FSH 
Pregnancy ng/ml fraction 
64 5.80 0.46 
66 6.40 0.50 
68 6.60 0.52 
70 6.32 0.49 
72 
74 
---
Progesterone LH or PMSG 
ng/ml ng/ml* 
25.3 
24.8 
8.0 
12.8 
19.1 
15.5 
Ovaries 
L:6x3, Foll-4, fh and Areas 
R:2xFoll, 4, fh, 4, sh 
L:6x3, Foll-2.5, sh and Areas 
R:2xF~11, 3, colI, 3, colI 
L:Foll~3~ s 
R:2xFoll, 2, soft, 1.5, sh 
L:Foll-4, s, 2xArea, 2, sh, 2, sh 
R:5x3, Foll-2, sh 
L:6x3, Foll-3, s 
R:3xl, Area-l.S, s 
, 
! 
I 
I 
I 
I 
I 
UJ 
C) 
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Footnoe: LH/PMSG measured in the Niswender Ovine System 
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The follicle in the right ovary continued to increase after 
Day 47 to be 12 Units on Day 51; thereafter decreasing in size, 
Several 2.5 to 4 Unit follicles were present until the end 
of the experiment on Day 74, some of which appeared to collapse 
or ovulate. Serum progesterone concentrations were generally 
high over this period and showed peaks consistent with second-
ary corpus luteum formation. PMSG was first elevated in serum 
on Day 36 or 37. 
10. Trudys Bye Bye: (see Table 48) 
FSH concentrations were elevated between Days 29~nd 33, - ~ 
with a further surge on Days 43 through 47. Levels were then 
generally high from Days 53 through Day 72 of pregnancy, 
On Day 21, the first day of observation, a 1.5 Unit follicle 
was present which possibly ovulated or collapsed by Day 25. 
A small follicle was palpable in the other ovary between 
Days 27 and 33. On Day 37, a follicle developed which was 
1.5 to 2 Units on Days 37 to 47, after which It either regressed 
or ovulated, However, this follicle may have ovulated prior 
to this, around Day 40, since ovarian palpation did not 
always differentiate a follicle from a newly formed corpus 
luteum. Serum progesterone concentrations increased moderately 
over Days 43 to 49. Further follicular activity commenced 
on Day 57, with the development of a 4 Unit follicle by Day 60, 
which either regressed or ovulated by Day 66, Thereafter no 
further follicular activity occurred until the experiment 
ended. 
PMSG was elevated by Day 36 or 37. 
TABLE 48: TRUDYS BYE BYE 
Day of FSH Progesterone 
Pregnancy ng/ml fraction ng/ml 
21 10.9 0.33 5.33 
22 12.1 0.37 4.53 
25 11. 4 0.35 4.13 
27 9.84 0.30 5.59 
29 16.0 0.49 4.79 
31 16.6 0.5 5.81 
33 15.7 0.48 4.39 
35 10.7 0.33 3.81 
37 8.69 0.26 5.06 
39 8.02 0.24 5.38 
41 8.48 0.26 5.22 
43 15.0 0,46 6.66 
44 25.8 0.78 7.46 
LH or PMSG 
ng/ml* 
20.1 
72.2 
24.6 
35.7 
855.2 
1015.5 
Ovaries 
L:S + H 
R:Foll-1.5, s 
L:Area-0.5, sh 
R:2xArea-1.5, vs, 0.5, £h 
L: 2x1, irreg 
R:Foll-1, fh 
L :Foll-1, s 
R:Foll-O.5, s 
L:Foll-1.5, f 
R:Foll-1, f 
L:Fo11-1.S, vs, Area-I, s 
R:Foll-1, f 
L :Foll-l, s 
R:Foll-0.5, £h 
L:2xl 
R:S + H 
L:Fo11-1.5, £h, Area-I, sh 
R:S + H 
L:Foll-2, sh 
R:S + H 
L:Foll-l. 5, vs 
R:S + H 
L:Foll-1.5, s 
R:S + H 
L:Foll-2, s 
R:S + H 
, 
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.>: 
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TABLE 48 ctd: 
Day of FSH 
Pregnancy ng/m1 fraction 
47 14,9 0.45 
49 10.1 0.31 
51 12.4 0.38 
53 17.9 0,54 
55 30.7 0.93 
57 20.3 0.62 
60 30.1 0.19 
62 32.9 1.00 
64 23.5 0.71 
66 28.4 0.86 
68 28,7 0.87 
Progesterone LH or PMSG 
ng/m1 ng/ml * 
9,73 
8,16 
6,66 
6,66 
6.66 
8.53 
9.06 
7.65 
8.53 
9,91 
8.57 
Ovaries 
L:Foll-1,5 
R:S + H 
L:2x1, irreg 
R:S + H 
L:Area-l, sh 
R:S + H 
L:2x1 
R:S + H 
L:2xl, irreg 
R:S + H 
L:Foll-1.7, sh 
R:S + H 
L :Foll-4, f 
R:S + H 
L:Foll-4, f 
R:S + H 
L :Foll-2, s 
R:S + H 
L :Area-1. 5, sh 
R:S + H 
L :Foll-1, fh 
R:S + H 
w 
o 
\.0 
TABLE 48 ctd: 
Day of FSH Progesterone LH or PMSG 
Pregnancy ng/m1 fraction ng/ml ng/m1 * 
70 29.8 0.91 7,57 
72 21.1 0.64 7,35 
74 14.4 0.44 9.86 
* Footnote: LH/PMSG measured in the Niswender Ovine System 
Ovaries 
I 
L:2x1. irreg I 
R:S + H ! 
L:2x1. H 
R:S + H 
:';: 
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11. Winabe'll: (see Table 49). 
A surge in serum FSH concentrations occurred between Days 5 
and 10, with the peak level occurring on Day 6. Levels were 
then generally low, but an elevation occurred on Days 36 and 
38, on Day 46, and Days 50 to 52. A marked increase occurred 
on Days 63 to 65, with a smaller increase on Days 69 to 71. 
The ovaries were generally large and irregular, but by 
Day 18, a follicle commenced development, reaching 2.5 Units 
by Day 28, thereafter regressing or ovulating. The other 
ovary (right) developed a 1. 5 Unit follicle on Day 32, 
which increased to 2.5 Units on Days 40 to 41 and then 
regressed or ovulated. In the left ov'ary, a follicle commenced 
development on Day 40 and was 1.5 to 2 Units from Days 41 
to 46 when it appeared to ovulate. Little activity occurred 
until Day 59 when a 2 Unit follicle developed, which became 
very soft in tension by Day 62 and then possibly ovulated. 
The ovaries were 2xl and irregular at the end of observations 
on Day 71. The timing of the elevation in serum concentrations 
of PMSG could not be determined precisely, since the Human 
System for measurement of LH/PMSG (used in this instance) 
is not as sensitive as the Niswender Ovine System, A gradual 
increase in LH/PMSG was observed from Days 38 through 46 and 
PMSG was definlLely present after Day 46. 
12. Young Anne: (see Table 50). 
Serum FSH concentrations were increased from Days 6 
through 10 following conception, after which the levels were 
low until a prolonged surge occurred between Days 36 and 54, 
with a peak on Day 48. 
A follicle which was present in the left ovary around 
TABLE 49: 
Day of FSH 
Pregnancy ng/rnl fraction 
-1 11. 3 0.30 
0 6.48 0.17 
1 5,14 0.14 
2 9.90 0.29 
3 11. 7 0,31 
4 10.9 0.29 
5 17.9 0.48 
6 21.5 0.57 
7 11.2 0.30 
8 13.4 0.36 
9 13.3 0.36 
10 16,4 0.44 
12 5.15 0.14 
WINABELL 
Progesterone LH or PMSG 
ng/rnl ng/rnl * 
157.0 
1,20 188.8 
1.47 194.8 
2.13 200.0 
4.39 180.0 
5.05 75.3 
4.80 88.1 
6.44 99.2 
6.44 27.3 
10.6 26,4 
7.18 22,9 
9.18 21.2 
6.38 12.1 
-~ 
Ovaries 
L:Fo11-1.7, sh 
R:S + H 
L:Fol1-3. vs 
R:S + H 
L:Area-1, vs 
R:3x1, irreg 
L:Area-l, s 
R:2x1, irreg 
L:Area-1.5, call 
R:2x1, irreg 
L:3x2, H 
R:2x1, Area, 1, sh 
L:2x2 .• H 
R:2x1 
L:3x2, H + irreg 
R:2x1 
L:2x2. H 
R:2x1, irreg 
L:2x1, irreg 
R:Area-1, sh 
L:2x2, irreg 
R:Area-l, sh 
I 
I 
I 
I 
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TABLE 49 ctd: 
Day of FSH 
Pregnancy ng/ml fraction 
14 14.0 0.37 
16 6.49 0.17 
18 10.5 0.28 
19 10.2 0.27 
22 13.5 0.36 
24 5.76 0.15 
26 10,4 0.28 
28 8,61 0.23 
30 4.64 0.12 
32 4,92 0,13 
34 7.28 0.19 
36 13.1 0,35 
Progesterone LH or PMSG 
ng/m1 ng/ml* 
7.05 
2.39 
3.06 
2.93 
3.19 
4.26 27.2 
3.46 35.3 
4.66 28.4 
4.26 31. 2 
2,66 39.7 
2.39 45.4 
3,59 34.2 
Ovaries 
L:2x3. irreg 
R:2x3, irreg 
L:2x2, irreg 
R:2x2, irreg 
L:Foll-l. f 
R: 2x2, irreg 
L:Fo11-2, fh 
R:2x1, irreg 
L:Foll-2. ~ 
R:2xl, irreg 
L:Foll-2, s 
R:2x2, irreg 
L:Foll-2.5, sh 
R:2x1, irreg 
L:Foll-2.5, s 
R:Area-1, s 
L:2xFo11-1.s, s. 1.5, sh 
R:2x1. irreg 
L:Foll-L5, sh 
R:Foll-1.5, s 
L:Foll-1.5. fh 
R:Foll-L5, sh 
L:Tri-lobed, Fall-I, f 
R:Foll-1.5, sh 
I 
, 
w 
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TABLE 49 ctd: 
Day of FSH Progesterone 
Pregnancy ng/m1 fraction ng/ml 
38 17.3 0.46 3,46 
40 7.54 0.20 5.05 
41 4,89 0.13 3.19 
44 7.97 0.21 4.79 
46 18.4 0.49 6.12 
48 6.57 0.18 5.72 
50 19.2 0.51 7,98 
52 17.5 0.47 8.11 
54 8.08 0,22 7.58 
57 7,24 0.19 6.78 
59 8.12 0.22 7.32 
61 5.91 0.16 12.0 
LH OI PMSG Ovaries 
ng/1II1 * 
53,3 L:3xl, irreg 
R:Foll-1.5, s 
53.4 L:3x1, irreg, FoIl-I, f 
R:2xFoll-2.5, vS J 1, f 
48.2 L:Foll-2, fh 
R:2xFoll-2,5, s, 1, fh 
66.8 L :Foll .. 1.5, sh 
R:2xPQl1-l.5, sh, 1, fh 
67.0 L:Foll-2, sh 
R:Foll-l, sh 
96.6 L:Area-l, s 
R:Foll-l, fh 
92.9 L: 3xl. 5, irreg 
R: Foll-l) f 
141.4 L:Area-l, sh 
R:Foll-l, fh 
147.8 L: Foll-2, coll 
R:Foll-l, fh 
147.0 L:3x1 
R:2xl, irreg 
145.7 L:4x2, FoI1-2, sh 
R:2x1, irreg 
131.5 L:Foll-2.5, s 
R:S + H 
-
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TABLE 49 ~td: 
Day of FSH Progesterone LH or PMSG Ovaries 
Pregnancy ng/ml fraction ng/ml ng/ml* 
63 3704 LO 23 01 14907 L:Foll-2, vs 
R:2xl, irreg 
65 2403 0,65 9098 134.5 L:Area-1, sh 
R:2x1, irreg 
67 10.8 0.29 7.32 132.2 L:Area-1, s 
R: 2x1, irreg 
69 18.6 0,50 8.11 150.8 
71 17.6 0.47 10.2 L:2x1, irreg 
R:2xl, irreg 
* 
Footnote: LH on Days -2 through 12 measured in the Niswender Ovine System. while LH/PMSG 
on Days 24 through 69 was measured in the Human System 
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TABLE 50: YOUNG ANNE 
Day of FSH Oestradiol-17B 
Pregnancy ng/m1 fraction pg/ml 
-1 11.4 0.35 
0 15.5 0,47 
~-
1 16.3 0.50 
2 16.4 0.50 
3 14.4 0.44 
4 14.3 0,44 
5 11.9 0.36 
6 20.0 0.61 
7 22.6 0.69 
8 17.3 0.53 
9 19.5 0.59 10,9 
10 20,1 0.61 10,8 
12 14.2 0.43 9.7 
Progesterone 
ng/ml 
0.1 
0.75 
0.39 
3.3 
4.75 
4.67 
5.01 
4.32 
4.40 
4.14 
Ovaries 
L:Foll-I, fh 
R:Foll-1.5, sh 
L:2xI, irreg 
R:FoIl-I.5, fh, Area-colI 
L:Area-I, fh 
R:Area-I, coIl 
L:2xI, irreg 
R:Area-l, colI 
L:Foll-I, sh 
R: 
L:Foll-1.5, sh 
R:Foll-I, f, Area-I, coll 
L:Area-I, s 
R:Area-0.5, vs 
L:Area-I, fh 
R:Area-I, coll 
L:Area-I, s 
R:2x1, irreg 
L:2xArea, 1, sh, 1, sh 
R:Area-1, vs 
::: ; 
, 
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TABLE 50 ctd: 
Day of FSH Oestradiol-17B 
Pregnancy ng/ml fraction pg/ml 
14 16.0 0.49 10.3 
16 13.0 0.40 83.2 
18 11.9 0.36 12.1 
19 9.8 
22 1108 0.36 13.1 
24 17.8 0.54 13.5 
26 9.63 0.29 14.8 
28 13.1 0.40 7.9 
30 10.7 0.32 8.4 
32 12.5 0,38 13.6 
34 6.82 0.21 27.6 
36 17.3 0.53 16.1 
(" 
Progesterone 
ng/ml 
3.99 
3.95 
1025 
1039 
2.D5 
3.33 
4.80 
4.53 
5.07 
3.4 
6.0 
2.99 
--
Ovaries 
L:Area-1.5, s 
R:Area-O.5, sh 
L:2xFo11-1, f, I, f 
R~Fo11-1.5, fh, Area-I, s 
L:2xAreas-1.5, sh, 1.5, sh 
R:Fo11-2, sh, Area-0.5, s 
L :Area-1.5, s 
R:Foll-2, sh 
L:2x1, irreg 
R:Foll-2.5, sh 
L:2x1, irreg 
R:Foll.2, vs 
L:2xl,irreg 
R:3xFoll-3, s, 1,5, sh, 1.5, sh 
L:2x1, irreg 
R:2xFo11, 3, s, 2.5, sh, Area-I.5, s 
L:S + H 
R:2xFo11, 2, s, 3.5, vs 
L:S + H 
R:2xFoll-2, s, 2,5, sh, Area-I, s 
L:S + H 
R:2xFoll, 2, sh, 2.5, vs 
L:S + H 
R:2xFol1-1.S, sh, 3. vs 
----- -- -
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TABLE 50 ctd: 
Day of FSH Oestradiol-17B 
Pregnancy ng/m1 fraction pg/m1 
38 19.2 0.59 17,4 
40 17.4 0.53 9.3 
41 12.4 0.38 13.1 
44 19.4 0.59 9.9 
46 19.9 0.61 21.5 
48 32.8 1.0 15.2 
50 16.7 0.51 13.9 
52 21.2 0.65 20.5 
54 20.4 0.62 21.4 
57 12.9 0.39 18.3 
59 11. 3 0.34 20,8 
61 8,57 0,26 21,3 
Progesterone 
ng/ml 
3.15 
2.88 
4.0 
7.73 
19.7 
22.9 
25.1 
18.1 
8.40 
14.7 
11.1 
13.6 
Ovaries 
L:Area-l, fh 
R:2xFoll-I.5, fh. 3, colI 
L:2xFoll-l. f. 1.5, s 
R:Foll-1.5, sh 
L:2x1. Area-I, fh 
R:FoI1-2.5, colI, 1.5, fh 
L:Area-I, fh 
R!Foll-2.5, colI 
L:2xl, irreg 
R:Foll-3, vs 
L:Area-l, s 
R:Area-2, col1 
L:2xl. tri-Iobed 
R:Fol1-I.5, coll 
L:2xl, irreg 
R:Area-l, s 
L:2xl, irreg 
R:Area-1. s 
L:2xl, irreg 
R:Area-0.5. s 
L:2xl. irreg 
R:Foll-I.5, fh. Area-0.5, colI 
L:2xFoI1-2, sh, 1, vs 
R:2xFoll-2, sh, 2, s 
/ 
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TABLE 50 ctd: 
Day of FSH Oestradiol-17B Progesterone 
Pregnancy ng/ml fraction ng/ml ng/ml 
63 10.2 0.31 5.2 11,3 
65 7.76 0.24 1604 13.3 
67 5.53 0.17 15.9 14.9 
69 10.1 0.31 15.5 
Ovaries 
L:2xFoll-3, fh, 1.5, s 
R:4x3~ 2xFo11-2, s, 1.5, fh 
L: 10x6. s Areas 
R:6x4, Area-2, vs, Foll-2,_s 
L:3xFoll-6, vs, 4, s, 2, s 
R:3xFo11-1.5,s, 1, sh, 1.5, fh 
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the time of ovulation (from the right ovary) reached a size 
of 1.5 Units on Day 5, and appeared to ovulate or regress 
by Day 6, Several follicles or areas were- present in the 
left ovary from Days 12 to 19, while in the right, a follicle 
commenced development on Day 16 reaching 2.5 Units on Day 22, 
Thereafter, its fate could not be determined because of the 
concomitant levelopment of two further follicles in this 
ovary, in which a 3 to 3.5 Unit follicle could be palpated 
until Day 30. An ovulation of one of these follicles in the 
right ovary appeared to occur by Day 32, with a further possible 
ovulation of a 3 Unit follicle by Day 38. A marked increase 
in serum progesterone concentrations commenced on Day 41, 
Little ovarian activity was palpable until Day 59, when several 
follicles commenced development, and by Day 65, the ovaries 
were very large (10 x 6 Units and 6 x 4 Units), and contained 
several follicles up to 6 Units in diameter, These structures 
were still present at the completion of the study on Day 67, 
The FSH and LH results in the mares studied during the 
periparturient period are shown in Fig. 34. Although no clear 
pattern emerges from these results, it is evident that in these 
mares in which it was measured, serum FSH concentrations 
show a three fold surge at some stage over the period between 
Days 4 and 20 prior to parturition. In all mares, with the 
exception of Ar Miss, a marked surge of FSH occurred within 
4 days prior to parturition (mean occurrence was two days 
before parturition), which, when averagedfor all the mares 
was five times the lowest level occurring over the preceding 
1 to 3 weeks. The only mare in which this pre-parturient 
surge did not occur was Ar Miss, who aborted due to 
FIGURE 34: 321 
Periparturient mares 
FSH -.t.I-------,-----:----:----~ 
30 Ar Miss not matad this oestrus !\A A /. 
Nota: mere aborted dUB 
to rh!nopneumonitis 
10 VtrlJ$ 
Frozina 
Light 'n Free 
:---/~~ 
/ V '/ "-.II .--11 
.......... -.~--....................... ... - ..... ' 
did no.t conceive.to this oestrus 
conce/wd 'atar In 58ason 
".---.---.-.' , ..... ~~ . --- ,.-.--.-.-.. 
Miss Balmain 
Module 
conceived at this oestrus 
True Lustre 
-25 -21 -17 -13 -9 -5 -1 5 9 
Days before foaling 
Parturition Days after foaling 
17 
10 
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rhinopneumonitus virus infection (conceived 11~12-74, foaled 
9-11-75) and in this mare, a marked surge of PSH was observed 
three days after parturition, Excluding Ar Miss, all mares 
had a further smaller surge of PSH 1 to 5 days after foaling 
(mean peak was 3 days after parturition). Therefore, on 
average, there was a 5 day interval between the pre-parturient 
and this first post"parturient FSH surge in all mares. In 
Ar Miss, an FSH surge was observed peaking on Day 8, 6 days 
after her preceding FSH surge 2 days after foaling, 
The mares c~me into oestrus at variable times after 
parturition, from Days 6 to 11" with ovulations occurring 
between Days 9 and 15, Serum concentrations of FSH were 
generally low during the early oestrous period, as occurs in 
the normal cycle (see Chapter IV), and where measured, serum 
LH concentrations increased just prior to, and following 
ovulation. Conception to this post- parturient ovulation 
occurred in Miss Balmain, Module, and True Lustre while 
Carol Time and Ar Miss were not mated, but Ar Miss conceived 
at the next oestrus. Frozina and Light'n Free both 
conceived later in the season, 
323 
DISCUSSION 
Since three of the twelve mares studied in early pregnancy 
conceived at an ovulation induced by exogenous GnRH, the results 
from these animals were considered separately to the remaining 
mares. 
The group of nine mares showing spontaneous cyclicity 
prior to the ovulation resulting in conception comprised Ar 
Miss, Betty Patch, Carol Time, False, Gay Fleur, Golden Road, 
Miss Balmain, Trudys Bye Bye and Young Anne. In this group 
. six mares were s~~died from the day of conception onward (Ar 
Miss, Betty Patch, Carol Time, False,Miss Balmain and Young 
Anne) and every mare showed an FSH surge between Days 4 and 
16, with the mean day of the peak occurring on Day 8 of 
pregnancy. This FSH surge was not accompanied by 
any palpab~e follicular growth, the surge appearing analagous 
to that occuring in the cycling mare about 8 to 9 days after 
the preceding ovulation (see Chapter IV). However, in five 
of these mares, a typical pre~ovulatory follicle (as determined 
by palpation) had developed by approximately Day 23, which 
is similar to the follicular growth observed in normal cycling 
mares, The sixth mare, Miss Balmain, in whom development of 
small follicles only began on Day 25 had a typical pre-ovulatory 
follicle of 3 Units by Day 33, It is possibly noteworthy 
that this mare had c(!mcei ved at an ovulation "induced" by PG, and 
this ovulation occurred 12 days after the preceding ovulation, 
thereby shortening the inter-ovulatory interval by 10 days. 
On the basis of the hypothesis advanced in Chapter IV - that 
the development of pre-ovulatory follicles depends on priming 
r.<".-:';·:".-.·-'.·-"_" 
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by two or more surges of FSH, one could postulate that in 
this mare, the absence of a palpable pre-ovulatory follicle 
by Day 23 could be due to the absence of an adequately FSHM 
primed follicle (see Chapter IV). The three mares in which 
observations began at 18 to 21 days of pregnancy also developed 
typical pre-ovulatory follicles by around Day 23 of pregnancy, 
Although not able to be definitively ascertained by 
ovarian palpation, it appeared that in two mares (Carol Time 
and Trudys Bye Bye) these pre-ovulatory follicles ovulated 
before Day 25, while in four of the remaining mares, the 
follicles seemed to slowly regress over the period until 
between Days 27-34 (Ar Miss, Betty Patch, Gay Fleur and Golden 
Road). In False and Young Anne, the follicle appeared to 
develop further and ovulate or collapse by Days 29 and 32 
respectively. In False, this ovulation was preceded by 
a marked surge in serum oestradiol-17B concentrations. None 
of these apparent ovulations resulted in the formation of 
secondary corpora lutea as assessed by serum progesterone 
concentrations. 
The FSH pattern in the mares from Day 16 of pregnancy 
onward was particularly variable. Four mares showed an 
increase in serum FSH concentrations at some time between 
Days 20 to 27 (Ar Miss, False, Gay Fleur and Golden Road), 
while Betty Patch and Carol Time showed a prolonged increase 
beginning on Day 21 and 23 respectively. Trudys Bye Bye 
had an FSH increase on Days 29 through 33, while Miss Balmain 
and Young Anne showed no elevations until later in the study. 
Similarly the follicular development in the mares was 
variable. Nonetheless Ar Miss, Betty Patch, Gay Fleur, Golden 
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Road and Young Anne showed an increase in follicular development 
over the period between 25 and 40 days, with Betty Patch and 
Gay Fleur appearing to ovulate these by Day 35, and in Ar Miss, 
Golden Road and Young Anne by Day 39. In Betty Patch and Gay 
Fleur, these apparent ovulations occurred before PMSG was present 
in serum, whereas in Ar Miss and Golden Road the ovulations 
occurred after the PMSG increase and although not measured 
in Young Anne, it would be expected that PMSG was also 
elevated in this mare prior to the ovulation. Secondary corpora 
lutea (as determined from serum progesterone concentrations), 
were probably formed in Ar Miss, Betty Patch, GQlden Road and 
Young Anne. While PMSG may have been fundamental in the 
formation of these secondary corpora lutea, a luteotrophic 
action of the PMSG on the primary corpus luteum cannot be 
discounted. In Betty Patch, this luteotrophic action may 
have been exerted on a secondary corpus luteum from the 
Day 35 ovulation which formed prior to PMSG. Serum FSH 
concentrations increased following the ovulations in 
Ar Miss, Golden Road and Young Anne, but the levels remained 
uniformly elevated in Betty Patch. 
Of the remaining mares Carol Time ana Trudys Bye Bye 
developed only small follicles over this period. whereas 
there was littJp. activity in the ovaries of Miss Balmain 
except the changes occurring following the ovulation or 
regression of the pre~ovulatory-like follicles present on Day 33. 
Serum FHS concentrations in these three mares were markedly 
different, with Carol Time having a prolonged surge (Days 23 
to 38), Trudys Bye Bye a surge on Days 29 to 33, and Miss 
Balmain showing no elevation at all. There was a further 
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surge of follicular activity in all except three mares around 
Days 42 to 49. This surge in Ar Miss, Betty Patch, Gay Fleur, 
Miss Balmain and Trudys Bye Bye resulted in apparent 
ovulations around Day 47 in Ar Miss, Gay Fleur and Trudys 
Bye Bye, with concomitant increases in serum progesterone 
concentrations. In Betty Patch and Miss Balmain, it was not 
evident whether the follicle(s) that developed ovulated 
or regressed, It is possibly relevant that in the three 
mares ovulating and establishing seconder>' corpora lutea, surges 
of FSH occurred around the time of this ovulation, as occurs 
near ovulation in the normal cycle (see Chapter IV); 
however, no surges occurr~d in Miss Balmain over this period, 
while the levels in Betty Patch remained consistently elevated o 
Of the three other mares Carol Time showed development of only 
small follicles over the period 30 to 49 days, while 
Golden Road and Young Anne had virtually no palpable follic-
ular activity. 
Six of the seven mares remaining in the study had 
another surge of follicular activity at some time after 
Day 50 0 In Ar Miss, a surge occurred between Days 49 and 
53 and again between Days 67 and 70 with an FSH increase 
occurring concomitantly with each surge, In Betty Patch, 
a large (5 UniL) follicle developed which ovulated by Day 55, 
prior to which serum FSH concentrations were decreased, increasing 
again after this ovulation. In Miss Balmain, marked growth 
occurred after Day 61, with ovulation of a 6 Unit follicle and 
subsequent secondary corpus luteum establishment occurring 
around Day 64. The serum FSH concentrations in this mare 
showed only one day peaks ih Days 67, 75, 82 and 86, 
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Similarly Trudys Bye Bye had a large (4 Unit) follicle present 
on Day 62, which subsequently ovulated, Serum FSH 
concentrations in this mare were elevated from Days 53 through 
72. In Carol Time, a 2,5 Unit follicle was present by Day 55, 
but this appeared to ovulate by Day 59, with serum FSH levels 
elevated from between Days 57 thr~)Ugh 66, Young Anne sh(!)wed 
marked follicular proliferation beginning on Day 59, the size 
and number of these making palpation to determine ovulation 
difficult; however, the surges in serum progesterone concentrations 
would indicate at least one, though possibly more secondary 
corpora lutea formed. In most mares, follicular activity 
decreased around Day 70, the ovaries becoming small and hard, 
In the two mares studied throughout the entire pregnancy, a 
diminution in serum FSH concentrations occurred in Miss Balmain 
from the fourth through the tenth month, whereas elevations 
continued as prolonged but infrequent surges in Carol Time, 
It is of interest that pronounced follicular activity was 
still occurring in Carol Time until the time when palpations 
became impossible with marked activity on Days 86 to 91, whereas 
the ovaries of Miss Balmain contained no follicles greater 
than 1 Unit after Day 71. 
In the thr~e mares in which the ovulation resulting in 
conception was induced by exogenous GnRH administration, FSH 
surges occurred between Days 6 and 11 in each mare, Follicular 
growth commenced by Days 13 to 18, with the development of 
a 2 to 2,5 Unit follicle by Days 25 to 28, The fate of this 
follicle was different between mares. In Contraband, the 
follicle possibly ovulated by Day 36, the time at which PMSG 
, ---- <-": ~ " -
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levels were first elevated, and appeared to form a corpus luteum. 
In Tanunda, the follicle appeared to ovulate by Day 27. while in 
Winabell, it app~ared to ovulate or to regress after Day 28. In 
the two mares in which ovulations were thought to have occurred 
there was a concomitant surge in serum FSH levels. Tanunda showed a 
further increase in follicular activity between Days 29 and 33, with 
ovulations possibly occurring. An FSH surge occurred in all three 
mares between approximately Days 35 and 40, and follicular develop~ 
ment also increase at this time, with Winabell ovulating or 
regressing a follicle near Day 40, and a further follicle by Day 48, 
Contraband appearing to ovulate and establish a corpus luteum by 
Day 44. and Tanunda ovulating by Day 41 with a concurrent progest-
erone increase. After this time.both FSH and ovarian changes were 
markedly di fferent between the mares 0 In Contraband, Ii ttle 
ovarian activity occurred after the ovulation on Day 44, and 
serum FSH concentrations were elevat.ed from Days 50 through 71. 
In Tanunda, extremely large follicles developed from Day 44 through 
74, with several ovulations occurring resulting in corpus luteum 
establishment and in this mare, serum FSH concentrations remained 
low. In Winabell, follicular activity occurred between Days 59 and 
62, with an ovulation around Day 61 and a concurrent increase 
in serum progesterone concentrations and this was preceded and 
f'o 11 owed' by an FSH surge. The finding of development of follicles up 
to pre-ovulatory sf ze during the first month of pregnancy prior to 
the appearance of PMSG agrees with the findings of others 
(Allen, 1974; Bain, 1967; Cole et aZ, 1931; and van 
Niekerk,1965), Since surges of FSH continue to occur 
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during this period and since comparable surges have been 
shown to cause the development of pre-ovulatory follicles in 
the normal cycle (see Chapter IV), it seems likely that this 
follicular growth in early pregnancy is caused by these 
repeated FSH surges, this study of the relationship between 
serum FSH concentrations and ovarian activity thus supports 
the hypothesis of van Rensberg and van Niekerk (1968) ~ that 
the waves of follicular growth and oestradiol synthesis 
(wi thin the follicles) commencing at about 2, 12, 22 and 32 
days post-ovulation in the pregnant mare indicates a cyclical 
pituitary release of gonadotrophins every 10 days. Since 
the present study shows that serum LHconcentrations are low 
during the first month of pregnancy, the gonadotrophin must 
be FSH. 
In the present study, it was evident that an FSH surge 
occurred in all mares around Day 8 after conception, and 
although some mares continued to exhibit surges of FSH at 
approximately 10 day intervals as occurs in the normal 
cycling mare (see Chapter IV), there was marked asynchrony 
in the timing of these surges between mares. If a relationship 
exists between a developing follicle and FSH secretion, such 
as a negative feedback on the pituitary or hypothalamus 
mediated by steroids produced by the follicle, then asynchrony 
of the timing of the FSH surges after Day 20 could be due 
to differing degrees of maturity of the follicles and their 
steroidogenic competence. The data reported herein support 
this suggestion, in that the fate of the pre-ovulatory 
follicle present in most of the pregnant mares by Day 22 was 
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variable between mares, appearing to either ovulate, regress 
or persist until ovulating at a later time. Also, the serum 
oestradiol~178 concentrations over this period are quite 
different between mares (viz False, Table 43 
and Ar Miss, Table 39). 
One consistent aspect of the fate of follicles prepared 
and primed to pre-ovulatory size by FSH during the first 
month of pregnancy is that such follicles, although undergoing 
changes indistinguishable from ovulations, as shown in 
the present study and by Allen (1974), do not form secondary 
corpora lutea. This has been established by studies showing 
that only the primary corpus luteum is present up until after 
Day 40 (Cole et aZ, 1931 and Squires et aZ, 1974a). However, 
it was shown in Chapter IV that a secondary corpora luteum 
formed in a mare with a retained corpus luteum (see False, 
Table 36 and Fig.31 ), indicating that corpora lutea can occas-
ionally be established in the presence of high levels of 
progesterone and in the absence of PMSG. This is analagous 
to the mid-luteal phase ovulations occurring in the cycling 
mare, which also form corpora lutea. 
However, when serum PMSG concentrations become elevated, 
it appears that previously FSH"prepared and primed follicles 
undergo pal~able changes indicative of ovulation, and 
establish secondary corpora lutea as evidenced by an increase 
in serum progesterone concentrations, Therefore, it appears 
that in the mare, PMSG may have an LH-like action, simulating 
the effect that LH has on similarly FSH~prepared and primed 
follicles during the normal ovulatory oestrous cycle 
(see Chapter IV). In this way, PMSG may cause the final 
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maturation, ovulation and corpus luteum establishment of these 
follicles. Cole et aZ (193l)p although only able to 
determine the presence of PMSG in serum, and not pituitary 
gonadotrophic hormone concentrations, similarly suggested 
that PMSG may result in the "luteinization phenomenon". In 
their study (Cole et aZ, 1931), they observed that during 
the first 40 days of pregnancyllripe follicles are being 
produced periodically"and that "this is ana1agous to the condition 
in the non-pregnant animal", but when the blood serum becomes 
positive (i.e. PMSG levels become elevated as determined by 
bioassay) luteinization occurs. 
However, in the intervening years-, this observation 
appears to have lacked further confirmation. The fact that 
PMSG has follicle stimulating effects in many animals has 
led, as Bain (1967) noted, to the specious form of reasoning 
associating ovarian activity in the pregnant mare with the 
appearance of the PMSG in the serum, and the observations 
of Cole et aZ (1931) have been overlooked. 
From the results presented in this present study, 
however, a role of FSH in the follicular proliferation during 
pregnancy is evident, both prior to the appearance of 
PMSG, and subsequent to it, since FSH surges occur at 
least until Day 70. That PMSG acts primarily as an LH-1ike 
hormone is substantiated both by increases in serum progest. 
erone concentrations occurring after the appearance of PMSG 
(Holtan et aZ, 1975, Squires et aZ, 1974c), and by the finding 
on necropsy of secondary corpora lutea in the ovaries of 
mares after Day 40 of pregnancy (Squires et aZ, 1974a). 
Furthermore, the marked increase shown in the present study of 
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the size of the individual follicles present when PMSG 
concentrations increase, is similar to the marked increase 
in the ovulatory follicle during oestrus in the cycling mare. 
when LH concentrations increase (see Chapter IV), 
Some support for these proposed roles of FSH and PMSG 
in early pregnancy in the mare can be obtained from the 
data of other workers. Allen (1974) pobserved that mares 
conceiving towards the end of the physiological breeding 
season rarely ovulate and form secondary corpora lutea in 
early pregnancy, despite the fact that PMSG levels were normal, 
It is shown in Chapter VI herein, and also in one of the pregnant 
mares sampled throughout pregnancy in this study (Miss Balmain) 
that FSH surges typical of the cycling mare cease during the 
physiological non-breeding season, Therefore, one can 
postulate that mares conceiving late in the breeding season 
in Allen's (1974) study did not have any adequately FSH-prep-
ared and primed follicles to undergo final maturation and 
ovulation when serum PMSG concentrations increased, 
In a study comparing the ovarian activity in hysterect~ 
omized mares and pregnant mares during the breeding season 
Squires et aZ (1974b) showed that follicular growth is 
comparable in both groups, but that secondary corpora lutea 
are formed only in the pregnant mares who produce PMSG. This 
provides further support for the concept that it is FSH 
which stimulates follicular growth in early pregnancy, and 
that PMSG has an LH-like action on these follicles, Squires 
and Ginther (1975) also observed that the primary corpus 
luteum regressed in size and secretory activity much earlier 
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in hysterectomized than pregnant mares (before the formation 
of secondary corpora lutea, but when PMSG levels had increased 
in the pregnant mare~ suggesting that PMSG may also be 
lute0trophic in the mare. A similar role of PMSG was 
proposed by Cole et aZ (1931). 
While this present study has clarified the hormonal 
control of the ovarian events associated with early pregnancy 
.,. 
in the mare. It does not indicate why secondary corpora 
lutea need to be established. Since van Rensburg and vah Nierkerk 
(1968) showed that the primary corpus luteum of pregnancy 
does not regress at about Day 40 then these secondary corpora 
are not established to take over the rple of the primary corpus 
luteum. Indeed Squires et aZ (1974a) have subsequently shown 
that all corporalutea (primary and secondary) persist for the 
same length of time (Days 180 to 220), 
Clearly the formation of secondary corpora lutea together 
with the elevation in PMSG results in an increased serum prog-
esterone concentration, the levels of which are quite low prior 
to Day 40 as shown in the present study and by Holtan et aZ 
(1975). The preliminary findings of this study indicate that 
during early pregnancy in the mare, the repeated FSH surges 
stimulate follicular growth so that serum concentrations of 
oestradiolN17S can reach concentrations as high as those 
preceding ovulation in the normal cycle, Thus it could 
be postulated that the function of the secondary corpora 
lutea is to increase serum progesterone concentrations to 
maintain the ratio progesterone: oestradiol"17S within limits 
compatable with early pregnancy, It this is true, it could be 
argued that mares conceiving near the end of the physiological 
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breeding season in which Allen (1974) found no secondary corpora 
lutea formed~ could not maintain pregnancy. However~ the 
failure of these mares to establish secondary corpora lutea 
appears to have been absence of appropriate FSH surges. There" 
fore, it is unlikely that follicles adequately mature to produce 
high concentrations of oestradiol-17S would ever develop, 
and therefore, the ratio progesterone: oestradiol-17S would 
remain consistent with continued pregnancy. 
Although the variability in these results1does not 
allow definitive interpretation, it is evident that in 
the first month of pregnancy in the mare when serum LH 
c0ncentrations are generally low, repeated FSH surges alone 
are sufficient for follicular development, and at times 
ovulation, but no for luteinization or corpous luteum estab-
lishment as ascertained from serum progesterone concentrations. 
However, after Day 35, when PMSG is present, ovulations do 
result in the formation of secondary corpora lutea. 
From the study of mares during the peri-parturient 
period, it was evident that FSH surges do occur prior to 
parturition when oestrogen levels are high (Nett et aZ, 
1975) and that such surges are responsible for the develop-
ment of the several I to 4 cm follicles observed in mares necropsied 
at parturition (Professor C.H.G. Irvine's and author's unpublished obser-
vations). The post-parturient FSH surge may prime these prepared 
follicles for ovulation 9 to 15 days after parturition. These observ-
ations are consistent with the findings in the cycling mare; that at 
least two, though possibly more preparative and priming surges of 
FSH must occur before final maturation. 
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CHAPTER Vt 
R4 
THE INDUCTION OF FOLLICULOGENESIS 
AND OVULATION IN THE ACYCLIC MARE WITH 
EXOGENOUS GONADOTROPHIN RELEASING HORMONE 
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INTRODUCTION 
In the Southern Hemisphere below the Tropic of Capricorn, during 
the winter months mares grazing on pasture may become acyclic, as 
evidenced by a fall in the frequency of ovulations to an average of 
21.85% over the months of June, July, August and September (Osborne, 
1966). Typically, mares ovaries become smaller than during the physiol-
ogical breeding season and are devoid of developing follicles leaving 
only hard stromal tissue (Van Niekerk et at, 1973bl and the mares fail 
to exhibit normal oestrous behaviour. While one can postulate that 
this cessation of cyclic follicular development and ovulation is due 
to a decrease in the level of the, gonadotrophins or absence of typical 
cyclic surges, which in turn is the result of a lowered or changed 
production of the gonadotrophin releasing hormone(s) (GnRH) , such a 
hypothesis cannot be substantiated until (i) these postulated differences 
between cyclic and acyclic mares can be confirmed by hormone assay, 
and eLi) administration of exogenous hormones to acyclic mares so as to 
produce the levels of the cyclic mare induces typical behavioural and 
ovarian cyclicity. 
In this study, the latter approach was pursued in an endeavour 
to induce follicular development and ovulation in acyclic mares with 
appropriate administration of exogenous GnRH (LH-RH, Hoechst), 
designed to reproduce the FSH and LH concentrations occurring during 
the normal ovulatory cycle. It was hoped that such a study would 
clarify whether (i) the absence of follicular growth and ovulation 
in the mare during the physiological non-breeding season is caused 
by a decline in the production of GnRH and, therefore, a cessation of FSH & 
LH changes typical 0f the normal cycle (ii) the FSH, LH and progesterone 
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changes occurring during the ovulatory cycle as defined in Chapter IV 
are in fact responsible for stimulating follicular growth, maturation, 
ovulation and corpus luteum establishment (iii) follicular growth and 
development culminating in ovulation and corpus luteum establishment can 
be induced in acyclic mares by reproducing with exogenous GnRH and 
progesterone, the hormonal changes occurring in the ovulatory cycle 
(iv) a single gonadotrophin releasing hormone (GnRH) can reproduce 
the FSH and LH changes typical of the ovulatory cycle. 
The occurrence of seasonal acyclicity in the mare has frequently 
been described, and variably termed "seasonal anoestrus", "anoestrum" 
and "winter anoestrus". The term "anoestrus" to describe acyclicity 
occurring in the winter/early spring months is a misnomer, both because 
the genuinely acyclic animal shows oestrus without any concomitant 
palpable follicular growth (Ginther, 1974; Gallagher, 1975) and also 
because "anoestrous" mares are not necessarily acyclic, since some 
mares show absence of oestrous behaviour during the winter months although 
cycles of follicular development still occur (Hughes et at, 1972b), 
For the purpose of this study, emphasis was placed on the degree of 
ovarian activity during the winter/early spring months, since this is 
a more appropriate indicator of how season is affecting gonadotrophic 
hormone production, Therefore, any reports by other workers 
describing and characterising "winter anoestrus", were considered 
relevant to the present study when applicable to "acyclicity" 0 
Ginther (1974) studied 14 mares (large ponies or pony/horse crosses) 
over a 12 month period, and defined the mean winter anoestrous 
season as lasting 214 ~ SO days, as calculated from the interval 
between the last day of the last ovulatory oestrus to the first day of the 
first ovulatory oestrus, This extended on average from 11 October 
to 11 May, with no ovulations in January, 
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February, or March in any other mares. Evans et at (1971) also observed 
mares during a 12 month period, and of the four mares studied, one 
had normal cyclic ovarian and oestrous behaviour for the entire year, 
but the remaining three mares were anovular for 2 to 3,5 months during 
the winter, after which normal ovarian and sexual behaviour was re-
established in September. In a more extensive study (Hughes et at, 
1972a) studied eleven mares (seven thoroughbreds and four quarter 
horses) over a two-year period, and found the incidence of winter 
acyclicity to be less frequent (occurred on only seven out of a possible 
22 occasions). At a latitude more comparable to the one at which the 
present study was carried out, Osborne (1966) made a study of 5,198 
pairs of ovaries collected from mares at slaughter and found the 
ovulation rate to be 26.9% in June, 20.5% in July, 18.5% in August, 
21.5% in September, 47.2% in October and 70.2% in November. 
To further characterise the winter/early spring period of acyclicity, 
van Niekerk et at, (1973b) made detailed anatomical and histological 
observations on the reproductive tracts of mares during the winter and 
spring months (July through October) in South Africa. Of the 42 mares 
examined, 12 were described as being in deep anoestrum with inactive 
ovaries, 16 in shallow anoestrum with active, but non-cycling ovaries, 
and 14 mares showing prolonged oestrous behaviour and with active but 
non-cycling ovaries. The ovaries of the mares in deep anoestrum 
were small (2.55 x 1.85 x 1,8 cm), bean-shaped, and firm, The cortex 
comprised mainly stromal tissue and blood vessels, with very few 
developing follicles present. The follicles that were present were less 
than 5 mm in size, with most of the larger ones undergoing atresia, 
and no corpora lutea were found, The average size of the Gvaries of 
the mares determined after they had been in shallow anoestrum for 2 
months, was 3,75 x 2,85 x 2,45 cm, The ovaries usually contained several 
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developing and atretic follicles up to 3 cm diameter, but 
rectal palpation indicated that none of the follicles ever 
ovulated, and this was confirmed on necroscopy by the absence of any 
corpora lutea. The follicles present were described as primary as 
well as several small, growing or atretic secondary follicles. The 
large number of these follicles between 0.5 and 2.5 cm gave the 
ovaries the appearance and feel of a bunch of grapes. Thirdly, 
the active non-cycling ovaries of mares with prolonged oestrous 
periods, were estimated from rectal palpation to be 4 x 3 x 2.5 ern 
in size. Both in size and morphology the ovaries of this group of 
mares were similar to those of mares in shallow anoestrum. 
Primarily because of the economic advantages to be gained, some 
attempts have been made to induce ovulation in mares showing 
acyclicity during the winter/early spring period, and so initiate the 
breeding season earlier, van Niekerk et aZ (1973a) administered 
progesterone to mares in varying depths of acyclicity, and found 
that the effectiveness of the treatment in inducing earlier ovulation 
WaS closely related to the degree of ovarian activity prior to the 
start of the experiment. Acyclic mares in prolonged oestrus given 
100 to 125 mg progesterone daily for seven days subsequently 
returned to oestrus and ovulated earlier than untreated mares. 
Acyclic mares in winter anoestrum with pronounced follicular growth 
prior to the administration of progesterone responded similarly. 
However, in acyclic mares in winter anoestrum with less active ovaries, 
the treatment was not as effective, and mares with inactive ovaries 
in deep anoestrum did not respond at all. 
As an alternative approach to inducing ovulation in seasonally 
anovulatory mares, Douglas et aZ (1975) administered equine pituitary 
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extracts (EPE) twice daily for 14 days to ponies deemed to be acyclic 
because of low serum progesterone concentrations and small inactive 
ovaries prior to the start of the experiment. The experiments were 
performed during the anovulatory season in January, March and April~ 
and at the two highest dose rates of EPE given, 87% of the treated 
mares ovulated, compared with 0% of the control mares. Of these 
ovulating mares, 58% had two or more ovulations during the first 
oestrus after treatment. All mares which ovulated failed to return 
to oestrus or re-ovulate at the expected time (one cycle length 
later) or by Day 45 at the end of the experiment. 
\ 
Although not designed to induce ovulation in seasonally acyclic 
mares~ some studies on the use of GnRH in mares have been described o 
Ginther and Wentworth (1974) injected pony mares assumed to be in 
late winter anoestrus with 400 llg GnRH i. v., and by 5 min after 
injection, observed a significant increase in serum LH concentrations, 
and levels were elevated until 50 minutes , after which they declined 
and were back to baseline by 12 h. This treatment did not appear 
to influence follicular development or to stimulate oestrus, but this 
was not critically examined. In the same study, 400 llg GnRH was 
given iov. to mares on Day 2 of oestrus, and LH concentrations increased 
gradually during the first 10 to 20 minutes, followed by high values 
for approximately 2 ho The same experiment was done but injecting 
the GnRH soc., ar...! this resulted in a more persistent increase in 
serum LH concentrations. Neither treatments, however. significantly 
altered follicular development, time of ovulation or length of 
oestrus. Garcia and Ginther (1975) also found that a single 
soc. injection of GnRH (given at varying dose rates) failed 
to shorten the interval to ovulation when given to pony mares on Day 
2 of oestrus. In the same study, continuous i. v. infusion of GnRH 
into pony mares on Day 2 of oestrus similarly did not advance ovulation 
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(when compared to control mares) but this treatment was more effect-
ive in stimulating and sustaining an LH release than when the same 
dose is given as a single injection, since LH levels were highest 
at 24 h after injection, compared with at 2 h when GnRH is given 
as on~ s.c. injection). An enhanced LH response to GnRH was also 
obtained by pre-treatment of the mares on Day 2 of oestrus with 0.5 
mg oestradiol-17B , and giving GnRH s.c. on Day 3 of oestrus. Heinz 
and Klug (1975) found a single injection of 1 to 4 mg GnRH induced 
no ovarian or behavioural response in mares with acyclic ovaries, 
although it did cause earlier ovulation in oestrous mares. Similarly 
Irvine et aZ (1975) found that a single injection of 2 mg GnRH 
given early in oestrus "appeared to hasten ovulation"; however, 
repeated dosage which maintained high serum LH levels was significantly 
(p < 0,05) effective in inducing ovulation. 
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MATERIALS AND' 'METHODS 
EXPERIMENTAL DESIGN: 
Acyclic mares at three stages of the winter physiological non-
breeding season were treated with exogenous GnRH (the synthetic decap-
eptide, also called LHnRH) and progesterone on a regime designed to 
reproduce the FSH and LH surges, and the luteal phase progesterone 
concentrations which occur during the normal ovulatory oestrous 
cycle (see Chapter IV). In one group of mares, progesterone admin-
istration was omitted. 
1. 'Hormonal Preparations 
(a) GnRH: The synthetic GnRH was obtained by gift from 
Dr K. Seeger, Hoechst, Frankfurt, Germany; Dr D.S. Irvine, 
Ayerst Laboratories, Montreal, Canada; and from 1.C.I. 
Australia Ltd. The Hoechst GnRH was received in an injectable 
form, but that from Ayerst Laboratories and from I.C.l. Ltd 
was as a powder and was reconstituted in isotonic saline to a 
concentration of 1 mg/ml prior to use. The Hoechst GnRH was 
used the most extensively in this study, but the source of 
GnRH for each injection is recorded in Tables 51 to 69. 
(b) Progesterone: Progesterone powder (Sigma Chemical Co., 
St Louis, Missouri, U.S.A.) was dissolved in 10 ml of ethanol 
"c 
and added to 90 ml of previously heated (above 1000C) peanut 
oil to give a final concentration of 150 mg progesterone/5 ml of 
ethanol:oil solution. 
2, Experimental Animals 
The mares were 400 to 600 kg standardbreds maintained at 
a commercial stud, Nevele R, 6 km from Lincoln College, ~nd two 
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standardbreds at the Lincoln College Research Farm. The mares 
were at all times grazing on mixed sward pastures with supplementary 
feeding of oaten, meadow or lucerne hay. Minimal natural shelter 
was provided, and the animals were not rugged. The mares were 
divided into three groups, depending on the stage of the non~ 
breeding season, and therefore presumably the depth of acyclicity 
at which the eXperiment was performed. Detailed histories of all 
the mares (see below) are shown in Appendix 1. 
Group I: This comprised six mares held at Nevele R stud treated 
from 31-10-74 to 22~11-74 when the mares were considered to be 
in shallow acyclicity. The mares were: Contraband, Gay Lustre, 
Pania, Tanunda, Winabell and Young Anne. Four further mares, 
Ambro Del filly, Donora, Lisa Twinkle and Meseta, were observed 
as controls for Group 1. 
GrouE II: This comprised two mares held at the Lincoln College 
Research Farm, treated from 16-9-74 to 8-10-74, when they were 
considered to be in mid-acyclicity. The mares were: Bonnylands 
and Mrs Oram. 
GrouE III: This comprised eight mares at Nevele R stud treated 
between 20-6-75 and 23-7-75, when the mares were in deep acyclicity 
The mares were: Annacy, Bright Sea, Compliment, Lottie's Express, 
Meseta, Oriental Scott, Robyn's Choice, and Young Trudy. 
All mares were selected for the experiment because they 
appeared to be acyclic over the I to 3 weeks prior to the start 
of the treatment as based on the following criteria: 
(a) Ovaries which were smaller than during the luteal phase of 
the cycle in the breeding season as determined by palpation per 
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* rectum, and were generally less than 1 Unit in their longest 
diameter. The ovaries felt hard or firm, indicating absence 
of any palpable follicular activity, except for four Group 1 
mares (Gay Lustre, Pania, Winabell and Young Anne) and one 
mare of Group 2 (Mrs Oram) which had ovaries that shQwed some 
degree of follicular activity before treatment began, as 
indicated in Tables 55, 56, 53, 57 and 59 for each mare respectively. 
These ovaries were consistent with the active, non-cycling 
ovaries of shallow "anoestrous" mares described by van Niekerk 
(1973b). Since this ovarian activity does not represent 
normal progressive follicular development leading to ovulation, 
this, together with a close examination of the previous 
histories of the mares, resulted in these animals being 
included in the experiment. 
(b) A serum progesterone concentration (method as described 
in Chapter III) taken prior to the commencement of the treatment 
of < 1 ng/mI, indicating absence of an active corpus luteum. 
(c) Absence of behavioural oestrus prior to the start of the 
treatment. However, oestrus behaviour for occasional days 
in mares with consistently small inactive ovaries was not 
regarded as evidence of ovarian cyclicity, since it is a 
characteristic of acyclic mares at irregular intervals during 
the winter non-breeding season (Ginther, 1974) and such mares 
were included in the study. 
* Since this study was initiated prior to complete metric conv-
ersion, all ovarian palpations were described in terms of "inches". 
Therefore, for the purposes of this thesis, all palpations 
are defined in Units, where 1 Unit = 2.5 cm. 
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3. Treatment Regime 
The mares in Groups I, II and III in shallow, mid- and 
deep acyc1icity respectively, were similarly treated with courses 
of GnRH at 10~day intervals in an attempt to reproduce the 
gonadotrophin surges which precede ovulation in the normally 
cycling mare. Progesterone was given to all mares except four 
in Group III (designated Group IIIb) to reproduce luteal phase 
progesterone concentrations (see Chapter IV). Day 1 of 
treatment was the day of the first injection of GnRH. 
Group I: The six mares in shallow acyclicity were given 1.0 mg GnRH 
at approximately 0730 and 1900 h on Day 1 and at 0730 on Day 2 
(first course), and similarly treated on Days 11 and 12 (second 
course), of treatment. For the third course they were given 0.4 
mg GnRH at 0730 h & 0.6 mg at 1900 h on Day 21, 0.6 mg at 0730 & 1900 h 
on Day 22, and 1.4 mg a~ 0730 h on day 23. This third course was 
omitted in one mare (Pania). Progesterone (150 mg i.m. per day) 
was given on Days 6 through 16 to three of the six mares 
(Contraband, Tanunda and Winabell). 
Group II: 
;\ 
The three mares in mid-ac¥.,flici ty were l treated as those 
," .... r·'~·~ 
in Group I except that an additional injection of 1.0 mg GnRH 
was given in course 1 and 2 at 1900 h on Day 2 and at 1900 h 
on Day 12. Progesterone (150 mg per day) was administered on 
Days 5 throl1~h 16. 
Group III: The eight mares in deep acyclicity were given 1.2 mg 
GnRH at approximately 0730 hand 1900 h on Day 1 , and at 
0900 h on Days 2 and 3 (first course). For the second course, 
1.2 mg GnRH was given at 0730 hand 1900 h on Day II, and at 
0830 and 0800 h on Days 12 and 13 of treatment. Four of the 
mares (Compliment, Lottie's Express, Oriental Scott and Robyn's 
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Choice) were given 150 mg progesterone per day on Days 6 through 
17 of treatment and were designated Group IIIao The remaining 
four mares receiving no exogenous progesterone (Annacy, Bright Sea, 
Meseta and Young Trudy) were designated Group IITbo Three mares. 
Annacy. Bright Sea and Young Trudy were given their third GnRH course 
beginning on Day 21 (100 mg GnRH at 1200 h on Day 21, at 0730 
and 2000 h on Day 22, and at 1100 h on Day 23) while Meseta began 
her third course on Day 22 (1.0 mg GnRH at 0739 hand 2003 h 
on Day 22, and at 1129 h on Day 23, and at 1433 h on Day 24)0 The 
four mares receiving exogenous progesterone (Compliment, Lottie's 
Express, Oriental Scott and Robyn's Choice) were given their third 
course of GnRH commencing on Day 22 (1.0 mg GnRH at 0745 and 2000 h 
on Day 22, 100 mg GnRH at 1140 h on Day 23, and 1.0 mg at 1440 h on 
Day 24). 
Prior to and after this third course, it was evident that in 
deeply acyclic mares, more especially those not receiving any 
~x)genous progesterone there was an apparent lack of response to 
the treatment in terms of follicular developmento Therefore, three 
of the mares not given any exogenous progesterone (Annacy, Bright 
Sea and Meseta) and one mare receiving progesterone (Oriental Scott) 
were given a fourth course of GnRH (100 mg GnRH at 0810 and 2000 h 
on Day 32, at 1505 h on Dqy 33, and at 0815 h on Day 34)0 One 
further mare receiving progesterone (Compliment) was similarly given 
a fourth course in an endeavour to induce the ovulation of a typical 
pre-ovulatory follicle which had developed during the third course. 
4. Measurement of Responses 
Blood samples were collected daily for several days prior to the 
first day of treatment, on those days during treatment when GnRH was 
not administered and for several days following the final day of treat-
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ment. On those days on which GnRH was administered, blood samples 
were collected immediately before injection of GnRH. and at 
frequent intervals following injection from 15 min through 12 h as 
described in Results. Blood samples were collected and frozen 
as described in Chapter IV (Methods) and serum FSH, LH, progesterone 
and oestradiol-17B concentrations measured as described in Chapter III 
with LH being determined by the Niswendep OVine System. FSH and LH 
determinations were made on all samples, and serum progesterone and 
oestradiol-17B on selected days as shown in Results. 
During the experiment, the mares were teased for oestrous 
behaviour and their ovaries palpated per rectum daily, or every second 
or third day as appropriate. The four control mares in Group I 
were teased and palpated, but not bled, except when required for 
progesterone assay. 
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RESULTS 
GROUP I: 
Prior to the start of the experiment the six mares in this group 
were considered to be in shallow acyclicity, as based on the season 
of the year at which the experiment was performed, and according to 
the criteria indicated in Materials and Methods. However, since the 
stud record books showed that in previous years 70% of the mares were 
cycling by the time of the year at which the experiment was completed, 
it wa~ probable that some of the six mares used would have begun 
to cycle spontaneously during the treatment. Examination of the 
hormonal and ovarian changes in each of the mares throughout the 
experiment indicated that three mares (Gay Lustre, Pania and Young 
Anne) showed such spontaneous activity. Therefore, these three 
mares were classed a posteriori as nonftacyclic, and their results 
considered separately from those of the remaining three mares 
(Contraband, Tanunda and Winabell) who were genuinely in shallow 
acyclici ty. 
MARES IN SHALLOW ACYCLICITY 
The hormonal, ovarian and behavioural changes occurring throughout 
the experiment in the three mares in shallow acyclicity are shown in 
Tables 51, 52 and 53 for Contraband, Tanunda and Winabell respectively, 
Table 54 shows the mean hormonal changes, the mean fractional changes 
in the gonadotrophins and the results of tests of significance on these 
mean changes in the gonadotrophins (paired t~tests comparing each 
value throughout the treatment with the mean value for each mare 
* over the five days prior to the first GnRH injection). In addition 
* It should be noted that due to the variability between mares in responses, 
some mean increases following GnRH were not significant although showing 
greater fractional increases than other increases which were significant. 
._ .. -: .... 
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LEGEND lWH TABLES 51 TO 53 
Day = the day a! the experiment, day 1 being the first 
day of treatment 
Time (hours) = the time at which the blood sample was 
collected, or GnRH administered 
GnRH :- sou~ce indicated for each injection 
Gonadotrophins :- expressed as ng/IDl Nuti eFSB or 
Hartree ,eLH (see text) 
Ovaries :- L = left ovary; R ~ right ovary 
Descriptions include : stating the size and 
tension of the ovary,e.g. ,L: trilobed,H ;: left 
ovary tri-lobed and hard; e.g. TJ: 2,c1 = left .ovary 
measures 2x1 'Units, Where 1 Unit;: 2.5 em (see 
Materials and Methods); e.g. L: S + H = left ovary 
small and hard. 
Stating st,ructures ip the ovary, these being 
either :- Foll = follicle, or Area = any soft 
structure not a follicle, often a corpus luteum. 
:3tating particulars of these structures in terms 
of diameter (0.6 to 6 Units) and tension as an 
indication of maturity where :- fb = firmish; 
f :: firm; sh :: softish; s = soft; vs = very soft; 
coll = collapsed (as in ovulation); rubbery:: 
"rubbery" in tension. 
e.g. L:Foll - 2, sh :: left ovary contains a softish 
follicle 2 Units in diameter 
e.g. L: 2x1, H; 2x'E'oll - 1, fh; 3.5, vs :: left ovary 
is 2x1 Units and hard, contains two follicles, one 
being 1 Unit in diameter and firmish in tension, the 
other 3.5 Units in diameter and very soft. 
TABLE 51: CONTRABAND 
-
DAY 'rIME PROGESTERONE OESTR>J)IOL -17 a GONAl)OTROP HINS HOURS AFTER GNRH ADMINIR'l'RA.TION 
Hours ng/m1 pg/m1 ng/m1 GnRH 0.5 1 2 3.0 5-8 10-12 OVARIES BEHAVIOUR DAY 
-5 1100 0.1 FSH, 5.81 L: 5 .... H 
LH: 5.32 R: 5 ..p H Not on 
-4 1100 0.1 FSH, 5.97 
LH, 9.74 
-3 120Q 0.1 FSH, 5.84 L: S + H 
LH, 7.11 R: 5 ... H In oestrus ? 
-2 0700 0.3 FSH, 4.98 
LH, 8.67 
-1 1030 0.1 FSH, 5.10 L: 5 + H 
LH, 9.93 R, S + a 
1 0703 0.3 FSH, 8.98 1.0 I'lg 33.5 27.2 22.8 14.2 7.73 5.70 L: S ... H 
Hoec'lotst 
La, 10.4 28.9 26.2 2Q.5 17.1 11. 0 9.90 R: S + H In oestrus 
1903 FSH, 5.70 1.0 mg 19.6 29.6 27.2 22.6 8.00 
Hoechst 
LH: 9. 9~ 21. 7 - 19.1 10.1 -
2 0656 0.1 FSH, 8.00 1.0 mg 14.9 15.0 14.7 14.2 8.85 L, S + H 
Hoechst 
LH, - 22.2 19.9 17.0 14 .5 13.0 R: S + H In oestrus 
3 1400 0.3 FSa, 8.14 L, S + H 
LH, 19.1 R: S + H Not on 
4 1100 0.5 FSH, 9.05 L, S + H 
La, 12.6 R: S + H ~.L In oestrus 
5 0645 0.1 FSH, 8.07 L, S + H ~ ... : 
LH, 17.6 R: S + H In oestrus 
6 1500 0.3 FSH, 6.14 L: S + H 
LH, 12.5 R, Fo11-< I, fh 
7 1200 1.60 5.2 FSH, 6.27 L: 5 + H 
LH, 11.0 R, Fo11-< I, fh Not on 
8 1400 1. 39 4.1 FSH, 7.59 L, S + H 
LH, 20.8 R: Foll-< 1, sh Not on 
9 1400 0.99 6.3 FSH, 14.1 L, S + H 
LH, 28.7 R: Foll-< 1, VS Not on 
10 1400 4.72 6.1 FSH, 11.7 L, S + H 
LH, 27.1 R: 5 + H Not on 
11 0638 6.67 FSH, 8.23 1. 0 mg 
Hoechst 
27.2 23.1 23.0 25.0 12.4 L: S + H 
LH, 15.3 54.4 50.1 15.2 24.2 - R: Area - < 1, vs Not on 
1838 FSH, 12.43 1.0 mg 21.8 
Hoechst 
20.6 17.9 15.6 15.6 
LH: - 38.3 36.8 18.0 12.6 12.7 
12 0637 1.71 FSH, 15.6 1.0 mg 
Hoechst 
14.1 19.9 17.9 15.2 16.9 L, S + H 
LH, 1'-.7 19.9 19.2 12.9 11. 7 12.6 R: S + H Not on 
13 1700 1. 87 FSH, 19.9 L: 2xArea-l, hi 1, f 
LH, 14.8 R, S + H 
14 1130 5.33 8.4 FSH, 12.8 L: S + irreg 
LH, 9.56 R: S + irreq Not on 
-.:;-
::: 
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TABLE 51: em CONTRABAND 
DAY TIME PROGESTERONE OESTRZlDIOL -17 e GONADOTROP BINS HOURS AFTER GNRH ADMINIS'1'RA.TION 
Hours ng/ml pg/ml ng/ml GnRH 0.5 1 2 3.0 5-8 10-12 OVARIES BEHAVIOUR DAY 
15 1400 3.47 FSH, 21.4 L: S + H 15 
LH, 12.4 R: 5 + H, Foll-l, fh Not on 
16 0700 1.92 22.1 FSH, 11.9 L: 2xl, irreg 16 
LH, 7.76 R, 2xl, FoIl-I, fh Not on 
17 1130 2.05 FSH, 10.6 L, Foll-l, fh 17 
La, 13.5 R: 2xFoll-l, fh, 1, fh 
18 0900 0.56 8.4 FSH, 7.26 18 
LH, 14.8 In oestrus 
19 1430 0.32 FSH, 8.91 19 LH, 31. 4 
20 1200 0.1 7.5 FSH, 9.25 L: S + irreg 20 
LH, 36.8 R: 5 + irreg Not on 
21 0712 0.1 12.6 FSH, 0.4 mg 7.88 13.9 15.1 14 .6 5.66 21 
Ayerst 
LH, 23.5 45.4 143.1 39.6 29.9 In oestrus 
1912 FSH, 5.66 0.6 mg 9.42 6.94 7.28 6.47 3.77 
Ayerst 
LH, 29.9 52.4 60.3 45.2 46.4 38.8 ." 
22 0712 0.48 12.1 FSH, 3.77 0.6 mg 9.51 12.4 la.5 8.65 6.74 L, ;2xF011-l, f, 1, f 22 
Ayerst 
LH, 38.8 55.0 60.5 49.3 39.9 34.9 R: FoIl-I, f In oestrus 
1911 FSH, 6.74 0.6 mg 3.18 6.84 7.30 5.95 5.31 
Ayerst 
LH, 34.9 48.4 62.5 48.9 47.2 34.4 
23 
23 0720 0.45 13.8 FSH, 5.31 1.4 mg 12.7 12.5 9.08 12.6 '" '" Ayerst ~ 
55.4 In oestrus 
LH, 34.4 65.6 62.7 60.4 
24 1100 0.32 20.1 FSH, 12.6 L: FoIl-I, 24 
LH: 36.1 R: FoIl-I, In oestrus 
25 0900 0.29 20.4 FSH, 7.71 L, Fol1-2, sh 25 LH, 39.9 R: 2xl, irreg In oestrus 
26 1200 0.1 16.3 FSH, 5.60 L, F0l1-3, s 26 LH, 56.5 R: 5 + H In oestrus 
27 1750 0.1 11.6 FSH, 4.05 L: Area-l,vs 27 
LH, 79.3 R: S + H 1'1ated 
28 1500 0.48 12.0 FSH, 7.17 L: Area - 2,5, vs 28 
LH'108.6 R: tri-lobed, H Partially in oestrus 
29 0800 0.99 FSH, 7.26 L: Area-2, s 29 
LH,107.5 R: S + H Not on 
30 0900 2.32 FSH, 9.38 L: Area - 2.5, s 30 
LH, 49.7 R, S + H Not on 
:i: 
.', 
-:. .;. ~~; 
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TABLE 52: TANUNDA 
HOURS AFTER GNRH ADHINISTRJ\TIOtl DAY TIME PROGESTERONE OESTRl\DIOL -17S GOl'1:n..nOTROPHINS 
3.0 5-8 12.0 I OVARIES BBHAVIOUR I DAY hours ng/IOI pg/ml ng/m1 GnRH 0.5 
-5 1100 0.3 L: 3xl.5, f" -5 FS~: 4.05 R: S + H Not on LH: 23.2 
-4 1110 0.4 FSH: 1.97 -4 
LH: 20.2 
-3 1200 0.1 FSH: 2.30 L: tri-lobed, H -3 
LH: 25.2 R: S + H Not on 
-2 0700 0.5 FSH: 2.38 -2 
LH: 23.5 
-1 1030 0.5 FSH: 5.82 L: 3x2, irreg, Area-I, vs -1 
LH: 23.0 R: 3x2, irreg, H 
0706 0.56 .F'SH: 4.22 1.0 mg 20.7 20.4 17.3 9.89 5.96 5.12 L: FoIl-I, fh 1 
Hoechst 
'LH: 26.1 73.3 50.6 30.1 23.9 15.6 9.44 R: S + H Not on 
1907 l'SH: 5.12 I.O mg 13.8 11.1 10.2 9.90 6.94 
Hoech"it 
LH: 9.44 27.3 23.0 17.8 17·3 10.1 
0700 0.1 FSH: 6.94 1.0 ITIg 16.0 12.7 11.4 10.4 7.86 L,: 2x2 
Poechst 
LH: 10.1 30.1 31.4 20.6 25.3 13.0 R: 2x2, H 
1400 
I 0.1 
13.9 FSH, 6.84 L: 3x2, H '>' 
VI LH: 20.8 R: 3x2, H Not on VI 
1100 No Sample 11.9 L: 3x2, H - R: 3x2, H In oestrus 4 
0700 a.1 7.7 FSH. 7.53 L: 2x2, H, FoIl -<1. f 5 
LH: 17.4 R: Foll-1.5, f In oestrus 
1500 0.3 13.4 FSH: 5.48 L: 2xl, irreg, H 
LH: 13.2 R: Area-I, s 
1200 1.07 FSH: 5.02 L: S + H 
LH: 11. 0 R: Area - 1, fh 
1400 2.48 FSH: 5.49 L: 2xl, irreg, H 
LH: 15.9 R: Foll-1. 3, sh 
1400 1. 73 FSH: 7.76 L: 2 I, H 
LH: 29.8 R: FoIl-I, 5 
10 1415 1. 6 3 FSH: 8.19 L: 5 + H 10 
LH: 14.9 R: Area-I.S, vs Not on 
11 0642 2.13 13.9 FRH: 9.46 1.0 mg 
Hoechst 
17.9 17.5 15.8 U.9 7.74 L: S + H 11 
LH: 17.8 44.9 47..1 36. 9 19.7 12.9 R: FoIl-I, 5 Not on 
1839 FSH: 7.74 l.r) I'lg 13.4 14. ) 15.8 15.8 8.26 
Ho~chst 
LH: 12.9 24.1 23.1 22.? 14.4 13. q 
12 0638 1. 79 14 .1 FSH: 8.26 1.'1 mg 14 .9 13.1 13.1 10.3 9.77 
IL:2Xl,H 12 Hoec~st 
LH: 13.9 22.6 24.7 16.7 14.5 17.4 R: Foll-I.S, 5 Not on 
13 1700 5.07 FSH: 9.92 L: 2xl, H 13 
LH: 15.2 R: Foll-l.s, vs 
>;. . 
:~~: ": 
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TABLE 52· ern TANUNDA 
DAY TIME PROGESTERONE OESTRADIOL -178 
HOU!lS AFTER GNRH ADr1Il1ISTRJl.TIOIl r,ON~OTROPHINS 
3.0 5-8 12.0 hours ng/'" 1 pg/m1 ng/m1 GnRH ~.5 1 2 OVARIES BEHAVIOUR DAY 
L, 2x1 14 
14 1130 4.53 FSH, 9.32 R: Foll-I.S, vs Not on LH, 16.6 
15 1400 3.33 6.9 FSH, 9.89 L: S + H 15 
LH, 19.0 ~: Foll-2, vs 
Fsa, 9.02 
L: 2xI, H 16 16 0700 3.47 R: FoII-I.S, vs La, 15.3 
17 L: ..2xI, H 
17 1130 2.93 10.3 FSH,10.7 R, Foll-1.5.s Not on Lli: 17.4 
18 L, 2xl. H 18 0900 0.1 10.7 FSH, 10.3 
R: FoIl-I. 5, S LR, 23.9 
19 
19 1450 0.8 12.1 FSH, 7.21 
Indifferent LH, 24.3 
20 
2Q 1230 0.1 12.4 FSH, 5.63 L, Foll-1. 5. fh 
L!'!, 27.2 R: FoIl-I, sh In oestrus 
21 0710 0.1 10.7 FSH, 6.62 0.4 mg 6.35 8.53 3.95 5.44 4.03 
21 
Z\yerst 23.9 20.9 1n oestrus 
LH, 19.1 25.6 30.7 29.4 
11.3 4.22 
1908 FSH, 4.03 0.6 TTlg 6.23 7.29 7.08 
Ayerst 27.7 26.3 
LH: 2t).9 33.5 31.1 38.3 
22 0718 0.1 15.2 FSIl, 4.22 0.6 rng 7.51 8.26 5.87 
4.14 7.23 L, Foll-2.5. f 22 
Ay~rst 27.3 29.9 R, Foll-l. sh In oestrus? 
LH, 26.3 38.0 36. a 32.0 
9.53 6.61 
7.41 3.62 '" 1909 FSH, 7.23 1).6 mg 7.36 \1' I 0\ Ayerst 31. 5 25.2 
LH, 29.9 49.7 35.5 30.4 23 9.93 
23 0716 0.1 16.6 FSH, 3.62 1.4 mg 6.19 10.7 7.35 
Ayerst 37.5 In oestrus - mated La, 25.2 38.5 43.4 33.1 
24 HOO 1).915 14.1 FSH, 8.77 L: 2xFoll-3, 5; 1, f 24 
LH, 35.3 R: FoIl-I, f In oestrus 
25 0900 0.80 12.5 FSH, 4.19 L: Foll-3, sh 25 
LH, 33.2 R: 5 + H 
26 1130 0.1 9.9 FSH, 4.94 L, Foll-2.5. sh 
26 LH: 41.8 R, Foll-1. fh In oestrus 
27 1730 0.1 9.3 FSH: 8.22 L: Foll-3, ruptured 
27 LH: 62.3 R: S + H In oestrus 
28 1630 0.1 10.2 FSH: 5.23 L: Area-2.S, collapsed 
28 LH, 80.1 R: S + H Uot on 
29 0800 3.4 FSH, 8.62 L: Area-2, sh 
29 LH: 56.3 R: S + H Not on 
30 0900 7.2 FSH: 11.~ L: Area-2, sh 
30 LH, 49.7 R: S + H Not on 
~~~ ::: 
.'.' 
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TABLE 53 WINABELL 
I 
DAY TIME PROGESTERONE OESTRADIOL -17B GONADOTROPHINS HOURS AFTER GNRH ADMINISTRATION 
Hours ng/ml pg/ml ng/ml GnR..'i 0.5 1 2 3.0 5-B 12.0 OVARIES BEHAVIOUR DAY -. 
-5 1030 0.1 FSH, 11.0 L: 3 x 1.5, H + irreg -5 
LH, 2ry .0 R: 4x2, Area-I, 5 Not on 
-4 1100 0.1 FSH, 5.20 
-4 LH, 15.7 
-3 1200 0.1 FSH, 6.51 L: 3x2, H -3 LH,24.7 R: 4x2, f Not on 
-2 0700 0.1 FSH, 7.11 L: 4x2, H + irreg -2 LH, 16.6 R: 4x2, Area-I, sh 
-1 1030 0.1 FSH! 4.64 L: 3x2, H + irreq -1 LH, IB.4 R: 5x3, Area-I, fh 
1 0709 0.45 FSH, 2.95 1.0 mg 21.1 25.0 14.5 14.5 10.B 6.20 L: 3x2, H + irreg 1 Hoechst 
LH, 20.5 65.5 56.6 37.2 24.7 14.0 14.5 R: 4x2, FoIl-I, sh Not on 
1910 FSH, 6.20 1.0 mg 14.7 22.6 IB .1 17.3 10.6 
Hoechst 
LH, 14.5 3B.2 35.B 2B.3 IB.7 13.5 
2 0703 0.1 FSH, 10.6 1.0 mg 23.4 26.0 IB.6 15.6 14.4 L: 3x2, irreg 2 Hoechst 
LH, 13.5 36. B 36.3 27.3 26.0 19.5 R: 3x2.1 irreg 
3 1400 0.3 FSH, IB.9 L, 3x2, H 3 '" ", LH, IB.B -- R: 4x2, H + irreg Not on "" 4 1100 0.1 FSH, 10.3 L, 3x2, H 4 LH, 21. 3 R: 2xFoll-l, sh; 1, sh Not on 
5 0700 0.1 FSH! 15.8 L: 3x2, H + irreg 5 LH, 20.3 R: 3x2, H + irreg In oestrus ? 
6 1500 0.1 FSH, 11.6 L, S + H 6 LH, 18.4 R, Foll-I, fh 
7 1200 3.06 FSH, 7.33 L, S + H 7 LH, 9.17 R: FoIl-I, sh 
8 1400 1. 58 FSH, 12.4 L: 2xl, irreg 8 LH: 20.1 R: FoIl-I, sh 
9 1500 3.59 FSH! 15.7 L: 2x2, H + irreg 9 LH, 37.1 R: Foll-l, 5 
10 1400 FSH, 12.0 L: 2xl, H 10 LH! 19.R R, Fo11-1, s Not on 
11 0640 6.25 FSH, 11.6 1.0 mg 47.0 46.0 32.1 27.1 11.7 L: 5 + H 11 Hoechst 
LH, 17.0 107.1 95 . .4 65.5 31. 6 14 .0 R: Area-I, sh 
1837 FSH, 11. 7 1.0 mg 23.0 22.2 25.7 20.5 9.21 
Hoechst 
LH, 14.0 55.4 46.9 39.4 28.2 21.1 
12 0635 10.90 4.5 FSH, 9.21 1.0 mg 30.6 25.1 21.0 ll. B 8.75 L: 2xl, H 12 Hoec'1st 
LH, 21.1 36. B 34.5 30.2 24.1 19.3 R: 3x2, H, Area - < 1, sh Not on 
13 1700 I 0.93 FSH, 17.7 L: 2xl, H + irreg 13 LH, 16.9 R: 2xl, irreg 
:': . , 
t 
TABLE 53 CTD WINABELL 
I 
DAY TIME PROGESTERONE OESTRADIOL -17 ~ GONADOTROPHINS HOURS AFTER GNRH ADMINISTRATION 
Hours ng/m1 pg/m1 ng/m1 GnRli 0.5 1 2 3.0 5-8 12.0 OVARIES BEHAVIOUR DAY -.. -
14 1130 4.39 FSH: 16.1 
L: 3x2, H + irreg 14 
LB: 15.5 R: 3x2, H, Foll-<l, sh Not on 
15 1400 2.93 9.0 FSH: 16.30 
L: 2xl, H + irreg 15 
iJl: 13.6 R: 3x2, H + irreg 
16 0700 2.87 FSH: 11.4 
L: 3x2, H 16 
LR: 9.62 R: 2x2, irreg Not on 
17 1130 0.83 7.2 FSH: 11.3 
L: 3x2, H 17 
LH: 13 .0 R: 2x2, irreg 
18 0900 3.19 50.3 FSH: 7.70 18 
LR: 12.0 
19 l430 0.48 6.2 FSH: 5.16 19 
LH: 16.7 In oestrus 
20 1230 0.43 9.0 FSB: 7.48 
L: Fo11-1, 1.5, fh 20 
LH: 21.6 R: 2x2, irreg In oestrus 
21 0707 0.8 14.6 FSH: 3.38 0.4 mg 9.05 14.0 10.2 13.7 10.8 21 
Ayerst 
LB: 32.0 60.2 76.5 65.0 52.8 50.4 In oestrus 
1906 FSH: 10.8 0.6 mg 57.0 49.9 15.2 6.35 9.81 
Ayerst 
LH: 50.4 95.0 110.0 77.7 73.3 68.1 
22 0708 0.45 19.2 FSH: 9.81 0.6 rng 16.3 13.9 12.9 15.2 10.1 
L: Fo11-2, sh 22 
Ayerst '" 
LB: 68.1 109.0 119.1 85.9 113.5 81.2 R: 2x2, irreg In oestrus '" C> 
1907 FSH: 10.1 0.6 mg 14.1 16.2 16.6 14.2 
10.0 
Ayerst 
LH: 81. 2 148.7 145.1 118.6 133.1 101. 0 
23 0713 0.69 22.2 FSB: 10.0 1.4 mg 
11.5 13.3 14.7 11.3 
23 
Ayerst 
LH: 101.0 - 198.2 178.4 156 . .6 In oestrus 
24 1100 1.20 21. 7 FSH: 6.48 
LH:188.8 
L: Foll-3, vs 24 
R: 2x2, irreg In oestrus - rna ed 
25 0900 1. 47 11. 3 FSH: 5.14 
L: Area - 1, vs 25 
LR:194.8 R: 3xl, H + i rreg In oestrus 
26 1230 2.13 14.5 FSH: Q.90 
L: Area-I, 5 26 
LH:200.0 R: 2xI, H + irreg 
Partii'l.lly in oe trus 
27 1730 4.39 10.8 FSH: 11.7 
L: Area-I.S, collapsed 27 
LH: 180.0 R: 2xl, H 
28 1500 5.05 9.1 FSH: 10.9 
L: 3x2, H 28 
LH: 75.3 R: 2xl 
Not on 
29 0800 4.80 FSH: 17.9 
L: 2x2, H 29 
LH: 88.1 R: 2xl, H 
Not on 
30 1400 6.44 FSH: 21.5 
L: 3x2, H + irreg 30 
LH: qq.2 R: 2xl, H 
Not on I 
I 
I 
'.', ... 
DAY 
-5 
-4 
-3 
-2 
-1 
.3 
10 
11 
11 
12 
13 
14 
IS 
16 
17 
IB 
19 
20 
21 
21 
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TABLE 54 
MBAN HORMONAL (FSH, LU, PROGESTERONE AND 0J::STRAOIOL ... 17a CONC~J'JTRA'l'IONS IN MARES 1;N SHALLOW ACYCLICITY 
(G~OUP I) THROUGH'WI' THE E.XPERIMENT AND ,/,HE FRACTIONAL CHANGE" I~ GONADOTROpHINS DURING THE TREATMENT 
TIME AFTER 
GnRH (Hours) 
FSK LH PROGF.STERONE OE;:STRADIOL -17B FRACTIONAL 
ng/ml "g/m! ng/mt pg/ml CHANGES t 
Mean SO .n Mean SO Haan ~D Mean SD FSH LH 
6.95 3.6 .. 3 
4.3B 2.1 
4.B. 4.3 
4.B2 2.4 
5.19 0.6 
-0.1 5.3B ~.2 
16. 4 9.5 
15.2 5.2 
19.0 10.3 
16.3 7.4 
17.1 6.6 
19.0 8.0 
0.2 
0.2 
0.1 
0.3 
0.2 
0.5 
0.1 
0.2 
0.0 
0,2 
0.2 
0.2 
1.0 mg GnRH 
0.5 
(0700 h) __ ~-----____ ---~-------__ ~---__ --__ -------------------------
1 
2 
25.1* 
24.2]11· 
19.2* 
7.3 
3.5 
4.2 
12.9 U 2,6 
5 - 8 8.16, 2.4 
12 5.67 0.5 
.3 
·55.9 
44.511" 
29.3 
~1. 9 
13.5 
11. 3 
23.7 
16.1 
B.4 
4.2 
7..3 
2.8 
1. 0 mg GnRH (1900 h) ~-------------------------------------------------------------------
0.5 16.0* 3.1 
21.19.3 
18.5 8.5 
16.6 6.4 
12 8.51* 1.9 
29.1 
29.4 
21. 7 
\5.4 
\1. B 
8.4 
•. 1 
5.7 
4.6 
2.4 0.1 0.0 
4.8 
4.6 
3.5 
3.3 
2.6 
1.7 
2,4 1. 3 
1.5 Q.a 
1.1 0.7 
3.0 1. 7 
4,0 1.7 
3.5 1. J 
J.2 0.9 
1.6 0.6 
1. 0 mg Gn~H (0700 h) --------------------~-----------------------------'-----------------------.. -----
0.5 
1 
- 9 
18.1* 4.~ 
17.9 7.1 
14.9* 3.6 
13.4" 2.7 
10.4 3.5 
11.3 6,6 
9.69 0.9 
10.5 4.6 
7.74 3.3 
6.21 
•• 49 
12.5*" 
10.6** 
9.76 
1.2 
3.5 
4.2 
2.1 
1.7 
29.7 
29.2* 
n·6 
21.9 
15.2 
19.6 
17.0 
IB.4 
14.7 
10.4 
lB.9 
31.9 
20.6 
1'6.7 
7.3 
B.4 
5.2 
6.4 
3.8 
+ .1 
6.2 
1.6 
3.2 
1.1 
2.7 
4. 6 
6.1 
1.3 
0.2 
0.3 
0.1 
Q.2 
1.91 
1.82 
2.10 
3.19 
5.02 
0.1 
0. 3 
0.0 
0,1 
1.0 
0.6 
1.3 
2.2 
2.5 
9.6 
B .0 
7.0 
9.B 
13,9 
6.2 
5.5 
1.0 
5.2 
).4 1. 7 
3,4 1. 7 
2.8 1. 3 
2,5 1.3 
2.0 0.9 
2.1 1.1 
1.6 0.6 
2.0 1.1 
1.5 0.9 
1.2 
1.6 
2.4 
2.0 
1.B 
O. fi 
1.1 
1.9 
1.2 
1.0 
-1.0 mg GnRH (0640 h) ---__ ------______ ----____ --__ --------------__________________________ ------------------
0.5 30.7 
12 
2 •• 9 
23.6* 
21. 3 
10.6* 
14.9 
15.1 
B.2 
B.2 
2.5 
6B.9 
62.5 
39.2 
.25.2 
13.5 
33, 'l 
2 •. 1 
2';.2 
6.0 
o .B 
5. B 
5.5 
4.5 
4.0 
2.0 
4.0 
3.7 
2.3 
1.5 
0.8 
1. 0 mg GnRH (1B40 h) -----------------__ ----__ ---____ ---------------------__ ------------------------
0.5 19.4* 
19.2*" 
19.8* 
3 17.3* 
12 11. 0 
. 5.2 
4.0 
5.2 
2.9 
4.0 
39.3 
35.6 
~6. 5 
19.4 
15,9 
15.7 
11.9 
11.3 
8.5 
4.5 4. BO 5.3 9.3 6. B 
1. 0 mg GnRH (0636 h) --------------------_________________________________ --__________ _ 
0.5 19.9 
19.4* 
17.3* 
12.4* 
5-0 11.B 
15,0* 
12.7" 
15.9 
10.6"'· 
10.9· 
9.42 
7.09 
7.45 
9,3 
6.0 
4.0 
2.5 
4.4 
5.2 
3.4 
5. ~ 
1.5 
0.4 
1.6 
1.9 
1.B 
-0.1 5.00 2.3 
26.4 
~6 .1 
19.9 
16.8 
16.4 
15.6 
14.0 
IS. Q 
10.9 
14.6 
16.9 
24.1 
2B.5 
25.6 
9.1 
7. B 
9.1 
6.5 
3.5 
1.1 
3.9 
3.5 
3.9 
2.4 
6.2 
7.4 
7.7 
9.1 
3 
2.62 
4; 75 
3.24 
2,75 
1.94 
1. 2B 
0.5 
0 •. 2 
0.3 
2.2 
o. '; 
0.3 
O. B 
1.1 
1.7 
0.2 
0.2 
0.4 
B.4 
9.0 
22.1 
9. B 
23·1 
9.2 
9.6 
12.6 
0.1 
2.2 
23.6 
4.2 
2.5 
2.0 
3.7 
3.6 
3. B 
3.3 
2.1 
3. B 
3.7 
3.3 
2.4 
2.2 
3.0 
2.4 
3.0 
2.1 
2.1 
1.6 
1.3 
1.4 
2.3 
2.1 
1.5 
1.1 
0.9 
1.5 
1.5 
1.2 
1.0 
1.0 
0.9 
0.8 
0.9 
0.6 
0.9 
1.0 
1.4 
1.7 
1.0 1.2 
o . 4 mg OnRJl (0700 h) ---~----~--~ ________________________ -----------_---------- _______ __ 
~f;O 
TABL~ etd; 
DAY 
22 
22 
23 
24 
25 
26 
27 
28 
29 
30 
OESTRADIOL -178 FSH LH PROO~ST~RON~ 
pg(ml TIME AFTER ng/ml n9/,.1 'ng/!I)l 
SO GnRII (HQurs) tlp.an .SO . Mean So Mean Sp Hqan 
0.5 7.76- 1.4 ~6. 4 20.~ 
12.1* 3.1 59. 9 23.4 
9.75 5.6 79.2 58.2 
3 11.2 5.0 39,8 14.5. 
12 6. B3 3.5 ~3. 7 15.1 
0.6 mg GnRH (1900 h) 
0.5 24.2 2B.4 ' .60.3 '31.5 
21.4 24 /. 7 67. 1 39.9 
9.B5 4.6 53. 7 21,0 
B.04 2.8 49.1 22.9 
12 5.93 ).4 44.4 21.5 O. J4 0.2 3 15.5 3.6 
0.6 mg GnRJI (0700 h) 
0.5 11.1 4.6 67.3 p.1 
11.5"- 2.9 72.1 42. ~ 
10.1* 3.0 5,\.7 27.5 
~. 33 5.6 60.2 46.6 J 
12 8.02 1.. B '3' 48.7 28.3 .3 
0.6 mg ~nRH (1900 h) 
0. 5 B.2l 5.5 79 •. 3 60.3 ~, 
10.9 4.8 ' B1..0 57.1 
10.2 S •• 66 ;0 46.5 
9.19 4.4 70 •• 54.7 
12 ~.31 3.3 53.5 41. 4 0.4 0.3 17.6 4.3 
1.4 Illg GnRH 10710 h) 
0.5 10.1 3.5 H.l 19.1 
l2.~u 1.3 , 101. 4 a4. 4 
lQ.4** '3.8 90.6 n .2 
U.3 1.3 83.2 64:2 
9.2B 3.1 86.7 88.4 Q.8 0.5 18.6 4.0 
5.68 loB 89,3 91.4 o. B 0 •• 14.7 4.9 
6.Bl 2.7 99.4 87.4 0.8 1..2 U.6 3.3 
7.99 3.B 107.2 63.6 1.53 2.5 10.6 1.2 
7.77 2.9 8B,0* 18.0 1.88 2,9 10.4 1.5 
11.3 5.8 84.0 25.9 3.06 1.9 
14.0 6,6 66.2 ~8. 6 5.32 2.6 
Fractional changes in 8&;r:u1ll, conoentl'B;tiQnl;l qt FSfI Bnd LR calpulated by dividing ABCh of the msliUl 
concentratioD'" from the beginning ot tr~atment;; unt~l the end of the e~erilllental period by tbe mean 
pre .. treatment baseline (days prior to Da,. 1 and 'O~ Day 1 at ..,0,1 h). On thoee occasions aft/i'r the 
beginning ot troatmelJt when there wae mj.sBing data, ttle !!lean pre ... trlJstmept baseline Qxcluc;ted the 
values tram the apprQ~riote mitres. 
Mean FSH and LH concentrations thrc;mghout the treatment war, compar\9d tp the mean pre-tr~8tment 
baseline (.paired t-te8t within each mars) and significant ditfer&noea at p<O.05 and. p .(0.01 
indicated by • and •• respectlvely. 
':: -::;:=:--=-.::; ~:::::;:~:; 5 :;~~_ 
FRACTIONAL 
CHANGES t 
FSH LH 
1.5 2.1 
2.3 3.0 
1.9 4.6 
2.1 2.3 
1.3 2.0 
4.6 3.5 
4. J 3.9 
1.9 3.1 
1.5 2.9 
1.1 2.6 
2.1 3.9 
2.2 4.2 
1.9 3.3 
\. B 3.5 
1.5 2.8 
1.6 4 .• 
2.1 4.7 
1.9 3.9 
1.7 4.1 
1.2 3.1 
1.9 3,3 
2.3 5.9 
2.0 5,3 
2.1 4.9 
1. B 5.1 
1.1 5.2 
1.3 5. B 
1.5 6.3 
1.5 5.1 
2. ~ 4.9 
2.7 3.9 
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Figs 35, 36 and 37 graphically illustrate daily serum concentrations 
of FSH and LH and, where measured, progesterone and oestradiol-178 
for Contraband, Tanunda and Winabell respectively, together with the 
changes in FSH and LH at 1, 3 and 10-12 h following each injection 
of GnRH. 
1. Hormonal Changes: 
Prior to the start of treatment serum levels of FSH showed 
some fluctuations, but did not surge as occurs in the normal 
oestrous cycle (see Chapter IV). The first injection of the 
first course of GnRH (on Day 1) caused a mean peak 4.8 fold 
increase in serum concentrations of FSH at 005 h following 
injection, with levels significantly elevated from 005 to 3 h, 
decreasing to baseline levels by l2h after injectiono The 
second and third injections of GnRH in this first course caused 
slightly reduced peak increases in FSH levels (4 and 304 fold), 
with significant elevations occurring at 0.5 and 12 h, and 
at 0.5, 2 and 3 h following each injection respectivelyo The 
FSH baseline between the first and second courses tended to be 
higher than prior to the first course (on average 1 08 times 
higher) with this elevation being significant on Days 9 and 10 0 
One mare (Winabe11) showed considerable fluctuation in FSH 
during this period. The first GnRH injection of the second course 
(on Day 11) caused a significant increase in mean serum FSH 
concentrations at 2 and 12 h, with a peak 5.8 fold increase 
at 005 h following iniection, The mean peak 3.8 fold increases 
in FSH following the second and third injections of this course were 
similar to those of the first course (although Winabe11 showed 
a much greater increase in mean serum FSH after the first 
injection of this course),and significant elevations in mean 
FSH concentrations occurred between 0.5 and 3 hand 1 and 3 h 
following each injection respectively. During this course of 
of GnRH, FSH levels 
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LEGEND FOR FIGURE~ 35 TO 37 
Serum concentrations of FSH and LH daily throughout the 
Experiment, and at 1, 3 and 10~12 hours after GnRH 
admini~tration, and pro&esterone and oestradio1-l7B as 
measured during the experiment in Contraband, Tanunda 
and Winabell. 
Days ::: day of experiment with Day 1 :;: the day of the 
first GnRH inj ection 
FSH expressed as ng/ml Nuti equine FSH (see Chapter III) 
LH expressed as nglml Hartree equine LH (see Chapter III) 
progesterone as nglml 
oestradiol-17S as pglml 
solid bar = oestrous behaviour shown 
vertical a~row = ovulation (where indicated together with 
a question mark, this indicates there 
was no certainty ovulation occurred) 
~ mare mated 
Treatment: GnRH was administered (as described in text) 
on Days 1 and 2, 11 and 12 and 21, 22 and 23. 
Progesterone (150 mg/day) was administered on 
Days 6 through 16 
Note: These figures should b~ read in conjunction with 
Tables 51 to 53 
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did not return to the mean pre-treatment baseline between injections, 
and by 12 h after injection, the levels were still twice the mean 
pre-treatment concentration. Following this course of GnRH, the 
mean FSH baseline was on average 2.5 times higher than the pre-
treatment baseline, the levels being significantly elevated on 
Days 13, 14, 16 and 17. When exogenous protesterone administration 
ceased, the me'an serum FSH levels declined towards the mean pre-
treatment baseline. The first injection of the third course 
(0.4 mg GnRH) resulted in a diminished mean peak FSH increase 
(2.3 times the mean pre-treatment concentration), and levels were 
significantly elevated between 0.5 and 1 h following injection. 
The second injection of this course (0.6 mg GnRH) caused a greater 
peak increase in mean serum FSH (4.6 fold at 0.5 h following inject-
ion), but levels were not significantly elevated. The third and 
fourth injections (0.6 mg GnRH) caused mean peak in~reases at 1 h 
of 2.2 and 2,1 fold, and levels were significantly elevated at 
1 and 2 h following the third injection, but not at all follow-
ing the fourth injection. The fifth injection (1.4 mg GnRH) 
caused a mean peak increase of 2.3 fold times the mean pre-treat-
ment baseline at 1 h after injection, with the levels significantly 
elevated between 1 and 2 h after the GnRH administration. Unlike 
during the second course of GnRH, the mean FSH concentrations 
between each injection of the third course declined to the mean 
pre-treatment baseline. Mean serum levels of FSH following the 
third course of GnRH were also similar to the mean pre-treatment 
baseline, but the concentrations were increasing on Days 29 and 
30 of the experiment when the observations ceased. 
Prior to treatment, serum concentrations of LH showed minimal 
fluctuations, although the baseline concentration was lower in 
367 
Contraband than in the other two mares. The first injection of 
the first course of GnRH caused a peak 3.3 fold increase in 
mean serUffi concentration of LH by 0.5 h, with levels being signif-
icantly elevated only at 1 h following injection. By 3 h, 
the mean LH concentrations were almost back to the mean pre-
treatment baseline, and by 5 to 8 h through 12 h post-injection 
decreased to below the mean pre-treatment level. The second 
injection caused a non-significant 1.7 fold peak increase at 
0,5 and 1 h, and again the LH level decreased rapidly so that 
by 3 through 12 h after injection the mean LH level was below 
the mean pre-treatment baseline. The third GnRH injection of this 
course similarly caused a peak 1.7 fold increase in mean LH 
concentration at 0.5 and 1 h, this increase being significant 
at 1 h, with levels below the mean pre-treatment baseline by 5 
to 8 h following injection. Between the first and second courses 
of GnRH the mean serum LH levels remained close to the mean pre-
treatment baseline. The first injection of the second course of 
GnRH caused a 4 fold increase in the mean LH concentration 
by 0.5 h following injection, but this increase was not significant, 
The response to this injection was, however, variable beheen the 
mares , with Winabe11 showing a much greater LH release than the 
other two mares. By 3 h after injection, mean LH levels were 
approaching the mean pre-treatment baseline, and by 12 h, were 
below this level. The second injection of the second course 
of GnRH caused a peak increase in mean serum LH of 2.3 times the 
mean pre-treatment concentration, while the peak increase following 
the third injection was 1.5 fold (at 0.5 and 1 h following injection), 
These increases in mean LH concentration were not significant, 
and following both the second and third injection the mean LH 
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concentration was back to the mean pre-treatment baseline by 3 h 
following injection. Between the second and third courses of 
GnRH, mean LH concentrations remained close to the mean pre-
treatment baseline, although following withdrawal of progesterone 
on Day 17, the mean LH concentrations did increase, The first 
injection of the third course of GnRH (0,4 mg GnRH) caused a peak 
4,6 fold increase in mean serum LH concentrations above mean pre-
treatment baseline at 2 h following injection, but the levels were 
not significantly elevated. The second, third and fourth injections 
of this GnRH course (0,6 mg) all resulted in mean peak serum 
LH concentration at 1 h following injection (3.9, 4.2 and 4.7 
times mean pre-treatment baseline respectively) but these 
increases were not significant. The fifth injection also 
resulted in a mean peak LH increase at 1 h following injection 
of GnRH (1.4 mg) and this was 5.9 times the mean pre-treatment 
baseline. During the third course of GnRH, unlike in the first 
and second courses, mean serum LH concentrations at 12 h after 
each injection of GnRH, were above the mean pre-treatment 
baseline, and actually increased progressively during the course, 
This increase in serum LH was especially marked in Winabe11, 
However, there was considerable variability between the mares in 
their LH response to GnRH during the entire third course, and 
this variability reSUlted in a failure to show significant 
increases by paired t-test. Following the third course of GnRH 
mean serum levels of LH remained elevated until the end of the 
experiment. In two mares, Tanunda and Winabe11, LH concentrations 
continued to increase for several days after the third course to 
reach the highest levels of the experiment on Days 28 and 26 
respectively. Apart from a single value during the third course 
(2 h following the first injection) Contraband also showed peak 
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LH levels several days after the third GnRH course (Day 28). 
The mean peak LH increase for th~ entire experiment also 
occurred several days after the third course of GnRH on Day 27 
(6.3 times mean pre-treatment baseline), but the only significant 
increase occurred on Day 28. 
Mean serum progesterone concentrations were consistently less 
than 1 ng/ml prior to the start of treatment, and remained at 
this low level until the first day after exogenous progesterone 
administration began. During progesterone administration on 
Days 6 through 16, the mean serum progesterone concentration 
varied between 1.,82 and 5.02 ng/ml. On Day 18, the progesterone 
levels had begun to decline (1.28 ng/!l1l) and were less than 
1 ng/ml on Day 19. The levels increased to above 1 ng/ml on 
Day 27 of treatment, and continued to rise to the end of the 
experiment when they were 5.32 ng/ml (Day 30). 
Serum oestradiol-17S concentrations were not measured 
throughout the experiment, but determinations were made at 
intervals from Day 7 through 28 of the treatment. Between Days 
7 and 15, the mean levels fluctuated very little (mean = 9.10 
+ - 3.7 pg/ml). However on Day 16, and on Day 18 of treatment, 
mean serum concentrations of oestradiol-17S were elevated, 
(22.1 and 23.1 pg/ml respectively), this being due to a one day 
peak in individual mares (Contraband on Day 16 and Winabell 
on Day 18). Following this, the mean oestradiol-17S concent-
rations were again similar to the levels found earlier in the 
experiment (9.10 pg/ml on Days 7 to 15) until on Day 21 
+ when they began to increase to reach peak levels of 18.6 
4.0 pg/ml on Day 24, following which the levels declined. 
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2. Ovarian Changes: 
Prior to the treatment and throughout the experiment, the 
activity )f the ovaries varied considerably between mares, and 
therefore the observations in the individual mares are reported. 
Note: I Unit = 2.5 cm 
(i) Contraband 
This mare had small, hard ovaries at the beginning 
of the experiment, and no activity was evident until Day 6 
when a firmish follicle less than 1 Unit developed. This 
follicle persisted with some changes in tension until 
Day 11. From Day 13 through 24, increased acti vi ty was 
detected, with the ovaries becoming larger and more irregular 
in shape, and one to threefollicIes of I Unit developing. 
By Day 25, one of these follicles had increased in size 
to 2 Units, and the activity in the contralateral ovary was 
diminished. On Day 26, the developing follicle had increased 
to 3 Units, and had become soft, consistent with maturation. 
By Day 27,the day on which the mare was mated, the ovary 
which had contained the follicle had only a'very soft area 
present, and on the succeeding days, a 2 to 2.5 Unit soft 
area comprising a corpus luteum (as evidenced by the 
progesterone results above) persisted. This mare was 
confirrr."d pregnant 40 days after conception and gave birth 
to a normal live foal. 
(ii) Tanunda 
Both ovaries in this mare were generally described 
as 2 x 1.5 Units prior to, and up until Day 5 of the 
experiment. Although these ovaries were not the typical 
small, hard ovaries of acyclic mares, they were hard, and 
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did not contain any developing follicles of detectable 
size. On Day 5, a 1.5 Unit follicle was present (right 
ovary), and this persisted until Day 24 of the experiment, 
over which time it was described as both an area and a 
follicle of variable tension. The left ovary, which was 
smaller than the right, showed no activity until a 1.5 Unit 
firmishfo11ic1e was recorded on Day 20. This follicle 
increased in size and maturity to be 3 Units and soft on 
Day 24; the mare being mated on Day 23. On Day 27 the 
follicle had ovulated and from Day 28 onwards a 2 to 2.5 
Unit softish area forming ~ corpus 1uteum (as shown by the 
progesterone increase shown above) was present. Pregnancy 
was confirmed 40 days after conception and the mare subse-
quently produced a live foal. 
(iii) Winabe11 
The ovaries of this mare were generally 3 x 1.5 Units 
prior to, and up until Day 5 of the experiment, but did not 
contain any palpable follicular activity. However, an i11-
defined 1 Unit area of variable tension was present in one 
ovary over the days prior to the start of the treatment, 
after which it was not detected. From Day 4 through 14 of 
treatment, the right ovary showed increased activity, and 
a 1 Unit follicle or area was usually detected. Through 
this period, the left ovary decreased in size, but by Day 16 
enlarged, and on Day 20, a 1.5 Unit firmish follicle 
was present. This follicle continued to develop and mature, 
and by Day 24 was a very soft 3 Unit follicle and the mare 
was mated on this day. By Day 25, the follicle had ruptured 
forming a corpus 1uteum (shown by an increase in serum 
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progesterone) and an area of 1 Unit which persisted until 
Day 27, following which both ovaries were described as 
npproximate1y 2 x 2 Units and hard. This mare was 
confirmed pregnant 40 days after conception and subsequently 
delivered a live foal. 
3, Behaviour: 
(i) Contraband 
This mare showed sporadic oestrous behaviour in the 
early part of the experiment, but during progesterone 
administration no oestrous behaviour was shown. Following 
progesterone withdrawal, the mare came into oestrus on 
Day 19, and remained in oestrus until Day 29. 
(ii) Tanunda 
(iii) 
This mare showed only occasional days of oestrous 
behaviour in the early part of the experiment (Days 4 
and 5) but was in oestrus from Day 20 through Day 27. 
Winabell 
This mare did not show oestrous behaviour in 
the early part of the experiment, except for a 
questionable response on Day 5, but was in oestrus on 
Days 19 through 26. 
MARES SHOWING Spr¥TANEOUS CYCLICITY 
The hormonal (FSH and progesterone) ovarian and behavioural 
changes throughout the experiment in the three mares showing 
spontaneous cyclicity during the treatment are shown in Table 55 
(Gay Lustre), Table 56 (Pania) and Table 57 (Young Anne), 
DAY 
-5 
-4 
-3 
-2 
-1 
10 
11 
12' 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
,5 
26 
27 
20 
29 
30 
TABLE 55: 
TI/'IE 
hours 
1100 
1100 
1200 
0700 
10]0 
0659 
1901 
0655 
1400 
1100 
0700 
1500 
1200 
1400 
1400 
1400 
0645 
,92] 
06H 
1700 
11]0 
1400 
0700 
1130 
0900 
1430 
1230 
0711 
1910 
0710 
1910 
0718 
1100 
0900 
1130 
1730 
1500 
00]0 
09]0 
I?ROGESTERONE 
ng/Iltl 
0.1 
0.59 
1,07 
1.12 
0.69 
1.44 
2,BO 
2.45 
5.47 
6.40 
6.67 
6.67 
6 ,1~ 
5. )) 
1. 39 
0.69 
o .B3 
0.29 
0.56 
1.17 
1.01 
GAY LUSTRE 373 
FSH 
og/"11 
2 .49 
3 .97 
5,09 
5.04 
7.01 
6,0] 
7 .~3 
4,01 
~. 03 
3.39 
3.08 
3. 5~ 
5.05 
5.05 
5.13 
5.90 
7.62 
14 .0 
6.20 
6.90 
0. 3 0 
9',01 
12.2 
7.17 
4.0] 
5.73 
7.79 
8.06 
6.21 
4.45 
4.0J, 
4.30 
7.26 
6.16 
] .84 
5.83 
5.99 
OnRH 0.5 
1.'0 mg '12.9 10.9 11.2 O.]~ 
Jioechst 
1.0 mg 10,.5 12.9 13.5 7,61 
Hoechst 
1.0 mg 5.75 6.29 6.63 5.59 0.34 
itoechst 
1.0 mg 12.1 lQ.2 B.20 9,02 
Heec-hat 
1,0, m9 9.57 9,93 10.9 10.7 
Hoechst 
'1.,0 mg p.1 1].] 19.] 9.]6 9.]] 
Hoeclll'lt 
0.4 mg 10,2 12.7 9.75 9.07 
.\ye,rs,t 
0.6 rng 9.64 IS.3 12.4 11.6 
Ayers~ 
0.6 mg 7.33 8.25 6.18 4.69 
Ayerst 
0.6 mg 7.9(i 8.28 7.6] 8.61 
Ayerst 
1.4 mg 5.72 6:70 7.60 6.92 
Ayerst 
Footnot., Ao for Table. 51 to 53 ( ••• page 352) 
10- 12 Ovaries 
L: 4x~ "'rea - I, s 
R: ]>< Foll - l.S, fP 
l. sh; I, fh 
J,..: h2, II 
R: Fall - 1.5, fh 
L: 4x3, II 
ft.: FoIl 1.5, fh 
6.83 L: 3x3, H + irr~g 
7.03 
R: Fall 1.5, f 
L: 3><3, II 
R: Fall 2, fh 
,'-i! Areq .,. 1.5, fh 
R: Fall - 3, sh 
L: Fall I. 5, f 
R: fol~ 2, fh 
,LI Fall 1.5, f 
Ih Fall 2, fh 
~: Fall 3, st) 
If: Fol). 2.5, I 
L: Fotl 3, lill 
R: Fall l.5, sh 
L: FoIl 3, fih 
R: Fall 2, sh 
L: Fall 2, vs, 
R: FoIl 1,5, sh 
L: Fall - loS, fJ 
~,Foll 1.3, sn 
~.90 L: Fall 1, f 
7.62 
7.79 
8.00 
RI FoIl l.7, sh 
L: FoIl - 2,f 
'R: fo~l - )...5, fh 
LI 2x2, H 
R: FoIl - loS, sh 
L: FoU -I, sh 
R: Fpll - 1, fh 
L; foIl - 1 . .5, f 
R: 2xl, Foll - .-: 1, 
L: Fall .., 2, f 
R: Fall - I, fh 
L: Foll - 1.5, sh 
R: FoIl - 1.5, f 
1,.: Fall -I, fh 
Ih FOIl -1, fh 
6.21 LI Fall - 1, fh 
H: 2x2, irreg 
4.45 
L FoIl .,.1, f 
R FoIl - 1.5, f 
L FoIl - 1.5, sh 
R FoIl - 2, &h 
L FoIl - 1.5, fh 
R FoIl - 2.5, sh 
L 2xI, II + irreg 
R roll - 3, sh 
L FoIl - 2)(\, H 
R foil - 3.5, sh 
L 2xl, 
R FoIl - 3, vs 
L 2x1" H 
R "rea - 1.5, 8 
Not on 
Not on 
III oC'strus 
Not on 
In OC!strus 
Not on 
Not 
Not 
Not on 
Not on 
Not on 
Not on 
Nnt no 
Not on 
Indifferent 
Nat on 
Not on? 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Mated 
Not on 
! 
1
_,-.. 
'.- . 
;:.:::~.:.,:. :~:~:;:":"~ ~:~~.: 
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TABLE 56: PANIA 
D~' TI~ nROGESTEJ\QNe' FS~ Fsn .. Hours After r1nRII r::'::~'-• hours ng/ml ng/ml GIlRH 0.5 1 2 3 5·8 10-12 OVilrifl:s ·5 1100 ],71 ~; !? + II ~: Fall - 1. 5, so 
-4 1100 0.8] 3,45 
-3 1200 2.94 I., S + I' q, 3 x Poll - 1. 5. sh' 
1. fh: 1. ff, I ~lot on 
-2 0700 0.77 2,36 I -1 1030 4,00 T.: 2~1 , iI e, 2>:}-'oll - I. s, ] ,sIll 
071)1 0,85 2.51 1.0 mg 13.) 1 4 ,1 •• 17 6 .?~ ~ .n'} S .03 I.: " + " lIoechj5t " ))(2, 2.xF'oll - <1 f1,: I 1, fh I 'lot on 
1913 5.0) 1,0 ",g 14 .4 13.2 13.3 p.8 12" 4 
lIoechst 
0705 0.1 12,4 I,') mq 12. 4 }fi,2 14,8 16,5 14.6 10: Poll - 1. f' 
Iloec~st ~: "'rn.il - 1, 8: fall 
i < I. sh 1400 0.1 1).6 I.: FoIl - 1. fh 
1 
R: 3'2. II + irrcq ~Iot on 
11QO 13.0 J.: roll - 1.5, fh .: )x2, i rrf'q In O"strlls 
0700 0.1 lQ.O 10: poll - 1.1], f 
R: 4x2, II + ir:-rC(I Not on 
150U I.: Poll - 1.7, sh ", 2>:1, irroq 
1200 0.1 9.67 10, Poll - 1.1, sh .: )x2, II 
1400 15.0 10, Poll - 1. 5. • ": 2Xl, II 
1400 0,1 11. 3 10: F'oll 2. f 
R: 2xl, II 
~O 1400 ~. 2.1 
10, F'c;>11 - 1. 5. sh 
R, 2x2, II + ir:-raq In O(!5trlls 
11 06 44 0.1 1.57 .1..0 mg P.55 7.67 6.60 10, l\n~a . 2, f 
Ho!'!ohst 
3:25 
R: 2x2, II + irrolJ I n Oestrus 
1840 1.0 mg 5,21 - 5.0) 4.25 
HQ~cI"H,t 
3, 49/ 12 
0640 0.1 ).25 ~.O mg 4,92 6.11 5.61 6.66 L: Area . 2, fo 
HOfilQh~t R: 2xl. irreg Tn Oestrus 
13 170Q 0.1 5.95 10, Fall 2.5. fh ., 2x2, II 
14 1130 5.02 !.: fo~l - 2. s!1 
~: Area - 1. vs \lot on 
15 1400 0,1 6·n 10: F9 11 - 2.5. sh 
" "'0 1 1-.1, ""e"l-l "<: ,,,,lo 10 0700 6,02 10: Fall - 2. ~. f"i 
R: Foll-l.5.l3h, Area -
L5, S In Oestrus 
p 11]0 0.1 8.80 L: Fall - ),sh 
R, 2~Foll - I. ~. sh, 
1. .h 
18 0900 16.5 
19 1430 9,98 
20 1230 0.1 13.9 10, Poll - 2, sh 
R; Fall - ovulated In oel"tru5 
21 0714 0.3 10.9 In Oestrus 
22 0.61 7.60 L, Fall 1. 5, sh 
R: Area - 0.5. rubbery Not on 
23 0800 7. 01 Not on 
24 1100 2.08 9.67 L, FQll - 1. 5. fh 
R, 2xl, irreg Not on 
25 0900 2.40 2.67 L: 2xFoli - 1. fh: 
1. sh 
R, Area - collapsed Not on 
26 1200 2. ~3 ],64 L: 2xFqU . 1. fh: 
1. sh 
R, S + H 
Footnote 1 Ali lor r~bl$. 51 to 53 (~ •• p~g. 352) 
TABLE 57: 
-5 
-4 
-3 
-2 
-1 
10 
11 
12 
13 
14 
15 
16 
17 
IB 
19 
20 
2l 
22 
23 
24 
25 
26 
27 
2B 
29 
30 
TIl1E 
h.)u .. :s 
1100 
llOO 
1200 
0700 
1030 
0656 
1905 
0658 
1400 
1100 
0700 
1500 
1200 
1400 
1400 
1400 
06]9 
1842 
0642 
1700 
11]0 
1400 
u71lu 
1130 
0900 
14]0 
1230 
0713 
1913 
0713 
1912 
0721 
1100 
0900 
1100 
1730 
1500 
0830 
0900 
PROGJ?S':'T:ROfIE 
0.67 
0.83 
0,98 
0.61 
0.3 
1. ]1 
0.1 
0.1 
0.3 
2.40 
2.35 
2.27 
1.99 
2.61 
).87 
2.66 
2.53 
0.1 
0.1 
0.1 
0.75 
0.39 
3.30 
4.75 
YOUNG ANNE 
FSI! 
ng/Pll 
10. <1 
9.80 
2.15 
3.43 
8.36 
8.31 
20.5 
25.8 
25.7 
26.4 
24.1 
22.8 
23.0 
22.4 
21. 2 
,nRlI 
1.0 mg 
Hoechst 
1.0 mg 
Hoechst 
1.0 mg 
Hoechst 
0.5 
17.6 
14.5 
29.4 
-1'" 
375 
FSH- Hours After GnRH 
1 2 ) 5-8 10-12 
14.0 12.1 12.1 9.R6 B.3l 
24.8 20.2 21.3 20.5 
32.] 28.6 28.6 30.6 
18.9 1.0 mg 7.6.7 2fl.2 22.1 17.5 14.0 
Hoechst 
14.0 1.0 mg 22.4 22.4 17.5 IR.) 26.1 
Hoechst 
26.1 1.0 mg 31.1 34.6 3D,') 28.4 27.] 
Hoechst 
29.2 
28.2 
29.7 
36.2 
25.6 
25.1 
22.5 
20.9 
.21.6 0.t1 mg 
Ayerst 
26.0 0.6 mg 
Ayerst 
23.3 0.6 rng 
Ayerst 
24.7 0.6 rng 
Ayerst 
7.60 1.4 mg 
Ayerst 
15.5 
Hi.3 
16.4 
14.4 
14.3 
11. 9 
20.0 
10.1 .10.7 30.(; 27.7 
33.132.628.126.5 
24.8 26.6 23.6 24.8 
8,86 12.5 9,56 19.1 
19.9 IB.4 12.9 11.4 
26.0 
23.3 
24.7 
7.60 
Footnoto: As tor Tables 51 to 53 (see page 352) 
Ovaries 
I.: + H 
R: + If 
L: S + II 
R: Fall - 1, fh 
L~ 2x2, f 
R: Fall - 1, fh 
L: 3x2, II 
R: 2x2, II 
L: Fall - 1, fh 
R: foIl - 1.5, sh 
L: 2x2, II 
Deh-"v,:"u:-r __ I 
Not on 
Not on 
In Oestrus 
R: Poll - 1.5, sh !Jot on 
L: 2xl, irreg 
11:: Poll - l.'l, B Tn OQstrlls 
L: fi + II 
R: roll - l.5, sh In Oestrus 
L: 2xl, II 
R: FoIl - 1 r collilpsed 
L: 2xl II 
R: FoIl - I, collapsed 
L: 2xI, Fall - '"1. s 
R: 2xl, lo.rea - 1 
L: 2xl, irreg 
~: Fall - 1.), sh 
L: Fall - 1, fh 
It: Fall - 1, fh Not 
L: Foll - 1, fh 
R: Fall - 1.5, sh Not 
L: 2xl 
R: 3x2, H Not on 
L: Fall - 1.5, ,<; 
R: roll - 1.5, s 
L: FoIL - I, s 
R: Fall - 2, sh Not 
L:Foll-l,a 
9.: l"oll -2.5, a Not 
L: Fall - 1, f 
R: FoIl - 2, s Not on 
L: FoIL - 0.75, f 
R: Fall -2, a 
L: Fall - i, f 
R: 2x Fall - 2.5, SI 
1. 5, sh 
L: Fall - 1, f 
R: 2xFoII - 1.5, Slii 
1. f 
L: Fall - I, fh 
R: 2xFoll - 2, sh; 
Not on 
Not on ? 
Hot 
Not on 
Not on? 
In Oestrus 
1, sh In Oestrus 
LI 2)(.1, irreg 
R: FoIl - 1. 5, fh, 
Area - collapsed 
LI 2xl 
n: ~xl, Area - col lap- Not on? 
sed 
L: 2xl, irreg 
R I Area - 1, collapsed 
L: Fall -1, sh 
R: Not on 
L: FoIl - 1.5, sh 
RI FoIL -1, f; Area -
1, collapsed Not on 
L: Area - 1,8 
R: 1r.rea - ( 1, VB Not on 
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1. Hormonal Changes: 
Serum FSH levels prior to the start of the treatment 
showed little fluctuation in Gay Lustre and Pania, but varied 
5 fold in Young Anne. The FSH responses to the first course of 
GnRH in Gay Lustre and Young Anne were lower than in the 
mares in shallow acyclicity, but the responses of Pania were 
comparable. Young Anne showed a marked increase in baseline 
FSH levels during the first GnRH course, and this increase 
persisted until after the third course when some decrease was 
measured. Pania also had a marked increase in baseline FSH 
concentrations between the first and second courses of GnRH (high-
er than the increase seen in the mares in shallow acyclici ty) , 
with a peak level occurring on Day 8, Gay Lustre, however, 
showed nQ such spontaneous FSH increase. All mares showed 
diminished FSH responses to the second course of GnRH compared 
to those of the mares in shallow ayclicity, but the responses 
to the third course were similar in both groups. 
Serum progesterone concentrations were uniformly low (less 
than 1 ng/ml) in all three mares prior to the start of the treat-
ment. However, increases from endogenous secretion were 
observed during the experiment in each of the mares, with levels 
consistent with an active corpus luteum occurring on Day 10 
through 23 in Gay Lustre, Day 9 through 21 in Young Anne, and 
from Day 24 (12 days after the last injection of GnRH) until 
the end of the experiment in Pania. 
2. Ovarian Changes: 
The ovaries of all three mares showed follicular 
activity prior to the start of the treatment, this being most 
marked in Gay Lustre and Pania. In Gay Lustre, this follicular 
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activity increased early in the treatment, and by Day 3, a 
3 Unit softish follicle was present which appeared to ovulate 
on approximately Day 9, and a corpus luteum established (see 
progesterone results above). The ovaries of this mare remained 
active throughout th~ experiment with one or two follicles 
consistently.detected, and on Day 24, a further follicle began 
to develop which matured and ultimately ovulated on Day 29 
of the experiment, and established a corpus luteum (as shown by 
the progesterone results above), In Pania, the follicular 
activity observed prior to the start of the treatment continued 
throughout the experiment, and a 2 to 3 Unit follicle was 
present in one ovary between Days 11 and 20. However, in the 
contralateral ovary, another follicle first detected on Day 15 
appeared to ovulate on Day 20, after reaching a maximum size 
of only 1.5 Units, and a corpus luteum was established (see 
progesterone results above). In Young Anne, an increase in 
follicular activity occurred on Day 3 of treatment with the 
development of a 1.5 Unit follicle which ovulated by Day 6, 
and established a corpus luteum, as determined from the increase 
in serum progesterone concentrations (see results above). 
Considerable follicular activity was detected in this mare 
throughout the experiment, and on Day 24 a 2 Unit softish 
follicle was present and the mare was mated. This follicle 
ovulated on Day 25, and a corpus luteum was established (see 
progesterone results above). The mare conceived to this 
ovulation and delivered a normal foal. 
3. Behaviour: 
Gay Lustre showed occasional days of oestrous behaviour 
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early in the experiment (Days 1 and 3 of treatment), which was 
prior to the first ovulation. No further oestrous behaviour 
occurred until Day 25, and the mare then stayed in oestrus 
until following ovulation on Day 29, Pania showed inconsistent 
oestrous behaviour throughout the experiment, being in oestrus 
the maj ori ty of the time up until two days following the 
ovulation which occurred on Day 20. Young Anne was in oestrus 
during the early part of the experiment (Days 1, 4 and 5), and 
following ovulation on Day 5, was not on until pay 23 when the 
mare was again in oestrus prior to ovulating on Day 25. 
CONTROL MARES 
Of the four Group I control mares (Ambro Del filly, Donora, 
Lisa Twinkle and Meseta), only one mare, Lisa Twinkle, ovulated during 
the experimental period on the equivalent of Day 21 of the treatment, 
Ambro Del filly showed no ovarian activity other than follicles of 
less than 1 Unit. Donora regressed a 0,8 Unit follicle on Day 7 
of the experiment, but showed no further activity. Meseta developed 
a 0.8 Unit follicle which regressed on Day 16 of the experiment. 
Regression of follicles was assessed both by ovarian palpation and 
progesterone assay. 
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GROUP II: 
The two mares in this group (Bonnylands and Mrs Oram) were 
considered to be in mid-acyclicity according to the time of the year 
at which the experiment was performed, when stud records show that 
approximately 25% of mares have begun cycling. The hormonal, 
ovarian and behavioural changes occurring throughout the experiment 
are shown in Table 58 (Bonnylands) and Table 59 (Mrs Oram) while the 
mean hormonal changes, the mean fractional changes in the gonado-
trophins and the results of tests of significance (using paired t-tests 
comparing each value after the beginning of treatment with the mean 
value for each mare over the five days prior to the first GnRH 
injection) arfil shown in Table 60 I Figs 38 and 39 graphically illustrate 
daily serum concentration of FSH and LH and, where measured, serum 
progesterone and oestradiol-176, as well as the FSH and LH changes 
at 1, 3 and 12 h following each injection, in Bonnylands and 
Mrs Oram respectively. 
1. Homonal Changes: 
The mean FSH concentrations prior to the start of the 
treatment showed little fluctuation, but the levels were consist-
ently higher in Mrs Oram than in Bonnylands. Following the first 
injection of the first course of GnRH, a mean peak 3,2 fold 
increase in serum FSH occurred at 0,75 h, with the levels 
significant 1), elevated at 0.75, 1 and 2 h after administration. 
Progessively diminishing responses in FSH occurred following 
the second, third and fourth injections of this course, with 
mean peak increases of 2.6 fold at 0.75 h, 2.1 fold at 0.75 and 
1 h, and 1.5 fold at 0,75 and 1 h following each injection 
respectively, The only significant increase occurred at 1,5 h 
following the second injection of this course, Between the first 
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LEGEND FOR TABLES 58 AND 59 
Day = the day of the experiment, day 1 being the first 
day of treatment 
Time (hours) = the time at which the b+ood sample was 
collected, or GnRH administered 
GnRH :- source indicated for each inj~ction 
Gonadotrophins : -expressed as ng/ml Nutieli'SH or 
Hartree eLH (see text) 
Ovaries :- L = left ovary; R = right ovary 
Descriptions include : stating the size and 
tension of the ovary, e~g. L: trilobed,H = left 
ovary tri-lobed and "hard; e.g~ L: 2~1 = lett ovary 
measures 2x1 Unit~, where .1 Unit ~ 2.5 em (see 
Materials and Methods); e~g. L: S + H = left ovary 
small and hard. 
Stating structures in the ovary, these being 
either :- Foil = follicle, or Area = any soft 
structure not a follicle, otten a corpus luteum. 
~)tating particulars of these structures in terms 
of diameter (0.6 to 6 Units) and tension as an 
indication of maturity where :- fh = firmish; 
f = firm; sh = softish; s = soft; va = very soft; 
colI = collapsed (as in ovulation); rubbery = 
"rubbery" in tension. 
e.g. L: FoIl - 2, sh = left ovary contains a softish 
follicle 2 Units in diameter 
e.g. L: 2x1, H; 2xFoll - 1, fh; 3.5, vs = left ovary 
is 2x1 Units and hard, contains two follicles, one 
being 1 Unit in diameter and firmish in tension, the 
other 3.5 Units in diameter and very soft. 
TABLE 58: BONNYUlNDS 
DAY TIME PROGESTERONE OESTRADIOL -1 n GONADOTROPllIN HOURS AFTER GNRH ADMINISTRATION 
hours ng/ml pg/ml ng/ml GnRH 0.25 0.5 0.75 1 1.5 2 3 4 5-8 
10-12 OVARIES BEHAVIOUR DAy 
-5 1700 0.1 FSH, 3.06 L, S + H -5 
LH , 10.8 R: 5 + H 
-4 1800 0.70 FSH, 2.62 L, S + H -4 
LH: 15.7 R: 5 + H 
-3 1600 0.85 FSH: 2.19 L: S + H -3 
LH: 16.2 R: 5 + H 
-2 1400 0.67 FSH: 7.95 -2 , 
LH: 14.6 
-1 1400 0.1 FSH: 2.79 T .. : S + H -1 
LH: 15~ 1 R: 5 + H Not on 
1 0944 0.1 FSH: 4.54 1.0 mg 17.4 19.7 19.4 17.1 14.4 13.0 7.75 6.511 4.99 3.90 L: S + H In Oestrus 1 
Hoechst - aggressive 
LH: 14.8 - 41.5 - 38.2 - 32.4 27.2 14.8 15.2 9.83 R: S + H 
1949 FSH: 3.90 1.0 mg 10.2 12.2 13.6 12.8 12.0 7.60 6.99 5.25 
Hoechst 
LH: 9.83 18.2 21.5 22.5 23.1 20.1 l8.7 19.3 15.6 
2 0823 0.1 FSH: 5.25 1.0 109 6.68 10.7 13.4 16.2 6.49 6.85 4.H 6.63 4.34 2.12 
L: 5 + H 2 
Hoechst 
LH: 15.6 23.8 2B.2 23.5 27.2 21. 4 22.2 21.3 18.6 16.5 13.6 
R: S + H In Oestrus 
1918 FSH: 2.12 1.0 mg 6.77 5.40 7.95 6.12 10.5 4.05 
Hoechst '" LH: 13.6 28.7 29.3 27.9 28.4 18.8 lB.3 ··L.= 5 + H ~ 
3 1100 0.3 FSH: 3.30 
R~ S + H In Oestrus 3 
LH: 17.4 
4 1100 0.1 FSH: 3.59 
L: 5 + H 4 
LH: 11.5 R: S + H 
In Oestrus 
5 0900 0.3 FSH: 2.22 
L: 5 + H 5 
LH: 14.0 
R: 5 + H In Oestrus 
6 1600 2.93 FSH: 3.55 
L: S + H Partially 6 
LH: 23.3 
R: 5 + H In Oestrus 
7 1700 3.37 9.9 FSH: 6.60 
L: 2xl 7 
LH: 15.8 
'R: S + H 
8 1700 2.13 9.0 FSH: 3.45 
L: S + H 8 
LH: 16.7 
R: S + H 
9 0900 3.73 8.3 FSH: 4.64 L: tri-lobed 
9 
LH: 18.3 R: S + H 
Not on 
10 1000 3.33 5.8 FSH: 4.03 
T.: Foll - 1, fh Not on 10 
LH: 15.7 
R: 5 + H 
11 0845 3.87 8.5 FSH: 4.26 1.0 mg 43.5 49.2 48.0 52.5 39.1 33.7 31.1 19.4 5.79 L: 2xFoll - 1, sh: 1.5, sh 
Not on 11 
Hoechst 
LH: 16.3 50.7 51.9 47.0 47.9 28.5 12.3 22.9 20.3 14.3 R: 5 + H 
1915 FSH: 5.79 1.0 mg 14.6 28.8 1°.1 18.5 12.4 11.2 11.0 6.14 
'Roechst 
LH: 14.3 21. 2 26.7 30.4 31. 5 17.6 19.5 18.3 17.2 
12 0845 2.40 9.0 FSH: 6.14 1.0 mg 23.2 25.9 25.7 19.4 19.7 17.1 12.5 11. 2 5.00 L: tri-lobed, FoIl - 1, sh 
12 
Hoechst 'R.: 2xl Not on 
LH: 17.2 32 .1 38.5 32.8 33.4 35.6 21.4 21.2 20.3 -
':;' 
TABLE 58· CTD BONNY LANDS 
DAY TIME PROGESTERONE OESTRADIOL -17S GONADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
4 5-8 10-12 OVARIES BEHAVIOUR DAY hours ng/rnl pg/ml ng/m1 GnRH 0.25 0.5 0.75 1 1.5 2 3 
1849 FSH: 5.00 1.0 mg 19.4 20.8 23.4 21. 2 19.0 15.2 12.5 
Hoechst 
LH: - 22.3 30.3 30.7 32.6 32.f; 27.7 28.3 L: 2xFoll - 1, 5; 1, 5 13 
13 l410 2.67 FSH: 4.R9 R: Foll - 0.7. sh 
LH: 17.9 
L: tri-lobed 14 
14 1115 3.68 FSH: 2.84 R: 5 + H Not on 
LH: 16.8 
L: tri-lobed 15 
15 1300 2.80 18.0 FSH: 2.53 R: 5 + H Not on 
LH: 17.4 
L: tri-lobed 16 
16 1130 5.60 17.8 FSH: 4.25 R: S + H Not on 
LH: 20.2 
L: 5 + H 17 
17 1330 0.83 14.7 FSH: 3.85 R: S. + H Not on 
LH 13.5 
L: tri-lobed, fh 18 
18 1130 0.1 16.8 FSH: 4.22 R: FoIl - 1, fh 
LH: 21.5 r...~ tri-lobed, fh 19 
19 1130 0.1 12.8 FSH: 6.40 1'(: Foll - 1. fh Not on 
LH: 22.0 
L: tri-lobed, fh 20 
20 1300 0.1 12.4 FSH: 2.15 R: FoIl - 1.5, sh In Oestrus? 
LH: 25.5 
21 0849 0.1 1.9 FSH: 1.84 0.4 mg 21.7 37.0 31.9 24.3 21.9 15.8 11.6 12.9 3.89 L: tri-lobed, f!l 21 
Hoechst 
LH: 13.1 57.8 60.6 61.6 63.0 37.3 43.7 36.3 24.8 16.0 R: FoIl - 2, s In Oestrus 
1904 FSH: 3.89 0.6 mg 17.9 20.5 18.6 19.4 16.5 17.6 ~ 3.. 91 
Hoechst \>I 
LH: 16.0 42.4 31.1 26.6 24.7 lR.3 28.3 14."0 '" '" 22 0821 0.1 4.0 FSH: 3.91 0.6 rng 19.8 19.8 18.0 19.8 22.2 19.5 12.0 9.80 13.9 I.' S + H 22 
Hoechst 
LH: 14.0 32.5 42.9 38.1 48.9 43.4 ,23.5 21.9 9.29 15.3 'R.: FoIl - 2.5, 5 In Oestrus 
1837 FSH: 13.9 0.6 mg 20.1 20.8 19.5 26.0 35.3 14.6 9.68 13.0 
Hoechst 
LH: 15.3 23.9 21.9 27.6 22.4 19.5 l4.1 12.1 12.0 
23 0847 0.1 9.3 FSH: 13.0 1.4 mg 20.7 20.5 21.2 21.2 20.1 17.6 16.2 16.1 L: FoIl - 1, 5 23 Hoechst 13.2 
LH: 12.2 37.2 32.9 30.8 39.2 27.1 24.6 18.5 16.3 13.8 R: FoIl - 1.5, s In Oestrus 
24 1530 0.5 28.4 FSH: 12.0 L: Foll - 1. sh 24 
LH:... 22.1 R= FoIl - ?.S In Oestrus 
25 1230 0.5 9.0 FSH: 9.33 L: tri-lobed, 5 + H 25 
LH: 5.94 R: FoIl - 1.5, sh 
26 1200 0.2 10.9 FSH: 13.3 L: tri-lobed, 5 + H In Oestrus - 26 
LH: 21.4 R: Foll - 1. sh aggressive 
27 1230 0.4 13.4 FSH: 14.3 L: 5 + H 27 
LH: - R: Foll - 1. fh In Oestrus? 
28 1400 0.3 6.5 FSH: 13.2 L: tri-·lobed, S + H 28 
LH: 9.46 R: FoIl - 1, fh In Oestrus? 
29 1200 0.2 FSH: 11.2 L: FoIl - l,s In Oestrus - 29 
LH: 7.55 'R: Foll - < 1, sh aggressive 
30 1200 0.2 FSH: 17.1 L: Foll - 1.5, sh In Oestrus - 30 
L.'l: 15.6 R: FoIl - • 1. fh aggressive 
TABLE Sg: MRS DRAM 
DAY TIME OESTRADIOL -178 GONADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours pg/ml ng!ml GnRH 0.25 0.5 0.75 1 1.5 2.0 3.0 4.0 5 ·8 10-l3 OVARIES BEHAVIOUR 
DAY 
-5 1700 FSH, ll.6 L: Area-I, fh -5 
LH, 16.4 R: Foll-l.S, sh 
-4 
-4 1800 0.1 FSH: 10.9 
LH, 16.7 
-3 
-3 1500 0.3 FSH, 12.8 L:.2xF'oll-<1, fh; < 1, fh 
LH, 20.1 R, l'oll-<l, f 
-2 
-2 1400 0.1 FSH, 11.9 
LH, 21.0 
-1 
-1 1400 0.3 FSH, 7.47 L: 5 + H 
LH, 15.0 R, Foll-1, ff) In oestrus 
0947 0.1 FSH, 9.76 1.0 mg 20.9 21. 6 26.6 23.4 29.2 20.6 24.8 21. 4 13.7 15.0 L: S + H 
Hoechst 
LH, 19.9 38.9 35.1 25.8 13.9 11.0 B.99 B.74 R: FoIl-I, fh Not on 
1954 0.1 FSH, 15.0 1.0 rng 19.6 23.9 24.1 17.8 19.1 18.9 12.6 5.64 
Hoecl1st 
LH, 8.74 17.3 22.4 19.6 20.7 20.2 15.8 16.6 9.04 
'" 0820 0.1 FSH, 5.64 1.0 mg 12.4 15.2 17.2 14.7 12.6 10.6 15.7 12.4 11. 0 5.20 I L, S + H OJ 
Hoechst '" 
LH: 9.04 16.2 20.6 21. 6 18.8 19.5 14.9 12.3 7.53 12.6 10.8 R,S+H 
1921 FSH, 5.20 1.0 mg 14.2 9.12 10.7 l3.7 11.1 7.30 6.81 
Hoec'l1st 
LH, 10.8 15.3 16.6 lR.9 16.5 H.2 14.3 12.8 
llOO 0.67 FSH, 3.29 L: S + H 
LH: 8.99 R: S + H 
llOO 0.67 FSH, 4.45 L, + H 
LB, 7.80 R, + H Not on 
0900 0.3 FSH, 5.47 L, + H 
LH: 7.21 R, + H 
1600 4.53 FSH, 5.07 L: S + H 
LH: 7.57 R: 5 + H Not on 
1700 4.67 13.3 FSH, 8.39 L: Area-I, 5 
LH, 9.92 R, Foll-l, fh 
1700 4.53 10.7 F5H: 7.67 L: S + 1-1 
LH, 4.04 R, Poll-loS, fh ·lot on 
0900 3.73 l3.2 FSH, 4.87 L: ,'\rea.-l, f 
LH: 2.9Q 'R: Poll-I, sh 
10 1000 6.l3 8.8 FSH: 7.34 1.' 7'l"rr:!'a - 1, sh 10 
LH, 3.00 '!1: Poll-l.S, sh 
TABLE 59: eTD MRS ORAM 
I 
DAY TIME PROGESTERO'E OESTRADIOL -176 GONADOTROPHIN 
Hours ng/rnl pg/rnl ng/m1 GnRH 0.25 0.5 
11 OB45 11.19 6.2 FSH, 7.61 1.0 mg 1B.9 19.9 
Hoechst 
LH: 7.90 17.6 13.6 
1912 FSH: 9.B4 1.0 mg 8.61 9.66 
Hoechst 
LH: 10.1 18.3 26.3 
12 OB44 12.53 10.6 FSH: 3.61 1.0 mg 6.77 9.14 
Hoechst 
LH:l1.3 15.6 20.3 
lB4 B FSH: 2.88 1.0 mg 6.43 12.8 
Hoechst 
LH: 12.7 15.7 21.0 
13 1400 1. 73 FSH: 4.93 
LH: 12.9 
14 1130 7.99 FSH: 5.15 
LH: 10.4 
15 1300 6.79 9.9 FSH: 8.97 
LH: 10.9 
16 1200 6.13 20.0 FSH: 6.85 
LH: 15.3 
17 1330 3.46 12.0 FSH: 7.38 
LH: 11.6 
18 
19 1130 1. 20 14.2 PSH: 3.2A 
LH: 14.5 
20 1300 1. 20 10.1 FSH: 2.48 
LH: 13.9 
HOURS AFTER GNRH ADMINISTRATION 
0.75 1 1.5 2.D 3.0 4.0 5··B 10-l3 
18.8 20.4 1B.3 17.3 11.1 10.5 9. B4 
17.2 20.4 19.9 17.4 15.7 13.3 10.1 
10 •• 11.2 9.70 9.5B 9.76 3.61 
22.7 14.7 21.1 16.5 16.5 11.3 
11. 2 10.9 B.B8 8.80 7.86 8.36 2.88 
19.1 14.9 16.6 18.0 10.5 14.7 12.7 
9.34 11.3 9.10 10.0 7.22 
26.0 21. 5 21.1 18.7 15.9 
,;: 
OVARIES BEHAVIOUR 
L: FoIl-loS, sh 
R: Fo11-.l. 7, sh; Not on 
Area-collapsed 
L: S + H 
R: FoIL-I, sh 
L: S + H 
R: FoIL-I, sh Not on 
L: 3xl. 5 
R: Foll-1, sh 
L: 5 + H 
R: Foll-1, sh Not on 
L: S + H 
R: Fol-I-I. sh Not on 
L: S + H 
R: 5 + H Not on 
L: FoIL-loS, sl) 
R: FoIL-I, sh Not on 
L: Foll-2, sh 
R: S + H ~ot on 
L: Foll-3, sh 
R: S + H Indifferen~ 
,;. 
-
.'," . 
to; 
::~ 
': ~~ .', 
DAY 
11 
12 
l3 
14 
15 
16 
17 
18 
19 
20 
'" en ., 
TABLE 59: [m MRS DRAM 
I 
DAY TIME PROGESTEROt OESTRADIOL -17 B GONADOTROPHIN 
Hours ng/rn1 pg/rnl ng/rnl GnRH 0.25 
21 0850 1.47 13.7 FSH, 2.77 0.4 mg 4.27 
Hoechst 
LH, 15.1 23.1 
1905 FSH, 2.54 0.6 rng 3.66 
Hoechst 
LH, 16.4 18.3 
22 0819 0.1 17.9 FSH, 5.33 0.6 rng 7.49 
Hoechst 
LH, 10.6 10.7 
FSH, 4.92 0.6 rng 6.38 
1836 Hoechst 
LH, 14.6 21.6 
FSH, 1.54 1.4 rng 4.99 
23 0846 0.59 
19.7 Hoechst 
LH, 14.1 22.8 
15.7 FSH, 4.50 
24 1500 0.1 LH, 15.6 
16.0 FSH, 4.61 
25 1200 0.1 LH, 16.4 
15.0 FSH, 4.08 
26 1200 0.1 LR, 13.7 
0.1 15.7 
FSH, 5.44 
27 1230 LH, 10.8 
0.2 17.4 
FSH, 4.45 
28 1400 LH, 18.0 
17.3 FSH, 2.61 
29 1200 0.2 LH, 17.5 
FSH, 4.45 
30 1200 0.2 LH: 20.7 
HOURS AFTER GNRH ADMINISTRATION 
0.5 0.75 1 1.5 2.0 3.0 
5.79 7.76 4.76 4.88 5.50 6.92 
26.0 32.2 32.4 25.7 26.9 20.8 
7.62 14.1 8.45 8.27 7.89 
36.0 33.8 34.7 24.3 20.9 
8.13 7.53 11 .0 8.51 7.72 6.68 
18.7 23.9 21.8 23.3 21. 7 23.3 
9.13 8.37 7.27 7.32 4.39 3.31 
28.7 28.9 23.4 33.0 28.6 17.4 
5.48 6.62 6.22 5.49 3.83 2.48 
31. 6 32.3 32.5 30.9 28.1 21. 7 
4.0 5··8 10-13 OVARIES 
4.36 2.54 L: Foll-2.5, sh 
20.9 16.4 R.:S+H 
5.33 
10.6 
6.88 4.92 L, Foll-4, sh 
20.0 14.6 R: S + H 
1.54 
14.1 
5.12 L, Foll-3.7, s 
17.7 21. 3 R: S + H 
L, Foll-3.7, s!1 
R, Foll-l 
L, Foll-3.5, s 
R: 5 + H 
L: Foll-3.S, vs 
R: 5 + H 
L: Foll-2.S, vs 
R: 5 + H 
L: Foll-2.S, sh 
R: 5 + H 
L: poll-2.S, 5 
R: S + H 
L: :a.rea- 2.5, sh 
R: S + H 
BEHAVIOUR 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Partially 
in oestrus 
Partially 
in oestrus 
Not on 
Not on 
DAY 
:::' 
:.> 
:i: 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
'" '" '" 
TABLE 60 ~86 
MEAN HORMONAL (rSH, LH, PROGESTElIONB AND OBSTRADIOJ,-17al CONCENTRI\TIONS IN MARES IN >lID ACYCLICITY (GROUP III 
mROUGHO~T THE BXPBRlMENT, AND THE fRACTIONfJ. CIIAIIG~8 IN !lONADOTROPHIHS DURING THE TREATMENT 
DAY TIME AFTER 
GnRH (Hours) 
-5 
-4 
-3 
rSH 
ng/ml 
Mean SO 
7.33 6.0 
6.76 5.9 
7.50 7.5 
-2 9.93 2.9 
-1 5.13 3,3 
-0.1 7.15 3.7 
Mean 
13.6 
16.2 
18.2 
11.8 
15.1 
17 .4 
LH 
ng/rol 
SO 
4.0 
0.7 
2.8 
1. 5 
0.1 
3.6 
PROGESTERONE 
ng/m;t 
Mean so 
0.1 0.0 
0.4 0,4 
0.6 
0.4 
0.2 
P .1 
0.4 
Q. ~ 
0.1 
0,0 
2. 
2 
OESTRADIOL -11 ~ 
pg/ml 
,.,ean so 
FRACTIONAL 
CHANGES t 
FSH LH 
1.0 mg GnRH (0945 hl-----~------------...:"..--~----------------------
0.25 19.2 2,5 
o . 50 20.7 1. 3 
0.75 
1 
1.5 
5 -
23,0" 5.1 
20.3" 4.5 
21.9 10.5 
16',8* 
16.3 
14 ,0 
9.35 
10-12 9.45 
5.4 
12.1 
lQ .5 
6.2 
7.9 
40.2 
]6.7 
29.1 
20.6 
12 ~ 9 
12.1 
9.29 
1.8 
2.2 
4."1 
9.4 
2.7 
4.4 
0,8 
2.6 
2.8 2.5 
3.2 
2.8 2.2 
.3.0 
2.3 
2.2 
1.9 
1.3 
1.3 
1.8 
1.3 
0.8 
0.7 
0.6 
1.0 mg GnRH (1950 hl--------~----------------------------------
0.25 14.9 
0,50 1B.l 
0.75 19.9 
15.3 
1.5 15.6** 
13.3 
9.90 
10-12 5.45 
6.6 
8.3 
7.4 
3.5 
5.0 
9.0 
4.0 
0.3 
17.8 
22 .0 
21.1 
H.9 
2.0.2 
17.3 
18.0 
12.3 
0.6 
0.6 
2.1 
1.7 
0.1 
2.1 
1.9 
"6' 0.1 0.0 
2.0 
2.5 
2.6 
2.1 
1.1 
1.3 
1.3 
1.3 
2.1 1.2 
1.8 1.1 
1.3 1.1 
0.7 0.9 
1.0 mg GnRJI (0922 hl---------------------~----~.:.-----------------
0.25 9.54 4.0 
3.2 
2.7 
1.1 
4.3 
0.5 13.0 
0.75 15.3 
1 15.5 
1.5 9.55 
- 8 
10-12 
8.73 2.7 
10.1 7,9 
9.5.2 4.1 
7.67 4.1 
3.66 2.2 
20. 0' 
24.4 
n.6 
23.0 
20,5 
18.6 
16.8 
13.1 
14 .6 
12.2 
5.4 
5.4 
1.3 
5.9 
1.3 
5.2 
6.4 
7.8 
2.8 
2.0 
1.3 1.2 
1.8 1.5 
2.1 1. 4 
2.1 1. 4 
1.3 1.3 
1.2 1.1 
1.4 1.0 
1. 3 0.8 
1.1 0.9 
0.5 0.7 
1.0 mg GnRH 11920 hi ---_-------~-_--------_'_ ____________________ _ 
0.25 10.5 5.3 
0.5 7.25 2.6 
0.75 10.7 
10.8 4.1 
1.5 9.61 3.5 
8.90 2.3 
B.43 6.2 
3.30 0.0 
4.02 0.6 
3.85 2.3 
4.31 1.1 
7.50 1.3 
5.56 3,0 
4.76 0.2 
22 .0. 
23.0 
18.9 
22.2 
23.3 
16.6 
9.5 
9.0 
8.1 
7.2 
3,2 
15.6 1.9 
'11.2 6.0 
9.65 2.6 
10.6 4.8 
15.4 11,1 
12.9 4.2 
10.7 8.S 
10.6 10.8 
0 , 5 0.3 
0.4 0.4 
0,3 0,0 
3.73 1.1 
4.02 0.9 
~.33 1.7 
3.73 0.0 
10 5.69 2.3 9.35 9.0 4.73 2.0 
11.6 
9.9 
10.9 
7.3 
7.4 
2.4 
1.2 
3.5 
2.1 
1.6 
1.4 1.3 
1.0 1.4 
1.0 1.0 
1.5 1.4 
1.2 1.4 
1.2 1.0 
1.2 1.0 
0.5 0.8 
0.6 0.6 
0.5 0.6 
0.6 0.9 
1.0 0.8 
0.8 0.7 
0.7 0.6 
0.9 0.6 
0.8 0.7 11 -0.1 5.94 2.4 12,21 5.9 7.54 5., 
11 
12 
1.0 mq GnRH (0845 h) 
0.25 31.2 11.4 
0.50 
0.75 
1 
1.5 
10-12 
34.6 
)).4 
36.5 
29.7 
20.7 
20.6 
22.7 
14.7 
25.5 11.6 
21.1 14.1 
15.0 6.3 
7.82 2.9 
34.2 23,4 
32.8 
32.1 
34.2 
24.2 
).4.9 
19.3 
16.8 
12.2 
27.1 
21.1 
19.4 
6.1 
3.6 
5.1 
5.0 
3.0 
4.3 2.1 
4.7 2.0 
4.6 2.0 
5.0 2.1 
3.9 1.5 
3.5 0.9 
2.9 1.2 
2.1 1.0 
1.1 0.7 
1.0 mg GnRH (1914 hl----------------________________________ ------------------------------------------------
0.25 11.6 
0.5 19.2 
0.75 15.0 
1 14.9 
1.5 11.1 
10.4 
10.4 
10-12 4.88 
4.2 
13.5 
5.9 
5.2 
1.9 
1.1 
0.9 
1.8 
19.8 
26.5 
26.6 
23.1 
19.4· 
18.0 
17.4 
14.3 
2.1 
0.3 
5.4 
11.9 
2.5 
2. + 
1.3 
4.2 7.45 7.1 9.8 1.1 
1.6 
2.6 
2.1 
2.0 
1.5 
1.4 
1.4 
0.7 
1.2 
1.6 
1.6 
1.4 
1.2 
1.1 
1.1 
0.9 
1 mg GnRH (0845 h) ________ . _____ ~ _______________________________ __ 
O.l\Y TIM!: Al"TB.R FSII 
ng/ml 
so 
12 
13 
14 
15 
16 
11 
18 
U 
20 
2l 
GnruJ Ulolltll) 
0.25 
0.50 
0.75 
1.5 
2 
Mean 
15.0 
17.5 
18.5 
11.6 
11.9 
10.3 
15.2 6.0 
14.3 7.7 
13.0 5.' 
10.2 3.3 
9.78 2.0 
10-1. 3.94 1.5 
1 "9 GORH (l94' hI 
0.25 12.' 
0,. S 16.9 
0.15 16.4 
16.3 
bS 14.1 
l 12.6 
a ~. 86 
4.91 
4.00 
'.2 
5.7 ... 
7.1 
7.0 
3.7 
3.7 
0.0 
1.6 
5.75 4.6 
5'.55 1.8 
5.62 2.5 
4.22 
4.84 2.2 
2.32 0.2 
-0.1 2.ll 0.7 
Mean 
23 •• 
2'.4 
26.0 
24.2 
26.1 
19.7 
15.9 
17.5 
12.'7 
19.0 
25.7 
2B.4 
27.1 
26 •• 
23.2 
22.1 
15.4 
13.6 
14.2 
17.8 
12.6 
21. 5 
10.3 
19.7 
14 .1 
LH 
ng/ml 
so 
11.7 
12.9 
9.7 
13.1 
13.4 
2.4 
7.6 
4.0 
4.7 
6.6 
J.3 
7.8 
~.1 
6.4 
8. B 
3.5 
4.5 
4.6 
3.5 
1.3 
5.3 
8.2 
1.4 
PROGSSTERONE 
n9/m1 
Mean SO 
;il t 20 O.? 
5.84 ~.O 
4.80 2.8 
5.81 0.4 
2.15 I.' 
0.1 
0.7 O. B 
0.7 
0.8 
0.8 
1.0 
oeSTRADIOl- -178 
pg/"l 
Mean SO 
14.0 
18 •• 
13.4 
16.8 
13 .5 
11.3 
7.0 
5.7 
1.6 
1.9 
1.0 
1.6 
8.3 
FRACTIONAL 
CHANGES t 
FSH LH 
2.1 1.5 
2.4 1.8 
2.5 1.6 
2.1 1.5 
2.0 1.6 
1.8 1.2 
1.4 1.0 
1.34 1.1 
0.5 0.7 
1.8 1.2 
2.) 1.6 
2.2 1. 7 
2.2 1. 7 
1,9 1.6 
1.7 1.4 
1, 4 1. 4 
0.7 0.9 
0.6 0.8 
0.8 O.q 
0.8 1.1 
0.8 0.8 
1.1 1.5 
0.7 1.1 
0.3 1.2 
0.3 0.9 
0.4 .. q GnRH (0850 hl----------------~~-----------------------
0.25 13.0 
O. ~O 21. 4 
0.75 l'.B 
1 14.5 
1.5 13.4 
10.7 
12.3 
22.1 
17.1 
lJ.8 
12.0 
7.3 
9.26 3.3 
8.~3 6.0 
10-12 3.22 1.0 
40.5 
43.3 
46 .• 
41.7 
31. 5 
35.3 
24.5 
24.5 
20.8 
21.6 
8.2 
11.9 
28.6 11.0 
22.9 2. B 
16.2 0.3 
1.8 2.5 
2.9 2.6 
2.7 2.9 
2.0 2.9 
1.8 1.' 
1.5 2.2 
1.3 1.7 
1.2 1.4 
0.4 1. 0 
0.6 r,'g GIlRH (1905 hl-,--------------------------_;_-----------------
0.25 10.8 10.1 
D.50 14.1 
0." 16.4 
1 13.9 
1. S 12.4 
12.7 
10-12 4.62 
9.1 
3.2 
7.7 
5. B 
6.9 
1.0 
30.4 17,0-
33.6. 3.5 
30.2 5.1 
29.7 7.1 
21.3 4.2 
24.6 S.2 
12.3 2.4 
0.6 rtlq OnnH (0820 hl----------
0.25 13.6 8.7 
0.3 
7.4 
0.50 14.0 
0.75 12.8 
1.5 
:( 
3 
15.4 6.2 
15.4 9.7 
13.6 8.3 
9.34 3.8 
0.34 2.1 
9.41 6.3 
22 O.~ "'9 GnRH (1837 hl-------
24 
U.25 13.2 '.7 
8.3 0.50 15.0 
0.75 
1.5 
13.9 
16.6 
21. 3 
9.50 
6.50 
7.' 
W-12 7.27 
13.2 
19.8 
7.2 
1.5 
8.1 
1.; "'9 anAH (0847 hl--------
0.25 12.8 11.1 
10.6 0.50 13.0 
0.75 13.9 10.3 
13.7 10.6 
1.5 12.8 10.3 
10.7 9.7 
9.34 9.7 
16.1 
'!i - U 9.16 5.7 
8.25 5.3 
21.6 15.4 
30.0 17.1 
31.0 10.0 
35.4 19.2 
3).4 14.2 
22.6 1.3 
H.6 1.0 
14 .6 
15.0 
22.8 
25. J 
28.3 
22 •• 
26.3 
H.4 
14. B 
13.2 
30.0 
32. ) 
7.6 
0.5 
1.6 
4.8 
0.9 
0.7 
9.5 
10.3 
3. B 
1.3 
10.2 
0.9 
31.6'* 1.1 
35.9 4.7 
29.0** 2.7 
26.4'" 2.5 
20,1'" 2.3 
17.0 1.0 
17.6 5.3 
4.6 
0.1 0.0 ll.O 
0.3 0.3 14.5 
0.3 0.3 22.1 
9.8 
7.4 
9.0 
1.5 1.9 
1.9 2.1 
2.2 1. 8 
1.. 1.8 
1.7 1.3 
1.7 1.5 
0.6 0.8 
1.9 1.) 
1.9 1.' 
1.8 1.' 
2.1 2.2 
2.1 2.0 
1.9 1.4 
1.3 1.4 
1.1 0.9 
1.3 0.9 
1.8 1.4 
2.1 1.5 
1.9 
2.3 
2.9 
1.3 
0.9 
1.0 
1.8 
1.8 
1.7 
1.4 
1." 
1.3 
0.' 
0.8 
1.8 
2.0 
1.9 1.9 
1.9 2.2 
1.8 1.8 
1.5 1.6 
1.) 1.2 
4.2 1. 0 
1.3 1.1 
1.1 1.2 
!y~ 6OS!tdl J88 
OAY 
25 
~6 
27 
~8 
~9 
30 
TIMJ AFTER YO" ~H ~ROGESTERqNE OESTRADIOL -178 
Gnllll (Hours) n9/m1 nq/ml ng/ml pg/ml 
Hean SO Mean SO n Hean SO Hean SO 
6.97 3.3 11. ~ 7.4 0.3 O. ] 12.5 5.0 
6.69 6.5 1',6 5.4 0.1 I) .0 13.0 2.9 
9.67 6.3 10.6 0.2 0.2 14 .6 1.6 
6.83 6. ~ P.7 6.0 O. ~ 0.0 1~.0 7.7 
6.91 6.1 12.5 7.0 O. ~ 0.0 1'. ] 
0.2 0.0 
fractional changes in serum o~nc'.Qtrationll!l· ot FSH and J.1l oalculated by dividing 8ach or the mean 
oOt\centrationo trbm the beginning or treat.ellt uptl1 t~e CIIJl,d at the expe1'1:lIentsJ,. pe:riod by the mean 
pre-troatment baseline (days prior to Day 1 and tm Day 1 at -0.1 b). On those occasions after the 
beginning of treatment whon there was misF.ling datn, the lIel).n pre~tr8atment baseline exclu~ed the 
values trom the appropriate mares. 
Haan FSH and Lil concentrations throughout the treatment were cOJII.llsred to the mesn pr('-treatment 
b ••• line (po1red t-te.t.w1th1n eaob .. are} and significant ditt~ronqe. at p<O.05 and p<O.01 
indioa.tad. by • and •• r'eapectively. 
,'':T:_~':' :,:.; _:_~ • .:_ :.~_:~ 
FRACTIONAL 
CHANGE t 
FSH LH 
1.0 0.7 
1.2 1.1 
1.4 0.6 
1.2 0.8 
0.9 0.8 
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LEGEND FOR FIGURES 38 AND 39 
Serum concentrations of FSH and LH daily throughout. the 
Experiment, and at 1, 3 and 10-12 hours after GnRH 
administration, and progesterone and oestradio1~17S as 
measured during the experiment in13onny1ands and Mrs Oram. 
Days ~ day of experiment with Day 1 = the day of the 
first GnRH .injection 
FSH expressed as ng/ml Nuti equine FSH (see Chapter Ill) 
LH expressed as ng/m1 Hgrtree equine LH (see Chapter III) 
progesterone as ng/m1 
oestradiol-17S as pg/m1 
solid bar = oestrous behaviour shown 
vertical arrow = ovulation (where indicated together with 
a question mark, this indicates there 
was no ~ertainty ovulation occurred) 
~ = mare mated 
Treatment: GnRH was administered (as described in text) 
on Days 1 and 2, 11 and 12 and 21, 22 and 23. 
Progesterone (150 mg/day) was administered on 
Days 5 through 16 
Note: These figures should be read in conjunction with 
Tables 58 and S9 
! 
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and second courses of GnRH, the mean FSH concentrations were 
below the mean pre~treatment value, which was primarily the result 
of a decrease in serum FSH in Mrs Dram over this period. 
The first injection of the second course of GnRH caused a mean 
peak increase of 5 fold at 1 h following injection, while the 
second, third and fourth injections caused mean peak increases 
of 2,6 fold at 0.5 h, 2.5 fold at 0.75 h, and 2.3 fold at 
0.5 h following each injection respectively. Because of the 
variation in response of the two mares, none of the increases 
during this course were significant. Following the second GnRH 
course, mean FSH levels were again below the mean pre-treatment 
baseline, this decrease being especially marked in Mrs Dram. 
However, both mares showed a decrease in serum FSH in the last 
days prior to the start of the third course, so that on Day 
20 and 21, the mean FSH concentrations were 0.3 of the mean 
pre-treatment baseline. The third course of GnRH caused mean 
peak increases in serum FSH of 2.9 fold at 0,5 h following the 
first injection, 2,2 fold at 0.75 h following the second injection, 
2.1 fold at 1 and 1.5 h after the third injection, 2.9 fold at 1.5 
h after the fourth injection, and 1.9 fold at 0.75 and 1 h following 
the fifth injection. The increases in FSH during the third GnRH 
courses were not significant, which reflects the large variation in 
response between the two mares. Following the third GnRH course, the 
mean FSH lb"els were similar to the mean pre-treatment baseline. 
LH levels prior to the start of the treatment were similar 
in both mares, and showed little fluctuation. The mean peak 
response to the first injection of the first GnRH course was a 
2.5 fold increase at 0,5 h following injection, while the 
remaining injections of this course caused diminished responses 
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(mean peak increases of 1.3 fold at 0,5, 0,75 and 1 h 
following the second injection, 1.5 fold at 0,5 h after the 
third injection, and 1.4 fold at 0.5, 1 and 1.5 h following the 
fourth injection). No significant LH increases occurred during 
this course. Between the first and second courses of GnRH, 
the mean LH concentrations were lower than the mean pre" 
treatment baseline, with a marked decrease occurring in Mrs Oram, 
This difference between the mares in terms of LH levels 
continued into the second course of GnRH, with the LH levels 
in Mrs Oram being much lower than those in Bonnylands. The 
mean peak increases following each GnRH injection in this 
course were 2.1 fold at 0.25 and 1 h after the first injection, 
1.6 fold at 0.5 and 0.75 h after the second injection, 1.B fold 
at 0,5 h following the third injection, and 1.7 fold at 0.75 
and 1 h after the fourth injection, Between the second and third 
GnRH courses, the mean LH concentrations were similar to the 
mean pre-treatment baseline, The first injection of the third 
GnRH course caused a 2,9 fold increase in mean serum LH 
concentrations at 0,75 and 1 h following injection, and the 
second injection caused a significant 2.1 fold increase at 0.5 
h after injection. Mean peak increases in LH following the 
third, fourth and fiffuinjections of this course were 2.2 
fold at 1 h, 1.7 fold at 0,75 hand 2.2 fold at 1 h following 
these injections respectively, The levels were significantly 
elevated following the fifth injection at 1.5, 2 and 3 h after 
administration of GnRH. Following the third course of GnRH, 
the mean LH levels returned to the pre-treatment baseline, 
Mean serum progesterone concentrations were uniformly low 
(less than 1 ng/ml) prior to the start of treatment, and remained 
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at this level, until Day 6, the first day after the start of 
exogenous progesterone administration. The mean levels remained 
between 2.15 and 7,54 ng/ml until Day18. On Day 19 through 
to the end of the experiment, the mean serum progesterone 
concentrations were less than 1 ng/ml. 
Serum oestradiol~178 concentrations were first measured 
on Day 7 of the treatment, and from this time until Day 12, little 
+ variation in concentration occurred (mean 9,44 ~ 2.3 pg/ml), 
Between Day 15 and 25, serum oestradiol-178 concentrations 
varied markedly in the two mares, with very low levels occurring 
in Bonnylands on Days 21 and 22 of the experiment, and a single 
increased level observed in Mrs Oram on Day 16. However, 
a gradual rise to a peak concentration on Day 24 occurred 
in Bonnylands, while the peak level, apart from that on Day 16, 
occurred in Mrs Oram on Day 23. 
2. Ovarian Changes: 
(i) Bonnylands 
The ovaries in this mare were consistently small 
and hard until Day 9 of the experiment, At this time, 
one ovary was described as tri~lobed, and on Day 10 
contained a firmish follicle of 1 Unit. The activity 
in this ovary, although variable, continued until Day 22 
In the contralateral ovary, activity was first detected 
on Day 18, and a follicle increased in size and maturity 
to be 2.5 Units and soft on Day 22, Ovulation was thought 
to have occurred on Day 24, although a corpus luteum was not 
established, as indicated by serum progesterone concentrat-
ions (see above). This mare ovulated spontaneously 19 
days after the induced ovulation. 
395 
(ii) Mrs Oram 
Prior to the start of the treatment, the ovaries 
of this mare showed some activity, with a number of small 
follicles being detected. However, both ovaries were 
small and hard from Day 2 through Day 6 of the experiment. 
On Day 7, follicular activity was present in one ovary, 
and this persisted until D,ay 16. On Day 18, activity 
in the contralateral ovary increased and a follicle 
progressively developed to be 4 Units and softish on 
Day 22, but futher matured to be 3.5 Units and very 
soft on Day 26. Ovulation was thought to occur on 
Day 26, but no corpus luteum was establishecl~ as shown by 
the low levels of progesterone (see above). This mare 
reverted to acyclicity for 29 days following this 
induced ovulation, 
3, Behaviour: 
Bonnylands was in oestrus during the early part of the 
experiment (Day 1 through Day 6), but not during this period 
of progesterone administration. She returned to oestrus on 
Day 21 and remained in oestrus until the end of the 
experiment, although her behaviour was more aggressive from Day 
26 onwards. 
Mrs Oram did not show true oestrus behaviour until Day 21 
of the experiment, and she remained in oestrus until Day 28, 
although the intensity of the signs of oestrus were diminished 
on Days 27 and 28. 
J". 
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GROUP III: 
The eight mares comprising this group were considered to be in deep 
aeyclicity at the time the experiment was performed. The results from 
Group IlIa mares, which received exogenous progesterone, were consid-
ered separately from those of Group IIIb mares which were not given 
exogenous progesterone. 
GROUP IlIa: 
i 
The hormonal, ovarian and behavioural changes in the mares in this 
group throughout the experiment are shown in Table 61 (Compliment), 
Table 62 (Lottie's Express), Table 63 (Oriental Scott) and Table 64 
(Robyn's Choice). The mean hormonal changes, the mean fractional changes 
in.gonadotrophins, and the results of tests for significance of the 
increase in gonadotrophin~ (comparing by paired t-test the mean value 
over the period prior to the start of the experiment, with each subse-
quent value for each mare) are shown in Table 65, whil~ the daily serum 
concentrations of FSH and LH, and, where measured, progesterone and 
oestradiol-17S, as well as the FSH and LH changes at 1, 3 and 12 h 
following each injection of GnRH are graphically illustrated in Fig. 40 
(Compliment), Fig. 41 (Lottie's Express), Fig. 42 (Oriental Scott) and 
Fig. 43 (Robyn's Choice). 
1. Hormonal Changes: 
The mean serum FSH levels measured every 1 to 3 days over the 
14 days prior to the experiment showed some fluctuation, contributed 
to by the variation observed in one mare (Lottie's Express), and 
by missing data on Day 1 at ~O.l h before the first injection of 
GnRH. The first GnRH injection of the first course caused a mean peak 
2.4 fold increase by 0,5 h, and levels remained significantly 
elevated from 0.5 h through 3 h after injection. The second, third 
and fourth GnRH injections of this course caused diminished 
responses (1.9 fold at a,s h, 1.9 fold at 0,5 h, and 2 fold 
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LEGEND FOR TABLES 61 TO 64 
Day = the day of the experiment, day 1 being the first 
day of treatment 
Time (hours) = the time at which the blood sample was 
collected, or GnRH administered 
GnRR :~ source indicated for each injection 
Gonadotrophins :- expressed as ng/ml Nutieli'SH or 
Hartree eLH (see text) 
Ovaries :- L = left ovary; R = right ovary 
Descriptions include : stating the size and 
tension of the ovary, e.g. L: trilobed,H = left 
ovary tri-lobed and_hard; e,g. L: 2~1 = le~t ovary 
measures 2x1 Units, where 1 unit = 2.5 c~ (see 
M~teria19 and Method~); e.g. L; S + H = left ovary 
small and hard. 
Stating structures in the ovary, these being 
either :- Foll =fo111cle, or Area = any soft 
structure Qot a follicle, often a corpus luteum. 
:3tating particulars of these structures in terms 
of diameter (0.6 to 6 Units) and tension as an 
indication of maturity where :- fb = firmish; 
f = firm; sh = softish; s = soft; vs = very soft; 
coll = collapsed (as in ovulation); rubbery = 
"rubbery" in tension. 
e.g. L: Foll -2, sh = le~t ovary contains a softish 
follicle 2 Units in diameter 
e.g. L: 2x1, H; 2xFoll - 1, fh; 3.5, vs = left ovary 
is 2x1 Units and hard, contains two follicles, one 
being 1 Unit in diameter and firmish in tension, the 
other 3.5 Units in diameter and very soft. 
T.~BLE 61· COMPLIMENT 
DAY TIME PROGESTERONE OESTRADIOL -17 B GONADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/ml pg/ml ng/ml r;n'r{H 0.5 l.Q 1.5 3.0 7.0 12.0 OVARIES BEHAVIOUR DAY 
-14 1030 ~.1 FSH: L: S + H -14 
LH: 19.5 R: S + H Not on 
-11 1330 I 0.96 FSH: 13.1 L: S + H -11 
I LH: 6.5 R: S + H Not on 
-9 1500 0.1 FSH: 12.7 L: 5 + H -9 
LB: 12.5 R: S + H Not on 
-7 1130 0.1 FSB: 11.4 L: S + H -7 
I LH: 6.25 R: 5 + H Not on 
-4 1130 0.3 FSH: 11.4 L: S + H -4 
LH: 10.0 R: S + H Not on 
-3 1730 0.67 FSH: 11.3 -3 
LH: 7.5 
-2 1500 0.40 F8H: 11. 0 L: S + H -2 
LH: 5.0 R: 5 + H Not on 
-1 18QO 
! 
0.1 FSH: 13.3 -1 
LH: 9.3 
1 0741 0.43 FSH: 1. 2 mg 43.6 40.6 34.9 30.2 24.7 22.1 L: 5 + H 1 
Ayerst 
LH: 3.5 24.5 18.0 15.5 15.0 9.5 9.8 R: 5 + H Not on 
'" 1943 FSH: 22.1 1.2 mg 40.1- 37.1 31.1 29.3 "" <X> 
Ayerst 
LH: 9.8 25.5 17.0 18.5 15.5 
2 0912 0.53 FSJI: 30.1 1.2 mg 26.2 30.2 26.3 21.0 18.3 L: S + H 2 
Ayerst 
LH: 7.5 19.5 21. 5 13.8 16.5 15.5 R: 5 + H Not on 
3 0935 0.4 FSH: 14.7 1.2 mg 31. 4 23.7 29.1 28.7 19.2 L: 5 + H 3 
Ayerst 
LH: 5.5 25.0 18.0 16.0 24.5 18.0 R: S + H In Oestrus 
4 2005 FSH: 12.0 L: 5 ... H 4 
LH: 21. 8 R: 5 + H Not on 
5 1343 FSH: 9.55 L: 5 + H 5 
LH: 12.5 R: S + H Not on 
6 1500 FSH: 24.2 L: 5 + H 6 
LH: 26.5 R: S + H Not on 
7 1600 FSH: 15.9 L: S + H 7 
LH: 21.8 R: Foll-0.5, f Not on 
8 1440 7.06 FSH: 19.2 L: 5 + H 8 
LH: 18.0 R: S + H Not on 
9 1150 FSH: 16.4 L: 5 + H 9 
LH: 24.5 R: 5 + H Not on 
10 0900 I 2.59 FSH' 13.5 L: S + H 10 LH: 22.0 R: Foll-O.S, sh Not on 
I 
11 0758 2.27 FSH: l'9.4 1.2 mg 48.2 55.2 43.4 42.3 29.9 14.2 L: 5 + H 11 
i 
Ayerst 
LH: 18.5 42.5 31. 5 25.5 30.0 21. 5 22.0 R: 5 + H Not on 
,'. ' 
::.: 
::: 
T.~BLE 61· CTD COMPLIMENT - .. 
DAY TIME PROGESTERONE OESTRADIOL -178 GONADOTROPHIN 
Hours ng/ml pg/ml ng/ml r;n'lt.'9 0.5 
1922 FSH, 14.2 1.2 mg 38.7 
leI 
LH, 22.0 32 .5 
12 1330 2.13 F'SH, 16.2 1.2 mg 29.3 
leI 
LA, 16.5 33.5 
13 0758 F'SH, 14.8 1.7. mg 31. 2 
leI 
LH, 21.0 35.0 
14 1400 
I 
2.08 FSH, 11.8 
LH, 22.0 
15 1430 9.2 FSH, 9.5~ 
LH, 26.3 
16 1030 4.00 FSH, 27.4 
LH, 26.8 
17 1450 6.13 4.9 FSH, 21. 7 
LH: 18.8 
18 1435 1. 68 FSH, 11.5 
LH, 25. a 
19 1440 3.20 4.8 FSH, 19.7 
LH, 28.0 
20 1200 0.56 8.4 F5H, 11. 8 
LH, 26.3 
21 1200 0.61 7.9 FSH, 4.93 
LH, 29.0 
22 0754 0.59 7.4 FSH, 3.S9 1.0 mg 30.5 
Hoechst 
LH, 32.0 49.0 
2012 F5H, 3.26 1.0 mg 20.4 
leI 
LH, 19.0 41.5 
23 1144 0.1 12.4 FSH, 5.47 1.0 mg 14.0 
leI 
LH, 19.0 31. 3 
24 1451 0.1 FSH, 2.59 1.0 mg 1. 26 reI 
LH, 20.9 23. ~ 
25 1640 0.3 6.0 FSH, 15.4 
LH, lS.R 
26 1445 0.83 10.2 FSH, 10.8 
LH, 11.9 
27 1510 0.1 13.9 FSH, 9.41 
LH;11.3 
28 1610 o .J 13.4 FSH, 14.0 
LH, 20.9 
29 1700 1. 01 8.8 FSH, 13.0 
LH, 21.3 
HOURS AFTER GNRH ADMINISTRATION 
1.0 1.5 3.0 7.0 12.0 
40.1 32.3 28.4 
32.5 37.7 23.9 
32.7 29.5 21. 7 19.0 
34.5 28.8 21. 3 18.3 
35.5 30.1 26.5 16.7 
31.3 37.0 23.5 17.0 
33.3 21.9 19.7 8.73 3.26 
34.3 31. 3 35.0 25.0 19.0 
17.8 14.1 10.7 
38.8 42.0 36.3 
14.1 10.1 14.2 3.51 
28.8 27.0 35.0 16.3 
1i.18 3.17 1. 92 7.12 
23.5 29.5 17.0 17.5 
OVARIES 
L: S + H 
R: S + H, FoIl - < -0.5, sh 
L, S + H 
R: S + H 
L: 2xl, irreg 
R, 2xFoll-1, sh; 0.5, fh 
L, Foll-1, fh 
R: 2xFoll-l.S, f; 0.5, s 
L, Foll-1. 3, fh 
R, 2xFo11-1, sh; 1, sh 
L, Foll-1, fh 
R, 2xFoll-0.5, fh; 0.5, fh 
L: Tri-lobed + irreg 
"R: Area-l,s 
L: S + H 
R, Foll-1, ·fh 
L: 2xFoll-l, fh; 1, fh 
R: 1.5xl, irreg 
L, 2xFoll-1, fh; 0.5, fh 
R, Foll-L 3, fh 
L: 3xFoll-l.5, sh; 1, Shi 1, fh 
R, Foll-1.5, sh 
L: 3xFoll-l, 5; 1, S; 1, fh 
R: 2xFoll-1.5, S; 2, sh 
L, 3xFoll-l.S, sh; 1.5, Shil,s 
R: 2xFoll-2, sh; 1, s 
L, 2xFoll-1.5.s; 1, s 
R: Foll-2.S, s 
L: 2xArea-l.S, vs; 1, vs 
-R: Foll-3. 5, s 
L: 1.5xl, tri-Iobed, f 
R: Foll-3, vs 
L: S + trilobed 
R: FoIl - 3, s 
L: 5 + H.bi-lobed 
R, Fo11-3, s 
BEHAVIOUR 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus - mater 
In oestrus I 
In oestrus - mated 
I 
DAY 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
'" '" '" 
.,' 
," ,'. 
,',' 
:> 
'", 
!i!: >. 
TABLE 61: CTD COMPLIMENT 
DAY TIME PROGESTERONE OESTRADIOL -17 S GONADOTROPHIN 
Hours ng/ml pg/ml ng/ml r:;n'l:t!-I 0.5 
30 1655 2.45 15.0 FSH, 13.3 
LH, 25.0 
31 1140 0.48 10.8 FSH, 17.7 
LH: 37.5 
32 0815 0.56 15.0 FSH, 5.89 1·0 mg 
Hoechst 
LH: 25.0 
1957 FSH: 11.4 1.0 mg 
Hoechst 
LH, 23.8 
33 1512 0 • .j3 FSH, 6.44 1.0mg 
Hoechst 
LH: 25.0 
34 0837 0.48 10.9 FSH, 12.0 1.0 mg 
leI 
LH, 20.0 
35 1427 1.01 FSH: 17.7 
LH: 23.4 
36 1215 1.41 FSH: 11.3 
LH, 17.5 
37 1338 1. 39 FSH, 11.9 
LH: 17.5 
38 1130 3.41 FSH: 7.36 
LH, 23.5 
39 1228 FSH: 3.41 
LH: 26.5 
40 1500 1. 09 FSH: 3.32 
LH: 26.3 
41 1500 2.93 FSH: 2.99 
LH: 19.3 
42 1700 5.07 FSH: 3.52 
LH: 22.5 
HOURS AFTER GNRH ADMINISTRATION 
1.0 1.5 3.0 7.0 12.0 OVARIES 
L: 1.5xl, H + irreg 
R: Foll-3, vs 
29.7 13.9 11. 4 L: 2xl, tri-lobed R: Foll-3, 5 
28.4 46.3 37.5 23.8 L: S + H 
62.5 17.9 R: Foll-3,vs 
22.6 40.8 
55.6 25.4 
17.5 35.0 L: S + H 
24.3 20.1 48.8 R: Foll-3, vs 29.5 29.5 
30.9 L: bi-lobed + irreg 
38.8 
R: Foll-vs, collapsed 
L: 2xl, Area-I, sh 
R: Area-3, vs 
L: 2xl, H 
R: Area-2,vs 
L, 2xl 
R: Area-2.5, vs 
L: 2xl, irreg 
R; Area - collapsed 
L: 2x1 
R: Area-vs, collapsed 
L: 1.5x1 
R: Area-2, vs, collapsed 
L: 1.5xl, 
R: Area-2, vs 
L: S + H, bi-lobed 
R: Area-l. 7, sh 
I 
BEHAVIOUR 
In oes"~'..l~ 
In oestrus 
In oestrus 
In oestrus? 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
DAY 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
;.; 
::~, ' 
:::: . 
'.:. 
., 
0 
0 
TABLE 62: LOTIIE'S EXPRESS 
DAY TIME PROGESTERONE OESTRADIOL -178 GONADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/ml pg/ml ng/rnl GnRH 0.5 1.0 1.5 3. D 
-
-14 1000 0.3 FSH: 19.4 
LH, 17.4 
-11 1300 0.8 FSH, 23.9 
LH, 19.0 
-7 1115 0.61 FSH, 7.10 
LH, 15.0 
-4 1130 0.61 FSH, 7.06 
LH, 17.4 
-3 1730 0.1 FSH, 3.10 
LH: -
-2 1500 0.1 FSH, 6.19 
LH, 25.0 
-1 1800 0.4 FSH, 6.28 
LH, 17.4 
1 0740 0.4 FSH, 12.4 1.2 mg 27.3 25.7 23.0 18.2 
Ayerst 
LH, 22.3 34.5 23.5 23.5 22.3 
1940 FSH, 11.6 1. 2 mg 20.9 24.0 21.2 16.8 
Ayerst 
LH, 23.5 31.3 26.8 25.0 19.0 
2 0908 0.5~ FSH, 13.5 1.2 mg 19.3 15.5 14.1 10.3 
Ayerst 
20.3 LH, 17.4 ~8.0 29.0 29.0 
3 0933 0.75 FSH, 5.29 1.2 mg 15.4 14.8 10.5 32.0 
Ayerst 
34.5 LH, 15.0 24.5 31.4 25.0 
4 2000 FSH, 24.3 
LH, 25.0 
5 1348 0.3 FSH, 21.0 
LH, 50.2 
6 1520 3.81 FSH, 10.5 
LH, 21. 3 
7 1600 FSH, 13.6 
LH, 46.5 
8 1420 7.60 FSH, 10.6 
LH, 2~.8 
9 1130 FSH, 35.8 
LH, 18.2 
10 0915 2.56 FSH, 35.9 
LH, 20.3 
11 0754 2.32 FSH, 30.9 1.2 mg 81. 9 76.0 67.R 66.0 
Ayerst 
LH, 26.8 191. 5 77.5 103.8 31. 4 
1919 FSH, 26.2 1.2 mg 73.5 64.6 59.4 25.8 
leI 
LH, 37.8 31. 4 50.2 42.0 31. 4 
7.0 12.0 OVARIES 
L: S + H 
R: S + H 
L: S + H 
R: S + H 
L: bi-lobed, H 
R: S + H 
L, S + H 
R: S + H 
L, S + bi-1obed 
R: S + H 
L, S + H 
R, S + H 
17.9 11.6 L, S + H 
21. 3 23.5 R, S + H 
3.48 L, S + H 
17 .4 R, S + H 
20.3 L: S + H 
37.5 R: Firm + irreg 
L: S + H 
R: sh + irreg 
L: 1.5xl, irreg 
R, Fo11-0. 5, fh 
L, S + H 
R: S + H 
L, S + H 
R: S + H, irreg 
L: 5 + H 
R, S + H 
L, S + H 
R, S + H 
42.4 26.2 L, S + H 
20.3 37.8 R, S + H 
,', .. 
BEHAVIOUR DAY 
-14 
Not on 
-11 
Not on ? 
In oestrus - aggress ve 
In oestrus 
In oestrus 
Not on 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
::;" ' 
~; 
:~~: 
:~~: :. 
:.: 
~: : 
-7 
-4 
-3 
-2 
-1 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
~ 
~ 
TABLE 62· ern LOTTI E 'S EXP RESS 
DAY TIME PROGESTERONE OESTRADIOL -178 GONADOTROPHIN 
Hours ng/m1 pg/m1 ng/m1 
--
12 1332 3.92 F5H: 17.6 
LH: 29.0 
13 0756 3.81 F5H: 16.3 
LH: 17.4 
14 1430 2.69 11.1 F5H: 17.6 
LH: 13.9 
15 1435 F5H: 15.3 
LH: 15.8 
16 1100 4.61 8.3 F5H: 25.7 
LH: 10.5 
17 1515 -F5H: 21. 2 
LH: 13.9 
18 1505 3. 07 8.3 F5H: 20.0 
LH: 1R.2 
19 1500 2.13 F5H: 17.7 
LH: 15.0 
20 1155 1.97 8.8 F5H: 19.2 
LH: 13.0 
21 1215 1.20 8.7 F5H: 12.3 
LH: 13.9 
22 0748 1. 60 6.B F5H: 9.34 
'-
LH: 10.5 
2010 
F5H: 21.9 
LH: 15.8 
23 1140 0.51 4.1 F5H: 20.8 
LH: 13.9 
24 1445 0.53 8.8 F5H: 19.1 
LH: 13. a 
25 1620 0.67 >130 F5H: 19.3 
LH: 21.5 
26 1430 0.93 9.8 F5H: 22.6 
LH: 25. a 
27 1525 0.45 10.0 F5H: 13.9 
LH: 17.4 
28 1630 0.4 F5H: 7. 04 
LH: 19. a 
29 1700 0.45 9.8 F5H: 18.8 
LH: 18.2 
30 1700 0.55 F5H: 33.0 
LH: 31. 3 
31 1145 0.4 F5H: 23.4 
LH: 23.5 
HOURS APTER GNRH ADMINISTRATION 
GnRH 0.5 1.0 1.5 3.0 7.0 12.0 
1.2 mg 48.5 44.7 44.8 43.4 25.3 
IeI 
58.8 68.0 26.8 96.5 58.8 
1.2 mg 41.8 48.7 40.2 28.5 21.1 
IeI 
58.8 34.5 26.8 29.0 15.8 
1.0 mg 74.6 71.1 65.1 49.2 26.4 21.9 Hoechst 
58.8 42.0 42.0 17.4 15.8 15.8 
1.0 mg 54.2 51.4 51.3 39.6 
IeI 
23.5 22.3 16.6 16.6 
1.0 mg 51.1 39.1 35.0 22.8 20.0 IeI 
23.5 23.5 15.8 13.9 10.5 
1.0 mg 65.6 56.3 51.0 42.7 23.3 IeI 
115.0 77.5 58.8 26.8 42.0 
OVARIES 
L: 5 + H 
R: S + H, irreg 
L: 5 + H 
R: 5 + H 
L: 5 + H 
R: 5 + H 
L: 2xl, irreg 
R: 5 + H 
L: S + H, irreg 
R: S + H 
L: Fo11-1, fh 
R: 5 + H 
L: FoIl-I, fh 
R: S + H 
L: Foll-l, sh 
R: 5 + H 
L: Fo11-1, sh 
R: S + H 
L: Foll-1.3, fh 
R: S + ~ 
L: Foll-l.s, sh, Area-l~5, vs 
R: Fo11-1, f 
L: 2xFoll-2 ,5; 2, fh 
R: 2xl, FoIl-I, fh 
L: 2xFoll-2, sh; 1, s 
R: Foll-l, fh 
L: 2xFo11-1.5, sh; 1, f 
R: tri-lobed + H 
L: 2xl, irreg 
R: S + H 
L: Area-I, collapsed,Foll-l,s"1 
R: 2xl, irreg 
L: Area-I, vs, Foll-l, fh 
R: 5 + H, irreg 
L: Area-l.5,collapsen,Foll-l,fh 
R: S + H 
L: 2xl + irreg, FoIl-I, f 
R: S ... H 
L: 2xl, A.rea-i, s 
R: S + H 
.-
BEHAVIOUR 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on? 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Not on ? 
Not on 
Not on 
Not on 
:" 
x 
:.; 
? " 
;:: 
DAY 
12 
13 
14 
15 
16 
17 
i8 
19 
20 
21 
22 ~ 
0 
N 
23 
24 
25 
26 
27 
28 
29 
30 
31 
TABLE 63: ORIENTAL scan 
DAY TIME !PROGESTERONE OESTRADIOL -178 GO"l'ADOTROmIN 
Hours ng/ml pg/ml ng/ml GnRH n .5 
-14 1030 0.1 FSH, 5.83 
LH, 8.54 
-11 1330 0.1 FSH, 5.45 
LH, 7.90 
-9 1445 0.1 FSH, 4.73 
LH, 6.72 
-7 1115 0.1 FSH, 4.11 
LH, 6.91 
-4 1130 0.1 FSH, 7.46 
LH, 10.5 
-3 1730 0.1 FSH, 6.13 
LH, 9.60 
-2 1500 0.1 FSH, 7.08 
LH, 11.8 
-1 1800 0.1 FSH, 9.14 
LH, 12.8 
1 0728 0.1 FSH, 8.22 1.2 mg 18.8 
Ayerst 
LH, 10.3 2n.7 
1931 FSH, 9.26 1.2 mg 11.6 
Ayerst 
LH, 9.57 16.4 
2 0906 0.1 FSH, 7.27 1.2 mg 11. 3 
Ayerst 
LH, 5.78 15.2 
3 0924 0.1 FSH, 10.7 1.2 mg 13.5 
Ayerst 
LH, 9.32 17.4 
4 1940 0.1 FSH, 14.5 
LH, 11.6 
5 1406 0.1 FSH, 6.42 
LH, 8.10 
6 1510 1.87 FSH, 9.71 
LH, 9.34 
7 1600 1. 39 FSH, 7.78 
LH, 7.56 
8 1430 11. 46 FSH, 4.38 
LH, 7.12 
9 1130 2.61 FSH, 9.05 
LH, 6.55 
10 0900 2.16 FSH, 8.42 
LH, 11.4 
11 0748 0.83 FSH, 11.0 1.2 mg 24.0 
Ayerst 
LH, 7.59 19.3 
HOURS AFTER GNRH ADMINISTRATION 
1.0 1.5 3.0 7.0 12.Q 
19.0 16.6 12.7 9.81 9.26 
12.6 21.2 11.4 7.27 9.57 
10.7 9.05 9.82 
15.0 18.9 14.6 
12.3 15.2 13.3 9.39 
13.8 15.7 13.6 11.1 
18.9 14.4 17.5 12.2 
17.2 17.3 14·4 7.77 
26.5 19.7 19.7 11.4 10.1 
23.4 20.8 13.8 7.56 10.7 
OVARIES BEHAVIOUR 
L: 5 + H 
R, S + H Not on 
L: S + H 
R: S + H Not on 
L: S + H 
R, S + H Not on 
L: S + H 
R: S + H Not on 
L: 5 + H 
R, S + H Not on 
L: S + H 
R: S + H In oestrus 
L: S + H 
R, S + H Not on 
L, S + H 
R, S + H Not on 
L, S + H 
R: S + Ii In oestrus 
L: 5 + H 
R, S + H In oestrus 
In oestrus 
L: S + H 
R: S + H 
L, S + H 
R, S + H Not on 
L: S + H 
R.: 5 + H Not on 
L, S + 11 
R: 5 + H Not on 
L: S + H 
R, S + H Not on 
L, S + H 
R: S + H Not on 
DAY 
-14 
-11 
-9 
-7 
-4 
-3 
-2 
-1 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
l!t::: 
:~:: 
.i 
':' 
.',' 
,\-, 
~ 
0 
'" 
TABLE 63: em ORIENTAL scan 
DAY TIME ROGESTERONE OESTRADIOL -178 GO'lADOTROFIUN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/ml pg/ml ng/ml GnRH 0.5 1.0 1.5 3.0 7.0 12.Q OVARIES BEHAVIOUR DAY 
1912 FSH, 10.1 1.2 mg 14.9 12.8 16.8 15. 2 
leI 
LH, 10.7 12.7 13.8 14.3 10.6 
12 1327 1.41 FSH, 9.46 1.2 mg 15.4 - 18.4 13.0 17.9 L: 5 + H 12 
Ie! 
LH: 6.27 15.4 18.6 13.1 11.4 9.41 R, S + H Not on 
13 0752 1.44 FSH, 15.3 42.6 31. 8 27.0 18.4 11.7 L, S + A 13 
LA, 6.22 21.5 20.1 16.2 13.6 9.41 R: S + H Not on 
14 1425 1.71 FSH, 12.0 L: S + H 14 
LA, 8.26 R, S + A Not on 
15 1410 1.20 FSH, 16.0 L: S + H 15 
LA, 11.8 R: S + H Not on 
16 1030 2.93 3.15 FSH, 16.9 L: 5 + H 16 
LH, 7.55 R: 5 + H Not on 
17 1445 10.53 FSH, 22.0 L, S + H 17 
LH, 9.59 R, S + H Not on 
18 1445 2.00 5.15 FSH, 18.6 L: S + H 18 
LH, 11. 3 R: S + H Not on 
19 1450 2.6 FSH, 21. 7 L: 5 + H 19 
LH, 12.6 R: S + H Not on 
20 1140 0.8 9.30 FSH, 21.0 L: 5 + H 20 
LH, 9.22 R, S + H Not on 
21 1205 0.3 7.15 FSH, 18.4 L, S + H 21 
LH, 14.6 R, Fo11-Q. 5, fh Not on -I'" 
0 
22 0742 0.4 FSH, 22.0 1. 0 mg 29.1 36.4 34.3 10.8 10.0 14.6 L, S + H 22 -I'" 
Hoechst 
LH, 10.8 21. 5 20.5 20.3 16.9 12.4 9.29 R, S + H Not on 
2005 8.72 FSH, 14.6 1.0 mg 26.7 33.3 26.1 23.3 
leI 
LH, 9.29 17.2 15.8 14.0 11.5 
23 1135 0.3 10.15 FSH, 19.4 1.0 mg 24.8 25.8 30.5 22.7 19.3 L: 5 + H 23 leI 
LH, 7.19 14.9 16.5 13.4 10.7 10.7 R: FoIl-I, fh Not on 
24 1442 0.51 12.0 FSH, 18.1 1.0 mg 21.6 26.2 30.8 29.3 28.0 L: S + H 24 leI 
LH, 5.16 11.8 10.5 12.0 10.3 5.35 R: FoIl-I, fh In oestrus 
25 1635 0.1 9.58 FSH, 25.6 L: 5 + H 25 
LH 6.41 R: Foll-O. 5, fh In oestrus 
26 1440 1. 31 7.72 FSH, 16.4 L: 5 + H 26 LH, 9.46 R: S + H In oestrus 
27 1520 0.48 FSH, 15.5 L: 5 + H 27 LH, 3.56 R, S + H In oestrus 
28 1620 0.1 FSH, 21.2 L: S + H 28 LH, 9.62 R, S + H In oestrus 
29 1700 0.1 FSH, 1. 72 L, S + H 29 LH, 5.20 R: 5 + H In oestrus 
'::: : 
':~: . 
TABLE 63: CTD ORIENTAL scan 
DAY TIME ~ROGESTERONE OESTRADIOL -178 GO"1ADOTROre IN 
Hours ng/ml pg/m1 ng/rn1 
30 1710 0.1 FSH: 8.78 
LH: 4.82 
31 1200 0.1 FSH: 9.55 
LH: 4.26 
32 0811 0.3 FSH: 5.80 
LH: 7. 06 
1952 FSH: 6.79 
LH: 9.10 
33 1511 1.47 FSH: 
LH: 
34 0831 0.1 FSH: 6.02 
LH: -
35 1435 0.1 FS1i: 6.41 
LB: -
36 1308 0. 1 FSH: 1.01 
LH: -
37 1308 0.4 FSH: 0.73 
LH: -
38 1130 0.4 FSH: -
LH: -
39 1145 0.1 FSH: -
LH: -
40 1710 0.1 FSH: 4.22 
LB: -
HOURS AFTER GNRH ADMINISTRATION 
GnRH 0.5 1.0 1.5 3.0 7.0 12.0 
1.0 mg 16.3 6.04 13.4 6.79 
Hoechst 
14.3 8.78 9.63 9.10 
1.0 rng 9.62 19.3 
Hoechst 
9.71 8.46 
1.0 mg 12.1 12.4 
Hoechst 
13.0 8.38 
1.0 mg 14.5 7.94 7.64 
Hoechst 
- - -
OVARIES BEHAVIOUR 
L: S + H 
R: S + H In oestrus 
L: 5 + H 
R: S + H In oestrus 
L: S + H 
R: S + H In oestrus 
L: S + H 
R: S + H In oestrus 
L: 5 + H 
R: S. + H In oestrus 
L: S + H 
R: S + H In oestrus 
L: S + H 
R: S + H In oestrus 
L: S + H 
R: S + H In oestrus 
L: 1.5x1, f 
R: S + H In oestrus 
L: S + H 
R: S + H In oestrus 
L: S + H 
R: S + H In oestrus 
I 
T" 
[;~ 
.\ 
:1:" 
DAY 
30 
31 
32 
33 
34 
35 ~ 0 
I.J> 
36 
37 
38 
39 
40 
DAY 
-14 
-11 
-9 
-7 
-4 
-3 
-2 
-1 
10 
11 
,,', 
TABLE 64: 
TIME 
Hours 
1030 
1330 
1500 
1130 
1130 
1730 
1500 
1800 
0730 
1932 
0902 
0922 
1940 
1407 
1515 
1600 
1425 
1210 
0900 
0745 
1911 
PROGESTERONE 
ng/ml 
0.1 
0.67 
0.3 
0.1 
0.1 
0.8 
0.1 
0.4 
0.48 
0.54 
0.48 
0.3 
0.3 
3.15 
6.53 
2.77 
ROBYN'S CHOICE 
OESTRADIOL -176 
pg/ml 
GON"DOTROPHIN 
ng/ml 
FSH, 
LP., 
FSH, 20.5 
LH, 9.85 
FSH, 21.6 
LH, 10.0 
FSH, 19.2 
LH, 7.86 
FSH, 21.7 
LH, 13.0 
FSH, 23.5 
LH, 23.6 
FSH, ' 20 
LH, 58.7 
FSH, ' 20 
LH, 15.7 
FSH, ' 20 
LH, 27.7 
FSH: 20.6 
LH, 39.1 
FSH, 20.2 
LH, 18.3 
FSH, 20.0 
LH, 22.4 
FSH, 20.4 
LH, 21.0 
FSH, 21. 3 
LH, 12.6 
FSH, 27.5 
LH: 4::!.3 
FSH, 13.5 
LH, 17.8 
FSH, 18.0 
LH, 33.7 
FSH, 14.6 
LH, 25.9 
FSH, 19.2 
LH, 55.3 
FSH, 29.9 
LH, 41.2 
FSH, 17.8 
LH,64.8 
GnRH 
1.7. mg 
Ayerst 
1.2 mg 
Ayerst 
1.2 mg 
Ayerst 
1.2 mg 
Ayerst 
1.2 rng 
Ayerst 
1.2 mg 
!~T 
HOURS AFTER GNRH ADMINISTRATION" 
0.5 1.0 1.5 3.0 7.0 
38.5 
52.5 
30.9 
53.2 
35.5 
63.8 
37.6 
97.7 
45.4 
100.2 
32.3 
76.8 
38.3 
48.8 
24.8 
53.2 
38.6 
55.6 
36.2 
79.3 
41.5 
RO.l 
33.8 
33.8 
35.0 
26.5 
43.1 
28.0 
51.8 
35.7 
79.7 
39.9 
89.7 
27.2 
99.0 105.9 
40.9 
28.4 
31.7 
33.0 
32.3 
39.6 
29.8 
52.0 
38.0 
57.8 
24.3 
68.8 
26.7 
26.0 
22.7 
35.7 
23.7 
25.8 
17.4 
43.5 
12.0 
20.-6 
39.1 
17.8 
64.8 
OVARIES 
L: 2xl. H + irreg 
R: S + H 
L~ 2xl, H + irreg 
R, 5 + H 
L: 2xl. H + irreg 
R: 5 + H 
L: 2xl, H + irreg 
R: S + H 
L: 2xl, H + irreg 
R: S + H 
L: 2xl, H + irreg 
R: S + H 
L: 2xI, H + irreg 
R: 5 + H 
L: 2xl, H + irreg 
R: S + H 
L: 2xl, H + irreg 
R: I.Sxl, H + irreg 
L: 2xI, H 
R: I.Sxl, FoIl - O.5~ fh 
L: 2xl. H + irreg 
R: S + H 
L: 2xl~ H + irreg 
R: l.Sxl, H + irreg 
L: 2xl, H + irreg 
R: I.SxI, II + irreg 
L: 2xI, H + irreg 
R: 1.5xl, I! + irreg 
L: 2xl, IJ + irre!) 
R: l.Sxl, 11 + irreg 
L: 2:-:1, 11 + irreg 
R: I.SxI, H + irreg 
BEHWIOUR 
Not on 
Not on 
Not on 
In oestrus 
In op.stru!'; 
Indifferent 
Not on 
In oestrus 
In oestrus 
In oestrus 
Not on 
Not on 
Not on 
Not on 
Not on 
"lot on 
Not on 
DAY 
-14 
-11 
-9 
-7 
-4 
-3 
-2 
-1 
10 
11 
':""; , 
') 
t 
'.'" I 
.:' .< ;. 
.., 
o 
'" 
DAY 
12 
13 
14 
15 
16 
17 
18 
19' 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
TABLE 64: 
TIME 
Hours 
1326 
0751 
1430 
1410 
1045 
1450 
1500 
1445 
1145 
1210 
0740 
2004 
1130 
1438 
1635 
1435 
1520 
1615 
1700 
1705 
1205 
em ROBYN'S CHOICE 
PROGESTERONEI OESTRADIOL -176 
ng/ml pg/ml 
2.03 
2.08 10.3 
3.47 7.13 
8.43 
2.99 7.13 
2.53 
1.71 8.10 
1.28 7.24 
1. 47 7.34 
0.69 6.16 
0.85 12.74 
0.3 8.32 
2.27 7.88 
0.72 
0.35 
1. 07 
0.3 
GONIUlOTROPHIN 
ng/ml 
FSH, 17_3 
LH, 45.4 
FSH, 20.3 
LB: 52.9 
FSH, 23.5 
LH, 52.5 
FSH, 19.5 
LH, 30.5 
FSH, 15.3 
LH, 27.3 
FSH, 24.0 
LH, 30.8 
FSI!, 26.5 
LH, 41.3 
FSH, 28.4 
LH, 29.4 
FSH, 20.0 
LH, 26.1 
FSH, 20.4 
LH, 38.5 
FSH, 10.1 
LH, 52.9 
FSH, 14.1 
LH, 45.7 
FSH, 16.6 
LH, 55.9 
FSH, 25.5 
LH, 62.3 
FSH, 21. 8 
LH, 48.7 
FSH, 32.7 
LH, 81.6 
FSH, 19.7 
LH, 42.6 
FSH, 12.3 
LH, 34.7 
FSH, 19.3 
LH, 44.4 
FSH, 10.8 
LH, 12.8 
FSH, 8.99 
LH, 22.3 
GnRH 
1. 2 Mg 
leI 
1.2 mg 
leI 
1.0 mg 
f..Joechst 
1.0 rng 
leI 
1.0 mg 
leI 
1.0 mg 
leI 
BOURS AFTER GNRH ADMINISTRATION 
0.5 1.0 1.5 3.0 7.0 
27.0 
112.3 
28.8 
113.0 
64.1 
23.3 22.6 
131.1 117.0 
30.8 27.8 
117.3 112.9 
64.0 57.5 
20.9 18.1 
57.0 47.7 
22.3 16.6 
100.9 50 .~ 
41.1 19.8 
12.0 
14.1 
183.5 
36.3 
182.0 185.8 
105.5 55.6' 45.7 
87.1 
33.8 
102.2 
42.1 
151. 4 
35.4 31. 3 
115.2 102.5 
33.1 
109.7 
40.9 
26.9 
87.7 
37.5 
129.8 137.2 
24.1 
68.6 
25.3 
S3.3 
24.0 
83.2 
19.1 
49.9 
24.7 
66.4 
OVARIES 
L: 2xl, H + irreg 
R: 1.5xl, H + irreg 
L: 2xl, H + irreg 
R: 1.5xl, H + irreg 
L: 2xl, H + irreg 
R: irreg, Foll-l, fh 
L: 2xl, H + irreg 
R: 1.5xl, H + irreg 
L: 2xl, H + irreg 
R, Foll-0.75, .fh 
L: 2xl, H + irreg 
R~ 1.5xl, H + irreg 
L~ lxl. H + irreg 
R: 2xI, H + irreg 
L: 2xl, H + irreg 
R: 2xl, n + irreg 
L: 2xI, H + irreg 
R: 1.5xl, H + irreg 
L: 2xl, H + irreg 
R, Foll-1, fh 
L: 2xI, H + irreg 
R: 1.5xl, H + irreg 
L, Fol1-2, fh 
R: 1.5xl, H + irreg 
L, Foll-2,sh 
R: 2xl, irreg 
L: Foll-3, s!1 
R: 1.Sxl, H + irreg 
L: Area -1 . 5, sb 
R: 1.5xl, H + irreg 
L: Area-l.s, s. Foll-2, sh 
R, Foll-1.5, f;, 
L: 2xFoll-2, S; 1.5, sh 
R, Poll-I. 5, fh 
L: Area-2, collaosed 
q: Foll-I.S, fh 
L: l\rea-l. S, s 
R: Foll-l.S, sh 
L: 2xl. irreg, Are~-l. s 
R, Foll-l, fh 
BEHWIOUR DAY 
12 
Not on 
13 
Not on 
14 
Not on 
15 
Not on 
16 
~ot on 
17 
Not on 
18 
Not on 
19 
Not on 
20 
Not on 
21 
~ot on 
22 
In oestrus 
23 
In oestrus 
24 
In oestrus 
25 
In oestrus 
26 
In oestrus 
27 
In oestrus 
28 
In oestrus 
29 
In oestrus 
30 
Tn oestrus. aqqressive . I 31 
In oestrus, aqf!ressive 
I 
~ 
:<, :' 
.:< I 
" }' 
,', . ~l~ " 
~~~ ~ 
MtAN IlO~tK>NAL (FSH, LU, ~ROGES~~ROHE AND OE~'l'Rf\DIQL'T'pa GONC~NTRATIQNS IN M1tRES IN DEEP ACYCLICIT'i (GROUP II~a) 
THROUPHO~T THE EXPERl~E~T. ~ND THE FRAC'l'ION/IL CHA~GES IN GO~I\DPTROPHI~S DU~ING ~HE TREATMENT 
TIME AFTER 
DAY GnllH (Hours) 
FSH 
ng/ml 
so 
LH 
ng/ml 
SO 
PROOESTEROUE 
, 09/I'll 
OESTAADIO~ -17B 
g/l'll 
FRACTIQNi\L 
CHANGES t 
·14 
-11 
-9 
-7 
-4 
.~ 
-2 
-1 
10 
11 
12 
13 
13 
14 
15 
-0.1 
Mean 
12.6 9.6 
15.V B,2 
13.0 9,4 
10 .. 4 6.6 
11,9 6.a 
H.O 9.0 
13,7 11.4 
14.0 9.3 
IB.B 14.9 
Mean 
15.1 5. B 
10.B 5.6 
9.74 2.9 
9.01 4,0 
12.7 
13,6 
2~ .1 
13.B 
16.0 
l,4 
B .B 
23.9 
3.6 
l~,O 
Mea... S[fI Mean SO FSI! LH 
0.15 0.1 
0.63 0.4 
0.17 0.1 
0.2]' Q.] 
q.2~ n.2 
0, 4~ 0.4 
0,1,9' 0.2 
0.25 0.2 
0,35 0.2 
1.2 mg GoRH (0735 hl-----~_~-_-_____ ~-_--_~-----_-------_· ___ · ____ _ 
0.5 
1 
1.5 
3 
12 
32,2*11.1, 
)0.9l1li 10.) 
27.1. 8.83 
25.5"* 12.6 
19.8 7.64 
15. 9 6.39 
33.1* 
25.7 
23.9* 
19.3· 
lfi .0 
20.5 
14.2 
16.0 
8.2 
7.6 
9.1 
14.0 
1. 2 mg Go"H 11935 hl------_-______ -'-~_-~---------_-~--__ _ 
0.5 25.9 
24.2 
1.S 22.0 
3 21. 9 
-0.1 17.B 
12.4 
10. B 
9.50 
10.4 
9. B 
31.6 15.7 
2B .. 0 P.6 
26.4* 11.'6 
2Q,5 8.5 
12.2
11vP 6.S 0.43 0.2 ,4 
~. 4 2.4 
2.3 loB 
~IO 1.7 
1.9 1.4 
1,5 1.1 
1.2 1.5 
). 9 2.3 
1.8 2.0 
1.6 1.9 
,.6 1. 5 
1. 3 0,9: 
1.2 mg Go"H _-_______________ ~---~-~-----_---~--~~-~ 
0.5 
1.5 
3 
-0.1 
25.6 12.3 
24.2 12.4 
20.9 7.24 
19.2 9.Bl 
13.5 S.67 
12.7 6.20 
4i,6 2B.1 
30.0 18.2 
27.6 17,~ 
22.5 U,5 
19.9 10.8 
13.1 7.4 0.43 0.3 
1. 9 ).0 
1. B 2.2 
1.6 2.0 
1.4 1.6 
1.0 1.4 
0.9 0.9 
1.2 mg GnRH -------___ ----~------~~~------------------------
0.5 
1 
1.5 
-0.1 
24.5 
23.4 
22.4 
27.0 
IB .8 
15.3 
14. 6 
IB .0 
12.7 
13.0 
flo 2 
19.3 
22. B 
11. 9 
9.30 
11.9 
6.48 
4.84 
3.60 
7.68 
9.2 
3.4 
6. g' 
12.6 
11. 9 
9.4 
41.2* 
36.5' 
34.5 
31.4· 
22.3 
,9.9 
20.9 
24.9 
23.4 
21. 4 
18, B 
27.3 
23.5 
37.9 
29.3 
30.4 
16. Q 
12. 6 ' 
5. B 
19,7 
13.7 
16.5 
11.5 
8.8 
19.3 
14.2 
0.2 
0.2) 
2.94 
1. 39 
8.16 
2.61 
2.52 
1. 81 
2.2 
0.,3 
0.9 
loB 
1.7 
1.7 
2.0 
1.4 
1.1 
) .1 
1.3 
0.9 
1.0 
1.6 
1.4 
1.7 
3.0 
2.6 
2.5 
2.3 
1.6 
1.4 
1.5 
loB 
1.7 
1.5 
1.3 
2.0 
1.7 1.2 mg Gnrul --_____________________ ---------__________ _ 
0.5 
1.5 
3 
12 
1. 2 mt;j" GnRH 
0.5 
1 
1.5 
-0.1 
49,9 23.9 
49.8* 21.0 
42.7 .... 1q.7 
41.5 19.0 
25.3 13.,8 
17.1 6.9 
39,9 24.6 
35.3 17.4 
33.9 10.2 
23.4 5.7 
15.1 l.a 
Ba.4 
53.1 
6/).1) 
33.3 
23,2 
33. B 
38.4 
4B.9 
,0.0 
33.7 
24.3 
76.7 
,29. B 
42.9 
1il. ~ 
14.9 
23.5 
a7.2 
36.6 
39.2 
25.0 
16.9 2.37 1.1 
3.7 6. J 
3.7 3. B 
J.2 4.3 
1.1 2.4 
1.9 1.7 
1.3 1.7 
3.0 2.8 
2.6 3.5 
2,5 ).6 
1.7 2.4 
1.1 1.7 
1.2 mg GnRH ------------------4-____________________ --____________ ----__ --------_______________________ __ 
0.5 
1 
1.5 
-0.1 
30.1 13.7 
33.6 10.7 
28.B 11.6 
24.B 13.0 
20.1 3,5 
16.7 2.5 
55.1 
63.1 
46.4 
46.6 
J3.6 
24 .4 
42.2 
49.8 
47.6 
3B.6 
23.5 
20.0 2.63 1,7 
1. 2 mg GnRH ----_____________ - __ ,, ________ ~ ____ _ 
0.5 
1.5 
36.1 7.1 
36.7* 9.) 
31. 3 6.1 
23.9 4.5 
16.5 3.8 
16.2 5.5 
15.1 4.1 
57.1 
50.8 
4B.2 
41. e 
40.3 
44.8 
43,9 
39.9 
23,2 18.6 
24.2 19.7 
21.0 8.B 
10.7 n.6 
2.2 3.9 
2.1 4.5 
2.1 ),) 
loB 3.3 
1. 5 2.4 
1.2 1.8 
2.7 4.1 
2.7 3.6 
2.3 3.5 
1.0 3.0 
1.2 1.7 
1.2 1.7 
1.1 1. 5 
TABLE 65 ctd: 
',rIME AFTER 
DAY GnRH (Hours) 
16 
17 
IB 
19 
20 
21 
22 -0.1 
FSH 
qg/lnl 
Mean SD 
21.3 6.1 
22.2 1.2 
19.? 6.2 
;n,9- 4,6 
18.0 4,2 
14.0 7.0 
1t.3 7.6 
Maan 
IB .0 
IS· ~ 
24.0 
21.3 
IB.7 
24.0 
26.6 
LH 
n9/I1)1 
SO 
10.5 
9.2 
12.9 
8.7 
B. B 
1~.9 
20. ? 
PROr.f,STE~ONE 
ng/ml 
Mean S[) 
~. 75 
.8,36 
2.44 
2.6 2 
1,26 
Q, ~5 
1.02 
0.7 
2·2 
0.7 
0.4 
p.7 
0.5 
0.6 
OESTRADIOL -17R 
pg/m1 
Mean - SD 
7.05 
4.9 
J? at) 
4. B 
R.65 
7.75 
'7.56 
2.B 
1.6 
0.5 
0.7 
O. B 
FRACTIONAL 
CHANGES t 
FSIf ~II 
1.6 1.3 
1.7 1.3 
1.4 1.7 
1.6 1,5 
1,3 1.3 
1. 0 1.7 
0.8 1,9 
1.0 mg G"~H -_...c..._-~ __ ~-~_-_-____ ~ _______ -:-----____ --_----____ _ 
0.5 
1 
1.5 
12 
49,6"* 23.:? 
51,4* 19.4 
4~.7- 20.1. 
30.2 17.9 
16,2 - 8.4 
13.5 7.7 
78.2 
69.7 
69. 9 
43.7 
27.2 
22.4 
72.0 
75.4 
77·.8 
42.1 
19.7 
16,0 
4 • 
4 
3.7 5.6 
3.8 5.0 
3.3 5.0 
2.2 3.1 
1.2 2.0 
1.0 1.6 
1.0 mg GnRH --~-------~---~-----_---_______ ------------------
0.5 
1.5 
22 3 
23 -0.1 
1.0 mg Gr'RH 
0.5 
-I. 5 
3 
24· -0.1 
34.4 14.7 
34.5 13.7 
30.7 15.5 
24.4 I1.B 
15.6 7.0 
30.9 15.7 
28.0 10,8 
25.6 10.9 
21.3 4.9 
15.5 B.O 
16.3 9.7 
.4 
-42.3 31.~ 
4B.0 45.R 
4],8 41.1 
33.3 25.9 
24.0 21.a 
43.0 
41.6 
36.0 
35.7 
21. 9 
25.3 
40,0 
43.7 
35.0 
33.5 
lB .• 
25.~ 
4 
_4 
0.40 _ o. ~ 
q.50 0.3 
~.20 3.B 
q.2 2.1 
2.~ 3.0 
2.6 3.4 
2.3 3.1 
1. B 2.4 
1.2 1.7 
2.3 3.1 
2.1 3.2 
1.9 2.6 
1.6 2.6 
1.2 1.6 
1. 2 loB 
1.0 m9 GoRH ----_------'-,---________ ----"'-_-----_-_---__ --------
25 
26 
27 
2B 
29 
30 
31 
0.5 
1.5 
3 
32 -0.1 
1.0 mg GnRH 
1 
12 
1.0 mg GnRH ( 
1 
33 -0,1 
1.0 m9 GnRH 
1 
34 -0.1 
35 
36 
37 
3B 
39 
40 
U 
42 
1.0 mg GnRH 
1 
32.6 27.6 
32.4 21.4 
30.6 20.1 
24.5 17.0 
20.8 9. J 
20.5 4.3 
20.6 
14.6 
13.6 
13.2 
9.4 
4.3 
5.9 
B .2 
7$.5 6~,4 
GO f 3 54.7 
59.4 55.4 
34.3 33.3 
32.8 27.1 
23.~ IB.2 0.34 0.2 38.5 61.0 
2.4 5.4 
2.4 4.3 
2. J .:1.3 
1.8 2.5 
1. 6 2 • .:1 
1.5 1.7 
32.0 33.B 1.34 0.7 B.90 1.3 1.5 2.3 
IB.7 16.9 0.44 G,3 11.95 2.8 1.1 1.3 
21,1 10,3 0.24 0.2 13,4 1.0 1.5 
22.3 16.3 0.52 0.5 9.3 0.7 1.0 1.6 
16.5 U.2 18.5 11.9· 1.1}4 1.0 15.1) 1.2 1.3 
14.9 6.9 21.9 ~3.6 0.32 '0.2 10.B 1.1 1.6 
5.B5 0.1 H.O 12.7 0.43 0.2 15.0 0.6 1.7 
hl----______________ ~ ________________ --____ r_------------__ --_ 
22.4 B.6 
17.9 16.7 
13.7 0.4 
9 • .10 3.3 
3B.4 
23. , 
23.6 
16.5 
34.1 
15.8 
19.7 
10.4 
2.4 4.2 
1.9 2.6 
1. 5 2.6 
1.0 I.B hl--__ ----____ ----______________________________ --__________________ ---
16 • .1 9.2 
lB.6 La 
6.44 
32.7 
24.6 
25.0 
32.4 
22.9 
0.95 0.7 
1, 7 3.6 
2.0 2.7 
0.5 2. B 
hl----________ ~--------------------~------------------------____ ---
14.8** 3.8 
IB.9 9.2 
9.01 4.2 
30.9 
21. 7 
20.0 
25.3 
.lB. B 
0.29 0.3 10. , 
1.6 3.4 
2.0 2.4 
1.0 2.2 hl----------__________________________________ ----__ ---_______ -
22.7 1.1.6 
16.1 11.6 
13.9 a.B 
.12.1 a. a 
6.16 7.3 
6.32 7.9 
7.36 
3.U 
3.77 0.6 
2.99 
3.52 
lB. B 
29.5 
29.5 
23. ~ 
17.5 
17.5 
23.5 
26.5 
26.3 
19.3 
22.5 
0.1 
0.1 
0.9 0.7 
1.91 2.1 
0.1 
0.6 0.7 
2.93 
5.07 
2.5 4.4 
1.7 3.3 
1.5 3.3 
1.3 2.6 
0.7 2.0 
0.7 2.0 
0.6 2.6 
0.3 3.0 
0.4 3.0 
0.2 2.2 
0.3 2.5 
410 
Fraot~onal ohango, in qOl'U1II qonoentratiqne ot r~" and J,R calcq~at.d ~y divl,ding .aoh or ~he meen 
concaotratiQDS fI'olD the beginning ot trflfltJII..nt UDt'l-~ tb1' end qt tJ;le exper~mental period by the mean 
pre-troatment b •• oUno (da18 prior to Da., 1 and '01> 1l0,1 1 at -Q.1 \1). On tho,e occao1one arter the 
beginning ot treatmeQt wh.en tb~re W81iJ m~B';.l~~ 4.~tlQ. tt/.e meaD pre-t:r,atm~nt baseline ,xclud~d tht!J 
vall\'~ troll tho apprqpri8t~' JDEJ.r~8. 
Hean li'SR and til CODc.entrat~ons thfoughout the treatment werfl compared to the mean pre-treat'iDlent 
ba.eUne (paired t-toet wHhin each mare) a~~ .ig\I1fioant ditr.r~nce. at p<. 0,05 and p<. 0.01 
indicated 'by • 8n4 •• ll'e8p8ctlve~;r. 
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LEGENp FOR F I GURJ;:S 40 TO 43 
Serum concentrations of FSH a~d LH daily throughout the 
Experiment, and at 1, 3 and 12 hours after GnRH 
administration, ~nd prog~sterrine and oestradiol-17B 
measured durin~ the experiment in Compliment, Lottie's 
Express, Oriental Scott and Robyn's Choi-ce. 
Days ~ day of experiment with Day 1 ~ the day of the 
first GnRH injection 
FSH expressed as ng/m1 Nuti equine FSH (see Chapter III) 
LH expressed as ng/ml Hartree equine LH (see Chapter III) 
progesterone as ng/ml 
oestradiol~17B as pg/ml 
solid bar = oestrous behaviour shown 
vertical arrow = ovulation (where indicated together with 
'* = mare mated 
a question mark, this indicates 
there ~as no certainty ovulation 
occurred) 
Treatment: GnRH. was administered (as described in text) 
on Days I, 2 and 3 apd 11, 12 and 13 and 22, 
23 and 24. Progesterone (150 mg/day) was 
administered on Days 6 through 17 
Note: These figures should be read in conjunction wjth 
Tables 61 to 64 
FIGURE 40 • 
SOi Compliment I I r 
t;~ I 40 • • <;/ 9, 
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at 3 h following each injection respectively), but no 
significant increases were induced. Immediately prior 
to each injection, the mean FSH levels were similar to the mean 
pre~treatment baseline. The mean concentrations remained at 
this baseline level between the first and second courses until 
Days 9, 10 and 11 when the levels were elevated (1.4 to 1.7 
fold). The second course of GnRH caused greater mean FSH 
increases than the first course, with peak increases (compared 
with the mean pre~treatment baseline) of 3.7 fold at 0.5 and 1 h 
following the first injection, 3 fold at 0.5 h following the 
second injection, 2,2 fold at 0.5 h following the third injection, 
and 2.7 fold at 0.5 and 1 h following the fourth injection. 
Significant increases occurred at 1 and 1.5 h following the first 
injection, and at 1 h following the fourth injection. Prior 
to each GnRH injection of this course, mean serum FSH concentra-
tions were similar to the mean pre~treatment baseline and they 
remained at this level on Days 14 and 15. However, on Day 16 
through 19 the mean FSH levels were elevated (1.4 to 1.7 times 
mean pre~treatment baseline) but then declined after Day 20 to 
be 0.8 times the mean pre~treatment baseline immediately prior 
to the thiTd course on Day 22. The first injection of the 
third course caused a mean peak 3.8 fold increase at 1 h, with 
levels significantly elevated from 0.5 through 1.5 h following 
injection. The second, third and fourth injections caused mean 
peak increases of 2,6 fold at 0.5 ani 1 h, 2.3 fold at 0.5 h, 
and 2.4 fold at 0.5 and 1 h following each injection respectively. 
Following the third GnRH course, the mean FSH levels remained 
slightly above (1.5 fold) the mean pre"treatment baseline on 
Day 25 and 26, then declined to the pre~treatment b~seline. 
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Compliment and Oriental Scott were given a fourth GnRH course. 
and the four injections induced in Compliment similar absolute 
increases in serum FSH as occurred in response to thi rd '~ourse. 
while Oriental Scott showed a much reduced response. 
Mean serum LH concentration showed minor fluctuations prior to 
the start of treatment, except on Day -2, when levels were elevated 
due to a spurious one day increase in Robyn's Choice. The first 
GnRH course induced peak increases in mean serum LH at 0.5 h after 
administration, of 2.4 fold, 2.3 fold, 3 fold and 3 fold following 
the first, second. third and fourth injections respectively. The 
levels were significantly elevated at 0.5, 1.5 and 3 h following the 
first injection, at 0.5 h following the second, and at 0.5, 1 and 
3 h following the fourth injection of this course. There was a 
significant decrease below the mean pretreatment baseline immediately 
prior to the third injection. Between the first and second courses of 
GnRH the mean LH concentrations remained above (1.3 to 2 fold) the mean 
pretreatment baseline. The second course of GnRH induced mean peak LH 
increases above the mean pretreatment baseline of 6.3 fold at 0.5 h 
after the first injectin, 3,6 fold at 1.5 h following the second 
injection, 4.5 fold at 1 h after the third injection. and 4.1 fold at 0.5 
h following the fourth injection. None of the increases were significant. 
Following each injection the mean LH levels fell towards baseline. but 
did not fall below the mean pretreatment baseline. Similarly. 
following the second GnRH course and prior to the third, mean LH 
concentrations remained above (1.3 to 1.9 fold) the mean pretreatment 
baseline. This elevation above the mean pretreatment baseline 
between both the first and second. and the second and third courses, 
is primarily due to an increase in LH concentrations 
in Compliment and Robyn's Choice. The third course of 
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GnRH caused peak increases in mean LH concentrations of 5.6, 
3.4, 3.2 and 5.4 fold the mean preNtreatment baseline at 0.5, 
1, 1, and 0,5 h following the first, second, third and fourth 
injections respectively. Immediately prior to the last three 
injections of this course the mean LH concentrations had 
dec~ined to levels similar to those between the second and 
third courses. Similar levels also occurred following the 
third course. Of the two mares given a fourth GnRH course, 
Compliment showed greater peak increases in LH than in earlier 
courses; responses of Oriental Scott were similar to earlier courses. 
Mean serum progesterone concentrations prior to the start 
of the experiment were uniformly low and remained at this level 
during treatment until exogenous progesterone administration 
commenced, and the mean levels were between 1.20 and 8.36 ng/m1 
on Days 6 through 20 of the experiment. After Day 20 the mean 
levels declined and remained at low levels until Day 36 of the 
experiment, except for an increase on Days 26 and 30, the 
increase on Day 26 being influenced by a progesterone rise in 
Oriental Scott and Robyn's Choice, and on Day 30 by a progesterone 
rise in Compliment and Robyn's Choice. After Day 36, one 
of the two mares (Compliment) receiving a fourth course of 
GnRH showp~ an increase in serum progesterone beginning on 
Day 37, and these elevated levels, although not shown in Table 61 
persisted for 17 to 20 days. 
Serum oestradiol-178 concentrations were first measured 
on Day 14 of the experiment, and the mean levels showed little 
fluctuation until Day 24 of the experiment, when the mean 
concentration was increased as both Oriental Scott and Robyn's 
Choice showed their peak oestradiol-17S concentration. 
The highest mean concentration occurred on Day 25, which was 
the~'esu1 t of an extrt\me1y high oestradiol-17S level in 
Lottie's Express on this day, Increases in oestradio1-l7S 
also occurred in Compliment on Days 27 and 28, with peak 
levels in this mare on Days 30 and 32, 
2. Ovarian Changes: 
(i) Compliment 
Both ovaries of this mare were small and hard prior 
to the start of treatment, and through until Day 7 of the 
experiment, when a D,S Unit follicle was detected, This 
follicle was also present on Days 10 and 12, but otherwise 
the ovaries remained small and hard until Day 14, At this 
time, several small follicles developed, with the ovaries 
increasing in size, and by Day 22, two 1,5 Unit follicles 
were present. On Day 24, the left ovary contained two 
1,5 Unit follicles, but on Day 26, these were described 
as very soft areas and on Day 27, the ovary was tri~lobed 
and firm, In the right ovary on Day 24, a 2 Unit 
softish follicle was present, and this continued to 
develop to be a 3 to 3.5 Unit soft or very soft follicle 
on Days 26 through 33. This follicle had collapsed 
by Day 34, and a very soft area persisted in this ovary 
until the end of the experiment. This area was a corpus 
1uteum, as evidenced by serum progesterone concentrations, 
with a life span of 17 to 20 days, 
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(b) Lottie's Express 
This mare had small hard ovaries prior to the start 
of the treatment, but some activity with an increase in 
the size of the ovaries occurred on Day 3 through 6 of 
the experiment. The ovaries then became small and hard 
again until Day 15 when an increase in size was recorded, 
followed by some follicular activity commencing on Day 17, 
This activity increased, and by Day 23, two follicles of 
2 Units were present. At least one of these appeared to 
ovulate, since on Day 25, no palpable follicles were 
present, though an area was detected in this ovary for the 
remainder of the experiment. 
(c) Oriental Scott 
The ovaries of this mare were hard and particularly 
small prior to the beginning of treatment, and remained this 
way until Day 20 of the experiment. On Day 21, a 0.5 Unit 
follicle was detected, which increased in size to be 1 Unit 
on Days 23 and 24, decreasing to 0,5 on Day 25, After 
this time the ovaries were again small and hard and no 
activity was detected during the remainder of the 
experiment. 
(d) Robyn's Choice 
One of the ovaries of this mare was described as small 
and hard, and the other as 2 x 1 Units and irregular prior 
to, and for the first two days of treatment, By Day 3, 
a slight increase in activity was evident, with an increase 
in size of the smaller ovary. No further development 
occurred until Day 14 when a follicle was detected, but 
this was not palpable on Day 17. No further development 
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occurred until Day 23 when a 2 Unit firmish follicle 
was present, and this matured to be a 3 Unit soft1sh 
follicle on Day 25. It appeared to ovulate at this 
time, and a collapsed area was present from Day 26 until 
the end of the experiment. 
3. Behaviour 
(i) Compliment 
This mare showed a single day of oestrous behaviour 
in the early part of the experiment (Day 3) with no 
further oestrous behaviour until Day 21. The mare remained 
in oestrus until Day 33, and.was mated on Days 27 and 29, 
but did not conceive. 
(ii) Lottie's Express 
This mare exhibited oestrous behaviour on numerous 
days during the early part of the experiment, but did not 
show oestrous behaviour during administration of exogenous 
progesterone. The mare was in oestrus on Days 23 ~hrough 
27. 
(iii) Oriental Scott 
This mare showed several days of oestrus behaviour 
early in the experimental period prior to the administration 
of progesterone. The mare returned to oestrus on Day 24, 
and remained in oestrus until the end of the experiment" 
(iv) Robyn's Choice 
This mare was in oestrus on several days during the 
early part of the experiment prior to the administration 
of progesterone. After progesterone withdrawal, the mare 
returned to oestrus on Day 22, and remained in oestrus 
~. 
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until the end of the experiment, although on Days 30 and 
31 aggressive behaviour was noted. 
GROUP IIIb: 
The hormonal, ovarian and behavioural changes in the four mares 
in this group throughout the experiment are shown in Table 66 (AnnacY)g 
Table 67 (Bright Sea), Table 68 (Meseta) and Table 69 (Young Trudy). 
The mean hormonal changes, the mean fractional changes in gonadotrophins, 
and the results of tests of significance (paired t~tests comparing the 
mean value over the period prior to the start of treatment with each 
subsequent value in each mare) are shown in Table 70. Daily serum 
concentrations of FSH and LH, and, where measured,progesterone& oestradiol 
-17S, together with the FSH and LH changes at 1, 3 and 12 h following each 
injection of GnRH are graphically illustrated in Fig. 44 (Annacy), Fig. 45 
(Bright Sea), Fig. 46 (Meseta), and Fig. 47 (Young Trudy) . 
1. Hormonal Changes: 
Prior to the start of the experiment, mean serum FSH concent-
rations showed some fluctuation, the levels being quite variable in 
each of the mares. The first injection of the first course of GnRH 
caused a significant increase in mean FSH concentrations from 0.5 
through 3 h after injection, as occurred in the Group IlIa mares. 
Mean peak increases induced by each injection of this course occurred 
between 0.5 and 1 h after injection, with the levels being higher than 
those induced in Group IlIa (mean peak increases of 3.1, 2.5, 2.8 and 
2.7 times the mean pre-treatment baseline following each successive 
injection). Between the first and second courses of GnRHg the 
mean FSH concentrations were similar to, or just above the mean 
pre-treatment baseline. The second course of GnRH caused 
significant increases in mean serum FSH at 1, 1.5 and 3 h 
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LEGEND :F'ORTABIJES 66 TO 69 
Day = the day of the experiment, day 1 being the first 
day of treatment 
Time (hours) = the time at which the blood sample was 
collected, or GnRH administered 
GnRH :~ source indicated for each injection 
Gonadotrophins : - e:x:press~d as ng/ml Nuti eJi'SH or 
Hartree eLH (see text) 
Ovaries :- L = left ovary; R = right ov~ry 
Descriptions include : stattng the size and 
tension of the ovary, e.g. L: trilqbed,H = left 
ovary tri-lobed and bard; e,g. L: 2x1 = left ovary 
measures 2x1 Unita, wh~re 1 Unit = 2.5 cm (see 
Materials and Methods); e.g. L: S + H.~ left ovary 
small and hard. 
Stating structures in the ovary, these being 
either :- Fall = follicle, or Area = any soft 
structure pot a follicle, often a corpus luteum. 
:3tating particulars of tbese structures in terms 
of diameter (0.6 to 6 Units) and tension as an 
indication of maturity where :- fh = firmish;· 
f = firm; sh = softish; s = soft; vs = very soft; 
call = collapsed (as in ovulation); rubbery = 
"rubbery" in tension. 
e.g. L: Fall - 2, sh = left ovary contains a softish 
follicle 2 Units in diameter 
e.~. L: 2x1, H; 2xFoll - 1, fh; 3.5, vs = left ovary 
is 2x1 U~its and hard, contains two follicles, one 
being 1 Unit in diam~ter and tirmish in tension, the 
other 3.5 Units in diameter and very soft. 
TABLE 66: ANNACY 
DAY TIME PROGESTERONE OESTRADIOL -17S G(')~lADOTROPHIN HOURS AFTER GNRH ~DMINISTRATION 
Hours ng/ml pg/ml ng/ml GnRH n.5 1.0 1.5 3.0 7.0 12.0 Ol/ARIES B'lIlAVIOUR 
DAY 
-14 1030 0.1 FSH: 12.8 L: S + il 
-14 
LH: - R: 5 + H Not on 
-11 1300 3.07 FSH: 9.13 L: Area - 1 _ 0, s 
-11 
LH: 31.6 R: S + H Not on 
-9 1445 1.07 FSH: 9.71 L: S + H 
-9 
LH: 48.8 R: S + H Not on 
-7 1115 2.21 FSI!: 7.26 L: 5 + H 
-7 
LH: 24.8 R: 5 + H Not on 
-4 1130 1.87 FSH: 4.38 L: Area - 0.5,· sh 
-4 
LH: 20.4 R: S + H Not on 
-3 1730 2.99 FSH: 5.63 
-3 
LH: 20.2 
-2 1500 1. 33 FSH: 7.51 
L: 5 + H -2 
LH: 25.7 
R: S + H Not on 
-1 1800 0.85 FSH: 12.2 
-1 
LH: 32.3 
1 0725 0.1 FSH: 13.1 1.2 mg 19.8 21. 5 19.5 16.9 12.5. 8.43 L: Area-O.s, S 
1 
Ayerst 
53.1 41.8 34.4 R: 5 + H LH: 33.5 53.4 51.7 51.5 Not on 
1923 FSH: 8.43 1.2 mg 16.3 13.9 14.1 14.3 
Ayerst 
39.7 ~ LH: 34.4 42.9 42.9 48.l '" 
2 0856 0.1 FSH: 6.30 1.2 mg 7.14 9.36 5.39 L· S + H 2 
~ 
11.8 10.6 
Ayerst 
40.7 37.8 R: S + H LH: 31.1 43.8 42.6 42.3 Not on 
3 0911 0.1 FSI!: 4.33 1.2 mg 12.7 10.6 10.9 9.32 8.59 L: S + H 3 
Ayerst 
42.9 40.3 R: 5 + H LH: 34.5 45.7 45.2 46.7 Not on 
4 1930 0.1 FSH: 8.26 L: S + H 
4 
LH: 28.4 R: S + H Not on 
5 1351 0.1 FSH: 8.14 
5 
LH: 33.4 Not on 
6 1520 0.1 FSH: 4.71 L: 5 + H 
6 
LH: 19.2 R: 5 + H Not on 
7 1600 0.85 FSH: 2.72 L: 5 + H 
7 
LH: 25.7 R: 5 + H Not on 
8 1430 0.64 FSH: 9.54 L: S + Il 8 
LB: 24.9 R: S + H Not on 
9 1120 0.3 FSH: 13.6 L: 5 + II 
9 
LH: 28.2 R: 5 + H Not on 
10 0900 1.17 FSIl: 7.15 L: S + H 10 
LH: 25.5 R: S + H Not on 
11 0735 0.1 FSH: 8.83 1.2 mg 23.8 40.0 41. 3 33.1 19.4 10.7 L: 5 + H 
11 
1\yerst 
31. 9 35.3 38.0 R: S + H LH: 23.0 45.5 45.7 39.7 Not on 
r 
>: 
TABLE 66: CTD ANNACY 
DAY TIME PROGESTERONE OESTRADIOL -178 GO'lADOTROPHIN 
Hours ng/ml pg/ml ng/ml GnRH n.5 
1905 F5H, 10.7 1.2 rog 31.1 
Ayerst 
LH, 38. n 43.7 
12 1320 0.5 FSH, 19.9 1.2 mg 23.8 
leI 
LH, 37.0 39.6 
13 0744 0.1 FSH, 8.58 1.2 mg 26.1 
leI 
LH, 28.6 34.7 
14 1420 0.1 FSH, 9.91 
LH, 22.2 
15 1440 0.1 FSH, 6.72 
LH, 22.9 
16 1045 0.4 FSH, 6.71 
LH, 13.2 
17 1500 0.64 FSH, 4.81 
LH, 19.6 
18 l440 0.59 FSH, 4.53 
LH, 20.8 
19 1520 0.1 FSH, 6.87 
LH, 15.3 
20 1135 0.1 FSH, 8.35 
LH, 16.3 
21 1200 1.28 FSH, 7.66 1.0 ",g 0;2.0 
leI 
LH, 22.3 39.6 
22 0732 0.77 FSH, 15.0 1.0 mg 52.7 
leI 
LH, 23.8 40.9 
1957 FSH, 17.9 1.0 mg 35.9 
leI 
LH, 31.2 40.4 
23 1122 0.93 FSH, 14.3 1.0 mg 26.0 
leI 
LH, 17.1 31. 8 
24 1650 0.88 Fsn, 11.5 
LH, 26.5 
25 1640 1.04 FSH, 12.1 
LA, 27.1 
26 1455 0.75 FSH, 6.31 
LH, 24.4 
27 1500 0.83 FSH, 8.01 
LH, 19.1 
28 1630 0.56 FSH, 4.69 
LH, 18.1 
HOURS AFTER GNRH ADMINISTRATION 
1.0 1.5 3.0 7.0 
12.0 
40.5 35.1 25.7 
46.2 46.6 46.6 
21. 7 25.5 21. 3 15.6 
38.6 40.3 35.1 34.7 
27.3 28.9 21.3 17.1 
38.9 36.0 28.9 33.7 
60.5 49.6 42.5 32.4 
40.1 37.2 36.8 22.6 
47.2 43.0 39.9 28.8 17.9 
28.0 35.6 24.8 24.0 31.2 
25.7 30.9 29.2 
29.9 32.5 31.0 
28.2 29.8 20.9 15.7 
32.5 23.4 35.2 25.6 
O'JARIES 
L: Area < 0.5, sh 
R, S + H 
L: 5 + H 
R: 5 + H 
L: S + H 
R: 5 + R 
L: S + H 
R: S + H 
L, S + H 
R: S + H 
L: S + H 
R, S + H 
L.: 5 + H 
R: 5 + H 
L: S + H 
R: 5 + H 
L, S + H 
R, S + H 
L: S + H 
R, S + H 
L, S + H 
R' S + H 
L' S + H 
R: S + H 
L' S + H 
R, S + H 
L: 5 + H 
R, S + H 
L: 5 + H 
R: S .... H 
L' S + H 
R: Foll-I.O, sh 
L: 5 + H 
R: S + H 
L: S + H 
R: S + H 
:: ... 
BEHAVIOUR 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
DAY 
.. 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
~:';: 
;:;." 
li! 
22 
23 
24 
25 
26 
27 
28 
..,. 
'" '" 
TABLE 66: CTD ANNACY 
DAY TIME PROGESTERONE OESTRADIOL -178 GO'lADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/ml pg/ml ng/ml GnRH 0.5 1.0 1.5 3.0 7.0 
12.0 OVARIES BBHAV!OUR DAY 
29 
29 1700 3.63 FSH, 10.5 L, 5 + H 
LH, 22.4 -R: S + H Not on 
30 
30 1645 0.80 FSH: -;.02 L: S + H 
LH, 22.4 R: S + H Not on 
31 1125 0.83 FSH, 25.6 L, 5 + H 
31 
LH, 24.8 R: S + H Not on 
32 0806 0.51 FSH, 6.83 
1.0 mg 22.6 32.6 14.8 16.8 L: 5 + H 32 
Hoechst 
LH, 16.9 29.8 34.1 24.4 20.3 R, 5 + H Not on 
1945 FSH,16.8 1.0 mg 34.2 29.1 
Hoechst 
LH, 20.3 32.2 27.7 
33 1506 0.10 PSH~ 14.0 1.0 m'J ~S.2 20.1 L: 2xl, irreg 33 
Hoechst 
LR, 29.3 28.9 30.2 R: S + H Not on 
34 0823 0.67 FSH,15.n 1.0 mg 17.0 20.7 16.7 L: 5 + H 34 " Hoechst Not on '" '" LH, 15.3 29.5 - - R: 5 + H 
35 1525 0.88 FSH, 5.96 L: Foll-O.7,fh, Area-I.O,S 35 
LH - R: lxl.5, f Not on 
36 1146 0.30 FSH, 5.68 L, 5 + H 36 
LH, - R, 5 + H "Not on 
38 1130 0.56 FSH,1l.4 L: S + H 38 
LH, - R, 5 + H Not on 
39 1125 0.48 FSH,10.7 L, 5 + H 39 
LH, - R: 5 + H Not on 
40 1457 FSH, - L: 5 + H 40 
LH, - R: 5 + H Not on 
41 1537 0.43 FSH, 14.6 L: 5 + H 41 
LH, - R: S + H Not on 
42 1640 0.37 FSH, 15.3 L: 5 + H 42 
LH, - R: 5 + H Not on 
::: : 
TABLE 67: BRIGHT SEA 
DAY TIME PROGESTERONJ: OESTRADIOL -17B GONADOTROPHIN 
Hours ng/m1 pg/m1 ng/m1 GnRH 0.5 
-14 1030 0.4 FSH: 1.53 
LH: 4.65 
-11 1330 0.5 FSH: 2.85 
LH: 6.03 
-9 1500 0.1 FSH: 1.10 
LH: 3.96 
-7 1130 0.45 FSH: 2.87 
LH: 
-4 1130 0.1 FSH: 3.12 
LB: 3.49 
-3 1730 0.1 FSH: 1.74 
LH: 1.40 
-2 1500 0.1 FSH: 3.41 
LB: 3.00 
-1 1800 0.1 FSH: 13.9 
LH: 8.20 
1 0730 0.3 FSB: 21.8 1.2 mg 30.6 
Ayerst 
LH: 15.3 16.0 
1929 FSB: 15.7 1.2 rng 33.9 
Ayerst 
LH: 9.98 31. 2 
2 0900 0.67 FSH: 24.3 1.2 mg 40.8 
Ayerst 
LB: 8.94 26.0 
3 0918 0.74 FSH: 11.1 1.2 mg 29.6 
Ayerst 
LB: 12.5 27.2 
4 1935 0.3 FSH: 17.9 
LH: 17.4 
5 1410 0.1 FSH: 11.9 
LB: 8.89 
6 1530 0.1 FSB: 10.7 
LB: 18.5 
7 1600 0.1 FSH: 4.02 
LB: 14.0 
8 1440 0.3 FSH: 9.34 
LH: 16.2 
9 1210 0.75 FSH: 13.4 
LH: 11.4 
10 0900 0.4 FSH: 1A.7 
LH: 17.0 
11 0742 0.1 FSH: 18.8 1.2 mg 82.7 
Ayerst 
LH: 10.3 45.6 
1907 l'SH: 26.3 1.2 mg 55.8 
leI 
LB: 24.6 40.3 
HOURS AFTER GNRH 7\.D"iINISTRATI-oN 
1.0 1.5 3.0 7.0 12.0 OVARIES 
L: 5 + H 
R: S + H 
L: 5 + H, irreg 
L: 5 + H, irreg 
L: 5 + H 
R: S + H 
L: 5 + H 
R: S + H 
L: 5 + H 
R: S + H 
L: S + H 
R: S + H 
30.9 27.7 24.6 20.9 15.7 L: S + H 
22.0 11. 3 9.76 9.98 R: 5 + H 
31. 9 31. 7 "35.7 
35.5 25.0 25.8 
39.6 20.0 19.6 15.5 L: S + H 
28.5 26.2 18.9 10.1 R: S + H 
31. 7 29.4 26.3 19.7 L: S + B 
17.9 30.0 22.2 15.9 R: S + H 
L: S + H 
R: 5 + H 
L: 5 + H, tri-lobed 
R: S + H 
L: 1.5xl, H 
R: 5 + H, Area-D.S, sh 
L: S + H 
R: 5 + H, Area - 1, s 
L: S + H, hi-lobed 
R: 5 + H, irreg 
L: S + H 
R: Foll-C.S, sh, Area-O.S, s 
76.7 69.9 60.5 34.6 26.3 L: S + H 
31.9 34.5 32.2 24.1 24.6 R: ~ + H, Foll-<O.S, sh 
57.7 38.9 
27.1 18.3 
BEHAVIOUR 
Not on 
Not on 
Not on 
Not On ? 
Not on 
Not on 
Not on ? 
Not On ? 
Not on ? 
Not on 
In oestrus ? 
In oestrus 
Not on ? 
Not on ? 
Not on 
~~ ; 
:.: 
,', ',:- . 
. > '" 
',' 
'," 
DAY 
-14 
-11 
-9 
-7 
-4 
-3 
-2 
-1 
1 
~ 
I\) 
"" 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
TABLE 67: eTD BRIGHT SEA 
DAY TIME PROGESTERONJ: OESTRADIOL -17~ GONADOTROPHIN 
Hours ng/ml pg/ml ng/ml GnRH 0.5 
12 1322 0.3 FSH, 17.8 1.2 rng 47.8 
leI 
LH, 6.77 24.7 
13 0746 0.1 FSH, 16.5 1.2 rng 39.9 
leI 
LH, 12.7 21. 8 
14 1430 0.4 FSH, 7.12 
LH: 5.30 
15 1425 0.1 FSH, 4.29 
LH, 7.78 
16 1105 0.1 FSH, 4.07 
LH, 5.22 
17 1525 1. 39 FSH, 3.95 
LH, 7.33 
18 1455 0.65 FSH, 3.7B 
LH, 5.63 
19 1455 3.09 FSH, 8.23 
LH: 2.97 
20 1140 0.56 FSH, 11.2 
LH, -
21 1205 1.12 FSH, 6.39 1.0 mg 103.2 
leI 
LH, 5.62 22.9 
22 0733 0.96 FSH, 22.0 1.0 mg 67.1 , leI 
LH, 8.31 20.4 
2000 FSH, 30.5 1.9 mg 
62.9 
leI 
LH, B .09 13.8 
FSH, 21.4 1.0 mg 54.8 23 1124 1.01 
leI 
LH, 5.30 18.1 
24 1700 0.69 FSH, 12.3 
LH, 9.16 
25 1625 0.3 FSH, 6.96 
LH, 4.73 
FSH, 7.10 26 1450 0.69 
LH, 3.83 
0.45 FSH, 8.35 27 1530 
La, 8.49 
0.43 FSH, 7.31 28 1625 LH, 6.75 
0.1 FSH, 4.86 29 1700 
La, 4.57 
HOURS AFTER GNRH I\D'IINISTRATION 
1.9 1.5 3.0 7.0 12.0 
43.1 40.2 31. 8 30.0 
22.2 20.4 17.5 14.7 
42.7 38.9 30.8 19.6 
23.3 lB.3 11. 7 6.47 
99.7 106.9 53.8 60.6 
19.2 21. 8 11. 2 11.5 
65.2 61.4 55.3 35.1 30.5 
19.4 17.1 15.5 14.2 8.09 
59.2 51.4 49.3 
19.7 13.2 9.17 
43.2 38.4 34.8 26.B 
31. 5 16.4 10.4 15.6 
OVARIES 
L: 5 + H 
R: 5 + H, Area-I, s 
L: S + H 
R: Area-I, s 
L, 5 + H 
R: 5 + H, Foll-O.S, fh 
L, S + H 
R, S + H 
L, S + H 
R, S + H 
L, S + H 
R~ 5 + H 
L: 5 + H 
R, S + H 
L: 5 + H, tri-lobed 
R: S + H 
L, S + H 
R: 5 +·H 
L, S +' 'R 
R: 5 + H 
L, S + H 
R, Foll-O. 5, fh 
L: 5 + H 
R: 2xFoll-l, fh, 0.5, sh 
L: 5 + H 
R, Foll-0.5, fh 
L, S + a 
R, Foll-0.5, f 
L, S + H 
R: 5 + H 
L: 5 + H 
R: 5 + H 
L: 5 + H 
R: S + H 
L: 5 + H 
R, 1.5xl 
BEH>'VIOUR 
Not on ? 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus ? 
'::-
:~ : 
.,: 
:.: 
DAY 
12 
13 
14 
15 
16 
17 
lB 
19 
20 
" 21 II) ()J 
22 
23 
24 
25 
26 
27 
2B 
29 
TABLE 67· CTn BRIGHT SEA 
DAY TIME PROGESTERONE OESTRADIOL -17S GONADOTROPHIN HOURS AFTER GNRH I\D'UNISTRATION 
Hours ng/ml pg/ml ng/ml GnRH 0.5 1.0 1.5 3.0 7.0 12.0 OVARIES BEHAVIOUR DAY 
30 1715 0.85 FSH: 5.98 L: S + H 30 
LR: - R: ~ + H Not art ? 
31 1150 0.59 FSH: 5.54 L: 1. 5xl 31 
LH: - R: S + H Not on 
32 0810 0.45 FSH: 8.80 1.0 mg 56.8 48.5 41.3 18.3 L: S + H 32 
Hoechst 
LH: 1. 85 21.4 16.0 5.41 6.89 R: S + H Not on 
1950 FSH: 18.3 1.0 mg 43. I} 30.1 
Hoechst 
LH: 6.89 13.4 6.70 Not on 
33 1509 0.3 FSH: 10.4 1.0 mg 33.7 18.9 L: 2xl, irreg 
33 
Hoechst 
LH: 3.84 21.4 14.9 R: R + H In oestrus 
34 0825 0.59 FSH: 9.75 1.0 mg 29.3 22.0 17.7 L: 1.Sxl, irreg 
34 
Hoechst ., 
LH: 9.15 - - - R: S + H "lot on ? '" '" 35 1410 0.80 FSH: 5.82 L: 5 + H 35 
LH: - R: S + H In oestrus 
36 1140 0.43 FSH: 4.32 L: S + Ii 36 
LH: - R: S + H In oestrus 
37 131}8 0.1 FSH: 6.41 L: S + H 37 
LH: - R: 5 + H In oestrus 
38 1130 0.4 FSH: 3.48 L: l~ 5xl, firm 38 
LH: - R: S + H In oestrus 
39 1210 0.1 FSH: 3.75 L: S + H 39 
LH: - R: 5 + H In oestrus 
40 1647 0.45 FSH: 5.26 L: S + H 40 
LH: - R: S + H In oestrus 
41 1544 0.83 FSH: 3.61 L: S + H 41 
LH: - R: S + irreg In oestrus 
-:. 
:; 
.::. ,. 
TABLE 68: MESETA 
DAY TIME PROGESTERONE OESTR'lDIOL -17 S GONADOTROPHIN HOURS AFTER 
Hours ng/ml pg/ml ng/ml GnRH 0.5 1.0 1.5 
-14 1030 0.1 FSH: 9.41 
LH: 21.1 
-11 1330 0.1 FSH: 8.22 
LH: 22.7 
-9 1500 0.1 FSH: 14.0 
LH: 18.9 
-7 1130 0.1 FSH: 35.5 
LH: 35.2 
-4 1130 1.01 FSH: 18.2 
LH: 29.1 
-3 1730 0.75 FSH: 12.5 
LH: 20.7 
-2 1500 0.1 FSH: 6.92 
LH: 33.9 
-1 1800 0.3 FSH: 12.5 
LH: 20.8 
1 0740 0.1 FSH: 8.20 1. 2 mg 40.7 41. 7 40.0 
Ayerst 
LH: 29.2 3Q.0 37.3 40.6 
1926 FSH: 17.9 1.2 mg 26.4 25.3 19.9 
Ayerst 
LH: 14.7 26.6 29.3 34.0 
2 0858 0.3 FSH: 18.1 1.2 mg 40.3 32.2 24.8 
Ayerst 
LH: 37.6 31. 5 20.8 29.1 
3 0915 0.72 FSH: 23.6 1.2 mg 38.7 42.3 39.9 
Ayerst 
LH: 10.3 29.6 34.6 18.2 
4 1930 0.4 FSH: 17.2 
LH: 8.96 
5 1356 0.1 FSH: 16.4 
LH: 5.09 
6 1310 0.43 FSH, 13.4 
LH: 
7 1600 0.3 FSH: 13.6 
LH: 
8 1430 0.69 FSH: 34.9 
LH: 18.2 
9 1200 0.56 FSH: 21.9 
LH: 
10 0915 0.88 FSH: 13.5 
LH: 21.1 
11 0740 FSH: 3.89 1.2 mg 40.6 28.5 38.9 
Ayerst 
LH: 23.2 28.8 29.8 20.7 
1910 FSH: 8.41 1.2 mg 17.9 22.9 19.8 
leI 
LH: 13.8 32.4 22.2 16.8 
GNRH ADMINISTRATION 
3.0 7.0 12.0 OVARIES 
L: 5 + H, hi-lobed 
R: 5 + H, bi-lobed 
L: 5 + H 
R: 5 + H, bi-lobed 
L: S + H 
R: S + H, irreg 
L: S + H 
R: 5 + H, irreg 
L: S + H, hi-lobed 
R: S + H 
L: 5 + H 
R: 5 + H 
24.4 24.2 17.9 L: S + H 
21.0 19.6 14.7 R: S + H 
22.0 
23.0 
25.0 20.9 L: S + H 
24.0 25.4 R: S + H 
31.3 20.5 L: S + H 
14.5 10.9 R: S + H 
L: S + H 
R: 5 + H, bi-lobed 
L, S + H 
R: S + H 
L: 5 + H 
R: 5 + H 
L: S + H 
R, 5 + H, bi-lobed 
L: 5 + H 
R: S + H 
L: 5 + H 
R; 5 + H 
28.4 17.0 8.41 L: S + H 
32.9 15.4 13.8 R: 5 + H 
20.3 
23.0 
BEHAVIOUR 
Not on 
Not on 
Not on 
In oestrus 
In oestrus 
Not on 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Uot on 
In oestrus 
In oestrus ? 
Not on ? 
Not on ? 
Not on ? 
DAY 
::: 
',; 
;:~ -
:~ 
-14 
-11 
-9 
-7 
-4 
-3 
-2 
-1 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
~ 
.". 
0 
TABLE 68: 
DAY 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
TIME 
Hours 
1375 
0749 
1420 
1415 
1100 
1515 
1510 
1510 
1130 
1210 
0738 
2003 
1128 
1433 
1630 
1430 
1505 
1625 
1700 
1653 
1153 
eTn MESETA 
PROGESTERONE IOEST~~DIOL -17S 
ng/ml pg/ml 
0.69 
0.3 
0.3 
0.80 12.0 
0.3 
0.69 8.9 
0.91 9.0 
0.61 11.2 
0.69 15.2 
0.61 17.4 
2.99 12.0 
0.53 11.4 
1.01 
6.93 
0.48 11.5 
0.59 14.8 
0.45 11.0 
0.1 
0.4 
0.53 
GONADOT'l.OPHIN 
ng/ml 
FSH, 27..2 
LH, 25.0 
FSH, 12.2 
LH, 18.1 
FSH, 3.52 
LH, 14.2 
FSH, 3.48 
LH, 28.9 
FSH, 1.99 
LH, 22.7 
FSH, 
LH, 25.3 
FSH, 8.32 
LH, 23.8 
FSH, 9.26 
LH, 20.8 
FSH, 9.83 
LH, 22.9 
FSH, 8.99 
LH,17.6 
FSI!, 5.87 
LH, 6.06 
FSH, 14.2 
LH, 13.6 
FSH, 6.72 
LH, 30.7 
FSH, 8.35 
LH, 17.7 
FSH, 9.97 
LH, 16.6 
"SH, 3.96 
LH, 30.1 
FSH, 7.02 
LH, 18.1 
FSH, 
LH: 
FSH, 5.89 
LH, 19.8 
FSH, 11. 3 
LH, 14.5 
FSH, 9.65 
LH,17.4 
GnRH 
1.2 mg 
leI 
1.2 mg 
leI 
1.0 mg 
Hoechst 
1.0 mg 
leI 
1.0 mg 
leI 
1.O rng 
leI 
0.5 
15.6 
21.0 
26.5 
30.1 
37.2 
31. a 
23.1 
27.2 
8.27 
28.8 
21.0 
22.2 
HOURS AFTER GNRH ADMIN-ISTRATION 
1.0 1.5 3.0 7.0 12.0 
24.1 
19.8 
25.4 
23.0 
38.1 
25.6 
19.4 
20.9 
12.9 
36.3 
20.7 
24.3 
19.4 
22.8 
16.5 
19.7 
34.3 
28.0 
18.0 
31. 2 
13.5 
14.4 
21.2 
18.0 
15.3 
23.4 
20.9 
27.0 
29.9 
25.6 
11.4 
28.0 
9.14 
'16.3 
19.3 
25.7 
15.6 
24.6 
19.6 
28.4 
17.0 
10.8 
7.05 
13.3 
13.3 
24.4 
14 .2 
13.6 
OVARIES 
L: S + H, bi-lobed 
R: S + H 
L, S + H 
R: S + H, bi-lobed 
L: S + H, hi-lobed 
R: 5 + H, hi-lobed 
L, S + H 
R~ S + H 
L: 1.5x1, irreg, sh 
R: 1.5xl, sh-
L~ I.Sxl, irreg, sh 
R: 1.5xl, irreg, sh 
L: 1.5xl, sh 
R, Foll-O. 5, fh 
L, FoIl-I. 5, sh 
R: 1. 5xl, sh 
L: I.Sxl, 5, Area-I.O, s 
R: 1.5:<1, f 
L: 1.5xl, H, irreg 
'R.: Foll-I.O, f 
L: tri-lobed 
R: Foll-I.O, 
L: 5 + H, bi-lobed 
R, FoIl-I. ° , fh 
L: 1.5xl, irreg 
R: 1.5xl, sh 
L: I.Sxl, tri-lobed 
R: 1.5xl, irreg 
L, 1. 5xl 
R, 1.5xl, H 
L: 2xl, irreg 
R: 2xl, irreg 
L: Area-I.S, s 
R, FoIl-I. 5, fh 
L: I.Sxl, 5 
R, Foll-1.5, 
L: 2x1, sh 
n, 1.5xl, Foll-l.0, fh 
L: 2xl, 2xAreas-l.O, 5 
q: 2xl, irreg, Foll-I.S, 
',' 
BEHAVIOUR 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Not on 
Not on 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
.', 
" .: .. 
::~ .' 
;.: 
':'. ': :< 
DAY 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 & 
..> 
23 
24 
25 
26 
27 
28 
29 
30 
31 
TABLE 68: CTD MESETA 
DAY TIME PROGESTERONE OESTRnJJIOL -17 S GONADOT~OPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/rnl pg/rnl ng/rnl GnRH 0.5 1.0 1.5 3.0 7.0 12.0 OVARIES BEHAVIOUR DAY 
32 OB08 0.61 FSH, 8.10 1.0 mg 33.7 32.5 22.2 19.6 L, 1.5xL H 32 
Hoechst 
LH, 28.3 39.4 37.8 45.1 94.4 R, Fell-1. 5, f In oestrus 
1949 FSH, 19.6 1.0 rng 23.9 19.3 
Hoechst 
LH; 94.4 80.3 25.2 
33 1507 1.2 FSH, 13.2 1.0 rng 23.1 19.4 L, 2xl, H 33 
Hoechst 
LH, 89.8 79.1 43.8 R: Foll-l.O, f In oestrus 
34 0826 0.7 FSH, 12.4 1.0 rng 24.3 21. 5 21.5 L, 1.5xl 34 
Hoechst 
LH, 17.1 25.9 34.9 - R: 2xl, irreg, l\rea-l. 0, £ In oestrus? 
35 1430 0.7 FSH, 13.0 L, 2xl 35 
LH, - R, 2xl In oestrus ? 
36 1208 1.0 FSH, 15.8 L: 2.Sxl.S, irreg 36 
~ 
\>0 
LH, - R: 2.5xl.5, irreg Not'";on ? '" 
37 1300 1.0 FSH, 11.6 L: 2x2, irreg 37 
LH, - R, S + H, Fell - < 0.5 Not on ? 
38 1130 0.9 FSH, 11.6 L: 2x2, 5 38 
LH, - R: 2xl, H Not on ? 
39 1203 0.9 Fsa, 25.9 L: 2x2, irreg 39 
LH, - R: 2xl, irreg Not on '? 
40 1640 0.6 FSH, 15.1 L: 2x2, f, irreg 40 
LH, - R, 2xl, f Not on ? 
41 1534 0.5 FSH, 12.0 L: 2x2, H 41 
LH, - R: 2xl, H, Foll-O. 75, s Not on ? 
TABLE 69: YOUNG TRUDY 
DAY TIME ~ROGESTERONE OESTRADIOL -178 GONADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/ml pg/ml ng/ml GnRH 0.5 1.0 1.5 3.0 7.0 12.0 OVAR,IES BEHAVIOUR DAY -
-14 1030 0.1 FSH: 15.6 L: S + B -14 
LH: 6.83 R: 5 + H Not on 
-11 1330 0.1 FSH: 15.1 L: S + H -11 
LH: 5.66 R: S + H 
-9 1500 0.1 FS8: 7.91 
L: S + H -9 LH: 8.28 R: 5 + H Not on 
-7 1130 0.1 FSH: 17.7 L: S + H -7 
LH: 13.4 R: S + H Not on 
-4 1130 0.1 FSH: 11.5 L: 5 + H -4 
LH: 8.27 R: S + H Not on 
-3 1730 0.72 FSH: 9.24 -3 
LH: 14.7 
-2 
L: S + H -2 
R: S + H Not on 
-1 1800 0.3 FSH: 12.2 -1 
LH: 5.39 
1 0742 0.51 FSH: 10.0 1.2 mg 33.2 31.3 27.0 21.6 13.6 10.8 L: S + B 1 
Ayerst ", 
LH: 8.85 35.1 22.3 17.6 30.3 32.8 17.7; R: S + H In oestrus ~ 
1947 FSH: 10.8 1.2 mg 22.9 20.8 20.4 14.3 '" '" Ayerst 
LH: 17.7 50.2 36.7 26.5 29.9 
2 0914 0.43 FSH: 9.24 1.2 mg 23.9 21.0 18.3' 13.0 8.39 L: S + H 2 
Ayerst 
LH: 13.1 34.6 35.8 31.4 36.0 21.8 R: Foll-O. 5. sh In oestrus 
3 0937 0.37 FSB: 9.11 1.2 mg 18.7 26.1 22.5 20.9 7.91 L: 5 + H~ tri-lobed 3 
Ayerst 
LH: 12.0 41.8 13.3 42.0 29.3 32.1 R: S + H. Foll-0.5. s In oestrus 
4 0.3 FSH: 7.02 L: 5 + H, Area - < 1, sh 4 
LH: 20.5 R: Foll-0.5. s In oestrus 
5 1404 0.43 FSH: 10.3 5 
LH: 35.9 Not on 
6 1510 0.37 FSH: 15.5 L: 1.5xl, irreg 6 
LH: 39.3 R: 2xAreas - < 1, sh; < 1, sh Not on 
7 1600 0.51 FSH: 8.72 L: FoIl - < 0.5, f - R: 3xFoll 7 
LH: 11.7 -0.5. sh;0.5. f; 0.5. f Not on 
8 1415 2.51 FSH: 8.48 L: S + H, irreg - R: 2xFoll 8 
LH: 31.8 -0.5.fh; 0.5.fh.Area-O.5. s Not on 
9 1145 0.56 FSH: 10.4 L: 5 + H, irreg - R: 2xFoll 9 
LB: 38.7 -0.5.fh; 0.5.fh.Area-0.5.vs In oestrus 
10 0900 1.12 FSH: 7.95 L: 5 + H - R: 2xFoll - 0.5, 10 
LH: 26.9 fh; 0.5. fh. Area-0.5. S Not on 
? 
::~, 
,', ::: " 
.~~ < 
TABLE 69: CTD YOUNG TRUDY 
DAY TIME ~ROGESTERONE OESTRADIOL -17 S GONADOTROPHIN HOURS AFTER GNRH ADMINISTRATION 
Hours ng/m1 pg/m1 ng/m1 GnRH 0.5 1.0 1.5 3.0 7.0 12.0 OVAR.IES BEHAVIOUR DAY -
11 OSOO 0.64 FSB: 21. 3 1.2 mg 4S.2 4S.9 44.1 35.4 20.9 16.S L: S + H 11 
Ayerst 
LB: 40.3 46.6 47.3 52.6 34.4 33.4 lS.3 R: 2xFoll-O.5,f; 0.5,f; Area 
1923 FSH: 16.S 1.2 rng 23.0 27.6 29.5 22.2 -0.5, vs Not on 
IeI 
LH: lS.3 27.6 34.7 27.3 21. 7 
12 1334 0.96 . FSH: 13.0 1.2 mg 2S .1 25.7 25.2 16.2 14.7 L: S + H 12 
IeI R: 2xFoll - < 0.5, f; < 0.5, 
LH: 27. S 36.6 34.3 lS.6 26.9 lS.4 f, Area - O. 5, s Not on 
13 0759 0.1 FSH: 9.69 1.2 mg 27.S 27.S 23.7 lS.4 12.9 L: S + H 13 
IeI 
LB: 20.7 36.3 31.1 33.1 41.6 21.9 R: S + H Not on 
14 1415 0.1 FSH: 10.5 L: 5 + H 14 
LH: 21.1 R: FoIl - < 0.5, fh, Area-l, s Not on 
15 1400 0.1 FSH: 16.0 L: S + H 15 
LH: 22.9 R: Foll - < 0.5, fh Not on .", 
16 1030 0.1 FSH: 9.62 L: S + irreg 16 '" ~LH: 15.S R: 5 + irreg Not on 
17 1455 0.1 FSH: 10.7 L: 1. 5xl, irreg 17 
LH: 23.S R: S + H Not on 
IS 1435 0.4 FSH: 17.1 L: 1.Sxl, Foll-D.5, fh IS 
LH: 9.54 R: S + H Not on ? 
19 1435 1. 39 FSH: 12.1 L: 5 + H 19 
LH: 21.7 R: S + H Not on ? 
20 1205 0.75 FSH: S.67 L: Foll-0.5, fh 20 
LH: 13.1 R: S + H Not on ? 
21 1200 0.40 FSH: 16.S 1.0 mg 
Hoechst 
56.2 56.0 62.2 44.1 22.5 L: Foll-0.5, fh 21 
LH: 24.S 25.6 29.6 22.3 15.3 24.5 R: S + H In oestrus 
22 0754 0.1 12.6 FSH: 15.6 0.5 mg 22 
Hoechst 39.3 33.2 39.1 27.9 16.3 23.7 L: S + H 
LH: 15.6 0.5 mg 22.4 33.7 26.6 14.2 14.4 25.S R: S + H In oestrus 
IeI 
2014 FSH: 23.7 1.0 mg 16.6 2S.4 29.S 24.S 
IeI 
LH: 25.S 11.0 2n.1 lS.7 29.4 
.:' 
;:.,' 
\: 
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TABLE 69, CTD YOUNG TRUDY 
DAY TIME ROGESTERONE OESTRADIOL -17 e GONADOTROPHIN 
Hours ng/rnl pg/rn1 ng/rn1 GnRH 
---
23 1145 0.3 10.1 FS8: 15.4 1.0 mg 
leI 
LH: 21.5 
24 1710 0.35 14.9 FSH: 8.59 
LB: 14.2 
25 1640 0.43 14.9 FSH: 15.n 
LH: 10.1 
26 1445 0.32 11.6 FSH: 5.39 
LB: 19.8 
27 1575 0.69 9.0 FSH: 7.93 
LH: 21.5 
28 1610 0.3 6.9 FSH: 9.97 
LH: 15.5 
29 1700 1.95 9.1 FSH: 8.16 
LH: 17.1 
30 1700 0.3 8.8 FSH: 11.9 
LH: 14.1 
31 1140 0.1 9.5 FSH: 12.2 
LH: 25.8 
32 1610 0.59 7.9 FSH: 14.7 
LB: 16.5 
33 1500 0.3 9.3 FSH: 10.9 
LH: 12.2 
HOURS AFTER GNRH ADMINISTRATION 
n.5 1.0 1.5 3.0 7.0 12.0 
27.7 21. 6 23.6 14.5 11.5 
25.9 26.4 20.9 24.7 23.0 
! 
OVAR,IES BEHAVIOUR 
L: S + H, irreg 
R: Fall-0.5, fil In oestrus 
L: S + H 
R: FoIl-I, fh In oestrus 
L: S + H 
R: Fall-I, fh In oestrus 
L: 5 + H 
R: 2xFall-1.5, sh; 1, fh In oestrus 
L: S + H 
R: 2xFoll-l.5, fh:l,fh,Area-l,s In oestrus 
L: S + H 
R: 3xFoll-l.5, shil, s~ 1, fh In oestrus 
L: 5 + H 
R: 3xFa11-1.5s: 1, fh; 1, fh In oestrus ? 
L: S + H 
R: 3xFoll-l.5, VS; 1,5; 1, fh In oestrus 
L: S + H - R: 2xFa11-1, fh: 
1, fh: 2xArea-l, S; 1,s In oestrus 
L: S + H 
R: 3xFoll-l, sh; 1, f; 1, f In oestrus 
L: S + H 
R: 4xFoll-each 1, fh 
-
::: ." 
::: 
.::: 
; ~: 
DAY 
23 
24 
25 
26 
27 
28 
29 -I' 
'" VI 
30 
31 
32 
33 
TABLE 
DAY 
-14 
-11 
-9 
-7 
-4 
-3 
-2 
-1 
10 
11 
12 
13 
13 
14 
15 
16 
17 
TIME AFTER 
GnRH (Hours 1 
-0.1 
Mean 
FSH 
ng/rol 
SD 
9.84 6.1 
8.83 5.0 
8.18 5.4 
15.8 14.5 
9.30 7.0 
7.28 4.6 
5.95 2.2 
12.7 0.8 
13.3 6.0 
Mean 
10.9 
16 .5 
20.0 
24.5 
LH 
ng/rol 
SD 
8 .~ 
12. a 
20.2 
10.9 
\5.3 11.6 
14.3 9.0 
20-:9 16.0 
16.7 12.4 
2\.711.6 
PROGESTERONE 
ng/ml 
M.ean SD 
0.18 0.2 
0.94 1.4 
0.34 0.5 
0.72 1.0 
0 177 0,9 
1.14 1.~ 
0.51 0.7 
0.39 0.3 
0.25 0.2 
OESTRADIOL -17 B 
g/rol 
Mean Sp 
MEAN FRl\CT roNAL 
CHANGES t 
FSH LH 
1.2 mg GnRH (0730 h)~------------_-_---__ ---__________ ~ 
0.5 31.1* 8.7 
3i.4 u 8.3 
1.5 28.6* 8.5 
21.9* 
17.8 
12 13.2 
3.6 
5.7 
4.4 
35. ga IS.4 
33.3 u 14.2 
30.3* 19.0 
28.5 18.4 
31.4 11.2 
19.2 10.6 
3.1 2.0 
]. ~ 1. I) 
2.8 1.7 
2.2 1.6 
I, B 1. 5 
1.) 1.1 
1.2 mg GnRH (1925 h)------_____________ -----~------------
0.5 24.9 
1 
1.5 
23.0 
21. 5 
21. 6 
-0.1 14.5 
7.3 
7.6 
7.4 
10.1 
S .2 
37.7 10.8 
36.1 5.6 
3].4 f1k 10.6 
29.6 7.3 
22.7 !J.8 0.38 Q.2 
2.5 2.1 
2.3 2.0 
2.1 1. 9 
2.1 1. 7 
1.4 1.3 
1. 2 mg GnRH (0900 h) --------------------------------------------------------------------
0.5 
1 
1.5 
28.0 16.0 
26.2 13.2 
18.4 5.9 
16.9 7.1 
7 12.5 7.0 
-0.1 12.0 8.2 
34.0* 7.5 
31.9 9.4 
32.3* 7.0 
29.9 10.2 
23.8 11.4 
17.3 11.5 0.48 0.] 
2.8 1. 9 
2.6 1. 8 
1.8 1.8 
1.7 1.7 
1. 2 1.) 
1.2 1.0 
1.2 mg GnRIl (0910 h)--------------------_--------_____________________ _ 
0.5 24.9 11.5 
1 27.7 1J.2 
1.5 25.7 12.2 
-0.1 
22.0 9.4 
14.2 6.9 
12.6 5.8 
11.7 3.5 
11.1 4.7 
7.27 
15.6 
14.8 
11.8 
13.2 
5.0 
12.9 
4.9 
5.4 
8.2 
36.J. 9.1 
27.8* 14.8 
34.2 12.9 
27.2 12.1 
24.8 13.7 
18.9 B.O 
20.8 16.1 
25.7 11.8 
17.1 
22.8 
26,1 
22.6 
24.2 
7.5 
7.1 
13.8 
4.5 
12.3 
0.28 0.1 
0.18 0.2 
0.25 0.2 
0.44 
1. 04 
0.54 
0.89 
0.28 
0.3 
1.0 
0.2 
0.4 
0.3 
2.5 2.0 
2.7 1.6 
2.5 1. 9 
2.2 1. 5 
1. 4 1. 4 
1.2 1.1 
1.2 1.2 
1.1 1.7 
0.7 
1.5 
1.5 
1.2 
1.3 
1.2 
1.3 
1.8 
1.3 
1.4 
1.2 mg Gn~ (0735 hl---________ - ___________________ ---_________ _ 
0.5 48.8 24.8 
48.7* 2Q.5 
1.5 48.6"" 14.4 
39.4* 14.4 
23.0 7.9 
12 15.6 8.0 
1.2 mg GnRH (1905 hl 
0.5 32.0 16.8 
30.39.1 
1.5 ]5.5 16.1 
26.8 8.4 
-0.1 18.2 3.9 
41.6 8.6 
)8.7 9.1 
36.9 13.2 
32.9 1.1 
27.1 9.2 
23.7 10,5 
36.0 7. 3 
34.4 12.0 
J9.5 
27.4 
24.1 
12.4 
13.0 
12.7 Q.3 
4.8 2.3 
4.8 2.2 
4.8 2.1 
3.9 1.8 
2.3 1.5 
1.5 1.3 
3.2 2.0 
2.6 1.6 
3.5 1. 7 
2.6 1. 5 
1.8 1.3 
1.2 rng GnRH (1320 h)-________________ --------------------__ ---___ 
0.5 27.6 11.4 
1 28.7 9.8 
1.5 27.6 
21. 2 
19.0 
-0.1 11.7 
8.9 
7.6 
7.4 
3.5 
30.5 
28.7 
25.5 
25.7 
23.1 
20.0 
9.0 
9.1 
10.0 
7.4 
8.7 
6.6 0.15 0.1 
2.7 1.7 
2.8 1.6 
2.7 1.4 
2.1 1. 4 
1.9 1.3 
1.2 1.1 
1.2 mg GnRH (0745 h)----------__________________________________ ~ __ 
0.5 30.1" 6.6 
1.5 
30.B* 8.0 
27.0 9.4 
22.9 5.5 
17.) 3.2 
7.763.2 
7.62 5.8 
5.60 ).3 
6.49 3.7 
30.7 
29.1 
26.8 
6.5 
7.5 
9.1 
27.3 12.3 
22.6 11.8 
15,7 
20.6 
14.2 
19.0 
7.8 
9.0 
7.2 
8.2 
0.23 0.2 
0.29 0.4 
12.0 
0.23 0.2 
0,71 0.5 
3.0 1. 7 
3.0 1. 6 
2.7 1. 5 
2.3 1.5 
1.7 1.3 
O. B 0.9 
0.8 1. 2 
0.6 0.8 
(j.7 1.1 
,.,.'.,. 
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TABLE 70 ctd; 
1B 
19 
20 
21 
22 
22 
2) 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
)5 
36 
37 
3B 
39 
40 
TIME AFTER 
GnRH (Hours) 
Mean 
FSII 
n~/ml 
Sp 
8.43 6.1 
9.12 2.2 
9.51 
-0.1 9.96 
1.3 
4.7 
He~n 
14.9 
15.2 
LH 
ng/ml 
SO 
B.7 
B .6 
17.4 5.0 
17.6 8.5 
PROGeST~RONE 
ng/rnl 
Mean !?p 
0.53 
0.85 
0,3 
0.4 
OESTRADIOL -17B 
pg/ml 
Mean SO 
9.0 
11. 2 
15.2 
17.4 
MEiAN FRACTIONAL 
CHANGES t 
FSlI LII 
0.8 0.8 
0,9 0.9 
0.9 
1.0 
1.0 
1.0 
1.0 mg OnRH (1200 hl-----~-_--__ --_--_~_-~-~-------------------
0.5 70.5 
1 72.1 
1.5 72.9 
3 46. S ... 
38.5 
-0.1 17.1 
2B .4 
24.0 
30.1 
6.1 
19.8 
3.) 
29.~· 9.0 
29.6· 10,5 
27.1 8.8 
21.1. .... ~3.8 
19.5 7.0 
13.4 8.0 1.H 12. ) 0.4 
7. B 
B.O 
B.O 
5.2 
4.2 
1.7 
2.0 
2.0 
1.8 
1.4 
1.3 
0.7 
1.0 mg GnRH (0730 h)-------______ -~-------'--~_-------_--_-----____ _ 
0.5 
1 
1.5 
12 
49.1* 13.8 
45.9* 14.1 
44.5* 11.8 
38.3'" 12.5 
24.3 9.2 
21.6 7.1 
31.4* 8.5 
26.7 5.9 
26 .. 7 7.4 
2.0. Q 6.0 
15.9 5.7 
19.7 10.7 
4.8 1. 8 
4.5 1. 5 
4. -4 1. 5 
3.8 1.1 
2.4 0.9 
2.1 1.1 
1.0 mg GnRH (2000 hl----------_--_-_______ ----------------------
0.5 34.6 
1 33.2 
1.5 J2.5 
28.7 
-0.1 14.5 
20.5 
17.8 
1).9 
15.7 
6.0 
23.1 
22.7 
23.9* 
24.4 
18.7 
13,5 
4.9 
9.5 
10.2 
10.6 0,69 0.3 10.8 0.9 
).4 1. 3 
3.3 1. 3 
3.2 1.) 
2.8 1.4 
1.4 1.0 
1.0 mg GnRH (1120 hl_----_____________ ---______ ---------__ --__ _ 
0.5 29.2 19.2 
12.8 
10.5 
11.1 
26.2 
31. 7 
18 . 8 
21.1 
18.9 
16.9 
5.9 
4.1 
4.1 
2.9 1.5 
2.6 1.8 
2.6 1.1 
2.0 1. 2 
1.5 1.1 
1.0 0.9 
1 26.5 
1.5 26. ) 
19.8 
15.3 8.5 
10.2 2.0 
10.8 
6.5 
7.3 0.73 ".3 14.9 
1.0 mg GnRH (1430 h)-----_________________ ------_______________ _ 
0.5 21.0 22.2 
24.3 
1.5 0.9 
1 20.7 
1.5 0.9 
21.2 18.0 
19.3 25.7 1.5 0.7 
1.5 
13.3 24.4 1.4 1.0 
11.0 3.4 14.6 11.6 ;:.18 3.2 14.9 1.0 1.0 
5.69 1.3 19.5 11.3 0.56 0.2 11.6 0.1 1.1 0.8 
7.83 0.6 16.8 5.7 0.64 0.2 11.9 4.1 0.6 1.1 
7.32 2.6 13.5 5.9 0.44 0.1 8.95 1..9 0.8 0,9 
7.35 2.5 16.0 7.9 1.45 1.7 9.1 0.8 0.8 
9.05 ).0 17.0 4.7 0.59 0.3 8.8 0.7 0.9 
13.2 B.7 22.7 4.6 0.51 0.3 '.5 0.9 0.8 
9.61 3.5 15.9 10.8 0.54 0.1 7.9 1.3 1.1 
1.0 mg GnRH (0800 h)_:-=-_:_---:--------------------------------0-.-9 _0_._9 ___ _ 
37.7 17.4 30.2 9.0 
)7.9 9.2 2g.) 11.7 
26.1 13.7 25.0 19,9 
12 
J.9 1.5 
J.9 1.4 
2.7 1.2 
18.2 1.4 40.5 47.1 
1 1.9 2 0 
.0 mg Gn~ (1950 h)-~:--~---:_=__:_-~-----------~---~---------~~~·~---
1 33.7 9.6 42.0 34.5 
26.2 6.0 19.9 11.5 3.5 2.1 
-0.1 12,5 1.9 41.0 44.2 0.48 0.5 9.3 2.7 1.0 
1.0 mg GnRH (1500 hl_-::-_--: ___ :_=__:_-~---------------------~--~I~.~2~2~.~3---
1 27.3 5.6 43.1 31.4 
19.5* 0.6 29.6 14.5 
-0.1 12.6 2.9 13.9 4.2 
1.0 mg GnRH (0820 h) 
1 23.5 
21. 4" 
15.8 
6,2 
0.7 
2.5 
9.19 5.7 
7.20· V5.9 
9.01 3.7 
1].6 11.4 
9.85 5.7 
8.63 4.8 
27.7 
34.9 
2.5 
0.65 0.1 
0.89 0.1 
O. sa 0.4 
0.5Q 0.6 
0.62 0.3 
0.39 0.] 
0.48 0.0 
2.8 
2.0 
1.3 
2.' 
2. ~ 
1.6 
1.0 
0.7 
0.9 
1.4 
1.0 
0.9 
2.1 
1.5 
0.7 
1.0 
1.4 
',._., '--:~ 
Fractional cbanges in serum concentr'liti.one Qt F9H and, .4" c9lc;ul4tQ~ by dividing each' of tbe mean 
concentratioDs from the beg~nllins ot tr(Jatw~'rIt \Intil tb.ft end ot tbe eXf'erim,nta~ per~od by the mean 
pre-treatment b,~eline (days Pl'tOI' to Doy 1 an(l 'aD Day 1 at -0.1 h). On tb()s& .occas:i.oQs atter the 
beginning ot treDtment when there ."o.s miHBing datil, tho Illl'u'tll pre'l"treallment baeeline exclude4 the 
values from the a~propr1ate m9.ras. 
Mean .FSH Ilnd LH ooncentrntions throughout the trentmeJ]t w"re ¢ompared to the mesn pre-treatment 
ba.eline (paired t-t •• t witbin •• ch ".r~) and aignificont differanP.a at 1'< 0,05 and p<'O,01 
indicated by • and •• raspoat!vely. 
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LEGEND FOR FIGURES 44 TO 47 
Serum concentrations of FSH and L1i throughout the 
Experiment, and at 1, 3 and 12 hours after GnRH 
administration, and progesterone and oestradiol-17B 
measured during the experiment in Anna~y, Bright 
Sea, Meseta and Young Tr~dy. 
Days day of experiment with Day 1 .. the day of the 
first GnRH injection 
FSH expressed as ng/ml Nuti equine FSH (see Chapter III) 
LH expressed as ng/ml Hartree equine LH (see Chapter lIT) 
progesterone as ng/ml 
oestradiol-17S as pg/ml 
solid bar = oestrous behaviour shown 
vertical arrow = ovulation (where indicated together with 
*' = mare mared 
a question mark, this indicates 
there was no certainty ovulation 
occurred) 
Treatment: GnRH was administered (as described in text) 
on Days I, 2 and 3 and n, 12 and 13 and 21/22 
through 23/24. 
Note: These figures should be read in conjunction with 
Tables 66 to 69 
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following the first injection, and at 0.5 and 1 h following the 
fourth injection. The mean peak increases in this course,which 
occurred at between 0.5 and 1.5 h after injection, were higher 
than those induced by the first course of GnRH, being 4.8. 3.5. 
2.8 and 3 times the mean pre-treatment baseline for each 
successive injection. These increases are also greater than those 
induced by the second GnRH course in the Group IlIa mares. 
Between the second and third GnRH courses. mean FSH levels fell 
below the mean pre-treatment baseline. The third course of 
GnRH induced further increases in the mean peak FSH concentrations 
(8, 4.8, 3.4 and 2.9 times the mean pre~treatment baseline 
following each GnRH injection) with the peaks occurring at 
between 0.5 and 1.Shafter administration. These increases were 
significant at 3 h after the first injection, and at 0.5 through 
3 h following the second injection. It should be noted that one 
mare, Meseta, was asynchronous with the other three mares and 
received her first GnRH injection of this course on Day 22, and 
not on Day 21. Therefore, weighting of the means occurs, since 
the responses to the first injection of this course include data 
from three mares, while the responses to the second and third 
injections include the data from the four mares. Following the 
third GnRH course, the mean FSH levels were similar to, or just 
below, the mean pre-treatment baseline. The fourth course of 
GnRH given to three mares induced mean peak increases of 3.9, 
3.5, 2.8 and 2.4 times the mean pre-treatment baseline following 
each successive injection. Following this course, mean FSH levels 
were close to the mean pre~treatment baseline, although the concen-
trations on Day 36 were significantly decreased. 
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Mean LH concentrations prior to the start of treatment 
were variable, and since the individual mares showed considerable 
differences in mean LH concentrations, variability on different 
days was increased when there was missing data, The first 
injection of the first GnRH course induced a peak 2 fold 
increase in mean LH concentrations above the mean pre"treatment 
baseline at 0.5 h after injection, with levels significantly 
elevated from 0.5 through 1.5 h after injection. The other 
injections of this course induced peak increases in mean LH 
concentrations of 2.1, 1.9 and 2 fold the mean pre-treatment 
baseline at 0,5 h after injection. The increases were 
significant at 1.5 h after the second injection, at 0,5 and 
1.5 h after the third injection, and at 1 h after the fourth 
injection. The responses by this group of mares to this 
GnRH course were slightly less than those of the Group IlIa 
mares, Following this first GnRH course, mean LH concentrations 
remained just above the mean pre~treatment baseline. The 
second course of GnRH did not result in any significant increases 
in mean LH concentrations, and the mean peak increases were 
less than in the first course (mean peak increases occurred 
at 0.5 h after each successive injection and were 2.3, 2.0, 
1.7 and 1.7 times the mean pre-treatment baseline). These 
increases ·.rere much lower than those in the Group IlIa mares 
during the second course. Between the second and third GnRH 
courses, mean LH concentrations remained close to the mean pre-
treatment baseline. The third course of GnRH induced significant 
increases in mean LH concentrations, but the fractional increases 
were again much smaller than those in the Group IlIa mares, 
with mean peak increases being 2.0, 1.8, 1,4 and 1.8 times the 
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mean pre"treatment baseline at each successive injection. The 
responses to this course are influenced by the different timing 
of the GnRH injections given to Meseta compared with the other 
three mares. Following this third GnRH course, the mean LH 
concentrations were at, or just below the mean pre "treatment 
baseline. Where measured, the mean LH responses to the fourth 
course of GnRH were small (the highest mean peak increase 
following any injection of this course was 2.1 times the mean 
preRtreatment baseline). 
Serum progesterone concentrations prior to the start of 
treatment were uniformly low in three of the four mares, but 
Annacy showed increased levels of serum progesterone on Days 
Rll through Day -1. Therefore, this mare did not fulfil the 
criteria for acyclicity, and was unintentionally included in 
the experiment because serum progesterone concentrations used 
for selection of mares were only determined on Day ~14 and 
on Day -19 prior to the treatment being initiated, and, as 
seen in Table 66 , the serum progesterone concentrations in 
Annacy were not sufficiently elevated to confirm the presence 
of a corpus luteum on these particular days. In addition, 
ovarian palpations were not in any way suggestive of cyclicity 
and since the mare did not come into oestrus or develop a 
follicle greater than 1.5 Unit during the entire experimental 
period, her results have been included. Mean serum progesterone 
levels throughout the treatment period remained low, but slight 
increases occurred in the mares on different days, with 
levels being above 1 ng/ml on Days 10, 21, 25 and 29 in Annacy, 
Days 17, 19, 21 and 23 in Bright Sea, on Days 22, 24, 25, 32, 
35 and 36 in Meseta, and on Days 8, 10, 19 and 29 in Young Trudy. 
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Serum oestradiol-17B concentrations were measured in only 
two mares, Meseta and Young Trudy_ Determinations were made 
during the latter part of the experiment and showed a peak 
concentration on Day 21 in Meseta, and on Days 24 and 25 in 
Young Trudy. 
2. Ovarian Changes 
(i) Annacy 
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The ovaries of this mare were small and hard prior 
to the start of treatment, but a soft area of 0.5 to 
1 Units was detected on three occasions over this period. 
During treatment, the ovaries remained small and hard, 
except for a 1 Unit softish follicle present on Day 26, 
then an interval of no activity until Day 33 through 36 when 
the ovaries showed a slight increase in size, with a 1 Unit 
firmish follicle detected on Day 35, but not on Day 37. 
(ii) Bright Sea 
The ovaries of this mare were small and hard prior to, 
and up until Day 4 of treatment, On Day 6, an increase 
in ovarian size was recorded, with a small area/follicle 
being present on Days 7 through14. It is possible that a 
corpus luteum was formed, since serum progesterone was 
3.09 ng/ml on Day 19, while the mean concentration over 
Days 17 to 23 was 1.25 ng/ml which was much higher than at 
any earlier period. The ovaries were again small and 
hard until an increase in activity occurred on Days 22 through 
25 with the development of a 0.5 to 1 Unit follicle. 
FQllowing this, and until the end of the experiment, the 
ovar;es were small and hard, except for a slight increase 
in size on Days 33 and 34. 
Ciii) Meseta 
The ovaries of this mare were small, hard and bi~ 
lobed prior to, and up until Day 16 of treatment, when an 
increase in ovarian size was recorded, and on Day 19, a 
1.5 Unit softish follicle was present which probably 
I 
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ovulated on that day, and gave rise to a short lived corpus 
luteum as suggested by a mean progesterone concentration 
of 2.86 ng/ml during Days 22 to 25. Following this, the 
ovaries remained increased in size, with a 1 Unit follicle 
present on Days 21 through 23, but not on Day 24, and a 
1.5 Unit follicle present on Days 28 through 32, and a 
1 Unit area recorded on Day 34, 
(iv) Young Trudy 
The ovaries of this mare were small and hard prior 
to the beginning of treatment, with increased ovarian 
activity occurring from Day 2 through Day 15. Three 0.5 
Unit follicles were present on Day 7, and two remained 
without increa~e in size until Day 12, after which they 
could not be detected. The third possibly ovulated on 
Day 7, since a soft to very soft area was present from 
Day 8 through 12, and the mean progesterone concentration 
during Days 7 to 12 was 1.16 ng/ml which was much higher 
than at any earlier period of the experiment. On Days 13 
through 22, very little ovarian activity was evident, but 
on Day 23 follicular development began which resulted in 
three follicles of 1.5 Units being present on Day 29, after 
which these follicles either ovulated or regressed over 
the period until the end of the experiment. 
3. Behaviour: 
(i) Annacy 
This mare did not show oestrus behaviour at any time 
during the whole experiment, 
(ii) Bright Sea 
This mare showed questionable oestrous behaviour over 
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the early part of the experiment, but showed true oestrous 
behaviour on Day 20 through 28 of the experiment, and on 
Days 33, and 35 through 41 of the experiment. 
(iii) Meseta 
This mare showed oestrous behaviour of varying 
intensity, and occasional days of non~oestrous behaviour 
over the entire period of the experiment, The periods 
during which true oestrous behaviour were recorded were 
Days 1 through 5, Days 22 through 25, and Days 30 through 
33. 
(iv) Young Trudy 
This mare showed oestrous behaviour in the early part 
of the experiment (Days 1 through 4) and from Day 21 until 
the end of the experiment. 
To indicate the different gonadotrophin responses between the 
four groups of mares (Group I, II, IlIa and IIIb), Table 71 
illustrates the mean peak fractional increase in serum FSH and LH 
following each GnRH injection for each group of mares, and also the 
average peak increase in each group for each GnRH course. 
TABLE 71: 
Course 1 
r.iean 
Course 2 
Mean 
Course 3 
Mean 
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Mean Fractional Increases Following Each GnRH Injection, 
and the Mean Peak Fractional Increases During Each GnRH 
Course 
Group I Group II Group IlIa Group IIIb 
Injection FSH LH J.SH LH FSH LH FSH LH 
1 4.8 3,3 3.2 2.5 2,4 2.4 3.1 2,0 
2 4.0 1,7 2.6 1.3 1.9 2.3 2,5 2.1 
3 3.4 1.7 2.1 1,5 1.9 3.0 2.8 1.9 
4 1.5 1.4 2,0 3.0 2,7 2.0 
4.1 2.2 2.4 1,7 2.1 2.7 2.8 2.0 
1 5,8 4.0 5,0 2.1 3.7 6.3 4,8 2.3 
2 3.8 2.3 2.6 1.6 3.0 3.6 3.5 2.0 
3 3.8 1,5 2.5 1.8 2.2 4,5 2.8 1,7 
4 2.3 1.7 2,7 4.1 3.0 1.7 
* 4.5 2.6 3.1 1.9 2.9 4.6 3.5 1.9 
1 2.3 4.6 2.9 2.9 3,8 5.6 8.0 2.0 
2 4.6 3.9 2.2 2,1 2.6 3.4 4.8 1.8 
3 2.2 4.2 2.1 2.2 2.3 3.2 3.4 1.4 
4 2.1 4.7 2.9 1.7 2.4 5.4 2.9 1.8 
5 2.3 5.9 1.9 2.2 
, 
* 2.7 4.7 2.4 2.2 2,8 4.4 4.8 1.8 
* Due to a marked increase in the serum LH baseline following 
the first GnRH course in two mares of Group IlIa, these 
fractional increases, which are related to the pre~treatment 
baseline, are probably over-estimated. 
Fractional increases calculated as described in text. 
'.' .~ : : 
I 
I 
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.on I SCUSSION 
It is evident from the results of the experiments that administration 
of similar regimes of GnRH and progesterone to acyclic mares induces 
variable hormonal and ovarian responses, depending on the depth of 
acyc1icity of the mares being treated. Group I mares, considered to be in 
shallow acyclicity,a11 responded to the treatment by developing follicles 
which ovulated between Days 24 and 27 of the experiment. establishing 
corpora 1utea, and conceiving to this induced ovulation. This response was 
presumably induced by the increases in serurn gonadotrophins occurring 
after each injection of GnRH. Although the treatment was designed to 
reproduce the gonadotrophin changes occurring in the normal ovulatory 
cycle of the mare (see Chapter IV) each inj ection of GnRH induced 
a peak increase in serum FSH at approximatety 1 h after administration 
following which the levels declined, so that each GnRH course resulted 
in 3 to 5 FSH peaks and troughs. However, it seems reasonable that 
these repeated peaks would cause a physiological response because :-
(a) binding of gonadotrophins to target sites on the ovary is firm 
and rapid, (b) physiological responses are induced by relatively brief 
exposure to gonadotrophins (Lindner et at, 1974) and (c) the peak 
fractional increases induced were similar to those of the normal cycle. 
In this way the treatment probably induced an ovarian response to the 
first and second GnRH courses comparable to that in response to the 
FSH surges occurring at approximately 22 and 12 days prior to 
ovulation in the normal cycling mare. These two surges are thought to 
"prime" follicles destined to ovulate at the next oestrus (see Chapter 
IV). The third GnRH course also induced an increase in serum FSH. 
although the GnRH was administered to cause an LH increase. An FSH surge 
occurs near the day of ovulation in the normal cycle of the mare (see 
Chapter IV) whereas the induced surge occurred approximately three days 
prior to ovulation. 
If FSH is the hormone responsible for priming follicles prior to 
ovulation, then the effect of LH released in response to the first 
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and second courses is questionable. However, it is noteworthy that 
the fractional increases in serum FSH during the first and second 
courses were higher than those in LH (mean FSH fractional increase was 
4.27 and that of LH was 2.4), and that such increases in serum FSH are 
comparable to the peak levels occurring in the normal cycle (see 
Chapter IV). On the other hand the fractional LH increases are much 
smaller than those occurring at ovulation in the normal cycle (see 
Chapter IV; Noden et aZ, 1974). It is, therefore, possible that such 
LH increases did not induce a physiological response because :-
(i) the increases were quantitatively inadequate, 01 (ii) LH receptors had 
not been induced by adequate FSH priming. However, during the third 
GnRH course the relative release of FSH and LH changed, and the mean 
peak fractional increase in FSH was 2.7, while that of LH was 4.7 
rising to 6.3 on Day 27 which was four days after the last GnRH 
injection. This increase in serum LH during and following the third 
course of GnRH was similar to that reported to occur near ovulation in 
the cycling mare (see Chapter IV; Whitmore et aZ, 1973) when it is 
thought to be involved in the final maturation and ovulation of a 
previously FSHRprimed follicle, and in corpus luteum establishment. 
It is likely that the same ovarian responses were induced by the LH 
surge resulting from the third course of GnRH:ince the follicles 
present had been primed by the FSH surges caused by the preceding 
two GnRH courses. 
The cause of the greater LH response during the third, than in 
the first and second, courses cannot be due solely to the low levels of 
serum progesterone during the third course since serum progesterone 
levels were also low in the first course. It seems more likely that 
the rising oestradiol~17B levels during the third course may have 
potentiated thIs LH release, since such a relationship has been 
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reported to occur in the mare (Garcia and Ginther, 1975). All mares 
showed an increase in serum oestradiol-17S concentrations between 
Days 21 and 25, and a subsequent LH increase between Days 24 and 30 
which was after the third GnRH course; a similar relationship between 
oestradiol-17S and LH occurs in the normal ovulatory cycle (see 
Chapter IV; Noden et at, 1975; Pattison et at, 1974). 
The administration of exogenous progesterone on Day 6 through 
16 did not inhibit the release of either FSH or LH following admini-
stration of GnRH on Days 11 and 12. On the days during progesterone 
administration in which GnRH was not administered, serum FSH 
concentrations were higher than the mean pre-treatment baseline, but 
such an increase did not occur in LH concentrations. 
The mares in Group II and in Group IlIa, considered to be in 
mid- and deep acyclicity respectively, also responded to the 
treatment by developing follicles which ovulated between Days 24 
and 26 of the experiment. With the exception of Oriental Scott 
(who developed only a small follicle) these follicles underwent all 
the palpable changes associated with follicular maturation and 
ovulation. However, no corpora lutea were established since 
progesterone levels, although occasionally showing transient increases 
following ovulation, did not continue to rise indicative of the 
presence of an active corpus luteum. If the gonadotrophins are 
responsible for inducing all stages of follicular development, 
ovulation, and cnrpus luteum establishment, then the failure of 
these mares to establish corpora lutea, when those in Group I 
given similar treatment did establish corpora lutea, must be due 
either to a decreased release of FSH and/or LH or to a decrease in 
the physiological effectiveness of these hormones, both occurring 
as a result of the season of the year, and therefore the depth of 
acyclicity at which the experiments were performed. 
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Comparison of the mean peak fractional increases occurring 
in each of the three GnRH courses indicates that the first and second 
courses of GnRH induced a greater release in the Group I mares 
(4.1, 4.5 and 2.7 in each successive course) than in the Group II 
mares (2.4, 3.1 and 2.4 in each successive course) or than in the 
Group IlIa mares (2.1, 2.9 and 2.8 in each successive course). How-
ever, such a comparison does not take into account the absolute 
amount of FSH released which is presumably the important factor in 
initiation of a physiological response in the target organ. Since 
the Group II and Group IlIa mares received an additional injection 
in the first two courses, these differences in the mean fractional 
FSH increases in these two groups when compared with Group I may not 
reflect the amount of FSH available for causing a physiological 
response. 
Comparison of the mean peak fractional increases in serum LH 
for each GnRH course in the three groups of mares indicated more 
pronounce9 differences between the groups. In Group I mares the mean 
peak fractional increases were 2.2, 2.6 and 4.7 in each successive 
course, in Group II the increases were 1.7, 1.9 and 2.2 in each 
successive course~ while in Group IlIa the mean peak fractional 
increases were 2.7, 4.6 and 4.4 in each successive course. A marked 
difference in the responses to the third GnRH course occurs between 
Group I and Grou~ II, with Group I mares having a greater response 
during the third course than in the first and second GnRH courses, 
whereas Group II have a smaller response to all three courses. However 1 
it appears that this does not apply to the responses of the mares 
in Group IlIa since these mares show a response to the second and 
third GnRH courses comparable to that induced in the Group I mares 
by the third GnRH course. Examination of the data indicates that 
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two of the group IlIa mares showed a marked increase in LH concent-
rations after the end of the first GnRH course, so that the mean 
LH concentrations between the three courses of GnRH were consider-
ably higher than the mean pre"treatment baseline, and consequently 
the mean peak fractional increases to the second and third GnRH 
courses were overstated and not truly indicative of the LH 
response induced. 
A difference between the LH response induced by the third 
course of GnRH in the Group I mares, and that in the mares of 
Groups II and IlIa is the absence of a progressive increase in 
serum LH as measured immediately prior to each successive injection 
of GnRH in the third course, and also the absence of a prolonged 
LH surge persisting several days after the third GnRH course. 
Therefore, it is apparent that one of the causes of the failure 
to establish corpora lutea in the Group II and Group IlIa mares 
could have been the absence of an LH surge typical of that associated 
with ovulation in the normal cycle, and which was induced in the 
Group I mares which did establish corpora lutea. The increased LH 
concentrations induced during and following the third GnRH course 
in the Group I mares was thought to have been associated with the 
concurrent increases in serum oestradiol~17B levels typical of 
those occurring just prior to ovulation in the normally cycling 
mare (see Chapter IV). It has been shown that administration of 
oestradiol~17B to mares on Day 2 of oestrus induced a significant LH 
rise by 24 h (Garcia and Ginther, 1975) while in ovariectomized 
heifers oestradiol-17B administration caused an initial depression in 
serum LH levels followed by a typcial pre-ovulatory surve between 20 
and 32 h after injection (Hausler and Malven, 1974). In anoe~trous 
ewes oestradiolft17B treatment caused a significant increase in serum 
LH by 9-12 h after injection, a peak level at 15 h, returning to 
pre-treatment levels by 21 to 24 h after treatment (Beck and Reeves, 
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1973). These increases, and their relationship to oestradiol, were 
similar to those occurring at ovulation in the normal cycling 
cow (Wettemann et at, 1972) and the normal cycling ewe (Scaramuzzi 
et at, 1970). Similarly in women in the follicular phase of the 
menstrual cycle, oestradiol benzoate administration induced an 
increase in serum LH concentration within 12 to 48 h after the 
last injection (Monroe et at~ 1972), although this increase 
may be preceded by an initial depression in LH (Tsai and Yen, 1971). 
Increased oestradiol-17S concentrations during and following 
the third GnRH course did not occur in the Group II mares since 
Bonnylands, although having a high concentration on Day 24, had 
very low levels during the third course, and Mrs Oram did not show 
a typical pre-ovulatory surge but maintained high baseline concent-
rations. Similarly, none of the Group IlIa mares had increases in 
serum oestradiol-17S concentrations typical of those occurring prior 
to ovulation in the cycling mare. It is, therefore, possible that 
the failure to induce a normal ovulatory 1M surge could be due to 
inappropriate oestradiol-17S concentrations. If oestradiol-l7S 
is produced from the pre-ovulatory follicles then the absence of 
adequate levels of oestradio1-l7S prior to ovulation must have been 
caused by the incompetence of the follicles themselves. This 
in turn probably reflects the inadequacy of the FSH-priming 
of these follicles. Two Group IlIa mares were given a fourth 
course of GnRH in an attempt to provide additional FSH priming. 
One mare, Oriental Scott, had shown very little ovarian activity 
earlier in the experiment and did not respond in terms of follicular 
development. However, the other mare, Compliment, who had a typical 
pre-ovulatory follicle before the fourth course was given, ovulated 
during the GnRH course and established a corpus 1uteum of normal life 
458 
span. This mare showed elevated serum oestradiol-17S concentrations 
immediately prior to this fourth course on Days 30 through 32 and the 
LH increases during the courses were higher than those induced by any 
other earlier courses. 
The difference in responsiveness between the Group I mares and 
the mares of Groups II and IlIa must be due 9 at least in part9 
to the relative refractoriness of the ovaries at different stages 
of acyclicity producing an effect similar to that seen in ewes treated 
with hypothalamic extracts at different stages of the anoestrous 
season (Domanski and Kochman, 1968). Post-morte~ studies show that 
the ovaries of ~ares at times comparable to mid- and deep acyclicity 
are small (2.7 x 1.9 X 1.9 cm) and comprise mainly connective tissue. 
stroma and b+ood vessels, with the only follicles present being 
less than 5 mm, whereas those ovaries of mares in shallow acyclicity 
were larger (3.8 x 2.9 x 2.5 cm) and contained developing follicles 
up to 3 cm in diameter (1.2 Units) but which became atretic and never 
matured and ovulated (van Niekerk et aZ. 1973b). Therefore, under 
similar regimes of GnRH and progesterone treatment, mares in shallow 
acyclicity are more likely to develop ovulatory follicles competent 
to establish corpora lutea. Such an observation suggests that the 
Group I mares had undergone some FSH stimulation prior to the start 
of the treatment even though no marked FSH surges typical of the 
normal cycle were measured in these mares either prior to or during 
treatment, except for the GnRH-induced surges. This casts some 
doubt on whether the Group I mares were genuinely acyclic. 
However. the results from the control mares indicate that without 
treatment, such previously FSH stimulated follicles seldom spontan~ 
eously mature and ovulate over the period of the experiment. In 
addition, the results from the Group I mares showing spontaneous 
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cyclicity indicate that GnRH treatment induces much earlier ovulation 
and corpus 1uteum establishment than occurs in the Group I mares who 
were genuinely acyclic. This must result from GnRH~induced 
stimulation of follicles already adequately primed and typical of 
those present in the cyclic mare. This is similar to the finding 
of Heinze and K1ug (1975) who treated 30 mares with developing 
and/or persistent follicles with different degrees of external oestrus 
by injection of 2 or 4 mg GnRH (Hoechst), and found that 20 of the 
mares showed clinical signs of oestrus. and ovulated 12 to 96 h after 
injection. However, they found similar treatment to acyclic mares 
(1 to 4 mg GnRH) produced no evidence of fo11ic~lar activity, 
although six of thes~ mares returned to normal ovarian activity 15 
days after treatment. 
In the cyclic mare. Irvine et at (1975) has shown that daily 
injection of 2 mg GnRH (Ayerst) from Day 2 of oestrus until ovulation 
significantly shortened the duration of oestrus and the time to 
ovulation. 
The results from the mares of Groups I, II and IlIa suggest 
that the experimental regime of GnRH and progesterone does stimulate 
the ovaries of acyclic mares to produce ovulatory follicles. These 
findings are similar to those of Ni11ius et at (1975) who treated 
four women with symptoms of anorexia nervosa and secondary amenorrhoea 
with 500 ~g GnRH three times daily for 26-30 days and induced 
follicular maturation and ovulation. as evident by changes in plasma 
progesterone and urinary oestrogen. As in the mares in shallow 
acyc1icity. the FSH response to the GnRH in the women decreased as 
the treatment continued and urinary oestrogens became elevated while 
the LH response increased. In the present study the failure to 
establish corpora 1utea after the induced ovulation in mares in mid~ 
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and deep acyclicity may indicate that additional FSH priming may be 
necessary to stimulate the development of follicles adequately 
mature to produce a pre-ovulatory serum oestradiol.17B surge, and 
so potentiate the LH surge necessary for corpus luteum establishment. 
Nillius et aZ (1975) also found that two of the women may have had 
an insufficiency of the corpus luteum, and in a subsequent study 
(Nillius and Wide, 1975) the GnRH was combined with injections of HCG 
around the time of ovulation which resulted in normal luteal function. 
The importance of exogenous progesterone administration in 
this regime is apparent from the responses of the mares of Group IIIb. 
None of these mares developed typical pre-ovulatory follicles. While 
they all responded to the GnRH treatment by developing follicles of 
0.5 to 1.5 Units throughout the experiment, these follicles appeared 
to "ovulate" or "collapse" before developing further. These "ovul-
ations" occurred randomly throughout the experimental period (from 
Day 7 through Day 35) and were often followed by a transient increase 
in serum progesterone concentrations. A role of progesterone in 
preventing the premature "ovulation" of inadequately primed follicles 
can be postulated, hut since exogenous progesterone administration 
did not prevent an LH increase in response to the second GnRH course 
in the mares of Groups I, II and IlIa, such an action cannot be 
mediated via LH suppression. Alternatively the failure of the Group 
IIIh mares to develop typical pre~ovulatory follicles could be due 
to a differential FSH response to the GnRH. However, the mean peak 
increases in FSH during the first three GnRH courses (2.8, 3.5 and 
4.8 times the mean pre.treatment baseline) are actually greater than 
those in the Group II and Group IlIa mares indicating that the failure 
to develop follicles of typical pre-ovulatory size was not likely 
to he caused by decreased FSH responses. 
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This study has clarified some of the factors which control 
cyclicity in the mare. It appears that by treatment of acyclic 
mares with exogenous GnRH and progesterone to closely reproduce the 
FSH, LH, progesterone and, indirectly, the serum oestradiol~17B 
concentrations typical of the normal ovulatory cycle (as described 
in Chapter IV), fOllicular growth, maturation and ovulation 
~nd corpus luteurn establi~ment can be induced. This indicates 
that the observed changes in the serurn concentration of these 
hormones throughout the normal ovulatory cycle of the mare as described 
in Chapter IV are responsible for the follicul~r growth, maturation, 
ovulation and corpus luteurn estaplishment which occurs. Conversely, 
it appears that absence of the sequential changes in these hormones 
is the cause of acyclicity in mares during the physiological non-
breeding season. Since progesterone alone does not induce all the 
stages of follicular maturation in the acyclic mare (van Niekerk 
et aZ, 1975a), the absence of FSH and LH surges typical of the normal 
cycle is probably the fundamental cause of such acyclicity. This 
has been confirmed by Douglas et aZ (1975) who administered equine 
pituitary extracts twice daily for fourteen days to acyclic ponies 
and induced ovulation in 87% of treated mares while none of the controls 
ovulated. Since the serurn levels of FSH and LH are controlled, at 
least in part, by the production of gonadotrophin releasing hormone(s) 
from the hypothalamus, then the absence of follicular maturation in 
the physiological non-breeding season reflects a decline in the 
production of GnRH. The hypothesis that only one releasing hormone, 
GnRH, controls FSH and LH release is given some support by this 
study isince all the sequential FSH and LH changes which cause 
follicular development and ovulation in the normal cycle were 
induced with one exogenous GnRH in mares in shallow acyclicity. 
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This appears to be the first study in which GnRH has been 
given to acyclic animals at intervals designed to reproduce the 
established sequence of serum gonadotrophin surges and. combined 
with progesterone treatment, has resulted in the consistently 
successful induction of fo11icu1ogenesis and ovulation. While 
Ni11ius et aZ (1975) have also successfully induced ovulation 
in acyclic women, the technique reported herein is more convenient, 
economical of GnRH and possibly more physiological. [Note: 
Part of the results reported herein have been published (Evans and 
Irvine, 197n 
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APPENDIX 1: 
DETAILS OF INDIVIDUAL HORSES USED 
IN THIS STUDY 
Note; Horses are listed in alphabetical order, together with 
any abbreviation of their name used in the text (e.g. 
Queensway abbreviated Q; New Boots abbreviated NB). 
The sex of the horse, and the age. stage of training and 
reproductive state at the time of sampling are 
indicated. together with any additional information 
relevant to the study. 
Nulliparous 
Primiparous 
Mul tiparous 
Cycling 
Training 
Rugged 
never produced a foal 
during first pregnancy 
having produced a foal 
showing evidence of ovarian and behavioural 
cyclicity 
horse in work, in hard. moderate or light 
training as defined in Chapter I 
covered with a water proof New Zealand rug 
(blanket) 
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APPENDIX 1: 
ADJUDICATE'SFOAL (dead): Standardbred -
Sampled: 17-8-73 
Having been slipped at 9 months gestation. 
ALLEMANDE: Thoroughbred 
Sampled: 16-10-73 
Mare 18 years. Multiparous, at foaling. 
ALLEMANDE'S FOAL: Thoroughbred 
Born: 16-10-73 
AMBRO DEL FILLY: Standardbred 
Sampled: 26-10-74 to 28-2-75 
3 years, Nulliparous, non-pregnant, acyclic 
and did not conceive this season. 
ANITA JANE: Standardbred 
Sampled: 12-10-72 
Mare, 5 years. In moderate training 
ANNACY: Standardbred 
Sampled: 6-6-75 to 12-8-75 
Mare, 4 years. Nulliparous, non-pregnant, acyclic. 
AR MISS: Standarc~red 
Sampled: November-December 1974 
Mare, 7 years. Primiparous~ early pregnant 
Sampled: November 1975 
Peri-parturient, foal died soon after birth due to 
rhinopneumonitis virus 
AUNT ADA: Standardbred 
Sampled: 26·10-73 to 24-11~73 
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Mare, 9 years. Multiparous, non-lactating, cycling, 
conceived during experiment. 
BALENCIAGA: Standardbred 
Sampled: 26-10-73 to 24.11.73 
Mare, 4 years. Nulliparous, cycling, conceived during 
experiment. 
BETTY PATCH: Standardbred 
Sampled: November-December 1974 
Mare, 4 years. Nulliparous, conceived during experiment. 
BLEDDYN: Standardbred 
Sampled: 3-6.73 
Gelding, aged. Not in training and not rugged. 
BLOSSOM SONG: Standardbred 
Sampled: 10-10-73 
Mare, 13 years. Multiparous, in late pregnancy. 
Sampled: 1-11-73 
Parturient 
Sampled: 8-11.73 
1 week post~partum 
BLOSSOM SONG'S FOAL: Standardbred 
Born: 1.11-73 
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BONNYLANDS: Standardbred 
Samp1ecl: 11-9-74 to 12~11~74 
Mare, 9 years. Multiparous, acyclic, non-lactating 
BRIGHT SEA: Standardbred 
Sampled: 6-6-75 to 12-8.75 
Mare, 9 years. Multiparous, acyclic, non-lactating 
BYEBYEBILL FILLY: (see Trudys Bye Bye) 
CAMPESINO: Standardbred , 
Sampled: 26-10-73 to 24~11.73 
Mare, 9 years. Cycling, non-lactating and did not 
conceive this season, 
CANNES: Thoroughbred 
Sampled: 17~10-73 
Mare, 8 years, Parturient. 
CANNES' FOAL: Thoroughbred 
Born: 17-10-73 
CAROL TIME: Thoroughbred 
Sampled: November 1974 • December 1975 
Mare, 9 years, Primiparous. Conceived during study 
and sampled throughout pregnancy and in peri-parturient 
period. 
CASSATINA: Thoroughbred 
Sampled: 11-7-72 
Mare, 13 years. Multiparous, not pregnant. 
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CHARLIE (abbreviated Ch): Standardbred 
Sampled: 24-3-72 
Stallion, 4 years. Hard training, rugged, cold on morning 
of sampling. 
Sampled: 11-4-72 
Hard training, rugged. 
Sampled: 20-6-72 
After very cold week~nd, three days after last race 
for season. Rugged. 
Sampled: 21-9-72 
Hard training, warm week prior but night before, cold, 
rugged. 
CM: Thoroughbred 
Sampled: 14-11-73 
Mare, mated, not pregnant, but not cycling. 
COMING DOWN (abbreviated to CD): Standardbred 
Sampled: 24-3-72 
Mare, 21 years. Multiparous, pregnant, non-lactating 
and cold on morning of sampling, 
Sampled: 20-6-72 
Pregnant, after very cold weekend, rugged. 
Sampled: 21-9-72 
Pregnant, previous weather fine and warm except for 
cold snap night before. 
Sampled: 9-11-72 
Immediately post-parturient. 
474 
COMING DOWN'S FOAL: Standardbred 
Born: 
COMING UP (abbreviated C.Up): Standardbred 
Sampled: 29-7-72 
Gelding, 3 years. Hard training, rugged. Previous week 
warm. night before cold. 
Sampled: 5-10-72 to 1-11-72 
Hard training, rugged. 
Sampled: 22-3-73 to 4.6-73 
Moderate training, rugged. 
CQMPLIMENT: Standardbred 
; 
Sampled: 6-6-75 to 12-8-75 
Mare, 7 years. Multiparous, acyclic» non-lactating 
CONTRABAND: Standardbred 
Sampled: 12-10-74 to 28-2-75 
Mare, 5 years. Nulliparous, acyclic, induced to ovulate, 
conceived during experiment. 
CORONITA: Standardbred . 
Sampled: 24.3-72 
Mare, 25 years. Multiparous, lactating, pregnant four 
months. Cold on morning of collection. 
Sampled: 20.6.72 
Non-lactating, pregnant, very cold weekend, rugged, 
Sampled: 21-9-72 
Non.1actating, pregnant, warm previous week, cold night 
before. 
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CORONITA'S FOAL: Standardbred 
Born: 14-12-72 
COURTESY TEIDLO (abbreviated to Court. Tedlo): Standardbred 
Sampled: 26.10-73 to 24-11.73 
Mare, 6 years. Nulliparous, cycling, conceived 
during experiment. 
DIRECT JAN: Standardbred 
Sampled: 14-10-75 and 15-10-75 
Mare, 10 years, Multiparous, non-lactating, in 
dioestrus. 
DONORA: Standardbred 
Sampled: 26-10·75 to 24-11-75 
Mare, 5 years. Nulliparous, cycling, conceived during 
experiment, lactating 
Sampled: 26··10.74 to 31-11.74 
Multiparous, acyclic. 
DREAMY MELODY: Standardbred , 
Sampled; November - December 1974 
Mare, 4 years. Nulliparous, cycling. 
EBLOUIR: Standardbred . 
Sampled: 26-10"73 to 24-11-73 
Mare, 4 years. Nulliparous, cycling, conceived during 
experiment. Last raced 29-9-73. 
EV QRIDE: Standardbred 
Sampled: 5-6-72 
Mare, 4 years. Out of training 4 weeks, rugged, 
continuouly in oestrus, 
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Ev Pride ctd: 
Sampled: 11-7 .. 72 
Out of training 4 months. 
FALSE: Standardbred 
Sampled: September 1974 
Mare, 4 years. Nulliparous, cycling, conceived during 
experiment. 
Sampled: November 1974 
Cycling, previously aborted with prostag1a~din at 
Day 29 of pregnancy. 
FALSE IDEA: Standardbred (abbreviated to F.I.) 
Sampled: 10-8-72 
Stallion, 7 years. Not in training 
FALSE JEWEL: Standardbred 
Sampled: 10-5-72 
Mare, 6 years. Nulliparous, hard training going very 
badly, rugged. 
FLYING TWINKLE: Standardbred 
Sampled: 5-10-73 
Mare, 8 years. Multiparous, post-parturient. 
FLYING TWINKLE'S FOAL: Standardbred 
Born: 5-10~73 
FOURINA: Standardbred 
Sampled: 29-11-73 
Mare, 14 years. Multiparous, 10 months pregnant. 
FROZINA: Standardbred 
Sampled: November 1975 
4?? 
Mare, 8 years. Multiparous, peri-parturient, normal 
foal. 
FURY RIVER: Standardbred 
Sampled: 26-10-73 to 24-11-73 
Mare, 15 years. Multiparous, non-lactating, cycling, 
did not conceive this season. 
GAY FLEUR: Standardbred 
Sampled: November-December 1974 
Mare, 4 years. Primiparous, early pregnant 
GAY LUSTRE: Standardbred 
Sampled: 31-10-74 to 28-2-75 
Mare, 5 years. Nulliparous, acyclic at start of 
experiments. Began cycling spontaneously during 
experiments. Did not conceive. 
GOLDEN ROAD: Standardbred 
Sampled: November - December 1974 
Mare, 4 years. Primiparous~ early pregnant 
GOOD YEAR: Standardbred 
Sampled: 10-5-72 
Colt, 1 year. Not in training. 
Sampled: 15-9-72 
Not in training, weather relatively warm, though still 
cold snaps. 
HAUGHTY STAR: Standardbred 
Sampled: 8-10-73 
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Mare, 5 years. P0stparturient. 
HAUGHTY STAR'S FOAL: Standardbred 
Born: 8-10-73 
HI BLUE: Standardbred 
Sampled: 12-10-72 
Gelding, 3 years. In light training, rugged. 
HINDU STAR: Standardbred 
SamP.led: 10-10-73 
Mare, 13 years. Multiparous, pregnant (11 months). 
HINDU STAR'S FOAL: Standardbred 
Born: 11-10-73 
HO: Thoraughbred/pony cross 
Sampled: 2.6-73 
Gelding, 4 years. In light training, rugged. 
HULL: Standardbred 
Sampled: 14-10-75 and 15-10-75 
Mare, 11 years. Multiparous, non-lactating and 
acyclic. 
INDIAN SABRE'S FOAL: Standardbred 
Born: 29-11-73 
INDIFFERENT'S FOAL: Standardbred 
Born: 16-12-72 
479 
LIGHT'N FREE: Standardbred 
Sampled: November - December 1974 
Mare, 4 years. Primiparous, periparturient, normal 
foal. 
LISA TWINKLE: Standardbred 
Sampled: 
Sampled: 
26-10-74 to 28-2-75 
Mare, 2 years. Nulliparous, acyclic, began cycling 
during experiments. 
14-10-75 and 15-10-75 
Nulliparous, in oestrus, conceived during this oestrus. 
LOTTIE'S EXPRESS: Standardbred 
Sampled: 26-10-73 to 24-11-73 
Sampled: 
Mare, 4 years. Nulliparous, cycling, conceived during 
experiment. Few weeks out of training. 
6-6-75 to 12-8-75 
Multiparous, acyclic~ non-lactating. 
LORDSHIP FILLY (abbreviated Lord. Filly): Standardbred 
Sampled: 26-10-73 to 24-11-73 
Mare, 3 years. Nulliparous, cycling, conceived during 
experiment. 
LORRETTA W.: Standardbred 
Sampled: 8-4-73 
Mare, 8 years. Multiparous, pregnant 4 months. 
LUMBAR: Standardbred (abbreviated to L.) 
Sampled: 11-7-72 
Mare, 16 years. Multiparous, pregnant 7.5 months. 
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Lumbar ctd: 
Sampled: 17.9-72 
Pregnant 10 m0nths, weather warm but night before cold. 
Sampled: 8-10-73 
Pregnant 10~ months. 
Sampled: 20.H)-73 
Parturient. 
Sampled: 30-10-73 
10 days post-part~. 
LUMBAR'S FOAL: Standardbred 
Foal 1: Born, 26-10-72 
Foal 2: Born, 20-10-73 
MAGINNESS: Standardbred 
Sampled: 4-6-73 
(Note: This is one of two horses named 
MaginnesB~ see next) 
Filly, 2 years. Nulliparous, not in training. 
MAGINNESS: Standardbred (Note: This is one of two horses named 
Maginness~ see above) 
Sampled: 26-10-73 to 24-11-73 
Mare, 4 years. Nulliparous, cycling, conceived during 
experiment. 
MARLIN SPIKE: Thoroughbred 
Sampled: 12-10-7:? 
Gelding, 8 years. In hard training, rugged. 
Sampled: 16-10-72 
In hard training, rugged. 
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MESETA: Standardbred 
Sampled: 26-10-74 to 30-11-74 
Samplecl: 
Mare, 15 years. Multiparous, acyclic and non-lactating. 
6-6-75 to 12-8.75 
Acyclic, non-lactating. 
MIGNON D'OR: Standardbred 
Sampled: 26-10-73 to 24.11-73 
Mare, 4 years. Nulliparous, cycling, conceived after 
end of experiment in that stud season. 
MINI BUDGET: Standardbred 
Sampled: 26-10-73 to 24-ll-73 
Mare, 3 years. Nulliparous, cycling, conceived after 
end of experiment in that stud season. 
MISS BALMAIN: Standardbred 
Sampled: November 1974 ~ December 1975 
Mare, 3 years. Nulliparous, sampled from time of 
conception, through pregnancy, until periparturient 
period, had normal live foal. 
MISS KUMAI: Thoroughbred 
Sampled: 8-10-73 
Mare, 8 years. Parturient. 
Sampled: 12-10-73 
4 days post-partum. 
MISS KUMAI'S FOAL: Thoroughbred 
Born: 8-10-73 
MODULE: Standardbred 
Sampled: November 1975 
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Mare, 8 years. Multiparous, periparturient, normal live 
foal. 
MRS GRAM: Standardbred 
Sampled: 9-9-74 to 3-12-74 
Mare~ aged. Multiparous, acyclic., non-lactating 
NEW BOOTS: Thoroughbred 
Samplea: 11-3-72 
Mare, 12 years. Nulliparous, aborted 1967-1968, non-pregnant. 
On post-mortem had a very shallow pituitary fossa and a small 
pituitary gland. 
NILE QUEEN: Standardbred 
Sampled: 26-10-73 to 24-11-73 
Mare, 4 years. Nulliparous, cycling, conceived during 
experiment. 
NOT FUNNY: Standardbred 
Sampled: 14-10-75 ana 15-10-75 
Mare, 5 years. Acyclic, Nulliparous 
ORIENTAL SCOTT: Stanaardbred 
Sampled: 6-6-75 to 12-8-75 
Mare, 15 years, Multiparous, acyclic! non-lactating 
PALAMETTE: Thoroughb+ed 
Sampled: 13-10-73 
Mare, 8 years. Multiparous, periparturient. 
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PALAMETTE'S FOAL: Thoroughbred 
Born: 13-10-73 
PANIA: Standardbred 
Sampled: 31-10ft74 to 28-2~75 
Mare, 7 years. Nulliparous, acyclic but began cycling 
spontaneously during experiment. Conceived January 1975. 
PETULUS' FOAL: Standardbred 
Born: 12-12-72 
PORTENIA: Standardbred 
Sampled: 24-10-73 to 29-11-73 
Mare, 5 years. Multiparous, dead foal 18~9-73 and early 
pregnant. 
POWER: Thoroughbred 
Sampled: 11-4-72 
Gelding 4 years. In hard training going badly. 
PRENTICE: Standardbred 
Sampled: November - December 1974 
Mare, 4 years. Nulliparous and cycling. 
PRINCESS AYESHA'S FOAL: Standardbred 
Born: 29-11M73 
QUEENSWAY: Standardbred 
Sampled: 11-7-72 
Mare, 10 years. Multiparous, pregnant 7 months. non-lactating 
Sampled: 18-9-72 
Pregnant 9 months. Warm weather except cold night before. 
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Queensway Gtd: 
Sampled: 13-11-72 
Immediately post-partum. 
QUEENSWAYiS FOAL: Standardbred 
Born: 13-11-72 
RAE'S PRIDE FOAL: Standardbred 
Born: 24-11-73 
Dead due to dystokia. 
RH: Thoroughbred 
Sampled: 14-11-73 
Mare, mated,non-pregnant but not cyclic. 
ROBYN'S CHOICE: Standardbred 
Sampled: 6-6-75 to 12-8-75 
Mare, 21 years. Multiparous, non-lactating, acyclic. 
ROSELAND BEAUTY: Standardbred 
Sampled: 28-9-73 
Mare, 8 years, Primiparous, parturient. 
ROSELAND BEAUTY'S FOAL: Standardbred 
Born: 28-9-73 
RS: Thoroughbred 
Sampled: 14-11-73 
Mare, mated,non-pregnant, but not cyclic, 
RUSSIAN DUCHESS: Thoroughbred 
Sampled: 14-10-73 
Mare, 15 years, Multiparous, parturient. 
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RUSSIAN DUCHESS' FOAL: Thoroughbred 
Born: 14-10-73 
SISTER STELLA: Standardbred 
Sampled: 26-10-73 to 21-11-73 
Mare, 5 years. Multiparous, cycling, conceived during 
experiment 9 lactating 
TANUNDA: Standardbred 
Sampled: 26-10-74 to 28-2-75 
Mare, 8 years. Multiparous, non-lactating, acyclic, 
conceived during experiment. 
TARA: Standardbred 
Sampled: 11-7-72 
Sampled: 
Mare, 6 years. Pregnant 9 months. 
17-9-72 
One week post-partum, previous week warm except night before 
cold. 
TARA'S FOAL: Standardbred 
Born: 10-9-72 
TERRA MARU: Standardbred 
Sampled: 26-10-73 to 24-11-73 
Mare, 7 years. Multiparous, non-lactating, cycling, conceived 
during experiment. 
TIFFANY STAR'S FOAL: Standardbred 
Born: 12-12-73 
TRIX: Pony 
Sampled: 19-10-73 to 18-11-73 
Mare, 22 years. Multiparous, non-lactating, cycling, not 
mated during experiment but conceived at next oestrus. 
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TRUE LUSTRE: Standardbred 
Sampled: November - December 1975 
Mare, 3 years. Primiparous, periparturient, normal live 
foal. 
TRUDYS BYE BYE: (Also known as Byebye Bill Filly and Bye Bye Bill 
Filly) Standardbred 
Sampled: 26.10-73 to 24-11-73 
Mare, 3 Years. Nulliparous, cycling, conceived during 
experiment, but did not foal. 
Sampled: November - December 1974 
Early pregnant. 
TWINKLE HALL: Standardbred 
Sampled: 4-10-73 
Mare, 21 years. Multiparous, parturient. 
Sampled: 26-10-73 to 24-11-73 
Lactating, cycling, conceived during experiment. 
TWINKLE HALL'S FOAL: Standardbred 
Born: 4-10-73 
VIVACE: Standardbred 
Sampled: 3-10-73 
Mare, 17 years. Multiparous, parturient. Weather had 
turned · .. ery cold and wet. 
VIVACE'S FOAL: Standardbred 
Born: 3-10-73 
WILD MIST: Standardbred 
Sampled: 10-10-73 
Mare, 9 years. Parturient, multiparous. 
Sampled: 12-10-73 
2 days post-partum. 
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WILD MIST'S FOAL: Standardbred 
Born: 10-10-73 
WINABELL: Standardbred 
Sampled 26-10-74 to 28-2-75 
Mare~ 11 years. Multiparous, acy~lic, induced to I ,', ',' 
i."'_< __ '." ____ ' L,'._ 
ovulate~ conceived during experiment. 
YANKEE EXPRESS FILLY (YANKEE HONEY) (abbreviated to Y. Express Filly): 
Standardbred 
Sampled: 26-10-73 to 24-11-73 
Mare, 3 years. Nulliparous, cycling, did not conceive 
this season. 
YOUNG ANNE: Standardbred 
Sampled: 31-10-74 to 28-2-75 
Mare, 18 years. Multiparous, acyc~ic but began cycling 
spontaneously during experiment and conceived. 
YOUNG TRUDY: Standardbred 
Sampled: 6-6-75 to 12-8-75 
Mare, 11 years. Multiparous, acyclic, non-lactating 
ZADIOS: Standardbred 
Sampled: 26-10-73 to 26-11-73 
Mare, 16 years. Multiparous, non-lactating, cycling 
and conceived during experiment. 
Sampled: 14-10-75 and 15-10-75 
Non-lactating, in oestrus, served 14-10-73 and conceived. 
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APPENDI X 2: 
Sen-lin ConcentT'Cltions .of FSH, LB. ProgesteronE?, Total T4 
and Total T3 in Cycling and Early Pregnant MQres, 
Spring 1973 
Note: Results are e~pressed graphic~lly .according to the day of 
the oestrous cycle or pregnancy, where : 
day 0 = day of ovulation, indicqted hy 't' 
so 1 id har = days of oestrus 
*= mare mated hy natural service 
-·ve numbers refer to days prior to ovulation 
+ve numhers refer to days after ovulation 
+ve numhers prefixed hy P days of nregnan~y 
+ve numhers nrefi xed by RCL = days of retaine<;l corpus luteum 
..... --. ng/ml Hartree equine FSH (see Chanter TIl) 
• • = ng/m 1 I-Iartree equine LH (see Chapter II 1) 
.----. ng/ml progesterone 
/}.---/}. TT3, total T3, ng/IOO ml 
0-0 TT4, total T4. ng/IOO ml 
When TT3 or TT4 (shown on overlay) were measured twice on 
the one day. the mean of the two values is shown 
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APPJNDIX 3: 
Serum Concentrations of FSH, LH, Progesterone, Total T4 
and Total T3 in Cycling and Early Pregnant Mares, 
Spring 1973 
Note: Results are shown for each mare according to date, and also 
Serum 
according to the day of the oestrous cycle or pregnancy, 
where: 
day 0 = day of ovulation 
~ve numbers refer to days prior to ovulation 
+ve numbers refer to days after ovulation 
+ve numbers prefixed by P = days of pregnancy 
+ve numbers prefixed by RCL = day of retained corpus 1uteum 
hormone concentrations expressed as : 
ng/m1 Hartree equine F8H (see Chapter III) 
ng/ml Hartree equine LH (see Chapter III) 
ng/m1 progesterone 
ng/lOO ml total T4 (TT4) 
ng/IOO ml total T3 (TT3) 
The mean concentrations of total T4 and T3 for each horse throughout 
the period of study is also shown, together with the standard 
deviation (SD) of this mean and the number of estimates contributing 
to the mean (n), 
When TT4 and TT3 were measured twice on the one day the average 
of these two values is indicated and incorporated in the calculation 
of the mean. When FSH, LH and progesterone were measured twice in 
the one day, the a.mo and porn. estimates are indicated bracketed 
together. 
AUNT ADA: 
Date Day 0f . TT4 TT3 
Sampled Cycle or llg/IOO ml ng/IOO m1 
Pregnancy 
26-10-73 - 3 3.71 101.0 
30-10-73 1 2.31 73,5 
1~11-73 3 2.80 102.5 
3-11-73 5/-15 1.03 97.5 
6-11-73 8/-12 2.15 119.0 
8-11-73 -10 2.51 124.5 
10 .. 11-73 ... 8 4.58 90.0 
13-11~73 '- 5 1.11 . 97.5 
15-11-73 ... 3 2.39 108.0 
16-11-73 - 2 3.18 94,3 
17-11-73 - 1 3.16 75.5 
18-11-73 a S,80 114.5 
19-11-73 P 1 3.58 80.5 
20-11-73 P 2 3.66 84.0 
22-11-73 P 4 2.41 66.0 
24-11-73 P 6 3.55 65.0 
FSH ill 
ng/m1 ng/ml 
64.1 36.9 
77.3 36.0 
40.4 33.7 
56.9 34.5 
49.9 35.3 
65.8 24.8 
37.7 21.6 
31.8 37.9 
71.2 . 26.7 
· { 65.3 22.2 
{ 62.~ 18.4 
88.8 23.5 
· { 87.9 25.1 
101.5 29.7 
· { 57.1 40.5 
58.9 41.9 
77.0 46.9 
54.9 34.2 
43.3 27.6 
71.5 27.6 
Progesterone I 
ng/ml 
0.1 
0.1 
0.9 
1.9 
3.6 
3.2 
1.5 
1.5 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.5 
0.1 
0.1 
0.1 
5.6 
5.7 
\.n 
I\) 
---:J 
,AUNT ADA ctd: 
Date TT4 
Sampled llg/lOO ml 
Mean 3000 
SD 1020 
n 16 
TT3 
ng/IOO ml 
93 03 
18,2 
16 
I 
;::: 
I,', 
,', 
'::: 
i:: 
.~ ~: 
.:'; 
",", 
\Jl 
I\) 
OJ 
BALENCIAG A, 
Date Day of TT4 
Sampled Cycle or ]Jg/lOO ml 
Pregnancy 
26-10-73 -13 2.91 
30-10-73 - 9 3.20 
1-11-73 - 7 4040 
3-11-73 .. 5 3.12 
6-11-73 - 2 3.13 
7-11-73 - 1 3030 
8-11-73 0 4.86 
9-11-73 P 1 3.14 
10-11-73 P 2 2.84 
13-11-73 P 5 1.42 
15-11-73 P 7 1.95 
17-11-73 P 9 1.14 
20-11-73 P12 1.53 
22-11-73 P14 1.95 
24-11-73 P16 2038 
Mean 2,75 
SD LOS 
n 15 
TT3 1=:SH 
ng/IOO m1 ng/ml 
97.5 48 05 
103.5 53.6 
107.5 5302 
96.0 28 09 
23.1 
8000 { 
905 
4204 
80,5 { 
41.9 
61.0 33.3 
22.3 
55.6 { 
72.1 
109.8 
93.0 10.0 
107.5 7.9 
58.0 20.2 
76.5 59.0 
50.5 27.1 
34.5 25.0 
78.7 
23.5 
14 
>:-, .. \' 
LH 
ng/ml 
, 
16 05 
18.1 
2108 
1702 
30 09 
32 05 
38.7 
42.0 
35.0 
41.5 
40.7 
25.2 
20.3 
18.6 
21.0 
19.0 
16.3 
Progesterone 
ng/ml 
8.0 
404 
3.6 
La 
001 
0.1 
0.1 
0.1 
0.1 
1.3 
0.8 
4.4 
7.6 
8.0 
7.9 
7.2 
4.7 
! 
I 
I 
I 
I 
\J1 
I\.) 
\.0 
BYEBYEBILL FILLY: 
Date Day of 113 
Sampled Cycle or ng/100 m1 
Pregnancy 
26-10-73 - 9 8705 
30-10-73 - 5 6103 
1-11-73 - 3 132 05 
2-11-73 - 2 81.8 
3-11-73 - 1 90.8 
4-11-73 0 104.8 
5-11-73 P 1 86.5 
6-11-73 P 2 72.3 
7-11-73 P 3 65.5 
8-11-73 P 4 87.5 
10-11-73 P 6 79.0 
13-11-73 P 9 107.8 
15-11-73 Pll 121.0 
17-11-73 PI3 56.0 
20-11-73 P16 38 00 
~SH 
ng/m1 
4100 
1307 
1407 
17.2 
{ 17.8 
22 05 
{ 33.2 
30.2 
{ 32.8 
37.2 
{ 37.7 
22.0 
{ 52.9 
38.4 
{ 59.2 
37.2 
57.9 
40.6 
31.9 
40.4 
30.4 
TH 
ng/m1 
9 06 
12 09 
703 
14.7 
18.7 
15.7 
37.3 
22.2 
31. 7 
29~9 
35.1 
29.4 
33.8 
26.9 
37.3 
22.5 
25.7 
23.1 
13.0 
18.3 
14.1 
Progesterone 
ng/m1 
0 01 
0 01 
0.1 
0.1 
0.1 
0.4 
0.5 
0.1 
0.2 
0.3 
1.6 
2.3 
3.0 
5.5 
5.5 
6.3 
9.1 
8.0 
7.6 
6.7 
8 00 
IJIi 
\)I 
o 
BYEBYEBILL FILLY ctd: 
Date Day of TT3 
Sampled Cycle or ng/IOO ml 
Pregnancy 
22-11-73 PIB 41,0 
24-11-73 P20 52,0 
Mean 80,3 
SD 26,7 
n 17 
- ---~--~ 
P~H ill 
ng/ml ng/ml 
30,4 7,1 
84,1 9,7 
------
Progesterone 
ng/ml 
5,5 
4,3 
I 
, 
I 
I 
I 
I 
:: 
\J1 
\)./ 
~ 
CAMPESINO: 
E_S ; 
Date Day of TT4 
Sampled Cycle or ]..lg/100 m1 
Pregnancy 
26-10 .. 73 3.09 
30-10-73 -15 1.97 
1-11-73 -13 2.01 
6-11-73 - 8 1.60 
8-11-73 - 6 1,72 
10-11-73 - 4 2.57 
13-11-73 - 1 2.44 
14-11-73 0 1.80 
15-11-73 1 2.43 
16-11-73 "- 1.94 
17-11-73 3 2.07 
20-11-73 6 1.42 
22-11-73 8 2.01 
24-11-73 10 1.49 
Mean 2.04 
SD 0.46 
n 14 
TT3 FSH 
ng/IOO ml ng/m1 
92.0 103,6 
77.0 93.1 
99.5 116.8 
81.2 241.0 
80.0 155.0 
91.5 103.5 
76.7 
70.3 { 94.8 
99.3 
72 .9 { 88.8 
124.6 
73.6 {105.0 
114.6 
71.5 . { 82.8 
57.5 109.0 
48.0 97.0 
50.5 107.5 
60.0 122.3 
73.3 
15.4 
14 
- --- ----
-
LH 
ng/ml 
, 
18.6 
24.6 
14.5 
24.1 
24.6 
23.6 
30.8 
29.0 
33.2 
31.6 
33.9 
37.2 
31.7 
30.2 
23.0 
14.9 
18.1 
16.2 
, 
Progesterone 
ng/m1 
10,2 
12.5 
12.1 
0.5 
0.8 
0.6 
1.7 
0.7 
0.8 
0.1 
1.3 
0.7 
2.0 
3.7 
9.1 
11.2 
14.2 
\J1 
\)j 
I\.) 
COURTESY TEDlO: 
t. f', 
Date Day of TT4 
Sampled Cycle or ]Jg/100 ml 
Pregnancy 
26-10-73 '" 9 2.82 
30-10-73 - 5 3060 
31-10-73 - 4 2 0 71 
1-11-73 - 3 2AS 
2-11-73 - 2 2.77 
3-11-73 - 1 3.S0 
4~1l-73 0 3.36 
5-11-73 P 1 3.SS 
6-11-73 P 2 1. 82 
7-11-73 P 3 1.66 
8-11-73 P 4 1.92 
10-11-73 P 6 2.24 
13-11-73 P 9 1,39 
," 
LH 
ng/ml 
23.2 
22.5 
{ 2006 
2200 
{ 30.7 
37.7 
37.7 
{ 38.0 
{>1000 
{>1000 
{>1000 
{11804 
7S.6 
{ 52.5 
49.7 
30.4 
24.0 
--- -- - ---
Progesterone 
ng/ml 
0.1 
0.1 
001 
1.1 
1.1 
003 
0.1 
001 
0.3 
2.0 
1.6 
0.1 
0.4 
3.2 
S.2 
7.2 
4.S 
5.3 
lS.2 
16.3 
10.7 
-- -
-,' .. 
:;: 
r: 
::[, 
'i: 
\J1 
\>I 
\>I 
COURTESY TED10 ctd: 
Date Day of 
Sampled Cycle or 
Pregnancy 
15-11-73 Pll 
17-11-73 PI3 
20-11-73 P16 
22-11-73 P18 
24-11-73 P20 
Mean 
SD 
n 
TT4 LH 
J.lg/lOO m1 ng/m1 
1.85 20,5 
2,01 20,1 
1,49 22,8 
1.46 14,6 
1.24 16,7 
2,32 
0,80 
18 
PrO!1estArone 
ng/rnl 
12,0 
6,7 
13,7 
7,0 
9,3 
\J1 
\).i 
~ 
DONORA: 
Date Day of TT3 
Sampled C/~le or ng/IOO ml 
Pregnancy 
26-10~73 -12 61,0 
30-10-73 - 8 47,5 
1-11-73 - 6 81,0 
2 ... 11 ... 73 .. S 45,3 
3 .. 11 .. 73 ~ 4 74,5 
4-11-73 - 3 72,8 
5-11-73 - 2 53.8 
6-11-73 - 1 64.0 
8-11-73 p 1 55,0 
1O~11-73 P 3 44.0 
13-11-73 P 6 39.0 
15-11-73 P 8 40,5 
17-11-73 PIO 32.0 
20-11-73 PI3 19,0 
22-11-73 PIS 4S.0 
24-11-73 PI7 47.5 
LH 
ng/ml 
19,4 
36,2 
28,1 
{ 9,3 
16,4 
{ 5,5 
1105 
{ 22.6 
18.9 
{ 2204 
45,1 
35.6 
44.5 
25.7 
13,0 
11,9 
9,3 
21,6 
16.3 
1 
1.5 
Progesterone 
ng/rnl 
0,4 
1,3 
0,9 
0,4 
0.1 
004 
0,1 
1,3 
. 0,1 
0.1 
0.1 
1,7 
4,8 
604 
1004 
5.6 
5.7 
5.6 
I 
I 
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EBLOUIR: 
Date Day of TT4 
Sampled Cycle or llg/100 rn1 
Pregnancy 
26-10-73 - 7 4.59 
30-10-73 - 3 4.25 
31-10-73 - 2 3.68 
1-11~ 73 - 1 4,03 
2-11-73 0 4.60 
3-11-73 P 1 3.61 
6-11-73 P 4 3.55 
8-11-73 P 6 3.00 
10-11-73 P 8 3,76 
13-11-73 Pll 3.83 
15-11-73 P13 4.14 
17-11-73 PI5 3.80 
20-11-73 PI8 2.95 
22-11-73 P20 5,02 
24-11-73 P22 4.02 
Mean 3.92 
SD 0.56 
n 15 
TT3 FSH 
ng/lOO rnl ng/rnl 
75.5 34,4 
82.0 { 31.0 
30.0 
64.3 { 48.0 
56.8 
75,5 58.0 
81.0 88.6 
44.5 72.0 
91.0 88,6 
63.0 62,5 
52.5 
43.0 
78.0 60.8 
35.0 
33.0 
53,0 
50.0 44.2 
61.4 
18.5 
15 
--
LH 
ng/rnl 
17.0 
20.6 
21.5 
27.2 
26.8 
30,0 
35.2 
36.2 
30,8 
20,3 
17,3 
17.3 
24,1 
20.8 
20.6 
22.4 
21.4 
Prog-e5t:f'!T'One I 
ng/rn1 
1,5 
0.1 
0.1 
0.1 
0.1 
0,1 
0.1 
0.1 
1.9 
3,3 
3.9 
3.3 
2.7 
1.9 
1.7 
2.5 
2.1 
- - --- -
\J1 
\}I 
'-J 
FURY RIVER: 
Date Day of TT4 
Sampled Cycle or llg/lOO m1 
Pregnancy 
26-10-73 2 4.14 
30-10-73 6 2.54 
1-11-73 8/-13 4.72 
3-11-73 -11 1. 80 
6-11-73 - 8 2.36 
8-11-73 - 6 2.61 
10-11-73 - 4 3.25 
13-11-73 - 1 2.59 
14-11-73 0 2.36 
15-11-73 1 2.52 
17-11-73 3 3.20 
20-11-73 6 2.31 
22-11-73 8/-15 1.83 
24-11-73 10/-13 2.71 
Mean 2.78 
SD 0.82 
n 14 
TT3 FSH 
ng/lOO m1 ng/m1 
38.5 39.8 
77.5 42.2 
110.0 56.4 
117.5 39.1 
72.5 44.1 
87.0 34.2 
132.0 25.8 
96.5 23.6 
93.5 . 24.2 { . 
32.5 
65.0 21.2 
95.0 54.0 
115.0 56.3 
73.0 37.7 
III .5 32.6 
91.8 
24.9 
14 
LH 
ng/ml 
18.0 
16.3 
13.1 
12.7 
15.6 
17.3 
20.0 
32.3 
30.5 
37.0 
29.2 
24.0 
21.0 
18.0 
13.5 
Progesterone 
ng/ml 
32.0 
>53.0 
45.0 
>53.0 
38.4 
3.0 
0.1 
0.1 
0.1 
0.1 
0.1 
2.4 
9.0 
10.5 
8.7 
I 
I 
, 
I 
I 
I 
i 
, 
I 
I 
\.n 
\).I 
ex> 
LOTTIE'S E'{PRESS: 
" 
Date Day of 
Sampled Cycle or 
Pregnancy 
26-10-73 
30-10-73 
1-11-73 -15 
3-11-73 -13 
6-11-73 -10 
8-11-73 - 8 
10-11-73 - 6 
13-11-73 - 3 
14-11-73 - 2 
15-11 ... 73 - 1 
16-11-73 0 
17-11-73 P 1 
18-11-73 P 2 
19-11-73 P 3 
- --- ---- - -- --- ---
FSH 
ng/ml 
26,0 
58,S 
42,9 
41, 7 
44,5 
50,0 
48,1 
{ 48,9 
29,5 
{ 39,1 
32,8 
{ 41,0 
29,9 
{ 42,2 
36,0 
{ 34,8 
31,2 
{ 32,3 
28,S 
{ 27,5 
34,3 
,--
LH 
ng/ml 
7,2 
17,3 
8,3 
8,9 
19,1 
14,9 
13,6 
24,7 
23,9 
22,3 
25,4 
28,9 
32,7 
27,6 
28,6 
31,7 
34,9 
36,4 
24,8 
14,2 
14,6 
I 
I 
, 
I 
I 
I 
I 
;:;' " 
rf: 
;:: 
,',' 
:i: 
\J1 
\).I 
'" 
LOTTIE'S EXPRESS ctd: 
Date Day of 
Sampled Cycle or 
Pregnancy 
20-11-73 P 4 
22-11-73 P 6 
24-11-73 P 8 
--
FSJ-f l ng/ml 
29,8 
39,1 
38,8 
LH 
ng/ml 
15 0 7 
17,3 
17,3 
':' 
\J1 
~ o 
LORDSHIP FILLY: 
Date Day of TT4 TT3 
Sampled Cycle or llg/100 ml ng/IOO m1 
Pregnancy 
26-10-73 - 9 3.29 60.0 
30-10-73 - 5 3.82 82.8 
31-10-73 - 4 2.74 46,1 
1-11-73 - 3 2,81 71.3 
2-11-73 - 2 2,72 60,6 
3-11-73 - 1 3057 8404 
4-11-73 0 2089 107,5 
5-11-73 1 2044 57 05 
6-11-73 2 1030 77 06 
7-11-73 3 2 099 57,7 
8-11-73 4/-15 2069 75.3 
10-11-73 6/-13 2.41 5800 
Pt::H LH 
ng/ml ng/ml 
50.1 1404 
{ 31.5 1904 
41.6 13.7 
{ 31.5 15.0 
45,6 19,1 
40 0 0 22,8 
{ 45,6 18,1 
45,2 17,8 
{ 5504 529 05 
76 05 37004 
{ 60 06 196r[6 
i 
56,3 159 09 
{ 9903 liDS,S 
I 
63,9 82.1 
{ 64 08 6615 
48'1 108,5 
{ 86,9 39.8 
55,0 37.0 
62,5 29,8 
92 05 21.4 
Progesterrme 
ng/ml 
004 
0.1 
0.1 
004 
0,1 
0,1 
001 
0.1 
0 07 
007 
003 
004 
0.7 
1.3 
2,1 
305 
3.4 
5 07 
5.5 
800 - ---
\J1 
..j:::' 
~ 
LORDSHIP FILLY ctd: 
Date Day of TT4 TT3 FSP tH Progesterone 
Sampled Cycle or ].lg/IOO m1 ng/l00 ml ng/m1 ng/ml ng/ml 
Pregnancy 
13-11-73 -10 2 002 58 05 4700 1409 ILl 
15-11-73 - 8 3018 74 08 31,2 10 02 507 
17-11-73 - 6 3083 4200 27 08 1206 200 
20-11-73 - 3 3098 51.5 { 4802 
9 07 0,4 
2703 15 00 001 
21-11-73 - 2 4 084 46.1 { -31.5 
9 04 001 
22.2 377.4 1.8 
22-11-73 - 1 3046 54.4 { 30.3 _ 
79 00 0.1 \J1 it 
53.0 55.4 001 
23-11-73 0 1.87 36.5 { 38.1 
32.1 005 
34.5 28.4 007 
24-11-73 P 1 1. 78 47.0 36.3 25.9 001 
Mean 2 093 62.5 
SO 0085 1703 
n 20 20 I 
I 
~. -~:: 
.';. r 
MAGINNESS: 
Date Day of TT3 
Sampled Cycle or ng/l00 rnl 
Pregnancy 
26-10-73 -16 92.0 
30-10-73 -12 65.0 
1-11-73 -10 108.5 
3-11-73 - 8 69.0 
6-11-73 - 5 85.0 
8-11-73 - 3 73.3 
9 .. 11 .. 73 ~ 2 76.5 
10 .. 11-73 - 1 75.8 
11-11-73 0 78.0 
12-11-73 P 1 58.0 
13-11-73 P 2 97.5 
15-11- 73 P 4 62.0 
17-11-73 P 6 46,0 
20-11-73 P 9 42.0 
22-11-73 Pll 76.5 
24-11-73 P13 67.5 
FSH Lf-f 
ng/ml ng/rnl 
27.2 7.6 
50.1 10.4 
36.8 5.8 
22.3 9.7 
24.8 13.0 
{ 25.5 14.5 
30.2 16.7 
37.4 15.2 
{ 
18.3 
53.4 22.4 
{ 60.4 23.6 
50.8 23.2 
{ 51.5 28.3 
60.0 28.1 
74.3 25.6 
64.7 18.1 
77 .8 18.8 
73.0 11.1 
97.3 11.2 
69.1 13.4 
Progesterone 
ng/rn1 
0.8 
3.0 
0.7 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.8 
3.1 
3.6 
2.7 
6.8 
2.8 
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MIGNON DiOR: 
Date Day of TT4 TT3 
Sampled Cycle or ].lg/100 m1 ng/lOO m1 
Pregnancy 
26-10-73 -16 3039 105.0 
30-10-73 -12 3.32 52.7 
1-11-73 -10 3.86 96.0 
3-11-73 - 8 3.68 68.0 
6-11873 - 5 2.95 83.5 
8-11-73 - 3 3.79 89.0 
9-11-73 - 2 4.13 83.9 
10-11-73 - 1 70.4 
11-1l-73 0 3.74 68.8 
12-11-73 1 3.50 67.8 
13-11-73 2 77.5 
15-11-73 4 3.61 72.5 
17-11-73 6/-15 3073 64 05 
20-11-73 9/-12 3.70 70.5 
22-11-73 11/-10 3.75 71.2 
FSH 
ng/m1 
34.4 
37.0 
58.7 
68.5 
62.7 
86.3 
67.7 
{ 97.6 
138.2 
{113.4 
165.2 
{ 63.9 
108.1 
{ 97.1 
110.1 
77.7 
48.1 
89.6 
139.1 
114.2 
LH 
ng/ml 
14.6 
8.2 
11.8 
15.8 
14.8 
15.1 
10.6 
17.8 
21.3 
24.7 
>1000 
>1000 
>1000 
1081. 7 
234.6 
119.7 
39.1 
33.8 
28.3 
17.6 
Progesterone 
ng/m1 
1.2 
5.8 
5.2 
3.6 
0.3 
0.1 
0.1 
0.1 
0.3 
0.1 
0.3 
0.1 
0.8 
0.4 
401 
4.5 
5.1 
3.7 
\Jl 
+:-
\J1 
MIGNON D'OR ctd: 
Date Day of TT4 TT3 FSH LH Progesterone 
Sampled Cycle or ]Jg/100 m1 ng/100 ml ng/ml ng/ml ng/ml 
Pregnancy 
24-11~ 73 13/-8 3,83 68,7 50,3 16,3 2,7 
Mean 3,64 75,6 
SD 0,28 13.0 
n 14 16 
- - - - - - --- - -- -- -- - ---- -- -- -
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MINI BUDGET: 
Date Day of TT4 
Sampled Cycle or llg/100 m1 
Pregnancy 
26-10-73 -10 2 061 
30-10-73 - 6 2028 
1-11-73 - 4 3023 
3-11-73 - 2 2.67 
6-11-73 1 1.83 
8-11-73 3 1.94 
10-11-73 5 2.27 
13-11-73 -13 2.49 
15-11-73 -11 1.80 
17-11-73 - 9 2.13 
20-11-73 - 6 2.20 
22-11-73 - 4 2.36 
23-11-73 - 3 2,24 
24-11-73 - 2 2,88 
25-11-73 - 1 2,78 
Mean 2,38 
SD 0.40 
n 15 
':.. 
TT3 FSH 
ng/lOO ml ng/ml 
98 05 146 05 
70 05 10309 
11000 83 09 
80.5 212,3 
67.5 128.5 
98.5 114.6 
57.5 236.0 
73.0 231. 7 
86.5 98.9 
67.3 103.9 
63.0 118,4 
83.8 . { 114.6 
153.9 
72.8 { 137.2 
122.3 
57.0 { 139.4 
244.5 
89.0 262.8 
78.4 
15.8 
15 
LH 
ng/ml 
804 
1704 
12.3 
29.8 
23.8 
15.8 
12.4 
9.4 
9.9 
7.4 
13.3 
21.2 
25.2 
25.0 
22.9 
33.5 
50.6 
49.9 
Progesterone 
ng/m1 
001 
001 
0.1 
0.1 
003 
2.3 
2.4 
3.3 
5.5 
5.2 
1.1 
0.7 
0.1 
0.5 
0.1 
0.1 
0.1 
, . 
'. ~:::' 
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NILE QUEEN: 
Date Day of FSH 
Sampled Cycle or ng/ml 
Pregnancy 
26-10-73 -15 20.1 
30-10-73 -11 38.8 
l-ll~ 73 - 9 37.2 
3-11-73 - 7 17.9 
6-11-73 - 4 
{ 15.8 
30.0 
7-11-73 - 3 { 10.1 
15.0 
8-11-73 - 2 14,4 
9-11-73 - 1 
{ 14,0 
16.6 
10-11-73 0 { 15.0 
22,0 
11-11-73 P 1 { 17,1 
17.7 
12-11-73 P 2 { 21,1 
16.9 
13-11-73 P 3 { 18,8 
13,8 
------------
.:' 
LH 
ng/ml 
26.3 
19.1 
17.0 
13.9 
22.9 
28.7 
26.2 
33.0 
23.2 
21,3 
24.8 
>1000 
>1000 
>1000 
>1000 
>1000 
>1000 
>1000 
-- ---
Progesterone 
ng/m1 
0.3 
L8 
0.1 
0.3 
0.1 
0.1 
0,1 
0,5 
0,1 
0,1 
0,1 
0.1 
0,1 
0.4 
0~6 
1.3 
2,7 
1.8 
3,5 
_J 
\.J1 
~ 
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NILE QUEEN ctd: 
Date Day of 
Sampled Cycle or 
Pregnancy 
14-11-73 P 4 
15-11-73 F 5 
17-11-73 P 7 
20-11-73 PIO 
22-11-73 P12 
24-11-73 P14 
FSH LH 
ng/m1 ng/m1 
{ 14.4 >1000 
15.2 >1000 
16.4 56.5 
20.4 39.5 
38.5 38.5 
41.8 41.8 
25.2 25.2 
Progesterone 
ng/m1 
4.7 
5.6 
6.5 
5.8 
6.7 
\.n 
~ 
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PORTENIA: 
Date Day of FSH 
Sampled Cycle or ng/m1 
Pregnancy 
26-10-73 P 2 60.0 
30-10-73 P 6 82.6 
1-11-73 P 8 85.4 
3-11-73 PIO 111.5 
6-11-73 P13 66.9 
8-11-73 PlS 66.9 
10-11-73 P17 75.8 
11-1l-73 P18 139.8 
92.0 
12-11-73 P19 {120.6 
78.8 
13-11-73 P20 { 
85.4 
76.9 
14-11-73 P21 { 
75.2 
50.2 
15-11-73 P22 48.5 
17-11-73 P24 53.9 
20-11-73 P27 106.6 
22-11-73 P29 71. 7 
24-11-73 P31 136.7 
LH 
ng/m1 
20.2 
19.1 
13.8 
18.5 
15.6 
17.0 
14.8 
16.3 
17 ~ 7 
18.0 
21.6 
23.5 
20.3 
20.5 
19.7 
17.3 
16.7 
19.0 
24.6 
31.8 
-~ 
Progesterone 
ng/m1 
2.7 
7.5 
3.1 
1.6 
3.9 
4.6 
2.7 
3.2 
4.5 
2.6 
6.9 
5.4 
6.4 
5.7 
6.2 
6.1 
5.5 
5.3 
6.3 
5.9 
--- --
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SISTER STELLA: 
Date Day of TT4 
Sampled Cycle or llg/lOO m1 
Pregnancy 
26-10-73 -12 3.83 
30-10~ 73 • 8 3.42 
1~11-73 - 6 3.25 
5-11-73 - 2 4.94 
7-11-73 0 6.79 
8-11-73 P 1 4.34 
9-11-73 P 2 2.90 
12-11-73 P 5 7.67 
14-11-73 P 7 2.34 
16-11-73 P 9 2.60 
19-11-73 P12 2.13 
21-11-73 P14 3.29 
Mean 3.96 
SD 1. 73 
'n 12 
TT3 FSH 
ng/100 ml ng/ml 
67.5 80.5 
121.0 35.3 
81.5 37.6 
114.0 '{ 19.2 
32.1 
84.0 65.7 
80.0 30.3 
48.4 { 54.6 
88.0 
83.8 88.4 
60.0 39.2 
78.0 114.1 
72 .0 75.0 
76.2 62.0 
80.5 
20.2 
12 
--- ---
J.H 
ng/m1 
25.1 
18.3 
24.1 
27.8 
17.1 
23.2 
21.4 
16.8 
21. 3 
16A 
14.9 
9.7 
16.8 
60.5 
, 
ProD"esterone 
ng/ml 
6.2 
5.9 
2.0 
0.7 
0.8 
0.7 
0.8 
1.8 
2.9 
6.8 
8.8 
7.9 
7.8 
6.5 
:::: 
';" 
',,,' 
::' ',,: 
\11 
\11 
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TERRA MARU: 
Date Day of FSH 
Sampled Cycle or ng/ml 
Pregnancy 
26-10-73 - 7 29.3 
30-10-73 - 3 37.9 
1-11-73 - 1 54.1 
3-11-73 1 35.8 
6-11-73 4 32.9 
8-11-73 6 33.0 
10-11-73 -13 46.6 
13-11-73 -10 45.9 
15-11-73 - 8 39.8 
17-11-73 - 6 
20-11-73 - 3 
. { 41. 8 
41.1 
21-11-73 - 2 { 34.3 
31.8 
22-11-73 - 1 36.7 
23-11-73 0 { 37.9 
44.5 
24-11-73 P 1 { 45.9 
40.5 
25-11-73 P 2 48.8 
LH 
ng/ml 
5.9 
7.6 
16.8 
17.9 
13.3 
9.5 
6.2 
7.3 
7.4 
8.4 
16.8 
17.9 
19.8 
18.4 
>1000 
>1000 
>1000 
533.0 
410.0 
256.0 
PrO!!e5terone 
ng/ml 
0.1 
0.1 
0.1 
0.5 
6.0 
8.7 
10.1 
9.6 
9.5 
2.8 
2.0 
0.5 
0.1 
0.3 
0.3 
0.3 
0.3 
0.4 
0.4 
1.3 
I 
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I 
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TRIX: 
Date Day of TT4 TT3 
Sampled Cycle or llg/lOO m1 ng/100 m1 
Pregnancy 
19-10-73 -14 3.62 50.0 
25-10-73 - 8 2.59 47.0 
27-10-73 - 6 2.50 48.0 
28-10-73 - 5 1.85 43.5 
29-10-73 - 4 1.63 54.0 
30-10-73 - 3 2.90 53.3 
31-10-73 - 2 1.90 44.9 
1-11-73 - 1 2.19 55.5 
2-11-73 0 2.24 47.0 
3-11-73 1 2.79 42.5 
4-11-73 2 2.64 57.5 
5-11-73 3 2.15 55.0 
9-11-73 7 1.31 50,,;5 
-
:.:: 
FSH 
ng/m1 
216.9 
96.5 
56.1 
{ 70.9 
76.5 
75.9 
105.5 
{ 
70.9 
{ 94.9 
119.2 
{138.0 
162.7 
. { 143.8 
169.7 
{130.3 
279.0 
. { 88.9 
162.7 
179.8 
119.2 
LH 
ng/ml 
23,8 
26.9 
16.2 
26.3 
21.4 
26.6 
16.9 
16.2 
22.1 
20.1 
2004 
19.4 
24.5 
27.0 
27.7 
31. 3 
26.3 
23.8 
15.0 
12.6 
ProCFP-sterone 
ng/ml 
0.1 
0.8 
0.5 
004 
0.3 
0.1 
0.8 
LO 
0.9 
0.1 
0.3 
0.1 
0.1 
1.3 
1.0 
5.0 
5,7 
7.1 
12.5 
I 
\J1 
\J1 
\),I 
TRIX ctd: 
tt. 
Date Day of TT4 
Sampled Cycle or ].lg/IOO ml 
Pregnancy 
13-11-73 -12 1,41 
16-11-73 - 9 1063 
18-11-73 - 7 1013 
Mean 2 016 
SD 0 067 
n 16 
- ---- - -~--~ ~-
TT3 FSH 
ng/100 m1 ng/ml 
4500 164 00 
5400 19204 
53 05 6800 
50 05 
5 00 
16 
---
LH 
ng/m1 
ILl 
15 03 
1404 
Progesterone 
ng/m1 
901 
1.9 
1,3 
.-
.. ; 
I 
! 
\J1 
\J1 
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TWINKLE HALL: 
Date Day of TT4 TT3 
Sampled Cycle or llg/100 m1 ng/l00 m1 
Pregnancy 
26-10-73 - 5 2.85 88.0 
30-10-73 - 1 2.24 100.0 
1-11-73 1 1. 76 50.0 
5-11-73 5 2.45 136.5 
7-11-73 7 8.08 80.0 
8-11-73 8/-13 2.61 122.5 
12-11-73 - 9 2.43 81.0 
14-11-73 - 7 1.28 93.0 
16-11-73 - 5 3.45 57.0 
19-11-73 - 2 6.82 70.0 
21-11-73 0 1.68 62.0 
23-11-73 P 2 1.88 57.0 
24-11-73 P 3 3.99 51.5 
Mean 3.19 80.7 
SD 2.04 27.1 
n 13 13 
FSH LH 
ng/m1 ng/ml 
10.0 9.7 
14.8 5.0 
29.1 15.1 
29.7 12.4 
24.9 4.5 
28.8 5.6 
28.2 11.2 
19.8 9.4 
13.3 14.0 
20.6 17.6 
10.8 12.0 
31.6 133.5 
29.1 64~9 
:::' 
Progesterone 
ng/m1 
0.1 
0.1 
0.1 
5.6 
6.6 
6.5 
3.0 
0.1 
0.1 
0.1 
0.1 
0.7 
2.7 
:.",' 
I 
I 
I 
i 
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:':. .r, 
::':: 
.',' 
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\}1 
\}1 
YANKEE EXPRESS FILLY: 
Date Day of TT4 TT3 
Sampled Cycle or ].lg/lOO m1 ng/IOO m1 
Pregnancy 
26-10-73 - 9 4.25 112.5 
30-10-73 - 5 3,61 92,5 
31-10-73 - 4 3.57 69,8 
1-11-73 - 3 3.75 107.5 
2-11-73 - 2 3.50 84.8 
3-11-73 - 1 4.21 54.3 
, 4-11-73 0 - o::t:; 71.0 
5-11-73 1 3.68 57.3 
6-11-73 2 3.15 85.0 
7-11-73 3 3.67 52,5 
8-11-73 4 2.95 66.5 
10-11-73 6 2.76 45.0 
FSH LH 
ng/m1 ng/m1 
46.9 10.7 
{ 26.3 13.9 
26.8 13.0 
{ 32.0 16.6 
31. 7 17.4 
34.4 19.3 
{ 37.8 27.9 
35.S 25.9 
{ 38.7 28.3 
37.8 30.4 
' { 40.2 40.7 
48.2 31.8 
' { 79.2 39.7 
57.2 37.4 
{ 48.9 26.9 
77.4 
. { 84.5 26.6 
118.2 39.3 
74.9 25.6 
73.5 20.1 
Progesterone 
ng/m1 
1.5 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.1 
0.3 
0.1 
0.4 
0.5 
1.3 
2.4 
2.8 
3.1 
3.9 
5.6 
4.8 
<::: -x' ,', 
"'. ~:f: :' : 
.I.' 
,::: 
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IJI 
IJI 
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YANKEE EXPRESS FILLY ctd: 
Date 
Sampled 
13-11-73 
15-11-73 
17-11-73 
20-11-73 
22-11" 73 
24-11-73 
Day of 
Cycle or 
Pregnancy 
9 
RCLl1 
RCL13 
RCL16 
RCLl8 
RCL20 
TT4 
l1g/l00 ml 
3.10 
2.20 
3.36 
3.39 
2.88 
3.76 
TT3 
ng/l00 ml 
75.0 
56.5 
27.5 
44.5 
46.0 
66.5 
FSH 
ng/ml 
92.2 
90.0 
72 .1 
53.1 
31.5 
24,0 
LH 
ng/ml 
19.3 
24.1 
25.0 
19.7 
15.9 
17.7 , , " 
Progesterone 
ng/ml 
,', 
,',: 
9.9 
7.3 
5-.5 
2.7 
3.1 
2.1 
-:;: 
:1; 
;:: 
':' 
: ;~' 
\11 
\11 
......:J 
ZADIOS: 
Date Day of FSH 
Sampled Cycle or ng/ml 
Pregnancy 
26-10-73 60.1 
30-10-73 -16 23.7 
1-11-73 -14 35.3 
3-11-73 -12 42.9 
6-11-73 - 9 46.0 
8-11-73 - 7 58.5 
10-11- 73 - 5 
42.4 
54.5 
11-11-73 - 4 { 40.5 
32.3 
12-11-73 - 3 { 35.8 
33.1 
13-11-73 - 2 . { 22.3 
22.3 
14-11-73 - 1 { 2L6 
15.5 
15-11-73 0 { 21.5 
25.5 
16-11-73 P 1 { 24,4 
25.1 
-
LH 
ng/ml 
28.8 
12,4 
8.6 
7.5 
11,4 
11.6 
21.1 
23.0 
9.4 
22.4 
15.5 
32.9 
20.1 
25.6 
24.1 
27.1 
29.3 
35.0 
33.6 
50.4 
--
Progesterone 
ng/m1 
2,4 
4~1 
5.7 
5.5 
6.4 
3.7 
1.9 
0.9 
1.8 
0.1 
0.1 
0.1 
1.5 
2,4 
1.3 
1.9 
1.3 
1.3 
1.3 
1.5 
! 
j 
I 
I 
I 
I 
I 
I 
~: j: 
,::},::., 
::;::; 
J:;": 
\J1 
\J1 
OJ 
ZADIas ctd: 
Date Day of FSH 
Sampled Cycle or ng/ml 
Pregnancy 
17-11-73 P 2 { 3900 
4701 
18-11-73 P 3 { 43.0 
50.4 
20-11-73 P 5 73.3 
22-11-73 P 7 108.5 
24-11-73 P 9 72.4 
-- ~ ---- --- --- -- ~------
LH 
ng/ml 
41.9 
4004 
4000 
33.7 
30.3 
23.6 
13.8 
L- _ 
~ -- - - -
Progesterone 
ng/ml 
204 
205 
2.8 
5.8 
6.7 
6.1 
4.6 
- -- ---~ 
, 
\J1 
\J1 
\.0 
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APPENDIX 4: 
Thyroid Hormone Concentrations Throughout the 
19.10.73 
Horse 
Trix 
25,10.?3 
Trix 
26.10.73 
Aunt Ada 
Ba1enciaga 
Bye Bye Bill Filly 
Campesino 
Courtesy Ted10 
Donora 
Eb10uir 
Fury River 
Lordship Pi lly 
Maginness 
Mignon D'O'" 
Mini Budget 
Sister Stella 
Twinkle Hall 
Yankee Express 
Filly 
* 
* Sampling Period, Spring 1973 
TT4 TT3 
jJg/100 m1 ng/100 
3.62 -' -' J 50,0 
n 1 1 
,,' 
Mean 3.62 50.0 
2.59 47,0 
n 1 1 
Mean 2.59 47.0 
3,71 101.0 
2.91 97.5 
87,S 
3.09 92.0 
2.82 
61.0 
4.59 75.5 
4.14 38,S 
3.29 60.0 
92.0 
3.39 105.0 
2.61 98,5 
3,83 67.5 
2.83 88.0 
4,25 112.5 
n 12 14 
Mean 3.46 84.0 
SD 0.64 20.8 
See Footnote, page 572 
m1 
-'--'-:"-:.",. 
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APPENDIX 4 ctd: 
27.10.73 
Horse TT4 
TT3 
llg/100 ml ng/lOO ml 
~ .. - -.. '-,,~,~.~.~.~~.-~~.~--.~.~ .~~~~,.-~ ... --
, T:dx 2051 48,0 
n 1 1 
Mean 2051 4800 
,_ ...... 
28,10.13 
Trix L85 43 05 
n 1 1 
Mean 1.85 4305 
29,10. ?3 
Trix 1.63 5400 
n 1 1 
Mean 1.63 5400 
r-~ --"---.. ----.---~ 
30.10.73 
1------. ·w_ 
Aunt Ada :.: 0 31 73 0S 
Balenciaga 3020 103,5 
Bye Bye Bill Filly 61,3 
Campesino 1,97 77,0 
Courtesy Tedl0 3.60 
Donora 47 oS 
Eb10uir 4025 8200 
Fury River 2054 7705 
Lordship Filly 3,82 82,8 
Maginnes5 6500 
Mignon D'Or 3032 52,7 
Mini Budget 2,28 70.5 
Sister Stella 3042 121.0 
Trix 2090 53,3 
Twinkle Hall 2024 10000 
Yankee Express 
Filly 3,61 9205 
n 13 15 
Mean 3,03 77 03 
SD 0,71 20,6 
-
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APPENDIX 4 ctd: 
31.10.73 
Horse TT4 TT3 ).lg/100 m1 ng/100 m1 
Trix .1.90 44.9 
Courtesy Ted10 2.71 
Eb10uir 3.68 64.3 
Lordship Filly 2.74 46.1 
Yankee Express 
Filly 3.57 69.8 
n 5 4 
Mean 2.92 56.3 
SO 0,73 12.7 
1.11.73 
Trix 2.19 55.5 
Aunt Ada 2.80 102.5 
Ba1enciaga 4.40 107.5 
Bye Bye Bill Filly 132.5 
Campesino 2.01 99.5 
Courtesy Ted10 2.45 
Donora 81.0 
Eb10uir 4.03 75.5 
Fury River 4.72 110.0 
Lordship Filly 2.81 71. 3 
Maginness 108.5 
Mignon DIOr 3.86 96.0 
Mini Budget 3.23 110.0 
Sister Stella 3.25 81.5 
Twinkle Hall 1, 76 50.0 
Yankee Express 
Filly 3.75 107.5 
n 13 15 
Mean 3.17 92.6 
SD 0.94 22.8 
APPENDIX 4 ctd: 563 
2.11.73 
Horse TT4 
TT3 
llg/lOO ml ng/IOO m1 
Bye Bye Bill Filly 81.8 
Courtesy Tedlo 2.77 
Donora 45.3 
Eb10uir 4,60 81.0 i::. ' .. : :C'.' 
Lordship Filly 2,72 60,6 
Trix 2.24 47.0 
Yankee Express 
Filly 3.50 84.8 
n 5 6 
Mean 3.17 66.7 
SD 0,92 18.1 
3.11.73 
Aunt Ada 1.03 97.5 
Ba1enciaga 3.12 96.0 
Bye Bye Bill Filly 90,8 
Courtesy Tedlo 3,50 
Donora 74.5 
Eblouir 3.61 44.5 
Fury River 1.80 117.5 
Lordship Filly 3.57 84.4 
Maginness 69,0 
Mignon DIOr 3.68 68,0 
Mini Budget 2.67 80,S 
Trix 2.79 42.5 
Yankee Express 
Filly 4.21 54.3 
n 10 12 
Mean 3.00 76.6 
SD 0.96 22.5 
4.11.73 
Bye Bye Bill Filly 104,8 
Courtesy Ted10 3.36 
Donora 72.8 
564 
APPENDIX 4 ctd: 
Horse TT4 TT3 
llg/100 ml ng/l00 ml 
Lordship Filly 2.89 107.5 
Trix 2.64 57.5 
Yankee Express 
Filly 3.55 71.0 
n 4 5 
Mean 3.11 82.7 
SD 0.42 22.2 
5.11, ?3 
Bye Bye Bill Filly 86.5 
Courtesy Tedl0 3.55 
Donora 5'3.8 
Lordship Filly 2.44 57.S 
Sister Stella 4.94 114.0 
Trix 2.15 55.0 
Twinkle Hall 2.45 136.5 
Yankee Express 
Filly 3.68 57.3 
n 6 7 
Mean 3.20 80.1 
SD 1.06 33.5 
6.11.73 
Aunt Ada 2.15 119.0 
Balenciaga 3,13 80.0 
Bye Bye Bill Filly 72.3 
Campesino 1.60 81.2 
" 
Courtesy Tedl0 1. 82 
Donora 64.0 
Eblouir 3.55 91.0 
Fury River 2.36 72 .5 
Lordship Filly 1. 30 77.6 
Maginness 85.0 
Mignon DIOr 2.95 83.5 
Mini Budget 1. 83 67.5 
Yankee Express 
Filly 3.15 85.0 
,-
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Horse TT4 
TT3 
]..Ig/100 rn1 ng/100 rn1 
n 10 12 
Mean 2.38 81.6 
SD 0.77 14.2 
7.11.73 
Ba1enciaga 3.30 80.5 
Bye Bye Bill Filly 65.5 
Courtesy Ted10 1.66 
Lordship Filly 2.99 57.7 
Sister Stella 6.79 84.0 
Twinkle Hall 8.08 80.0 
Yankee Express 
Filly 3.67 52.5 
n 6 6 
Mean 4.42 70.0 
SD 2.47 13.3 
8.11.73 
Aunt Ada 2.51 124.5 
Ba1enciaga 4.86 61.0 
Bye Bye Bill Filly 87.5 
Carnpesino 1.72 80.0 
Courtesy Ted10 1.92 
Donora 55.0 
Eb10uir 3.00 63.0 
Fury River 2.61 87.0 
Lordship E lly 2.69 75.3 
Maginness 73.3 
Mignon D'Or 3.79 89.0 
Mini Budget 1.94 98.5 
Sister Stella 4.34 80.0 
Twinkle Hall 2.61 122.5 
Yankee Express 
Filly 2.95 66.5 
n 12 14 
Mean 2.91 83.1 
SD 0.97 21.0 
, -
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9.11.73 
Horse TT4 TT3 
llg/100 ml ng/l00 ml 
Balenciaga 3.14 55.6 
Maginness 76,5 
Mignon D'Or 4.13 83.9 
Sister Stella 2.90 48.4 
Trix 1. 31 56.5 
n 4 5 
Mean 2.87 64.2 
SO 1.17 15.2 
10,11.73 
Aunt Ada 4.58 90.0 
Balenciaga 2.84 
Bye Bye Bill Filly 79.0 
Campesino 2.57 91.5 
Courtesy Tedl0 2.24 
Donora 44.0 
Eblouir 3.76 52.5 
Fury River 3.25 132.0 
Lordship Filly 2.41 58.0 
Maginness 75.8 
Mignon D'Or 70.4 ., ........ ' ..... . 
Mini Budget 2.27 57.5 
Yankee Express 
Filly 3.80 45.0 
n 9 11 
Mean 3.08 72.3 
SO 0.82 25.8 
11.11.?3 
Maginness 78.0 
Mignon D'Or 3.74 68.8 
n 1 2 
Mean 3.74 73.4 
SO 6.5 
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12.11. ?3 
Horse TT4 TT3 
llg/100 m1 ng/100 m1 
-
Maginness 58.0 
Mignon D'Or 3,50 67.8 
Sister Stella 7.67 83.8 
I'-~' .' _. 
Twinkle Hall 2.43 81.0 
n 3 4 
Mean 4.53 72.7 
SD 2.77 12.0 
13.11.73 
Aunt Ada 1.11 97.5 
Ba1enciaga 1.42 93.0 
Bye Bye Bill Filly 107.8 
Campesino 2.44 70.3 
Courtesy Ted10 1. 39 
Donora 39.0 
Eb10uir 3.83 43.0 
Fury River 2.59 96.5 
Lordship Filly 2.02 58.5 
Maginness 97.5 
Mignon D'Or 77.5 
Mini Budget 2.49 73.0 
Trix 1. 41 45.0 
Yankee Express 
Filly ~.10 75.0 
n 10 13 
Mean 2.18 74.9 
SD 0.87 23.1 
14.11.73 
Campesino 1. 80 72.9 
Fury River 2.36 93.5 
Sister Stella 2.34 60.0 
Twinkle Hall 1. 28 93.0 
n 4 4 
Mean 1. 95 79.9 
SD 0.51 16.3 
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15.11.73 
Horse TT4 
TT3 
]Jg/IOO ml ng/IOO ml 
Aunt Ada 2.39 108.0 
Balenciaga 1.95 107.5 
Bye Bye Bill Filly 121.0 
Campesino 2.43 73.6 
Courtesy Tedlo 1. 85 
Donora 40.5 
Eblouir 4.14 78.0 
Fury River 2.52 65.0 
Lordship Filly 3.18 74,8 '-':<':<.> -. " .-. 
Maginness 62.0 
Mignon D'Or 3.61 72.5 
Mini Budget 1.80 86.5 
Yankee Express 
Filly 2.20 56.5 
n 10 12 
Mean 2.61 78.8 
SO 0.79 23.4 
16.11.73 
Aunt Ada 3.18 94.3 
Campesino 1.94 71.5 
Sister Stella 2.60 78.0 
Trix 1.63 54.0 
Twinkle Hall 3.45 57.0 
n 5 5 
Mean 2.56 71.0 
SO 0.78 16.4 
17.11.73 
Aunt Ada 3.16 75.5 
Balenciaga 1.14 58.0 
Bye Bye Bill Filly 56.0 
Campesino 2.07 57.5 
Courtesy Tedlo 2.01 
Donora 32.0 
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Horse TT4 
TT3 
]Jg/100 m1 ng/100 m1 
Eb10uir 3.80 35.0 
Fury River 3.20 95.0 
Lordship Filly 3.83 42.0 
Maginness 46.0 
r· 
Mignon D'Or 3.73 64.5 
Mini Budget 2.13 67.3 
Yankee Express 
Filly 3.35 27.5 
n 10 12 
Mean 2.84 54.7 
SD 0.94 19.6 
18.11.73 
Aunt Ada 5.80 114.5 
'- ~." : - -.- -.- -
Trix 1.13 53.5 
n 2 2 
Mean 3.47 84.0 
SD 3.30 43.1 
19.11.73 
Aunt Ada 3.58 80.5 
Sister Stella 2.13 72.0 
Twi nk 1 e Hall 6.82 70.0 
n 3 3 
Mean 4.18 74.7 
SD 2.40 5.6 
20.11.73 
Aunt Ada 3.66 84.0 
Ba1enciaga 1.53 76.5 
Bye Bye Bill Filly 38.0 
Campesino 1. 42 48.0 
Courtesy Ted10 1.49 
Donora· 19.0 
Eb10uir 2.95 33.0 
Fury River 2.31 115.0 
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Horse TT4 TT3 
flg/ 1OO m1 ng/100 m1 
Lordship Filly 3.98 51.5 
Maginness 42.0 
Mignon D'Dr 3.70 70.5 
Mini Budget 2.20 63.0 
Yankee Express 
Filly 3.39 44.5 
n 10 12 
Mean 2.66 57.1 
SO 1.00 26.2 
21.11.73 
Lordship Filly 4.84 46.1 
Sister Stella 3,29 76.2 
Twinkle Hall 1,68 62.0 
n 3 3 
Mean 3.27 61.4 
SO 1.58 15.1 
22,11,73 
Aunt Ada 2.41 66.0 
Ba1enciaga 1.95 SO,S 
Bye Bye Bill Filly 41.0 
Campesino 2.01 50.5 
Courtesy Ted10 1.46 
Donora 45.0 
Eb10uir 5.02 53.0 
Fury River 1.83 73.0 
Lordship Filly 3.46 54.4 
Maginness 76.5 
Mignon D'Dr 3.75 71.2 
Mini Budget 2.36 83.8 
Yankee Express 
Filly 2.88 46.0 
n 10 12 
Mean 2.71 59.2 
SO 1.09 14.1 
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. 
23.11.73 
Horse TT4 
TT3 
llg/IOO ml ng/IOO ml 
Lordship Filly 1. 87 36.5 
Mini Budget 2,24 72.8 
Twinkle Hall 1.88 57.0 
n 3 3 i,·---
Mean 2.00 55,4 
SD 0,21 18.2 
24.11.73 
Aunt Ada 3.55 65.0 
Balenciaga 2.38 34.5 
Bye Bye Bill Filly 52.0 
Campesino 1.49 • 60.0 
Courtesy Tedlo 1. 24 
Don0ra 47.5 
Eblouir 4.02 50.0 
Fury River 2.71 111.5 
Lordship Filly 1. 78 47.0 
Maginness 67.5 
Mignon DIOr 3,83 68.7 
Mini Budget 2.88 57.0 
Twinkle Hall 3,99 51.5 
Yankee Express 
Filly 3. 76 66.5 
n 11 13 
Mean 2.88 59.9 
SD 1. 04 18.4 
25.11.73 
Mini Budget 2.78 89.0 
n 1 1 
Mean 2.78 89.0 
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FOOTNOTE FOR APPENDIX 4: , 
Mean thyroid hormone concentrations according to date 
throughout the sampling period, where : 
TT4 :; total T4 
TT3 = total T3 
Mean TT4 = mean total T4 for that day 
Mean TT3 = mean total T3 for that day 
SD :;: standard deviation of the mean 
n = number of estimates contributing to the mean 
Note: Where a horse was sampled twice on the one day, the average 
of these two estimates was included in the calculation 
of the mean thyroid hormone concentrations for that day 
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APPENDlX 5: 
Thyroid Hormone Concentrations Throughout the 
* Oestrous Cycle and Early Pregnancy 
Day 0 (day of ovu Zation) 
Horse Date TT4 
Sampled llg/100 m1 
Aunt Ada 18ftl1-73 5.80 
Ba1enciaga 8-11-73 4.86 
Bye Bye Bill Filly 4-11-73 
C~mpesino 14-11-73 1.80 
Courtesy T~dlo 4-11-73 3.36 
Eb10uir 2-11-73 4.60 
Fury River 14-11-73 2.36 
Lordship Filly 4-11~ 73 2.89 
Lordship Filly 23-11-73 1. 87 
Mag:i.nness 11-11-73 
Mignon D'Or 11-11-73 3.74 
Sister Stella 7-11-73 6.79 
Trix 2-11-73 2.24 
Twinkle Hall 21-11-73 1.68 
Yankee Express 
Filly 4-11-73 3.55 
n 13 
Mean 3.50 
SD 1.6 
<-
Dab 1 
Aunt Ada 30-10-73 2.31 
Campesino 15-11-73 2.43 
Fury River 15-11-73 2.52 
Lordship Filly 5-11-73 2.44 
Mignon D'Or L~-11-73 5.50 
Mini Budget 6-11-73 1. 83 
* See Footnote, page 586 
i' 
TT3 
ng/100 ml 
114.5 
61.0 
104.8 
72.9 
81.0 
93.5 
107.5 
36.5 
78.0 
68.8 
84.0 
47.0 
62.0 
71.0 
14 
77,3 
22.5 
73.5 
73,6 
65.0 
57.5 
67.8 
67.5 
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Horse Date 
TT4 TT3 
Sampled llg/100 rn1 ng/100 rn1 
Trix 3-11-73 2.79 42.5 
Twinkle Hall 1~11-73 1. 76 50,0 
Yankee Express 
Filly 5~1l-73 3.68 57.3 -
n 9 9 
!, .. :, ... 
Mean 2.58 61.6 
SD 0.7 10,6 
Day 2 
Carnpesino 16-11-73 1.94 71.5 
Fury River 26-10-73 4.14 38.5 r". '_:-> .. 
Lordship Filly 6-ll~ 73 1. 30 77.6 
M~gnon D'Or 13-11-73 77.5 
Trix 4-11-73 2.64 57.5 
Yankee Express 
Filly 6-11-73 3.15 85.0 
n 5 6 
Mean 2.63 67.9 
SD 1.10 17.1 
Day 3 
Aunt Ada 1-11-73 2.80 102.5 
Carnpesino 17-11-73 2.07 57.5 
Fury River 17-11~73 3.20 95.0 
Lordship Filly 7-11-73 2.99 57.7 
Mini Budget 8-11-73 1. 94 98.5 
Trix 5-11-73 2.15 55.0 
Yankee Express 
Filly 7-11~73 3.67 52.5 
n 7 7 
Mean 2.69 74.1 
SD 0,7 23.1 
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Day 4 
Horse Date TT4 
TT3 
Sampled ]..lg/100 m1 ng/100 m1 
Lordship Fi 11y 8-11-73 2.69 75.3 
Mignon D'Or lS-11-73 3.61 72.5 
Yankee Express 
Filly 8-11-73 2.95 66.5 
n 3 3 
Mean 3.08 71.4 
SD 0.47 4.5 
Day [) 
Aunt Ada 3~11~ 73 1.03 97.5 
Mini Budget 10·11-73 2.27 57.5 
Twinkle Hall 5~11-73 2.45 136.5 
n 3 3 
Mean 1.92 97.2 
SD 0.77 39.5 
Day 6 ii, 
Campesino 20-11-73 1.42 48.0 
Fury River 30-10-73 2.54 77.5 
Fury River 20-11.73 2.31 115.0 
Lordship Filly 10-11-73 2.41 58.0 
Mignon D'Or 17-11-73 3.73 64.5 
Yan~ee Express 
Filly 10-11-73 3.80 45.0 
n 6 6 
Mean 2.70 68.0 
SD 0.91 25.9 
Day ? 
Trix 9-11-73 1. 31 56.5 
Twinkle Hall 7-11-73 8.08 80.0 
n 2 2 
Mean 4.70 68.3 
SO 4.79 16.6 
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c 4P. 
Day 8 through Day 20 (retainedeorpu$ luteum) 
Horse Date TT4 
TT3 
Sampled ]Jg/IOO ml ng/IOO ml 
Campesino 22-11-73 2.01 50.5 
Campesino 24~11-73 1.49 60,0 
Yankee Express 
Filly l3~11-73 3.10 75.0 
Yankee Express 
Filly 15-11-73 2.20 56.5 
Yankee Express 
Filly 17-11-73 3.36 27.5 
Yankee Express 
Filly 20-11-73 3.39 44.5 
Yankee Express 
Filly 22-11.73 2.88 46.0 
Yankee Express 
H11y 24-11-73 3.76 66.5 
n 2 2 
* Mean 2.44 54.0 
SD 0.97 1.8 
Day ... 14 and -15 
Fury River 1-11-73 4.72 110.0 
Fury RiVer 22-11-73 1. 83 73.0 
n 2 2 
Mean 3.28 91.5 
SD 2.04 26.2 
Day -13 
Balenciaga 26-10-73 2.91 97.5 
Campesino 1-11-73 2.01 99.5 
Fury River 24-11-73 2.71 111.5 
Mini Budget 13-11-73 2.49 73.0 
Twinkle Hall 8-11-73 2.61 122.5 
n 5 5 
Mean 2.55 100,8 
SD 0.34 18.5 
* Where a horse was sampled twice in one day the average of these 
two estimates was included in the calculation of the mean thyroid 
hormone concentrations for that day. 
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Day -22 
Horse Date 
TT4 TT3 
Sampled l1g/100 m1 ng/100 m1 
Aunt Ada 6-11-73 2.15 119.0 
Donora 26"10-73 61.0 
Maginness 30-10 .. 73 65.0 
M::j.gnon D'Or 20-11- 73 3.70 70.5 
Trix 13-11-73 1.41 45.0 
n 3 5 
Mean 2.42 72.1 
SD 1.17 27.9 
Day -11 
Fury River 3"11-73 1.80 117.5 
Min::j. Budget 15-11"73 1. 80 86,S 
n 2 2 
Mean 1.8 102,0 
SD 0.0 21.9 
pay -10 
Aunt Ada 8-11-73 2.51 124.5 
Lordship Fi 11y 13-11-73 2.02 58.5 
Maginness 1-11-73 108.5 
Mignon D'Or 22-11-73 3.75 71. 2 
n 3 4 
Mean 2.76 90.7 
SD 0,89 31.0 
Day -9 
Ba1enciaga 30-10-73 3.20 103.5 
Bye Bye Bill Filly 26-10-73 87.5 
CO\,lrtesy Ted10 26-10-73 2.82 
Lordship Fi 11y 26-10-73 3.29 60.0 
Mini Budget 17-11-73 2.13 67.3 
Trix 16-11-73 1.63 54.0 
Twinkle Hall 12-11-73 2.43 81.0 
Yankee Express 
Filly 26-10 .. 73 4.25 112.5 
t--> 
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Horse Date TT4 TT3 Sampled llg/100 m1 ng/100 m1 
n 7 7 
Mean 2.82 80.8 
SD 0.86 22,0 
Day -8 
Aunt Ada 10-11-73 4.58 90.0 
Ca.mpesino 6-11-73 1.60 81. 2 
Donora 30-10-73 47.5 
Fury River 6-11-73 2.36 72.5 
M",ginness 3-11-73 69,0 
Mignon D'Ol' 3-11-73 3.68 68.0 
Mignon D'Or 24-11-73 3.83 68.7 
Sister Stella 30-10-73 3.42 121.0 
Trix 25-10-73 2.59 47.0 
n 7 9 
Mean 3.15 73.9 
SD 1.02 22.5 
Dqy -'1 
Ba1enciaga 1-11-73 4.40 107.5 
Eb10uir 26-10-73 4.59 75.5 
Trix 18-11-73 1.13 53.5 
Twinkle Hall 14-11-73 1. 28 93.0 
n 4 4 
Mean 2.85 82.4 
SD 1.90 23.3 
Day -6 
Campesino 8-11-73 1.72 80.0 
Donora 1-11.73 81.0 
Fury River 8-11-73 2.61 87.0 
Lordship Filly 17-11-73 3.83 42.0 
Mini Budget 20-11-73 2.20 63.0 
Sister Stella 1-11-73 3.25 81.5 
Trix 27-10-73 2.51 48.0 
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Horse Date TT4 
TT3 
Sampled llg/100 m1 n~/100 ml 
n 6 7 
Mean 2.69 68.9 
SD 0.75 18.0 
I 
Day -5 
~ , ... : . 
Aunt Ada 13-11-73 1.11 97.5 
~l:llenctagl;l. 3-11-73 3,12 96.0 
Bye By~ Bill Filly 30- 1 0-73 61. 3 
CO\.fr~esy redlo 30-10-73 3.60 
Donora 2-11-73 45.3 
LQrdship Filly 30R10-73 3.82 82.8 
M~ginness 6-11-73 85,0 
MignQl1 D'Or 6-11-73 2.95 83.5 
Trix 28-10-73 1. 85 43.5 
Tw~nk1e Hall 16-11-73 3.45 57.0 
Twinkle Ha~l 26-10-73 2.83 88.0 
Yankee Express 
FiPY 30-10-73 3.61 92.5 
n 9 11 
Mean 2.93 75.7 
SO 0.90 20.1 
Day -4 
Campesino 10-11-73 2.57 91.5 
~ourtesy Ted10 31-10-73 2.71 
Donora 3-11-73 74.S 
Fury River 10-11-73 3.25 132.0 
Lordship Filly 31-10-73 2.74 46.1 
Min~ Budget 22-11-73 2.36 83.8 
Mini Budget 1-11-73 3.23 110.0 
Trix 29-10-73 1.63 54.0 
Yanl<e~ Express 
Filly 31-10-73 3.57 69.8 
n 8 8 
Mean 2.76 82.7 
SO 0.61 28.4 
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Day .,3 , . --
j:: ;=~~;::~:::::; -,.:::~; 
Hqrs~ Date TT4 TT3 Sampled llg/100 m1 ng/100 m1 
Aunt Ada 15-11-73 2.39 108.0 
~ye Bye Bill Filly 1-11-73 132,5 
Courte!?y 'f~q10 1.11 .. 73 2.45 
:--.-.:----:.;--<." 
Donora 4"11"7~ 72.8 
Eb10uir 30-10-73 4.25 82.0 
LordsJlip Filly 1-11-73 2.81 71. 3 
Lordship Filly 20-11-73 3.98 51.5 
Maginness 8 .. 11-73 73.3 
Mignon DIOr 8-11-73 3.79 89.0 
Mini Budg~t 23 .. 11 .. 73 2.24 72.8 
TlI'!X . 30-10-73 2.90 53.3 
Yankee J!X}lress 
Fill)" 1·11-73 3.75 107.5 
n 9 11 
Mean 3.17 83.1 
SD 0.77 24.5 
Day -2 
Aunt Ada 16-11 .. 73 3.18 94.3 
Ba1enciflrga 6-11-73 3.13 80,0 
Bye ~ye Bil~ Filly 2-11-73 81. 8 
Courtesy Tedl0 2-11-73 2.77 
Donora 5-11-73 53.8 
Eb10Ulr 31-10-73 3.68 64.3 
Lordship Filly 2·11-73 2.72 60.6 
Lordship Filly 21-11.73 4.84 46.1 
Maginness 9-11-73 76.5 
Mignon DIOr 9-11-73 4.13 83.9 
Mini Budget 3-11-73 2.67 80.5 
Mini Budget 24-11-73 2.88 57.0 
Sister St~lla 5-11-73 4.94 114.0 
Trix 31-10-73 1. 90 44.9 
Twinkle Hall 19-11-73 6.82 70.0 
Yankee Expre:;15 
Filly 2-11-73 3,50 84.8 
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HOllse Date Sampled 
Day ... 1 
I 
Aunt Ada 17-11-73 
~alenciaga 7.11~73 
~ye Bye Bill Filly 3-11-73 
CaJllpesino 13-11-73 
CQurtesy redIa 3-11-73 
Dono1"a 6-11-73 
EblQuir 1-11-73 
FUfY Rlv,r 13~11-73 
Lordship Filly 3-11-73 
LQrdship Filly 22-11-73 
Magifmess 10-11-73 
Mignon D'Or 10-11-73 
Mi~i Budget 25~11-73 
Trix 1-11-73 
Twink1(:) Hall 30-10-73 
Yankee Express 
Filly 3-11-73 
P! 
Aunt Ada 19-11-73 
~alenciaga 9-11-73 
Bye aye Sill Filly 5-11-73 
Courtesy Tedlo 5-11-73 
Donora 8-11-73 
Eb1ouil" 3-11-73 
LOl'~ship Filly 24-11-73 
Milginness 12-11-73 
Si~ter Slella 8-11-73 
'I 
581 
TT4 
]Jg/100 m1 
13 
Mean 3.63 
SD 1. 30 
3.16 
3.30 
2.44 
3.50 
4.03 
2.59 
3.57 
3.46 
2.78 
2.19 
2.24 
4.21 
n 12 
Mean 3.12 
SD 0.68 
3,58 
3.14 
3.55 
3.61 
1. 78 
4.34 
TT3 
ng/100 m1 
15 
72.8 
18.8 
75.5 
80.5 
90.8 
70,3 
64.0 
75,5 
96.5 
84.4 
54.4 
75.8 
70.4 
89.0 
55.5 
100.0 
54.3 
15 
75.8 
14.7 
80.5 
55.6 
86.5 
55.0 
44.5 
47.0 
58.0 
80.0 
1 "., 
I, 
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Horse Date TT4 TT3 Sampled llg/100 m1 ng/100 m1 
n 6 8 
Mean 3.33 63.4 
SD 0.85 16.4 
P2 
Aunt Ada" 20-11-73 3.66 84.0 
Ba1enciaga 10-11-73 2.84 
Bye Bye Bill Filly 6-11-73 72.3 
COllrtesy Ted10 6-11-73 1.82 
Maginness 13-11-73 97.5 
Sister Stella 9-11-73 2.90 48.4 
Twinkle Hall 23-11-73 1. 88 57,0 
n 5 5 
Mean 2.62 71. 8 
SD 0.77 19.9 
P3 
Bye Bye Bill Filly 7-11-73 65.5 
Courtesy Ted10 7-11-73 1.66 
Donora 10-11-73 44.0 
Twinkle Hall 24-11-73 3.99 51.5 
n 2 3 
Mean 2.83 53.7 
SD 1.65 10,9 
P4 
Aunt Ada 22-11-73 2.41 66.0 
Bye Bye Bill Filly 8-11-73 87,S 
Courtesy Ted10 8-11-73 1. 92 
Eb10uir 6-11-73 3.55 91.0 
Maginness 15-11-73 62.0 
n 3 4 
Mean 2.63 76.6 
SD 0.84 14.7 
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P5 
Horse Date TT4 TT3 Sampled llg/100 ml ng/100 m1 
Ba1enciaga 13-11.73 1.42 93.0 
Sister Stella 12-11-73 7.67 83.8 
n 2 2 
Mean 4.55 88.4 
SD 4.42 6.5 
P6 
Aunt Ada 24-11-73 3.55 65.0 
Bye Bye Bill Filly 10-11-73 79.0 
Courtesy Tedl0 10-11-73 2.24 
Donora 13-11-73 39.0 
Eblouir 8-11-73 3.00 63.0 
Maginness 17-11-73 46.0 
n 3 5 
Mean 2.93 58.4 
SD 0,66 16.0 
P? 
Sa1enciaga 15-11-73 1.95 107.5 
Sister Stella 14-11.73 2.34 60.0 
n 2 2 
Mean 2.15 83.8 
SD 0,28 33.6 
PB 
Donora 15-11-73 40.5 
Eb10uir 10-11-73 3.76 52.5 
n 1 2 
Mean 3.76 46.5 
SD 8.5 
P9 
Balenciaga 17-11-73 1.14 58.0 
Bye Bye Bill Filly 13-11-73 107.8 
Courtesy Ted10 13-11.73 1. 39 
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Horse Date TT4 TT3 Sampled llg/100 m1 ng/lUO m1 
Maginness 20 .. 11-73 42.0 
Sister Stel1a 16-11-73 2.60 78.0 
n 3 4 
Mean 1.71 71.5 
SD 0.78 28.4 
P10 
Donora 17-11~ 73 32.0 
n 1 
Mean 32.0 
Pll 
Bye Bye Bill Filly 15-11-73 121.0 
Courtesy Ted10 15-11-73 1. 85 
Eb10uir 13-11-73 3.83 43.0 
Maginness 22-11-73 76.5 
n 2 3 
Mean 2,84 80.2 
SD 1.40 39,1 
P12 
Ba1enciaga 20-11-73 1.53 76.5 
Sister Stella 19-11-73 2.13 72.0 
n 2 3 
Mean 1.83 74.3 
SD 0.42 3.2 
P13 
Bye Bye Bill Filly 17-n-73 56.0 
Courtesy Ted10 17-11-73 2.01 
Eb10uir 15-11-73 4.14 78.0 
Donora 20-11-73 19.0 
Maginness 24-11-73 67.5 
n 2 4 
Mean 3.08 55.1 
SD 1. 51 25.7 
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P14 
Horse Date 
TT4 TT3 
Sampled llg/100 m1 ng/100 m1 
Ba1enciaga 22-11-73 1.95 50.5 
S~ster Stella 21-11-73 3.29 76.2 
n 2 2 
Mean 2.62 63.4 
SD 0.95 18.2 
P15 
Eb10uir 17-11-73 3.80 35.0 
Don0r~ 22-11-73 45.0 
n 1 2 
Mean 3.80 40.0 
SD 7.0 
P16 
Ba1enciaga 24-11-73 2.38 34.5 
Bye Bye Bill Filly 20-11-73 38.0 
Courtesy Ted10 20-11-73 1.49 
n 2 2 
Mean 1. 94 36.3 
SD 0.63 2.5 
Pl? 
Donora 24-11-73 47.5 
n 1 
Mean 47.5 
P18 
Bye Bye Bill Filly 22-11-73 41.0 
Courtesy Ted10 22-11.73 1.46 
Eb10uir 20-11-73 2.95 33.0 
n 2 2 
Mean 2.21 37.0 
SD 1.05 5.7 
.. 
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APPENDIX 5 ctd: 
P20 
Horse Date TT4 TT3 Sampled llg/IOO ml ng/lOO ml 
Bye Bye Bill Filly 24-11-73 52.0 
Courtesy Tedlo 24-11-73 1. 24 
Eblouir 22-11.,. 73 5.02 53.0 
n 2 2 
Mean 3.13 52.4 
SD 2.67 0.7 
P22 
Eblouir 24-11-73 4.02 50.0 
n 1 1 
Mean 4.02 50.0 
Footnote: Day of Cycle or Prengancy: Positive numbers refer to 
number of days after ovulation, whereas negative 
numbers refer to the number of days prior to the next 
ovulation (designated a posteriori) and the number of 
days into pregnancy prefixed by P. 
SD = standard deviation of the mean 
n = number of sample estimates contributing to the mean 
TT4 = Total T4 
TT3 = Total T3 
Where a horse was sampled twice in one day the average 
of these two estimates was included in the calculation 
of the mean thyroid hormone concentrations for that day. 
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APPENDIX 6: 
Serum Concentrations of FSH, LH, Oestradiol-l78 and 
Progesterone in Cycling and Early Pregnant Mares, 
Spring 1974 
Note: Results are shown for each mare according to the day of 
the oestrous cycle or pregnancy, where: 
day 0 = day of ovulation 
-ve numbers refer to days prior to ovulation 
+ve numbers refer to days after ovulation 
+ve numbers prefixed by P = days of pregnancy 
Serum concentrations of hormones expressed as : 
ng/ml Nuti equine FSH (see Chapter III) 
ng/ml Hartree equine LH (see Chapter III) 
pg/ml oestradiol-178 
ng/ml progesterone 
APPENDIX 6 ctd: DREAMY MeLODY 
Day 6-£ FSH LH Progesterone Oestradiol-17S 
Cycle ng/ml ng/ml ng/ml ng/ml 
-1 8,49 22,0 
0 11,5 0,64 19,0 
1 9,27 0,91 15,3 
2 9,51 2,32 14,1 
3 14,5 3.95 8,1 
4 15,3 65.3 5.15 6,3 
5 16,6 58.5 7,95 
-14 16.1 59,2 9.07 5,2 
-13 14,7 78,2 11.2 8.0 
-12 8.49 71.2 8.93 10.3 
-11 14.4 91.5 8,13 12.0 
-10 6,69 41,8 6,40 11. 7 
-9 5.21 10,5 9,33 6.2 
- - - - - ---
* Ovarian palpations described as in Table 36 
Ovaries* 
L:3xl,S, 
R:Fol1-6~ vs 
L:S + H 
R : Fa 11- 7, vs 
L:5 + H 
R :Foll-coll 
L:3xLS 
R:Area-coll 
L:2xl, irreg 
R:Area-coll 
L:5 + H 
R:Area-coll 
L:5 + H 
R:Area-2, s 
L:5 + H 
R:Area-1.5, s 
L:5 + H 
R~Area-1. 5, s 
L:5 + H 
R:Area-1, vs 
L:5 + H 
R:Area-1.7, s 
L:S + H 
R:Area-L3, s 
Behaviour 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus? 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
:.:-
:::: ,. 
:< 
' .. 
I 
\J1 
OJ 
OJ 
APPENDIX 6 ctd: DREAMY MELODY 
Day of FSH LH Progesterone Oestradiol-17i3 
Cycle ng/m ng/ml' ng/ml ng/m1 
-8 5,01 38,7 6,11 9,5 
... 
-I 4,60 74,7 7,36 10,3 
-6 3,33 47,8 3,07 10,6 
-5 2,77 52,0 0,20 12,3 
-4 1. 76 77,6 0,37 11.2 
-3 1.03 74,1 0040 11.0 
-2 1. 32 63,1 0.29 12.5 
-1 2,16 93.2 0.29 17,4 
0 5.99 182,1 0,13 15.5 
1 1.94 56.5 0.65 10.6 
2 1.22 456.7 1.01 
3 8.56 434.1 1.81 
4 7,80 366,9 3041 
5 12,3 498 0 5 4,35 
6 15,0 349 0 6 
* Ovarian palpations described as in Table 36 
Ovaries'k 
L:S + H 
R: 2xArea-0 ,5" s; 005, s 
L:Area-O,5,s 
R:Foll?-2,s 
L:8 + H 
R:Foll-1.5, sh 
L:Area-1, 5 
R:Foll-2, s 
L:Foll ?-I, fh, 
R:Foll-1. 5, sh 
L:8 + H 
R:2xFoII-I.5, 5; 1, 5 
L:8 + H 
R:2xFoII-3, 5; 1, sh 
L:Area-I, s 
R:Foll-3,5, s 
L:8 + H 
R:Foll-6, s 
L:8 + H 
R:Foll-2, colI 
L:2xl, H 
R:FoIl-I.5, 5, colI 
L:8 + H 
R: FoIl-I, colI 
L:8 + H 
R:Area-I, s 
L:5 + H 
R:Area-1, s 
Behaviour 
Not on 
Not on 
Not on 
In oestrus? 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
Not on 
Not on 
--
i 
, 
, 
I 
I 
I 
\J1 
CO 
'" 
APPENDIX6·CTD: FALSE 
Day of 
Cycle or FSH Oestradiol-17S 
Pregnancy ng/ml pg/m1 
.13 7.96 9.4 
-12 18.1 9.0 
wll 9.31 10.8 
-10 16.5 8.3 
.9 10.6 9.7 
-8 12.1 8.0 
.. 7 11.6 8.3 
-6 11.3 11.9 
-5 11.0 10.8 
-4 14.4 12.3 
-3 8.34 28.9 
-2 7.74 34.8 
-1 12.1 19.7 
0 10.6 32.1 
PI 10.3 11.2 
P2 1604 12.6 
P3 12.6 10.7 
P4 9.84 13.9 
P5 9.68 15.7 
P6 6.65 16.6 
P7 13.8 13.5 
P8 15.3 16.8 
P9 22.5 19.4 
PI0 18.3 17.4 
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Ovaries* 
L:S + H 
R:S + H 
L:Foll-0.5, £h 
R:S + H 
L:Fo11-1, £h 
R:S + H 
L:Fo11-1.5, sh 
R:S + H 
L:Fol1-2.7, sh 
R:S + H 
L:Fol1-3, sh 
R:S + H 
L :Fol1-4. 3, s 
R:S + H 
L:Foll-4, s 
R:Fo11-1, fh 
L:Foll-coll 
R:Fo11-1, s 
L:Area-2, vs 
R :Foll-l, s 
L:Area-2, vs 
R:Fo11-0.S, s 
L:Area-1.5, rubbery 
R:S + H 
L:Area-1.5, rubbery 
R:S + H 
L:Area-LS, rubbery 
R:S + H 
L:Area-1.5, rubbery 
R:S + H 
Behaviour 
In oestrus 
In oestrus 
In oestrus 
In oestrus 
mated 
Not on 
Not on 
Not on 
,- .,_.-
",.-,"" 
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APPENDIX6ctd: FALSE 
\ 
Day of 
Cycle or FSH Oestradiol-178 Ovaries * Behaviour 
Pregnancy ng/ml ng/ml 
PI: 14.6 9.7 Not on 
P12 17.4 9.9 L:Foll?-l.S~ sh 
R:S + H Not on 
P13 9.34 10.1 -
P14 8.21 9.7 L:Foll?-l.S, sh 
Area-O.S, rubbery 
R:S + H 
* Ovarian palpations described as in Table 36 
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APPENDIX 6·CTD: PRENTICE 
Day of FSH Oestradiol-17B Ovaries* Behaviour 
Cycle ng/m1 ng/m1 
.7 8.74 L:Foll-1, sh 
R:S + H Not on 
-6 9.04 L:Foll-l.s, s 
R:S + H Not on 
Ms 6,74 L:Foll-2, s 
R:S + H Not on 
~4 L:Foll-1.s, s 
R:S + H Not on 
-3 10.8 L :Foll-2, s 
R:S + H Not on 
-2 13.3 L:Foll-1.s, sh 
R:S + H In oestrus 
.. 1 12.1 L:Foll-2 • s 
R:S + H In oestrus 
a 15.4 L:Foll-coll 
R:S + H In oestrus 
1 13.6 Not on 
2 8.46 L:Foll-1. fh 
R:S + H Not on 
3 8.35 Not on 
4 6.12 Not on 
S So 74 L:Area-1.5, sh 
R:S + H Not on 
~14 21.3 Not on 
-13 14 0 3 L:Foll-0.5. fh 
R:S + H Not on 
-12 27.0 L:Foll-l.s, sh 
R:S + H Not on 
-11 32.4 L:Foll-l.s, sh 
R:S + H Not on 
-10 32.3 L:Foll-1.s. s 
R:S + H Not on 
-9 26.3 L:Foll-l. 3, s 
R:S + H 
-8 10.9 Not on 
-7 20.7 L:Foll-1, vs 
R:S + H Not on 
-6 17.6 7.0 Not on 
-5 15.0 2.6 L: 2xFoll, l,sh; 
0.5, fh 
R:S + H Not on 
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APPENDIX "0 " ctd: PRENTICE 
Day of FSH Oestradio1ft178 Ovaries Behaviour 
Cycle ng/m1 ng/m1 
"4 18.9 14.6 Not on 
-3 12.4 L:Foll-1.5, s 
R:S + H In oestrus 
A2 19.9 9.7 L :Foll-1. 7. s 
R:S + H In oestrus 
-1 35 03 5 08 L:Foll-1.S, vs 
R:S + H In oestrus 
0 21.3 6.3 L:Foll-coll 
R:S + H In oestrus 
1 32.1 7.1 L:Area-1, sh 
R:S + H In oestrus 
2 22.0 15.1 Not on 
3 13.4 10.7 L:Area-l05, s 
R:S + H Not on 
4 12.7 5.2 L:Area-1 05, sh 
R:S + H Not on 
5 20.3 6.7 Not on 
*' Ovarian palpations described as in Table 36 
APPENDIX 6 ctd: TRUDYS BYE BYE 
Day of 
Cycle or FSH LH Progesterone Oestradiol-17B 
Pregnancy nQ"/ml ng/m1 ng/ml pgiml 
-1 9.46 39.4 0.1 20.0 
0 11.2 51.9 001 
1 9.99 57.2 0.1 508 
2 9.16 60.7 0.67 
3 205.8 
4 5.46 2.45 3.2 
5 17.0 52.4 5.47 3.9 
-13 13.4 34.7 8.75 4.8 
-12 11. 2 43.3 11.1 
-11 12.8 24.5 9.87 10.3 
-10 1106 21. 7 10.5 
-9 7.36 30.5 8.80 7.42 
-8 6.95 16.0 8.00 
-7 5.37 22.2 8.80 8.39 
-6 8.70 28.2 9.12 
-5 10.8 40.1 4.32 10.0 
,.' 
-
,. 
Ovarian palpations described in Table 36 
Ovaries" 
L:Foll-3. s 
R:S + H 
L :Foll-coll 
R:S + H 
L:S + H 
R:S + H 
L: 
R:S + H 
L :Foll-0.5, vs 
R:S + H 
L:Area-1, sh 
R:S + H 
L:S + H 
R:S + H 
L:S + H 
R:S + H 
L:2x1. irreg 
R:S + H 
L:2xFol1, 1, f; 1.5, f 
R:S + H 
Behaviour 
" In oestrus 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
Not on 
I 
\J1 
\.0 
~ 
APPENDIX 6 ctd: TRUDYS BYE BYE 
Day of 
Cycle or FSH LH Progesterone Oestradiol-178 
Pregnancy ng/m1 ng/ml ng/m1 pg/ml 
-4 8049 50.7 0.82 
-3 6.72 32.5 0.4 11,6 
-2 4.53 53.2 0.99 18.1 
-1 6.0 114.2 0.53 13.5 
0 10.8 160.8 0.48 5.81 
PI 11.8 321.4 0.92 
P2 12.2 299.9 1.28 8.04 
P3 7.30 140.9 4.53 
P4 9.98" 103.1 4.67 6045 
P5 16.6 135.8 6.08 
* Ovarian palpations described as in Table 36 
OV1.ries* . 
L :Fol1-3.5, s 
R:S + H 
L : Fall-call 
R:S + H 
- '. 
Behaviour 
In oestrus 
In oestrus 
In oestrus 
Not on 
Not on 
Not on 
Not on 
I 
IJl 
--0 
IJl 
